Citrus Sinensis ID: 005519
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 692 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.930 | 0.757 | 0.444 | 1e-157 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.923 | 0.754 | 0.433 | 1e-153 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.878 | 0.776 | 0.432 | 1e-152 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.924 | 0.759 | 0.436 | 1e-151 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.916 | 0.761 | 0.438 | 1e-150 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.927 | 0.749 | 0.430 | 1e-148 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.946 | 0.771 | 0.423 | 1e-145 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.919 | 0.752 | 0.425 | 1e-142 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.920 | 0.746 | 0.417 | 1e-136 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.906 | 0.744 | 0.409 | 1e-134 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 556 bits (1433), Expect = e-157, Method: Compositional matrix adjust.
Identities = 302/679 (44%), Positives = 429/679 (63%), Gaps = 35/679 (5%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVA 93
+S++A+TL+ + I T+VSP FELGFF PG Y+GIWY+ I T VWVA
Sbjct: 25 YSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVA 84
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNP-VAQLLDNGNLVIRDN 151
NR++P+ G L +S+ NLV+L+QS+ +WS+N++ +V++P VA+LLDNGN V+RD+
Sbjct: 85 NRDTPLSSSIGTLKISD-SNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDS 143
Query: 152 SGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIH 211
S + + LWQSFD+PTDT+L MKLGWD +TG R+ SWKS DDPS G+F+ +L+
Sbjct: 144 KNS-APDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202
Query: 212 VLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKDEVYYMYESYSSPII 270
P++ ++N ++ +GPWNG+ F P F + +K+EV Y + S +
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVY 262
Query: 271 MILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGF 329
L ++ G +QR W E + W F+ AP C Y +CG C + + C C++GF
Sbjct: 263 SRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGF 322
Query: 330 KFKSQQ-------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAEC 382
K ++ Q + CVR C GD F +L +KLPD S++ + +KECE +C
Sbjct: 323 KPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKC 382
Query: 383 LKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNKKLLWI 442
L++C+C A+AN+ + GSGC+ W G+L D++ + G +Y+R+ A++ +K+
Sbjct: 383 LRDCNCTAFANTDIRGSGSGCVTWTGELFDIR--NYAKGGQDLYVRLAATDLEDKRNRSA 440
Query: 443 IVI---LVLPLVILPCVYIARQWSRKRKEN---ETKNLD---TNQDLLAFDVNMGITTRT 493
+I + + +++L I W RK+K + ET +D ++DLL +V I++R
Sbjct: 441 KIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVV--ISSRR 498
Query: 494 NEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVA 553
+ E + D D LPL F V AT NFS +KLG+GGFG VYKG+LL+GQE+A
Sbjct: 499 HISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMA 552
Query: 554 VKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF 613
VKRLS S QG EFKNE+ LIA+LQH NLVRLL CC++ GEK+LIYEY+ N SLD LF
Sbjct: 553 VKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLF 612
Query: 614 DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
D ++ L WQ+R II+GIA+GLLYLHQ SR RIIHRDLKASNILLD++M PKISDFGM
Sbjct: 613 DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGM 672
Query: 674 ARMFGGDELQGNTKRIVGT 692
AR+FG DE + NT+++VGT
Sbjct: 673 ARIFGRDETEANTRKVVGT 691
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 542 bits (1396), Expect = e-153, Method: Compositional matrix adjust.
Identities = 296/683 (43%), Positives = 424/683 (62%), Gaps = 44/683 (6%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWVA 93
FS+ A + T I +T++SPSQ FELGFF+P S Y+GIWY+ IP T VWVA
Sbjct: 23 FSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVA 82
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA-QLLDNGNLVIRDN 151
NR++P+ NG L +S+ NLV+ +QS+ +WS+N++ +V++PVA +LLD GN V+RD
Sbjct: 83 NRDNPLSSSNGTLKISD-NNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD- 140
Query: 152 SGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTG-LERYQTSWKSADDPSPGNFTHRLDI 210
S +N +LWQSFD+PTDT+L MK+GWD ++G R SWK+ DDPS G+F+ +L
Sbjct: 141 SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRT 200
Query: 211 HVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI------VVQNKDEVYYMYES 264
P+ +YN + +GPW G F S P +P+ +N +V Y Y
Sbjct: 201 SGFPEFYIYNKESITYRSGPWLGNRFSSVPG-----MKPVDYIDNSFTENNQQVVYSYRV 255
Query: 265 YSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHC 323
+ I IL ++ G +QRL W E + W+ + +P C +Y +CG C + + C
Sbjct: 256 NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPIC 315
Query: 324 ECLEGFKFKSQQNQT------CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKE 377
C++GF+ ++Q CVR C D F +L ++LPD + S+++ + LKE
Sbjct: 316 NCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKE 375
Query: 378 CEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNK 437
CE CLK C+C A+AN+ + +GGSGC++W G L D++ + G +Y+RV A + +K
Sbjct: 376 CEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIR--NYAKGGQDLYVRVAAGDLEDK 433
Query: 438 KLLWIIVI---LVLPLVILPCVYIARQWSRKRKENET-----KNLDTNQDLLAFDVNMGI 489
++ +I + + +++L I W RK+K + T +L +QD L ++
Sbjct: 434 RIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKAS 493
Query: 490 TTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNG 549
+ T++ ++K+ LPL + ++ AT NFS +KLG+GGFG VYKG LL+G
Sbjct: 494 RSYTSK--------ENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDG 545
Query: 550 QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609
+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LIYEY+ N SLD
Sbjct: 546 KEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLD 605
Query: 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669
LFD T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+LLD++M PKIS
Sbjct: 606 SHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKIS 665
Query: 670 DFGMARMFGGDELQGNTKRIVGT 692
DFGMAR+FG +E + NT+R+VGT
Sbjct: 666 DFGMARIFGREETEANTRRVVGT 688
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 540 bits (1390), Expect = e-152, Method: Compositional matrix adjust.
Identities = 297/687 (43%), Positives = 410/687 (59%), Gaps = 79/687 (11%)
Query: 24 NIFSSLI--FYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIW 81
N+ LI + I + A D L ++DG+T+VS FE+GFFSPG S+NRY+GIW
Sbjct: 5 NVLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIW 64
Query: 82 YQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNV-----SREVKN 135
Y++I TVVWVANR+SP+ D +G L VS G+L L N N IWSS+ ++N
Sbjct: 65 YKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRN 124
Query: 136 PVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKS 195
P+ Q+LD GNLV+R NSG + + Y+WQS DYP D L GMK G + TGL R+ TSW++
Sbjct: 125 PIVQILDTGNLVVR-NSGDD--QDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRA 181
Query: 196 ADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQN 254
DDPS GN+T+++D + +PQ + S TGPWNG+ F P+ I++ V
Sbjct: 182 IDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFT 241
Query: 255 KDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNS 313
++EVYY Y+ + ++ +++NP G +QR W + W + +A C Y CG
Sbjct: 242 EEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYG 301
Query: 314 ICSVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSG-DRFKKLDDIKLPDLL 365
C+++++ C CL+GF K+ Q ++ CVR DC G D F K+ +KLPD
Sbjct: 302 SCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTR 361
Query: 366 DVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSI 425
+++M+L EC+ CL+NC+C AY+ + DGG GC++WFGDLID+++ + NG +
Sbjct: 362 TSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNE--NGQDL 419
Query: 426 YIRVPASEQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDV 485
Y+R+ +SE + R+ SR
Sbjct: 420 YVRLASSE---------------------IETLQRESSR--------------------- 437
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
+++R E +D LP +V+ AT FS +KLG+GGFGPVYKG
Sbjct: 438 ---VSSRKQE-----------EEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGT 483
Query: 546 LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605
L GQEVAVKRLS S QG++EFKNE+ LIAKLQHRNLV++LG C+++ E++LIYEY N
Sbjct: 484 LACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPN 543
Query: 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665
KSLD F+FD ++ L W RV II GIA+G+LYLH+ SRLRIIHRDLKASN+LLD MN
Sbjct: 544 KSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMN 603
Query: 666 PKISDFGMARMFGGDELQGNTKRIVGT 692
KISDFG+AR GGDE + NT R+VGT
Sbjct: 604 AKISDFGLARTLGGDETEANTTRVVGT 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 535 bits (1377), Expect = e-151, Method: Compositional matrix adjust.
Identities = 296/678 (43%), Positives = 424/678 (62%), Gaps = 38/678 (5%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWVA 93
FS++ +TL+ T I +T++SPSQ FELGFF+P S Y+GIWY+ IP T VWVA
Sbjct: 23 FSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVA 82
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA-QLLDNGNLVIRDN 151
NR++P+ NG L +S NLV+ +QS+ +WS+N++ +V++PVA +LLDNGN ++RD
Sbjct: 83 NRDNPLSSSNGTLKISG-NNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD- 140
Query: 152 SGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIH 211
S LWQSFD+PTDT+L MKLGWD +TG R SWK+ DDPS G F+ +L+
Sbjct: 141 ----SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETS 196
Query: 212 VLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKDEVYYMYESYSSPII 270
P+ + + + +GPWNG+ F S P + +K+EV Y Y + +
Sbjct: 197 EFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLY 256
Query: 271 MILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGF 329
L +N G +QRL W E + W+ + +P C +Y CG C + +C C++GF
Sbjct: 257 SRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGF 316
Query: 330 KFKSQQ-------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAEC 382
K ++Q + C+R C D F +L +KLPD ++ + LK C+ C
Sbjct: 317 KPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERC 376
Query: 383 LKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNKKLLWI 442
L++C+C A+AN+ + +GGSGC++W +++D++ + G +Y+R+ A+E +K++
Sbjct: 377 LEDCNCTAFANADIRNGGSGCVIWTREILDMR--NYAKGGQDLYVRLAAAELEDKRIKNE 434
Query: 443 IVI---LVLPLVILPCVYIARQWSRKRKEN---ETKNLDT--NQDLLAFDVNMGITTRTN 494
+I + + +++L I W RK+K + +T N+D +QD L DV + T+
Sbjct: 435 KIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTS 494
Query: 495 EFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAV 554
+ + KS+ LPL ++ AT NFS +KLG+GGFG VYKGRLL+G+E+AV
Sbjct: 495 K--------EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAV 546
Query: 555 KRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD 614
KRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LIYEY+ N SLD LFD
Sbjct: 547 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 606
Query: 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+LLD++M PKISDFGMA
Sbjct: 607 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 666
Query: 675 RMFGGDELQGNTKRIVGT 692
R+FG +E + NT+R+VGT
Sbjct: 667 RIFGREETEANTRRVVGT 684
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 533 bits (1372), Expect = e-150, Method: Compositional matrix adjust.
Identities = 300/684 (43%), Positives = 405/684 (59%), Gaps = 50/684 (7%)
Query: 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVANRNS 97
++ DT+ +RDGE ++S +RF GFFS G S+ RYVGIWY QI T+VWVANR+
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 98 PIVDKNGVLTVSNRGNLVLLNQSNGT--IWSSNVSREVKNP--VAQLLDNGNLVIRDNSG 153
PI D +G++ SNRGNL + N T IWS+NVS + P VA L D GNLV+ D
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 154 SNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVL 213
S W+SFD+PTDT L M+LG+ + GL+R TSWKS DP G+ R++
Sbjct: 137 GRS----FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 214 PQVCVYNGSAKYTCTGPWNGVAFGSAPSNTT-FIFQPIVVQNKDEVYYMYESYSSPIIMI 272
PQ+ +Y G + G W G + P +IF V N+DEV + Y + +I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 273 LRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSV--DQTSHCECLEGF 329
VN G + R W W F++ P C +Y CGPN C +T C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 330 K-------FKSQQNQTCVRS-HSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAE 381
+ F + C + +S C D F KL +K+PD D S++ ++ LKEC+
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQR 372
Query: 382 CLKNCSCRAYANS--KVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASE------ 433
CLKNCSC AYA++ + G GCL W G ++D + N +G YIRV E
Sbjct: 373 CLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVDKEELARWNR 430
Query: 434 ---QGNKKLLWIIVILVLPLVILPCVY--IARQWSRKRKENETKNLDTNQDLLAFDVNMG 488
G +++L I++ L+ +++L + + R+ +RK N ++ N + FD
Sbjct: 431 NGLSGKRRVLLILISLIAAVMLLTVILFCVVRE---RRKSNRHRSSSANFAPVPFD---- 483
Query: 489 ITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLN 548
F E+ +DK+++ LPLF ++ AAT NFS Q+KLG GGFGPVYKG L N
Sbjct: 484 -------FDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQN 536
Query: 549 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608
E+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCC+E EK+L+YEY+ NKSL
Sbjct: 537 RMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSL 596
Query: 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668
D F+F ++ L W R+ I+ GIA+G+LYLHQ SRLRIIHRDLKASNILLD M PKI
Sbjct: 597 DYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKI 656
Query: 669 SDFGMARMFGGDELQGNTKRIVGT 692
SDFGMAR+FGG++++G T R+VGT
Sbjct: 657 SDFGMARIFGGNQMEGCTSRVVGT 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 525 bits (1352), Expect = e-148, Method: Compositional matrix adjust.
Identities = 292/679 (43%), Positives = 427/679 (62%), Gaps = 37/679 (5%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNR-YVGIWYQQIPD-TVVWV 92
S+ +TL+ T I +TLVSP FE+GFF ++ +R Y+G+WY+++ D T VWV
Sbjct: 29 LSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWYLGMWYKKVSDRTYVWV 85
Query: 93 ANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR--EVKNPVAQLLDNGNLVIRD 150
ANR++P+ + G L +S NLVLL+ SN +W +N++R E VA+LL NGN V+RD
Sbjct: 86 ANRDNPLSNAIGTLKISG-NNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFVMRD 144
Query: 151 NSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDI 210
+S ++++E YLWQSFDYPTDT+L MKLG++L+TGL R+ TSW+S+DDPS GNF+++L+
Sbjct: 145 SSNNDASE-YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLET 203
Query: 211 HVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKDEVYYMYESYSSPI 269
LP+ + + +GPWNG+ F P + + ++N +EV Y + ++
Sbjct: 204 QSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNNSF 263
Query: 270 IMILRVNPLGQVQRLIWHEMSTGWQVFFTAP-DPFCH-YGDCGPNSICSVDQTSHCECLE 327
L + G QRL W+ W F+++P DP C Y CGP + C V+ + C C++
Sbjct: 264 YSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCNCIQ 323
Query: 328 GFKFKSQQNQT-------CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEA 380
GF ++ Q C+R C SGD F ++ +KLP+ +++ S+ +KEC+
Sbjct: 324 GFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDGFTRMKKMKLPETTMATVDRSIGVKECKK 382
Query: 381 ECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKK-TDNHTNGVSIYIRVPASEQGNK-- 437
C+ +C+C A+AN+ + +GGSGC++W L D++ + +G +Y+R+ A++ K
Sbjct: 383 RCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAKKRN 442
Query: 438 ---KLLWIIV-ILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRT 493
K++ + V + VL L+I+ C++ +Q K N NQ+L +N + +
Sbjct: 443 ASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQNL---PMNEMVLSSK 499
Query: 494 NEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVA 553
EF G+ K ++ LPL +V ATENFS +KLG+GGFG VYKGRLL+G+E+A
Sbjct: 500 REF-----SGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIA 554
Query: 554 VKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF 613
VKRLS S QG EF NE+ LIA+LQH NLV++LGCCIE EK+LIYEY+ N SLD +LF
Sbjct: 555 VKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLF 614
Query: 614 DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
T++ L W R I +G+A+GLLYLHQ SR RIIHRDLK SNILLD++M PKISDFGM
Sbjct: 615 GKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGM 674
Query: 674 ARMFGGDELQGNTKRIVGT 692
AR+F DE + NT ++VGT
Sbjct: 675 ARIFERDETEANTMKVVGT 693
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 514 bits (1325), Expect = e-145, Method: Compositional matrix adjust.
Identities = 295/696 (42%), Positives = 424/696 (60%), Gaps = 41/696 (5%)
Query: 26 FSSLIFYWVIKFSLAADTLTPTTLIRDG---ETLVSPSQRFELGFFSPGKSQNRYVGIWY 82
S +++++ + S+AA+T+ +RDG + LVSP + FELGFFSPG S +R++GIWY
Sbjct: 11 LSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWY 70
Query: 83 QQIPD-TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREV---KNPVA 138
I D VVWVANR +PI D++GVL +SN GNLVLL+ N T+WSSN+ N V
Sbjct: 71 GNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVV 130
Query: 139 QLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADD 198
+ D GN V+ + T+ +W+SF++PTDT L M++ + +TG SW+S D
Sbjct: 131 SIHDTGNFVLSETD----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETD 186
Query: 199 PSPGNFTHRLDIHVLPQVCVYNGS-AKYTCTGPWNGVAFGSAPSN---TTFIFQPIVVQN 254
PSPGN++ +D P++ ++ G+ + +G WN F P+ T +++ +
Sbjct: 187 PSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSP 246
Query: 255 KDE---VYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCG 310
DE VY+ Y +++ +V G + L W+E W F + PD C Y CG
Sbjct: 247 PDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCG 306
Query: 311 PNSICSVDQTSH-CECLEGFKFKSQQN--QTCVRSHSSDCKSG-----DRFKKLDDIKLP 362
IC + ++ C C+ G++ S N + C R C+ D F L +KLP
Sbjct: 307 KFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISVGEDEFLTLKSVKLP 366
Query: 363 DLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNG 422
D ++ + ++ ++C CL+NCSC AY+ GG GC++W DL+DL++ + G
Sbjct: 367 DF-EIPEHNLVDPEDCRERCLRNCSCNAYS----LVGGIGCMIWNQDLVDLQQFE--AGG 419
Query: 423 VSIYIRVPASEQG-NKKLLWIIVILVLPLVILPCVYIARQWSRKRKENET-----KNLDT 476
S++IR+ SE G N+K +++ VL VIL ++ W KRK++ + KN DT
Sbjct: 420 SSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDT 479
Query: 477 NQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEG 536
+ + + T+ + + +GK S LP+FS ++ AT +F +++LG G
Sbjct: 480 SVVVADLTKSKETTSAFSGSVDIMIEGK-AVNTSELPVFSLNAIAIATNDFCKENELGRG 538
Query: 537 GFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596
GFGPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRLLGCC E EK
Sbjct: 539 GFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEK 598
Query: 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656
+L+YEYM NKSLD FLFD TK+ L+ W+LR II+GIA+GLLYLH+ SRLRIIHRDLK S
Sbjct: 599 MLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVS 658
Query: 657 NILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
N+LLD MNPKISDFGMAR+FGG++ + NT R+VGT
Sbjct: 659 NVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGT 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 507 bits (1306), Expect = e-142, Method: Compositional matrix adjust.
Identities = 290/681 (42%), Positives = 410/681 (60%), Gaps = 45/681 (6%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVANRNSPIV 100
+T+ + ++DG+ + S +RF GFFS G S+ RYVGIWY Q+ + T+VWVANR+ PI
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 101 DKNGVLTVSNRGNLVLLNQSNGT--IWSSNVSREVKNP--VAQLLDNGNLVIRDNSGSNS 156
D +G++ S RGNL + NGT IWS++V ++ P VA+L D GNLV+ D S
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 157 TESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQV 216
W+SF++PT+T+L MK G+ ++G++R TSW+S DP GN T+R++ PQ+
Sbjct: 143 ----FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 217 CVYNGSAKYTCTGPWNGVAFGSAPSNTT-FIFQPIVVQNKDEVYYMYESYSSPIIMILRV 275
+Y G + TG W G + P T FIF V N DEV Y + + + +
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 276 NPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQTS--HCECLEGFKFK 332
N G +QR W+ W F++AP+ C Y CG N C T C CL G++ K
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 333 SQQN-------QTCVRSHS-SDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK 384
+ ++ C R + S C + F KL +K+P+ V+++ ++ LKECE CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 385 NCSCRAYANS--KVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASE----QGN-- 436
NCSC AYA++ + DG GCL W G+++D + ++G Y+RV SE GN
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTY--LSSGQDFYLRVDKSELARWNGNGA 436
Query: 437 --KKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLA---FDVNMGITT 491
KK L +I+I ++ +V+L + ++R+ ++ L A FD+
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 492 RTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQE 551
E DKS+ LPLF +++ AT NF+ Q+KLG GGFGPVYKG L NG E
Sbjct: 497 EELE---------DKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGME 547
Query: 552 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF 611
+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCC+E EK+L+YEY+ NKSLD F
Sbjct: 548 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 607
Query: 612 LFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671
+F ++ L W R+ II GI +G+LYLHQ SRLRIIHRDLKASN+LLD M PKI+DF
Sbjct: 608 IFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 667
Query: 672 GMARMFGGDELQGNTKRIVGT 692
G+AR+FGG++++G+T R+VGT
Sbjct: 668 GLARIFGGNQIEGSTNRVVGT 688
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 487 bits (1253), Expect = e-136, Method: Compositional matrix adjust.
Identities = 285/682 (41%), Positives = 410/682 (60%), Gaps = 45/682 (6%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVA 93
S++ +TL+ T I +T+VSP FELGFF + Y+GIWY++I T VWVA
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVA 86
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPV-AQLLDNGNLVIRDNS 152
NR++P+ + G+L +SN NLV+L+ S+ +WS+N++ V++ V A+LLDNGN V+R S
Sbjct: 87 NRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLR-GS 144
Query: 153 GSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHV 212
N ++ +LWQSFD+PTDT+L MKLG D + GL R+ TSWKS+ DPS G+F +L+
Sbjct: 145 KINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLG 204
Query: 213 LPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTF---IFQPIVVQNKDEVYYMYESYSSPI 269
LP+ + + +GPW+G+ F + I+ +N++EV Y +
Sbjct: 205 LPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYN--FTENREEVAYTFRVTDHNS 262
Query: 270 IMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQTSHCECLEG 328
L +N +G+++ +W W +F+ P C YG CGP + C + + C C++G
Sbjct: 263 YSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKG 322
Query: 329 FKFKSQQNQT-------CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAE 381
F+ S Q+ C R C DRF +L ++K+P +++ + LKECE +
Sbjct: 323 FQPLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEK 381
Query: 382 CLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNKKLLW 441
C +C+C AYANS + +GGSGC++W G+ D++ + +G +++R+ A+E G ++ +
Sbjct: 382 CKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIR--NYAADGQDLFVRLAAAEFGERRTIR 439
Query: 442 II---------VILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTR 492
++LVL +I C + +Q + D Q+L+
Sbjct: 440 GKIIGLIIGISLMLVLSFIIY-CFWKKKQKRARATAAPIGYRDRIQELII---------- 488
Query: 493 TNEFCEADGD-GKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQE 551
TN + G + +D LPL F +V ATENFS + LG GGFG VYKGRLL+GQE
Sbjct: 489 TNGVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQE 548
Query: 552 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF 611
+AVKRLS S QG EFKNE+ LIA+LQH NLVRLL CCI EKILIYEY+ N SLD
Sbjct: 549 IAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSH 608
Query: 612 LFDPTK-KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670
LF+ T+ + L WQ R II+GIA+GLLYLHQ SR +IIHRDLKASN+LLD++M PKISD
Sbjct: 609 LFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISD 668
Query: 671 FGMARMFGGDELQGNTKRIVGT 692
FGMAR+F DE + NT+++VGT
Sbjct: 669 FGMARIFERDETEANTRKVVGT 690
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1231), Expect = e-134, Method: Compositional matrix adjust.
Identities = 282/689 (40%), Positives = 396/689 (57%), Gaps = 62/689 (8%)
Query: 40 AADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQI-PDTVVWVANRNSP 98
+++ T IR+G++L+S + FELGFF+P S RYVGIWY+ I P TVVWVANR P
Sbjct: 28 TSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKP 87
Query: 99 IVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTE 158
++D G L +++ GNLV++N N TIWS+NV E N VA L G+LV+ +S
Sbjct: 88 LLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVLCSDS---DRR 144
Query: 159 SYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCV 218
+ W+SF+ PTDT L GM++ + G R WKS DPSPG ++ +D ++ +
Sbjct: 145 KWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVI 204
Query: 219 YNGSAKYTCTGPWNGVAFGSAP-----SNTTFIFQPIVVQNKD-EVYYMYESYSSPIIMI 272
+ G + +GPWN F P +N + F+ ++D VY+ Y + S +
Sbjct: 205 WEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLR 264
Query: 273 LRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQ---TSHCECLEG 328
+ P G ++ W++ W + P C Y CG S+C + + C C++G
Sbjct: 265 FWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCIDG 324
Query: 329 FKFKSQQNQTCVRSHSSDCK--------------SGDRFKKLDDIKLPDLLDVSLNESMN 374
F+ Q+Q R S C+ D F L IK+PD V L+ N
Sbjct: 325 FE-PVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHN--N 381
Query: 375 LKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQ 434
+ C+ C ++CSC+AYA G GC++W DLID++ + N SI IR+ S+
Sbjct: 382 SETCKDVCARDCSCKAYALVV----GIGCMIWTRDLIDMEHFERGGN--SINIRLAGSKL 435
Query: 435 GNKK---LLWIIVILVLPLVILP-CVYIARQWSR-------KRKENETKNLDTNQDLLAF 483
G K LWIIV V+ +L C++I ++ + K+K+ ++ N+D +
Sbjct: 436 GGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSS 495
Query: 484 DVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYK 543
+ + + D+ LP+FSF SV +AT +F+ ++KLG+GGFG VYK
Sbjct: 496 PIKVLVG--------------DQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYK 541
Query: 544 GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603
G G+E+AVKRLS +S QGL+EFKNE++LIAKLQHRNLVRLLGCCIE EK+L+YEYM
Sbjct: 542 GNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYM 601
Query: 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663
NKSLD FLFD +K+ L W+ R +I GIA+GLLYLH+ SRL+IIHRDLKASNILLD
Sbjct: 602 PNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTE 661
Query: 664 MNPKISDFGMARMFGGDELQGNTKRIVGT 692
MNPKISDFGMAR+F + NT R+VGT
Sbjct: 662 MNPKISDFGMARIFNYRQDHANTIRVVGT 690
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 692 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.920 | 0.794 | 0.507 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.924 | 0.770 | 0.490 | 1e-178 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.891 | 0.570 | 0.495 | 1e-176 | |
| 359493740 | 2422 | PREDICTED: uncharacterized protein LOC10 | 0.926 | 0.264 | 0.467 | 1e-173 | |
| 224115136 | 843 | predicted protein [Populus trichocarpa] | 0.947 | 0.778 | 0.475 | 1e-173 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.943 | 0.781 | 0.494 | 1e-173 | |
| 359493730 | 770 | PREDICTED: G-type lectin S-receptor-like | 0.885 | 0.796 | 0.479 | 1e-173 | |
| 359493715 | 1603 | PREDICTED: uncharacterized protein LOC10 | 0.901 | 0.389 | 0.497 | 1e-173 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.932 | 0.788 | 0.490 | 1e-172 | |
| 359493727 | 1767 | PREDICTED: uncharacterized protein LOC10 | 0.916 | 0.358 | 0.486 | 1e-172 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/689 (50%), Positives = 462/689 (67%), Gaps = 52/689 (7%)
Query: 17 MEILPCFNIFSSLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNR 76
ME LP F FS+L + S +AD +TP ++DG+TL+S SQ FELGFFSPG S+ R
Sbjct: 1 MESLPFFIFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKYR 60
Query: 77 YVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNP 136
YVGIWY++ P+TVVWVANRN+P+ D GVLT+ NRGNLVLL+Q IWSSN S + P
Sbjct: 61 YVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAGP 120
Query: 137 VAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSA 196
VAQLLD+GNLV+RDN S +TESY WQSFD P+DT+L GMKLGW+L+TG ERY +W+S
Sbjct: 121 VAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRSI 180
Query: 197 DDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPIVVQNKD 256
DPSPG+FT+RLDIH LPQ+ + GS K +GPWNG+ FG P +F+PI+V+N+D
Sbjct: 181 SDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNED 240
Query: 257 EVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSIC 315
E+YY Y ++ + L +N G V+RL+ + ++GW ++ P C +YG CG N IC
Sbjct: 241 EIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGIC 300
Query: 316 SVDQTSHCECLEGFKFKSQQ---------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLD 366
+ CECL+GFK ++ ++ C + DC+SG+ F KL +KLPDLL+
Sbjct: 301 RTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDLLE 360
Query: 367 VSLNESMNLKECEAECLKNCSCRAYANSKVTDG--GSGCLMWFGDLIDLKKTDNHTNGVS 424
LNESMNLKECEAEC KNCSC A+A + ++ G GSGCLMWFG+LID+++ T G
Sbjct: 361 FRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIGQD 420
Query: 425 IYIRVPASEQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFD 484
I+IRVPASE + +AR S+++K +T + + LL
Sbjct: 421 IHIRVPASE----------------------LEMARS-SKRKKMLKTALVASMSALLGIF 457
Query: 485 VNMGITTRTNEFCEADGDGKDKSKDS-SLPLFSFASVTAATENFSIQSKLGEGGFGPVYK 543
V+ G D+ K+ PLF ++ AT NF+ S +G GGFG VYK
Sbjct: 458 VS----------------GMDRRKEGMEAPLFDLDTIATATNNFAPDSIIGAGGFGSVYK 501
Query: 544 GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603
G+LL GQE+AVK+LS SGQG++EF+NE++LIAKLQHRNLV LLG CI + E++LIYEYM
Sbjct: 502 GKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYEYM 561
Query: 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663
NKSLD F+FD + LLGW+ R II GIA+GLLYLHQ S+L+I+HRDLK SN+LLD +
Sbjct: 562 PNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLDSN 621
Query: 664 MNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ PKISDFG+AR+ G D + T+R++GT
Sbjct: 622 LIPKISDFGLARISGDDGKETKTRRVIGT 650
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 631 bits (1627), Expect = e-178, Method: Compositional matrix adjust.
Identities = 337/687 (49%), Positives = 448/687 (65%), Gaps = 47/687 (6%)
Query: 28 SLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD 87
S++F+ I S A +++ T + DG+TLVS FELGFFSPG S+NRY+GIWY++I
Sbjct: 18 SIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKISS 76
Query: 88 -TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNL 146
TVVWVANRN+P+ D +G+L + GNL +N +NGTIWSSN+SR NPVAQLLD GNL
Sbjct: 77 FTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGNL 136
Query: 147 VIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTH 206
V+R + N E++LWQSFDYP D+ L GMK G TGL RY TSWKS DPS G +T+
Sbjct: 137 VVRAEN-DNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKYTN 195
Query: 207 RLDIHVLPQVCVYNGSAKYTCTGPWNGVAFG---SAPSNTTFIFQPIVVQNKDEVYYMYE 263
+LD + LPQ + GS +GPWNG+ F + N + F+ V N++E+YY Y+
Sbjct: 196 KLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFE--FVFNQEEIYYKYQ 253
Query: 264 SYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSH 322
+S ++ + ++P G +QR W + + W ++ TA C + CG + +C+++ +
Sbjct: 254 IANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPA 313
Query: 323 CECLEGFKFKSQQ-------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNL 375
C+CL+ F+ KS + +Q CVR DC +G+ F K IK+PD N+++NL
Sbjct: 314 CDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINL 373
Query: 376 KECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPAS--- 432
+ECE CLKNCSC AYAN V DGGSGC++WFGDLID+++ + NG IYIR+ AS
Sbjct: 374 EECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNE--NGQDIYIRIAASVID 431
Query: 433 ----EQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETK---NLDTNQDLLAFDV 485
+G K++ I++ + L L + + ++ RK K+ + N+ TN
Sbjct: 432 KPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNP------- 484
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
E D + +++D LPLF A++T AT FSI +KLG+GGFGPVYKG
Sbjct: 485 ------------EQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGI 532
Query: 546 LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605
L +GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLV+LLGCCIE E++LIYEYM N
Sbjct: 533 LQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPN 592
Query: 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665
KSLD F+FD + LL W R II+GIA+GLLYLHQ SRLRIIHRDLKASNILLD MN
Sbjct: 593 KSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMN 652
Query: 666 PKISDFGMARMFGGDELQGNTKRIVGT 692
PKISDFGMAR FGGDE NT RIVGT
Sbjct: 653 PKISDFGMARSFGGDETSANTSRIVGT 679
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1613), Expect = e-176, Method: Compositional matrix adjust.
Identities = 331/668 (49%), Positives = 433/668 (64%), Gaps = 51/668 (7%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIV 100
AD++ I D ETLVS Q FELGFFSPG S+NRY+GIWY+ P T VWVANRN+PI
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNST-ES 159
D GVLT+ N G LVLLNQS IWS N+SR +NPVAQLL+ GNLV+RD GSN T +S
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRD--GSNETSKS 413
Query: 160 YLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVY 219
Y+WQSFD P+DTML GMK+GW+L+TGL+R TSWKS+DDPS G+F++ DI+VLP + +
Sbjct: 414 YIWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLG 473
Query: 220 NGSAKYTCTGPWNGVAFGSAPSNTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLG 279
GS+K +GPWNG+ F +++ + V N DEVY +YES ++ II L +N G
Sbjct: 474 VGSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSG 533
Query: 280 QVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGFKFKSQQ--- 335
+QRL+ + S+ W ++ P C +YG CG N IC + + CECL GF KSQ+
Sbjct: 534 FLQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWD 593
Query: 336 ----NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAY 391
+ C R DC+ + F K+ +KLPDL+D + ++L+EC+ CL NCSC AY
Sbjct: 594 MFNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAY 653
Query: 392 ANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQG---NKKLLWIIVILVL 448
A + +G GCLMW GDLID+++ + + IYIR+ SE G N+K +++ILV+
Sbjct: 654 AYTN-PNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVI 712
Query: 449 P----LVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGK 504
++ L + R W ++ MG D +
Sbjct: 713 STFSGILTLGLSFWFRFWKKR--------------------TMGT------------DQE 740
Query: 505 DKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG 564
K ++ LPLF ++ AT NFS +K+G GGFG VYKG L G VAVKRLS S QG
Sbjct: 741 SKKENLELPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSAQG 800
Query: 565 LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQ 624
++EFKNE +LIAKLQH+NLVRLLGCCI+ E+IL+YEYM NKSLD F+FD ++ LL W
Sbjct: 801 VQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLAWD 860
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
R I+ GIA+GLLYLHQ SR +IIHRDLK SNILLD ++NPKISDFG+AR+FG +E++
Sbjct: 861 KRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEMET 920
Query: 685 NTKRIVGT 692
TKRIVGT
Sbjct: 921 RTKRIVGT 928
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1588), Expect = e-173, Method: Compositional matrix adjust.
Identities = 337/721 (46%), Positives = 446/721 (61%), Gaps = 80/721 (11%)
Query: 26 FSSLIF-YWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQ 84
F++L+ + +++ S+A DTLT +I DGET+ S FELGFFSP S+NRYVGIWY++
Sbjct: 4 FATLVLVFSILRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYVGIWYKK 63
Query: 85 IPD-TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDN 143
+ TVVWVANR P+ +G+L V++RG LV+LN +N TIWSSN SR +NP AQLLD+
Sbjct: 64 VATRTVVWVANRQIPLTASSGILKVTDRGTLVILNGTNTTIWSSNSSRPAQNPNAQLLDS 123
Query: 144 GNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGN 203
GNLV+++ + S+S E++LWQSFDYP +T+L GMK G + TGL+RY +SWK+ DDPS GN
Sbjct: 124 GNLVMKNGNDSDS-ENFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLSSWKTTDDPSIGN 182
Query: 204 FTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQNKDEVYYMY 262
FT+RLD PQ+ V NGS +GPWNG+ F P ++ + N E YY +
Sbjct: 183 FTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYAFIFNDKETYYTF 242
Query: 263 ESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTS 321
E +S +I L ++P G QR W + ++ W ++ +A C Y CG IC ++++
Sbjct: 243 ELVNSSVITRLVLSPEGYAQRFTWIDRTSDWILYSSAQTDDCDSYALCGVYGICEINRSP 302
Query: 322 HCECLEGFKFKSQQN-------QTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMN 374
CEC++GF+ K Q N CVRS C+ + F K +KLPD + NESMN
Sbjct: 303 KCECMKGFEPKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSGVKLPDTRNSWFNESMN 362
Query: 375 LKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQ 434
LKEC + CL NCSC AY NS + GGSGCL+WFGDLID+++ NG YIR+ SE
Sbjct: 363 LKECASLCLGNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYTE--NGQDFYIRMAKSEL 420
Query: 435 G------------------------------------NKKLLWIIV-------ILVLPLV 451
G K W+IV I++L LV
Sbjct: 421 GMSLSVPYLRIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRKWVIVSTVSIVGIILLSLV 480
Query: 452 ILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSS 511
+ +Y+ R+ +RK N NL + + ++N ++ +D
Sbjct: 481 L--TLYVLRKKRLRRKGN---NLYSKHNCKGAEIN------------------EREEDLE 517
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
LPLF ++ AT+NFS +KLGEGGFGPVYKG L +G+E+AVKRLS +S QGL EFKNE
Sbjct: 518 LPLFDLDTILNATDNFSNDNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNE 577
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
+ I+KLQHRNLV+LLGCCI EK+LIYEYM NKSLD F+FD + +L W R II+
Sbjct: 578 VTHISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIIN 637
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
GIA+GLLYLHQ SRLRIIHRDLKA N+LLD MNP+ISDFGMAR F G+E + TKR+VG
Sbjct: 638 GIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVG 697
Query: 692 T 692
T
Sbjct: 698 T 698
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1588), Expect = e-173, Method: Compositional matrix adjust.
Identities = 326/685 (47%), Positives = 440/685 (64%), Gaps = 29/685 (4%)
Query: 19 ILPCFNIFSSLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYV 78
IL I + L+ + + KFS A D+++P+ + DG+TLVS FELGFFSPG S+ Y+
Sbjct: 2 ILAFVFIITKLLLF-LFKFSTALDSISPSEFMIDGKTLVSEKGTFELGFFSPGISKKSYL 60
Query: 79 GIWYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLL-NQSNGTIWSSNVSREVKNP 136
GIWY+ IP T+VWVANR +PI D +G+L V N ++VLL N +N +WSSN +++ +P
Sbjct: 61 GIWYKNIPVRTIVWVANRRNPINDSSGLLKVDNCSDIVLLSNNTNTVVWSSNSTKKASSP 120
Query: 137 VAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSA 196
+ QLLD+GNLV+RD + S LWQSFDYP DTML GMK+GWDLR G + +SWKS+
Sbjct: 121 ILQLLDSGNLVLRDKNDGRS--GLLWQSFDYPCDTMLPGMKIGWDLRAGFDWRLSSWKSS 178
Query: 197 DDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAF-GSAPSNTTFIFQPIVVQNK 255
DDPSPG+FT ++ P+V + GS K+ +GPWNGV F GS +F V N
Sbjct: 179 DDPSPGDFTMGIERESNPEVVAWKGSKKHYRSGPWNGVGFSGSTEVKPNPVFYFTFVSNN 238
Query: 256 DEVYYMY--ESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPN 312
EVYY++ +S S+ I ++ + Q W+E + W + + P C +YG CG N
Sbjct: 239 IEVYYIFNLKSESTVITRLVLNHTTSDRQCYTWNEETQTWVLQVSVPRDHCDNYGLCGAN 298
Query: 313 SICSVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLL 365
+ C + C+CLE FK KS + +Q CVR+ DC+ GD F K D +KLPD
Sbjct: 299 ANCIFNAIPVCQCLEKFKPKSPEEWNKMDWSQGCVRNKELDCQKGDGFIKFDGLKLPDAT 358
Query: 366 DVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSI 425
+N+ MNLKEC+A+CL NCSC AY+N + GGSGC WFGDL+D++ G +
Sbjct: 359 HSWVNKDMNLKECKAKCLGNCSCMAYSNLDIRGGGSGCANWFGDLMDIRLVPG--GGQEL 416
Query: 426 YIRVPASEQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDV 485
YIR+ ASE G+++ + I + ++ + S + + K+ +
Sbjct: 417 YIRMHASEIGDREAKANMKIAAIATAVVGLILGTLTISYHVSKEKAKSAENTS------- 469
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
+ RT + D + + +D LPLF+F+++ AT NFS+ +KLGEGGFGPVY+G+
Sbjct: 470 ----SERTENDWKNDTNNGGQKEDMELPLFAFSAIADATNNFSVNNKLGEGGFGPVYRGK 525
Query: 546 LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605
L +G E+AVKRLS SGQG EFKNE++LI KLQHRNLV+LLGCC ++ EK+LIYEYM N
Sbjct: 526 LEDGLEIAVKRLSRCSGQGFSEFKNEVILINKLQHRNLVKLLGCCSQREEKMLIYEYMPN 585
Query: 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665
+SLD F+FD TK LL W R II GIA+GLLYLHQ SRLRIIHRDLKASN+LLD HMN
Sbjct: 586 RSLDFFIFDETKGRLLDWSRRFNIISGIARGLLYLHQDSRLRIIHRDLKASNVLLDDHMN 645
Query: 666 PKISDFGMARMFGGDELQGNTKRIV 690
PKISDFG+ARMF D+ +G+T R+
Sbjct: 646 PKISDFGLARMFVADQTEGDTSRVT 670
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1585), Expect = e-173, Method: Compositional matrix adjust.
Identities = 333/674 (49%), Positives = 438/674 (64%), Gaps = 21/674 (3%)
Query: 36 KFSLAADTLTPTTLIRDG--ETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWV 92
+F A+TLT + IRDG TLVS FELGFFSPG S+NRYVGIWY+ IP TVVWV
Sbjct: 14 RFCNTANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWV 73
Query: 93 ANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTI-WSSNVSREVKNPVAQLLDNGNLVIRDN 151
ANRN+PI D +G L + N GNLVL++ +N T+ WSSN + ++ + +LLD+GNLV+RD
Sbjct: 74 ANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRDE 133
Query: 152 SGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIH 211
NS SYLWQSFDYP+DTML GMKLGWDLR GL+R ++WKS DDPS G+FT +
Sbjct: 134 KDVNSG-SYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQ 192
Query: 212 VLPQVCVYNGSAKYTCTGPWNGVAF-GSAPSNTTFIFQPIVVQNKDEVYYMYESYSSPII 270
P++ ++ GS KY +GPWNG+ F G A +F V N +EVYY Y + +I
Sbjct: 193 SNPELVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEEVYYTYNLKNKSLI 252
Query: 271 MILRVNPLGQV--QRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLE 327
L +N QR W+E+S W+++ P +C +Y CG C + Q+ CECLE
Sbjct: 253 TRLVMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCIISQSPVCECLE 312
Query: 328 GFKFKSQQN-------QTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEA 380
F KS ++ Q CVR+ DC+ GD F K +KLPD + +N++MNLKEC +
Sbjct: 313 KFTPKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRS 372
Query: 381 ECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGN-KKL 439
+CL+NCSC AY + + + SGC +WFGDLID+++ + G IYIR+ ASE L
Sbjct: 373 KCLQNCSCMAYTATDIKER-SGCAIWFGDLIDIRQFPD--GGQEIYIRMNASESSECLSL 429
Query: 440 LWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTN-EFCE 498
+ + + + L + + + + + KR E + D + ++ +T E
Sbjct: 430 IKMEMGIALSIFVACGMLLVAYYIFKRTEKLKAHYSFLLVYHVCDSHSLLSEKTGGNREE 489
Query: 499 ADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLS 558
D +D LPLF F ++ AT FS+ +K+GEGGFGPVYKG L +GQE+AVK LS
Sbjct: 490 NDQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLEDGQEIAVKTLS 549
Query: 559 NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK 618
SGQGL EFKNE++LI KLQHRNLV+LLGCCI+ EKIL+YEYM N+SLD F+FD T+
Sbjct: 550 RSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSLDSFIFDQTRG 609
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
LL W R II GIA+GLLYLHQ SRLRI+HRDLKASN+LLD+ MNPKISDFG+ARM G
Sbjct: 610 KLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMVG 669
Query: 679 GDELQGNTKRIVGT 692
GD+ +GNT R++GT
Sbjct: 670 GDQTEGNTTRVIGT 683
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493730|ref|XP_003634656.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1585), Expect = e-173, Method: Compositional matrix adjust.
Identities = 330/688 (47%), Positives = 428/688 (62%), Gaps = 75/688 (10%)
Query: 17 MEILPCFNIFSSLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNR 76
M+ L S +F +++ S A DT+ IRDGET+ S F+LGFFSPG S+NR
Sbjct: 1 MDALATVVFIFSYVFS-LLRISTAVDTINVNQHIRDGETITSAGGTFQLGFFSPGDSKNR 59
Query: 77 YVGIWYQQI-PDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKN 135
Y+GIWY+++ P TVVWVANR SP+ D +GVL V+ +G LV+++ +NG +W+SN SR ++
Sbjct: 60 YLGIWYKKVAPQTVVWVANRESPLTDSSGVLKVTQQGTLVVVSGTNGILWNSNSSRSAQD 119
Query: 136 PVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKS 195
P AQLL++GNLV+R+ + S+ E++LWQSFDYP DT+L GMK GW+ TGL+RY +SWKS
Sbjct: 120 PNAQLLESGNLVMRNGNDSDP-ENFLWQSFDYPCDTLLPGMKFGWNRVTGLDRYLSSWKS 178
Query: 196 ADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAP---SNTTFIFQPIVV 252
ADDPS GNFT+ +D+ PQ + NG GPWNGV FG P +N+ F F V
Sbjct: 179 ADDPSKGNFTYGIDLSGFPQPFLRNGLTVKFRAGPWNGVRFGGIPQLTNNSLFTFD--YV 236
Query: 253 QNKDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGP 311
N+ E+Y++Y +S + + + P G +R W + W ++ TA C +Y CG
Sbjct: 237 SNEKEIYFIYYLVNSSVFVRRVLTPDGYSRRFTWTDKKNEWTLYSTAQRDDCDNYAICGV 296
Query: 312 NSICSVDQTSHCECLEGFKFKSQQN-------QTCVRSHSSDCKSGDRFKKLDDIKLPDL 364
IC +D++ CEC++GF+ K Q N + CVRS DC+ GD F K +KLPD
Sbjct: 297 YGICKIDESPKCECMKGFRPKFQSNWDMADWSKGCVRSTPLDCQKGDGFVKYSGVKLPDT 356
Query: 365 LDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVS 424
+ +ESMNLKEC + CL+NCSC AYANS + GGSGCL+WF DLID++ D NG
Sbjct: 357 RNSWFDESMNLKECASLCLRNCSCTAYANSDIRGGGSGCLLWFDDLIDIR--DFTQNGQE 414
Query: 425 IYIRVPASEQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFD 484
Y R+ ASE G Y+ K KE E + DL
Sbjct: 415 FYARMAASESG---------------------YM----DHKSKEGENNEGQEHLDL---- 445
Query: 485 VNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKG 544
PLF+ A++ AT NFS ++KLGEGGFGPVYKG
Sbjct: 446 ----------------------------PLFNLATLLNATNNFSEENKLGEGGFGPVYKG 477
Query: 545 RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604
L GQE+AVK +S S QGLKEFKNE+ I KLQHRNLV+LLGCCI E++LIYEYM
Sbjct: 478 ILQEGQEIAVKMMSKTSRQGLKEFKNEVESITKLQHRNLVKLLGCCIHGRERLLIYEYMP 537
Query: 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664
NKSLD+++FD + +L W R II+GIA+GLLYLHQ SRLRIIHRDLKA NILLD M
Sbjct: 538 NKSLDLYIFDHMRSRVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENILLDNEM 597
Query: 665 NPKISDFGMARMFGGDELQGNTKRIVGT 692
PKISDFG+AR FGG+E + NT R+VGT
Sbjct: 598 TPKISDFGIARSFGGNETEANTTRVVGT 625
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493715|ref|XP_002280938.2| PREDICTED: uncharacterized protein LOC100246941 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 614 bits (1584), Expect = e-173, Method: Compositional matrix adjust.
Identities = 335/674 (49%), Positives = 433/674 (64%), Gaps = 50/674 (7%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWVANRNSPI 99
DT+ L+RDGE L S FELGFF P S RY+G+WY+++ TVVWVANR +P+
Sbjct: 813 VDTIALNQLLRDGEILTSAGGSFELGFFRPDNSSRRYLGMWYKKVSIRTVVWVANRETPL 872
Query: 100 VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTES 159
D +GVL V+++G L +LN +N +WSSN SR +NP AQ+L++GNLV++D + N E+
Sbjct: 873 ADSSGVLKVTDQGTLAVLNGTNTILWSSNSSRSARNPTAQILESGNLVMKDGNDDNP-EN 931
Query: 160 YLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVY 219
+LWQSFDYP +T+L GMKLG + TGL+RY ++WKSADDPS G+FT+RLD PQ+ +
Sbjct: 932 FLWQSFDYPCNTLLPGMKLGRNTVTGLDRYLSAWKSADDPSKGDFTYRLDPRGYPQLILR 991
Query: 220 NGSAKYTCTGPWNGVAFGSAPS---NTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVN 276
GSA +GPWNGV F P N+ + ++ V N+ E+Y+ YE +S ++ L +N
Sbjct: 992 KGSAVTFRSGPWNGVRFSGFPELGPNSIYTYE--FVFNEKEMYFRYELVNSSVVSRLVLN 1049
Query: 277 PLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGFKFKSQQ 335
P G QR+ W + + GW ++ +AP C Y CG IC+++++ CEC+EGF K Q
Sbjct: 1050 PDGSKQRVNWIDRTNGWILYSSAPKDDCDSYALCGVYGICNINRSPKCECMEGFVPKFQN 1109
Query: 336 N-------QTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSC 388
+ CVRS DC++G+ F K +KLPD + N SM L EC A CL NCSC
Sbjct: 1110 DWDMADWSNGCVRSTPLDCQNGEGFVKFSGVKLPDTRNSWFNRSMGLMECAAVCLSNCSC 1169
Query: 389 RAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGN----------KK 438
AY N + DGGSGCL+WFGDLID+++ + NG IY+R+ ASE G KK
Sbjct: 1170 TAYTNLDIRDGGSGCLLWFGDLIDIREFNE--NGQEIYVRMAASELGGSKESGSNLKGKK 1227
Query: 439 LLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEFCE 498
WIIV V +VI+ + K K K + +++ +G
Sbjct: 1228 RKWIIVGSVSSVVIILVSLFLTLYLLKTKRQRKKGT------MGYNLEVG---------- 1271
Query: 499 ADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLS 558
+DS L LF FA+V+ AT +FS +KLGEGGFG VYKG L GQE+AVKRLS
Sbjct: 1272 -------HKEDSKLQLFDFATVSKATNHFSFDNKLGEGGFGLVYKGILQEGQEIAVKRLS 1324
Query: 559 NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK 618
SGQGL E KNE++ IAKLQHRNLVRLLGCCI EK+LIYEYM NKSLD F+FD T+
Sbjct: 1325 KDSGQGLDELKNEVIYIAKLQHRNLVRLLGCCIHGEEKMLIYEYMSNKSLDSFIFDKTQS 1384
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
L W R II+GIA+GLLYLHQ SRLRIIHRDLKA NILLD+ M PKISDFGMAR FG
Sbjct: 1385 MELDWNKRFLIINGIARGLLYLHQDSRLRIIHRDLKAGNILLDEEMAPKISDFGMARSFG 1444
Query: 679 GDELQGNTKRIVGT 692
G+E + NTKR+VGT
Sbjct: 1445 GNETEANTKRVVGT 1458
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1578), Expect = e-172, Method: Compositional matrix adjust.
Identities = 338/689 (49%), Positives = 444/689 (64%), Gaps = 44/689 (6%)
Query: 24 NIFSSLIFYW-----VIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYV 78
N+F+ L+F + +++ S A D++T I+DGET++S FELGF G S+N+Y+
Sbjct: 2 NLFTELVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYL 61
Query: 79 GIWYQQI-PDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPV 137
GIWY+++ P TVVWVANR P+ D +G L V+++G+LV+LN SNG IWSSN SR +NP
Sbjct: 62 GIWYKKVTPRTVVWVANRELPVTDSSGXLKVTDQGSLVILNGSNGLIWSSNSSRSARNPT 121
Query: 138 AQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSAD 197
AQLLD+GNLVI+ + S+ +++LWQSFDYP DT+L GMK G + TGL+RY +SWKS D
Sbjct: 122 AQLLDSGNLVIKSGNDSDP-DNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSND 180
Query: 198 DPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQNKD 256
DPS G+FT+ LD PQ+ + +GS +GPWNG+ F P +F V N+
Sbjct: 181 DPSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEK 240
Query: 257 EVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSIC 315
E+Y+ Y+ +S ++ L +NP G VQRLIW + W V+ TA C Y CG S C
Sbjct: 241 EMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCGAYSTC 300
Query: 316 SVDQTSHCECLEGF--KFKSQQNQT-----CVRSHSSDCKSGDRFKKLDDIKLPDLLDVS 368
++ ++ C C++GF KF Q + CVR S DC+ GD F K +KLPD +
Sbjct: 301 NIHRSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPDTRNSW 360
Query: 369 LNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIR 428
NESMNLKEC + C +NCSC AY NS + GGSGCL+WFGDLID+K+ NG YIR
Sbjct: 361 FNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTE--NGQDFYIR 418
Query: 429 VPASE----QGNKKLLWIIVILV-LPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAF 483
+ ASE K W+IV V + +IL + + +KR + +
Sbjct: 419 MAASELDAISKVTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRK------------- 465
Query: 484 DVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYK 543
G T NE E + ++ +D LPLF ++ AT NFS +KLGEGGFGPVYK
Sbjct: 466 ----GTTELNNEGAETN----ERQEDLELPLFXLDTILNATHNFSRNNKLGEGGFGPVYK 517
Query: 544 GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603
G L +G+E+AVKRLS +S QGL EFKNE++ I+KLQHRNLV+LLGCCI EK+LIYEYM
Sbjct: 518 GMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYEYM 577
Query: 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663
NKSL+ F+FD + +L W R II+GIA+GLLYLHQ SRLRIIHRDLKA N+LLD
Sbjct: 578 PNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNE 637
Query: 664 MNPKISDFGMARMFGGDELQGNTKRIVGT 692
MNP+ISDFGMAR FGG+E TKR+VGT
Sbjct: 638 MNPRISDFGMARSFGGNETIARTKRVVGT 666
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493727|ref|XP_002280656.2| PREDICTED: uncharacterized protein LOC100243545 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1577), Expect = e-172, Method: Compositional matrix adjust.
Identities = 330/678 (48%), Positives = 423/678 (62%), Gaps = 44/678 (6%)
Query: 28 SLIFYWVI---KFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQ 84
++IF +V+ + S+A DT+ I DGET+ S FELGFFSPG S+NRY+GIWY++
Sbjct: 8 AVIFSYVLSLLRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKK 67
Query: 85 IPDT-VVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDN 143
VVWVANR SPI D +GVL V+ G LVL+N +NG +W+S SR ++P AQLL++
Sbjct: 68 ASKKPVVWVANRESPITDSSGVLKVTQPGILVLVNGTNGILWNSTSSRSAQDPNAQLLES 127
Query: 144 GNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGN 203
GNLV+R N E++LWQSFDYP DT+L GMKLG + GL+RY +SWKSADDPS GN
Sbjct: 128 GNLVMR-NGNDRDPENFLWQSFDYPCDTLLPGMKLGRNRVAGLDRYLSSWKSADDPSKGN 186
Query: 204 FTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNT-TFIFQPIVVQNKDEVYYMY 262
FT+ +D PQ+ + NG A GPWNG+ F P T ++ V N+ E+YY+Y
Sbjct: 187 FTYWIDPSGFPQLLLRNGLAVAFRPGPWNGIRFSGIPQLTINPVYSYEYVSNEKEIYYIY 246
Query: 263 ESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTS 321
+S +IM L + P G QR IW + W ++ TA C +Y CG N IC +DQ+
Sbjct: 247 SLVNSSVIMRLVLTPDGAAQRSIWTDKKNEWTLYSTAQRDQCDNYAICGVNGICKIDQSP 306
Query: 322 HCECLEGFKFKSQQN-------QTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMN 374
+CEC++GF+ K Q N CVRS DC+ GD F K +KLPD NESMN
Sbjct: 307 NCECMKGFRPKFQSNWDMEDWSNGCVRSTPLDCQKGDGFVKYSGVKLPDTRSSWFNESMN 366
Query: 375 LKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQ 434
LKEC + CL NCSC AYANS + GGSGCL+WFGDLID++ D NG Y+R+ A++
Sbjct: 367 LKECASLCLSNCSCTAYANSDIRGGGSGCLLWFGDLIDIR--DFTENGQEFYVRMAAADL 424
Query: 435 GNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTN 494
K KR N ++ N +L ++ N
Sbjct: 425 ETTK-------------------------EKRLGNRLNSIFVNSLILHSILHFAAYMEHN 459
Query: 495 EFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAV 554
G+ + + LPLF ++ AT NFS +KLGEGGFGPVYKG L GQE+AV
Sbjct: 460 S---KGGENNEGQEHLELPLFDLDTLLNATNNFSSDNKLGEGGFGPVYKGILQEGQEIAV 516
Query: 555 KRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD 614
K +S S QGLKEFKNE+ IAKLQHRNLV+LLGCCI E++LIYE+M NKSLD+F+FD
Sbjct: 517 KMMSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCIHGRERLLIYEHMPNKSLDLFIFD 576
Query: 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
++ +L W R II+GIAQGLLYLH+ SRLRIIHRDLKA NILLD M PKISDFG+
Sbjct: 577 QMRRRVLDWPKRFLIINGIAQGLLYLHRDSRLRIIHRDLKAENILLDNEMIPKISDFGIT 636
Query: 675 RMFGGDELQGNTKRIVGT 692
FGG+E++ NT R+ T
Sbjct: 637 GSFGGNEIETNTTRVART 654
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 692 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.585 | 0.517 | 0.397 | 1.1e-144 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.958 | 0.78 | 0.427 | 5.3e-143 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.940 | 0.772 | 0.422 | 1e-139 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.947 | 0.774 | 0.424 | 1.7e-139 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.572 | 0.485 | 0.358 | 1.8e-131 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.901 | 0.734 | 0.420 | 7.8e-126 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.261 | 0.225 | 0.662 | 7.2e-124 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.921 | 0.757 | 0.402 | 2.6e-118 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.261 | 0.223 | 0.618 | 2.9e-116 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.261 | 0.225 | 0.646 | 1.3e-115 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 1.1e-144, Sum P(2) = 1.1e-144
Identities = 170/428 (39%), Positives = 251/428 (58%)
Query: 24 NIFSSLIF--YWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIW 81
N+ LI + I + A D L ++DG+T+VS FE+GFFSPG S+NRY+GIW
Sbjct: 5 NVLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIW 64
Query: 82 YQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVS-----REVKN 135
Y++I TVVWVANR+SP+ D +G L VS G+L L N N IWSS+ S ++N
Sbjct: 65 YKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRN 124
Query: 136 PVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKS 195
P+ Q+LD GNLV+R NSG + + Y+WQS DYP D L GMK G + TGL R+ TSW++
Sbjct: 125 PIVQILDTGNLVVR-NSGDD--QDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRA 181
Query: 196 ADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQN 254
DDPS GN+T+++D + +PQ + S TGPWNG+ F P+ I++ V
Sbjct: 182 IDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFT 241
Query: 255 KDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNS 313
++EVYY Y+ + ++ +++NP G +QR W + W + +A C Y CG
Sbjct: 242 EEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYG 301
Query: 314 ICSVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSG-DRFXXXXXXXXXXXX 365
C+++++ C CL+GF K+ Q ++ CVR DC G D F
Sbjct: 302 SCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTR 361
Query: 366 XVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSI 425
+++M+L EC+ CL+NC+C AY+ + DGG GC++WFGDLID+++ + NG +
Sbjct: 362 TSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNE--NGQDL 419
Query: 426 YIRVPASE 433
Y+R+ +SE
Sbjct: 420 YVRLASSE 427
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1398 (497.2 bits), Expect = 5.3e-143, P = 5.3e-143
Identities = 301/704 (42%), Positives = 423/704 (60%)
Query: 17 MEILPCF-NIFSSLIFYWVIKF---SLAADTLTPTT--LIRDGETLVSPSQRFELGFFSP 70
M LP F + ++ F+ +I F S++A+TL+ + I T+VSP FELGFF P
Sbjct: 1 MRGLPNFYHSYTFFFFFLLILFPAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKP 60
Query: 71 GKSQNRYVGIWYQQIPD-TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNV 129
G Y+GIWY+ I T VWVANR++P+ G L +S+ NLV+L+QS+ +WS+N+
Sbjct: 61 GLDSRWYLGIWYKAISKRTYVWVANRDTPLSSSIGTLKISD-SNLVVLDQSDTPVWSTNL 119
Query: 130 SR-EVKNP-VAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLE 187
+ +V++P VA+LLDNGN V+RD+ S + + LWQSFD+PTDT+L MKLGWD +TG
Sbjct: 120 TGGDVRSPLVAELLDNGNFVLRDSKNS-APDGVLWQSFDFPTDTLLPEMKLGWDAKTGFN 178
Query: 188 RYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIF 247
R+ SWKS DDPS G+F+ +L+ P++ ++N ++ +GPWNG+ F P F +
Sbjct: 179 RFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEY 238
Query: 248 QPI-VVQNKDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-H 305
+K+EV Y + S + L ++ G +QR W E + W F+ AP C
Sbjct: 239 MVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDE 298
Query: 306 YGDCGPNSICSVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSGDRFXXXXX 358
Y +CG C + + C C++GFK ++ Q + CVR C GD F
Sbjct: 299 YKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKK 358
Query: 359 XXXXXXXXVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDN 418
S++ + +KECE +CL++C+C A+AN+ + GSGC+ W G+L D++ N
Sbjct: 359 MKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIR---N 415
Query: 419 HTNG-VSIYIRVPASE---QGNKKXXXXXXXXXXXXXXXXXXYIARQWSRKRKEN---ET 471
+ G +Y+R+ A++ + N+ I W RK+K + ET
Sbjct: 416 YAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIET 475
Query: 472 KNLD---TNQDLLAFDVNMGITTRTNEFCEAXXXXXXXXXXXXLPLFSFASVTAATENFS 528
+D ++DLL +V I++R + E LPL F V AT NFS
Sbjct: 476 PIVDHQLRSRDLLMNEVV--ISSRRHISRE------NNTDDLELPLMEFEEVAMATNNFS 527
Query: 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
+KLG+GGFG VYKG+LL+GQE+AVKRLS S QG EFKNE+ LIA+LQH NLVRLL
Sbjct: 528 NANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLA 587
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
CC++ GEK+LIYEY+ N SLD LFD ++ L WQ+R II+GIA+GLLYLHQ SR RI
Sbjct: 588 CCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRI 647
Query: 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
IHRDLKASNILLD++M PKISDFGMAR+FG DE + NT+++VGT
Sbjct: 648 IHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGT 691
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1367 (486.3 bits), Expect = 1.0e-139, P = 1.0e-139
Identities = 293/693 (42%), Positives = 411/693 (59%)
Query: 23 FNIFSSLIFYWVIKFSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGI 80
F IF LI + + FS++ +TL+ T I +T++SPSQ FELGFF+P S Y+GI
Sbjct: 11 FFIFLILILF--LAFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGI 68
Query: 81 WYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA 138
WY+ IP T VWVANR++P+ NG L +S NLV+ +QS+ +WS+N++ +V++PVA
Sbjct: 69 WYKIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVA 127
Query: 139 -QLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSAD 197
+LLDNGN ++RD S LWQSFD+PTDT+L MKLGWD +TG R SWK+ D
Sbjct: 128 AELLDNGNFLLRD-----SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTD 182
Query: 198 DPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKD 256
DPS G F+ +L+ P+ + + + +GPWNG+ F S P + +K+
Sbjct: 183 DPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE 242
Query: 257 EVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSIC 315
EV Y Y + + L +N G +QRL W E + W+ + +P C +Y CG C
Sbjct: 243 EVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYC 302
Query: 316 SVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSGDRFXXXXXXXXXXXXXVS 368
+ +C C++GFK ++Q + C+R C D F
Sbjct: 303 DSNSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATI 362
Query: 369 LNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNG-VSIYI 427
++ + LK C+ CL++C+C A+AN+ + +GGSGC++W +++D++ N+ G +Y+
Sbjct: 363 VDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMR---NYAKGGQDLYV 419
Query: 428 RVPASEQGNKKXXXXXXXXXXXXXXXX---XXYIARQWSRKRKEN---ETKNLDT--NQD 479
R+ A+E +K+ I W RK+K + +T N+D +QD
Sbjct: 420 RLAAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQD 479
Query: 480 LLAFDVNMGITTRTNEFCEAXXXXXXXXXXXXLPLFSFASVTAATENFSIQSKLGEGGFG 539
L DV + +R LPL ++ AT NFS +KLG+GGFG
Sbjct: 480 SLINDV---VVSR-----RGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFG 531
Query: 540 PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599
VYKGRLL+G+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LI
Sbjct: 532 IVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLI 591
Query: 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
YEY+ N SLD LFD T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+L
Sbjct: 592 YEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVL 651
Query: 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
LD++M PKISDFGMAR+FG +E + NT+R+VGT
Sbjct: 652 LDKNMTPKISDFGMARIFGREETEANTRRVVGT 684
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1365 (485.6 bits), Expect = 1.7e-139, P = 1.7e-139
Identities = 293/691 (42%), Positives = 408/691 (59%)
Query: 23 FNIFSSLIFYWVIKFSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGI 80
F +F ++F + FS+ A + T I +T++SPSQ FELGFF+P S Y+GI
Sbjct: 12 FILFIIILF---LAFSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGI 68
Query: 81 WYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA 138
WY+ IP T VWVANR++P+ NG L +S+ NLV+ +QS+ +WS+N++ +V++PVA
Sbjct: 69 WYKIIPIRTYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVA 127
Query: 139 -QLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTG-LERYQTSWKSA 196
+LLD GN V+RD S +N +LWQSFD+PTDT+L MK+GWD ++G R SWK+
Sbjct: 128 AELLDYGNFVLRD-SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTT 186
Query: 197 DDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIF-QPIVVQNK 255
DDPS G+F+ +L P+ +YN + +GPW G F S P + +N
Sbjct: 187 DDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENN 246
Query: 256 DEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSI 314
+V Y Y + I IL ++ G +QRL W E + W+ + +P C +Y +CG
Sbjct: 247 QQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGY 306
Query: 315 CSVDQTSHCECLEGFKFKSQQ------NQTCVRSHSSDCKSGDRFXXXXXXXXXXXXXVS 368
C + + C C++GF+ ++Q + CVR C D F S
Sbjct: 307 CDANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETS 366
Query: 369 LNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNG-VSIYI 427
+++ + LKECE CLK C+C A+AN+ + +GGSGC++W G L D++ N+ G +Y+
Sbjct: 367 VDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIR---NYAKGGQDLYV 423
Query: 428 RVPASEQGNK--KXXXXXXXXXXXXXXXXXXYIARQ-WSRKRKENETKNLDTNQDLLAFD 484
RV A + +K K +I W RK+K + T + T D
Sbjct: 424 RVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSIT--IQTP----IVD 477
Query: 485 VNMGITTRTNEFCEAXXXXXXXXXXXX---LPLFSFASVTAATENFSIQSKLGEGGFGPV 541
+ + NE +A LPL + ++ AT NFS +KLG+GGFG V
Sbjct: 478 LVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIV 537
Query: 542 YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601
YKG LL+G+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LIYE
Sbjct: 538 YKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYE 597
Query: 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661
Y+ N SLD LFD T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+LLD
Sbjct: 598 YLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLD 657
Query: 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
++M PKISDFGMAR+FG +E + NT+R+VGT
Sbjct: 658 KNMTPKISDFGMARIFGREETEANTRRVVGT 688
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 684 (245.8 bits), Expect = 1.8e-131, Sum P(2) = 1.8e-131
Identities = 155/432 (35%), Positives = 239/432 (55%)
Query: 24 NIFSSLIFYWVIKFSLAAD--TLTPTTLIRDGETLVSPSQRFELGFFSPGKS---QNRYV 78
++FS +F S+A D +TP ++DG+TL SP Q F+LGFFS + Q+R++
Sbjct: 6 SLFSLSLFLISSSLSVALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFL 65
Query: 79 GIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSN-----VSREV 133
G+WY + P VVWVANRN+P+ +G L +S+ G+L L + + +WSS+ S+
Sbjct: 66 GLWYME-PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTA 124
Query: 134 KNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSW 193
NP+ ++ +GNL+ S+ E+ LWQSFDYP +T+L GMKLG + +T +E +SW
Sbjct: 125 NNPLLKISCSGNLI-----SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSW 179
Query: 194 KSADDPSPGNFTHRLDIHVLPQVCVY-NGSAKYTCT-GPWNGVAFGSAPS--NTTFIFQP 249
K+ DPSPG+FT LD LPQ+ + NG + Y+ G WNG++F AP+ +F
Sbjct: 180 KTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDY 239
Query: 250 IVVQNKDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGD 308
+ EV Y + I+ L +N G++ R I + + W + TAP+ C +Y
Sbjct: 240 KFTSSAQEVNYSWTPRHR-IVSRLVLNNTGKLHRFIQSKQNQ-WILANTAPEDECDYYSI 297
Query: 309 CGPNSICSVDQ--TSHCECLEGFKFKSQQNQT-------CVRSHSSDCKSGDRFXXXXXX 359
CG ++C ++ T C CL+GFK KS + CV ++C+ D F
Sbjct: 298 CGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGL 357
Query: 360 XX--XXXXXVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTD 417
M L++C+ +C NCSC AYAN+ + +GG GCL+WFGDL+D+++
Sbjct: 358 KLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYS 417
Query: 418 NHTNGVSIYIRV 429
+ G +YIR+
Sbjct: 418 SF--GQDVYIRM 427
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1236 (440.2 bits), Expect = 7.8e-126, P = 7.8e-126
Identities = 279/664 (42%), Positives = 391/664 (58%)
Query: 56 LVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVANRNSPIVDKNGVLTVSNRGNL 114
LVSP + FELGFFSPG S +R++GIWY I D VVWVANR +PI D++GVL +SN GNL
Sbjct: 44 LVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNL 103
Query: 115 VLLNQSNGTIWSSNVSREV---KNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDT 171
VLL+ N T+WSSN+ N V + D GN V+ + T+ +W+SF++PTDT
Sbjct: 104 VLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETD----TDRPIWESFNHPTDT 159
Query: 172 MLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGS-AKYTCTGP 230
L M++ + +TG SW+S DPSPGN++ +D P++ ++ G+ + +G
Sbjct: 160 FLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQ 219
Query: 231 WNGVAFGSAPSN---TTFIFQPIVVQNKDEVYYMYESY--SSPIIMI-LRVNPLGQVQRL 284
WN F P+ T +++ + DE +Y +Y S P +++ +V G + L
Sbjct: 220 WNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEEL 279
Query: 285 IWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSH-CECLEGFKFKSQQNQT--CV 340
W+E W F + PD C Y CG IC + ++ C C+ G++ S N + C
Sbjct: 280 RWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCR 339
Query: 341 RSHSSDCKS----GDRFXXXXXXXXXXXXXVSLNESMNLKECEAECLKNCSCRAYANSKV 396
R C+ G+ + + ++ ++C CL+NCSC AY S V
Sbjct: 340 RRTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNLVDPEDCRERCLRNCSCNAY--SLV 397
Query: 397 TDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQG-NKKXXXXXXXXXXXXXXXXX 455
GG GC++W DL+DL++ + G S++IR+ SE G N+K
Sbjct: 398 --GGIGCMIWNQDLVDLQQFE--AGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIG 453
Query: 456 XYIARQWSRKRKENET-----KNLDTNQDLLAFDVNMGITTRTNEFCEAXXXXXXXXX-- 508
+ W KRK++ + KN DT+ ++ D+ T T+ F +
Sbjct: 454 IFALLLWRFKRKKDVSGAYCGKNTDTS--VVVADLTKSKET-TSAFSGSVDIMIEGKAVN 510
Query: 509 XXXLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEF 568
LP+FS ++ AT +F +++LG GGFGPVYKG L +G+E+AVKRLS +SGQG+ EF
Sbjct: 511 TSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEF 570
Query: 569 KNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR 628
KNE++LIAKLQHRNLVRLLGCC E EK+L+YEYM NKSLD FLFD TK+ L+ W+LR
Sbjct: 571 KNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFS 630
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
II+GIA+GLLYLH+ SRLRIIHRDLK SN+LLD MNPKISDFGMAR+FGG++ + NT R
Sbjct: 631 IIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVR 690
Query: 689 IVGT 692
+VGT
Sbjct: 691 VVGT 694
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 632 (227.5 bits), Expect = 7.2e-124, Sum P(2) = 7.2e-124
Identities = 120/181 (66%), Positives = 147/181 (81%)
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
L F ++ AT NFS+ +KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG +EF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
++LI+KLQHRNLVR+LGCCIE+ EK+LIYE+MVNKSLD FLFD K+ + W R II
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
GIA+GLLYLH SRLR+IHRDLK SNILLD+ MNPKISDFG+ARM+ G E Q NT+R+VG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 692 T 692
T
Sbjct: 656 T 656
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1165 (415.2 bits), Expect = 2.6e-118, P = 2.6e-118
Identities = 272/676 (40%), Positives = 373/676 (55%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQI-PDTVVWVANRNSPI 99
+++ T IR+G++L+S + FELGFF+P S RYVGIWY+ I P TVVWVANR P+
Sbjct: 29 SNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKPL 88
Query: 100 VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTES 159
+D G L +++ GNLV++N N TIWS+NV E N VA L G+LV+ +S
Sbjct: 89 LDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVLCSDS---DRRK 145
Query: 160 YLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVY 219
+ W+SF+ PTDT L GM++ + G R WKS DPSPG ++ +D ++ ++
Sbjct: 146 WYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVIW 205
Query: 220 NGSAKYTCTGPWNGVAFGSAPSN---TTFI--FQPIVVQNKD-EVYYMYESYSSPIIMIL 273
G + +GPWN F P T +I F+ ++D VY+ Y + S +
Sbjct: 206 EGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLRF 265
Query: 274 RVNPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQ---TSHCECLEGF 329
+ P G ++ W++ W + P C Y CG S+C + + C C++GF
Sbjct: 266 WIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCIDGF 325
Query: 330 K--FKSQQNQT-----CVRSHSSDCKSG------DRFXXXXXXXXXXXXXVSLNESMNLK 376
+ + Q N C R +C D F V L+ N +
Sbjct: 326 EPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHN--NSE 383
Query: 377 ECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGN 436
C+ C ++CSC+AYA V G GC++W DLID++ + G SI IR+ S+ G
Sbjct: 384 TCKDVCARDCSCKAYA--LVV--GIGCMIWTRDLIDMEHFER--GGNSINIRLAGSKLGG 437
Query: 437 KKXXXXXXXXXXXXXXXXXXYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEF 496
K + K K++ L +D+ D+ I R
Sbjct: 438 GKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDI---IENRDYSS 494
Query: 497 CEAXXXXXXXXXXXXLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKR 556
LP+FSF SV +AT +F+ ++KLG+GGFG VYKG G+E+AVKR
Sbjct: 495 SPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKR 554
Query: 557 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPT 616
LS +S QGL+EFKNE++LIAKLQHRNLVRLLGCCIE EK+L+YEYM NKSLD FLFD +
Sbjct: 555 LSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDES 614
Query: 617 KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
K+ L W+ R +I GIA+GLLYLH+ SRL+IIHRDLKASNILLD MNPKISDFGMAR+
Sbjct: 615 KQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARI 674
Query: 677 FGGDELQGNTKRIVGT 692
F + NT R+VGT
Sbjct: 675 FNYRQDHANTIRVVGT 690
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 606 (218.4 bits), Expect = 2.9e-116, Sum P(2) = 2.9e-116
Identities = 112/181 (61%), Positives = 146/181 (80%)
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
L F ++ AT+NFS+ +KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG +EF NE
Sbjct: 481 LKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 540
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
++LI+KLQH+NLVR+LGCCIE E++L+YE+++NKSLD FLFD K+ + W R II+
Sbjct: 541 IVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFNIIE 600
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
GIA+GL YLH+ S LR+IHRDLK SNILLD+ MNPKISDFG+ARM+ G E Q NT+R+ G
Sbjct: 601 GIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVAG 660
Query: 692 T 692
T
Sbjct: 661 T 661
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 1.3e-115, Sum P(2) = 1.3e-115
Identities = 117/181 (64%), Positives = 146/181 (80%)
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
L F ++ AT NFS+ +KLG+GGFGPVYKG+L +G+E+AVKRLS+ SGQG +EF NE
Sbjct: 474 LYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 533
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
++LI+KLQH NLVR+LGCCIE E++L+YE+MVNKSLD F+FD K+ + W R II
Sbjct: 534 ILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPKRFSIIQ 593
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
GIA+GLLYLH+ SRLRIIHRD+K SNILLD MNPKISDFG+ARM+ G + Q NT+RIVG
Sbjct: 594 GIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTRRIVG 653
Query: 692 T 692
T
Sbjct: 654 T 654
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 692 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-41 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 5e-41 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 8e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-39 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-27 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 5e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-21 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-19 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 4e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-10 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.003 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.003 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.004 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.004 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 59/154 (38%), Positives = 83/154 (53%), Gaps = 11/154 (7%)
Query: 528 SIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 581
++ KLGEG FG VYKG+L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+LLG C E+ ++ EYM L +L + L + IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
IHRDL A N L+ +++ KISDFG++R
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 59/154 (38%), Positives = 83/154 (53%), Gaps = 10/154 (6%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNG-----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 581
++ KLGEG FG VYKG L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+LLG C E+ +++ EYM L +L + L + IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
IHRDL A N L+ +++ KISDFG++R
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 5e-41
Identities = 57/115 (49%), Positives = 72/115 (62%), Gaps = 6/115 (5%)
Query: 86 PDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGN 145
TVVWVANR +P+ D + L + + GNLVL + + +WSSN S + VA L D+GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 146 LVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPS 200
LV+ DNSG LWQSFD+PTDT+L G K G ++ G R TSWKS DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 8e-41
Identities = 54/120 (45%), Positives = 71/120 (59%), Gaps = 6/120 (5%)
Query: 49 LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTV 108
+ G+TLVS FELGFF Y I Y+ TVVWVANR++P + LT+
Sbjct: 3 PLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTL 61
Query: 109 SNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYP 168
+ GNLV+ + S +WSSN +R N V LLD+GNLV+ D+ G ++LWQSFDYP
Sbjct: 62 QSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDG-----NFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 61/155 (39%), Positives = 82/155 (52%), Gaps = 14/155 (9%)
Query: 532 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRL 586
KLGEG FG VYKG+L EVAVK L S + K+F E ++ KL H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
LG C E+ L+ EYM L +L F +K L + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ +HRDL A N L+ + + KISDFG++R
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-38
Identities = 56/119 (47%), Positives = 73/119 (61%), Gaps = 7/119 (5%)
Query: 49 LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTV 108
+ G+TLVS + FELGFF+ QN Y I Y+ TVVWVANR++P V + LT+
Sbjct: 3 TLSSGQTLVSGNSLFELGFFTLI-MQNDYNLILYKSSSRTVVWVANRDNP-VSDSCTLTL 60
Query: 109 SNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167
+ GNLVL + +WSSN + N V LLD+GNLVI D+ G ++LWQSFDY
Sbjct: 61 QSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 4e-38
Identities = 57/161 (35%), Positives = 82/161 (50%), Gaps = 11/161 (6%)
Query: 527 FSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH 580
+ KLGEG FG VYKG L +VAVK L + + +EF E ++ KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N+VRLLG C + ++ EYM L FL L + +++ IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+HRDL A N L+ +++ KISDFG++R D+
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD 156
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 9e-38
Identities = 62/163 (38%), Positives = 87/163 (53%), Gaps = 10/163 (6%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
LGEGGFG VY R G++VA+K + + L E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
++ L+ EY SL L + K L +RI+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 651 RDLKASNILLDQ-HMNPKISDFGMARMFGGDELQGNTKRIVGT 692
RDLK NILLD + K++DFG++++ D+ T IVGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 56/169 (33%), Positives = 85/169 (50%), Gaps = 11/169 (6%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ + KLG G FG VYK + G+ VAVK L ++ + + + E+ ++ +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
VRL+ ++ L+ EY L +L ++ L +I I +GL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH-- 115
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
IIHRDLK NILLD++ KI+DFG+A+ + VGT
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGT 161
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 56/173 (32%), Positives = 79/173 (45%), Gaps = 21/173 (12%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 584
+ I KLGEG FG VY R G+ VA+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
RL ++ + L+ EY L L + Q I L Y
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ--------ILSALEY 112
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
LH I+HRDLK NILLD+ + K++DFG+AR E VGT
Sbjct: 113 LHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 55/171 (32%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 532 KLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG G FG VY G+ +AVK LS S + L+ + E+ +++ LQH N+VR G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 589 CCIEQGEK-ILIY-EYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
++ + + I+ EY+ SL L +R I +GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-------VIRKYTRQ-ILEGLAYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I+HRD+K +NIL+D K++DFG A+ G E T + GT
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 56/171 (32%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 526 NFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQHRN 582
N+ + +G G FG VYKG L G VA+K++S + LK E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLH 641
+V+ +G +I EY N SL + KK L + + QGL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ +IHRD+KA+NIL + K++DFG+A + +VGT
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 61/158 (38%), Positives = 82/158 (51%), Gaps = 7/158 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG G FG V+ G +VAVK L + F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 585 RLLGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+L C + E I I EYM SL FL K L QL V + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-VDMAAQIAEGMAYLE-- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
IHRDL A NIL+ +++ KI+DFG+AR+ DE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-26
Identities = 34/67 (50%), Positives = 46/67 (68%), Gaps = 1/67 (1%)
Query: 347 CKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMW 406
C GD F +L ++KLPD ++ S+ LKECE CL NCSC AYA + + GGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59
Query: 407 FGDLIDL 413
G+L+D+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 52/153 (33%), Positives = 79/153 (51%), Gaps = 13/153 (8%)
Query: 531 SKLGEGGFGPVYKGRLLN-----GQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLV 584
+LGEG FG V R G++VAVK L+ + Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 585 RLLGCCIEQGEKI--LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ G C + G + LI EY+ + SL +L + + + + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
R IHRDL A NIL++ KISDFG+A+
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 56/167 (33%), Positives = 88/167 (52%), Gaps = 9/167 (5%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
F I K+G+GGFG VYK R G+EVA+K + +S + ++ NE+ ++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
G +++ E ++ E+ SL L T + L Q+ + + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCKELLKGLEYLHSN-- 117
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
IIHRD+KA+NILL K+ DFG++ +VGT
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 51/159 (32%), Positives = 82/159 (51%), Gaps = 18/159 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E F+++ KLG G FG V++G N VA+K L + ++F+ E+ + +L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-----HLL--GWQLRVRIIDGIAQGL 637
L C +I E M SL FL P + L+ Q +A+G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
YL + IHRDL A NIL+ + + K++DFG+AR+
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 29/178 (16%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQH 580
+ +++GEG +G VYK R G+ VA+K++ ++ KE E+ L+ KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57
Query: 581 RNLVRLLGCCIE--QGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
N+VRL +G +++EYM + S +V + K + QL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK-QL------- 109
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+GL YLH I+HRD+K SNIL++ K++DFG+AR + T R++
Sbjct: 110 -LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 60/163 (36%), Positives = 83/163 (50%), Gaps = 23/163 (14%)
Query: 533 LGEGGFGPVYKGRL--LNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
LGEG FG VYKG L N + VA+K L N + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLF-------------DPTKKHLLGWQLRVRIIDG 632
LLG C ++ +++EY+ + L FL D T K L + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
IA G+ YL S +HRDL A N L+ + + KISDFG++R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 52/160 (32%), Positives = 86/160 (53%), Gaps = 22/160 (13%)
Query: 533 LGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + VA+K L ++ + KE +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 587 LGCCIEQGEKI-LIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLH 641
LG C+ ++ LI + M L ++ + ++LL W ++ IA+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ R++HRDL A N+L+ + KI+DFG+A++ DE
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 59/165 (35%), Positives = 89/165 (53%), Gaps = 10/165 (6%)
Query: 528 SIQSKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRN 582
+I+ +G G FG V +GRL L G++ VA+K L S + +F E ++ + H N
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++RL G + ++I EYM N SLD FL + K V ++ GIA G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL-- 122
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
S + +HRDL A NIL++ ++ K+SDFG++R E TK
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 21/176 (11%)
Query: 524 TENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQH 580
E + K+GEG G VYK G+EVA+K RL Q+ + + NE++++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKH 74
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSL----DVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
N+V + E ++ EYM SL + + + + QG
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI------AYVCREVLQG 128
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
L YLH +IHRD+K+ NILL + + K++DFG A + + +VGT
Sbjct: 129 LEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 23/162 (14%)
Query: 533 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVR 585
LGEG FG V+ G + + VAVK L + ++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL------------FDPTKKHLLGWQLRVRIIDGI 633
G C E I+++EYM + L+ FL D L QL ++I I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL-LQIAVQI 131
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
A G++YL + +HRDL N L+ + KI DFGM+R
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (238), Expect = 1e-21
Identities = 59/167 (35%), Positives = 87/167 (52%), Gaps = 33/167 (19%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ----SGQGLKEFKNEMMLIAKLQ 579
+ KLGEG +G VYK R G+ VA+K RL N+ L+E L+ +L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS----LLKELK 56
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFL------FDPTK-KHLLGWQLRVRIID 631
H N+V+LL I K+ L++EY + L +L P K ++ +QL
Sbjct: 57 HPNIVKLL-DVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIM-YQL------ 107
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+GL Y H + RI+HRDLK NIL+++ K++DFG+AR FG
Sbjct: 108 --LRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 58/188 (30%), Positives = 91/188 (48%), Gaps = 31/188 (16%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ------GLKEFKNEMMLI 575
++ I KLGEG FG VYK R + G+ VA+K++ + + L+E K ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQL---RVR---- 628
KL+H N+V L+ +E+ +K K V++ P H L L V+
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSK------RKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115
Query: 629 ----IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
+ + +G+ YLH+ I+HRD+KA+NIL+D KI+DFG+AR + G
Sbjct: 116 QIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 685 NTKRIVGT 692
GT
Sbjct: 173 KGGGGGGT 180
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-21
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 343 HSSDCKSG---DRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDG 399
+C D F KL D+KLPD ++ +++L+EC CL NCSC AYA +G
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDN-ASAIT-AISLEECREACLSNCSCTAYAY---NNG 55
Query: 400 GSGCLMWFGDLIDLKKTDNHTNGVSIYIRVP 430
GCL+W G L +L+ + G ++Y+R+
Sbjct: 56 SGGCLLWNGLLNNLRSLSS--GGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 48/145 (33%), Positives = 78/145 (53%), Gaps = 6/145 (4%)
Query: 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
+ +G+G FG V G GQ+VAVK L + S + F E ++ L+H NLV+LLG
Sbjct: 12 ATIGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
++ ++ EYM SL +L + + Q +D + +G+ YL + +H
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD-VCEGMEYLEEK---NFVH 125
Query: 651 RDLKASNILLDQHMNPKISDFGMAR 675
RDL A N+L+ + + K+SDFG+A+
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.0 bits (237), Expect = 4e-21
Identities = 57/176 (32%), Positives = 87/176 (49%), Gaps = 14/176 (7%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH-R 581
++ I KLGEG FG VY R + + VA+K L+ + + ++ F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+L ++G L+ EY+ SL+ L +K L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMN-PKISDFGMARMFGGD----ELQGNTKRIVGT 692
IIHRD+K NILLD+ K+ DFG+A++ + VGT
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 56/157 (35%), Positives = 80/157 (50%), Gaps = 9/157 (5%)
Query: 528 SIQ--SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
SIQ KLG G FG V++G N VAVK L + K+F E ++ KL+H L++
Sbjct: 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQ 65
Query: 586 LLGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
L C E I I E M SL +L + L QL + + +A G+ YL +
Sbjct: 66 LYAVCT-LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL-IDMAAQVASGMAYLEAQN 123
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
IHRDL A N+L+ ++ K++DFG+AR+ D
Sbjct: 124 ---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 60/161 (37%), Positives = 86/161 (53%), Gaps = 14/161 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E + KLG G FG V+ G +VA+K L Q + F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV-RIID---GIAQGLLYL 640
RL + Q +I EYM N SL FL P G +L + ++ID IA+G+ ++
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPE-----GIKLTINKLIDMAAQIAEGMAFI 118
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
R IHRDL+A+NIL+ + + KI+DFG+AR+ +E
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E F I KLGEG +G VYK GQ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
V+ G + + ++ EY S D + T K L ++ I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAA-ILYQTLKGLEYLHS 117
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ IHRD+KA NILL++ K++DFG++ + NT ++GT
Sbjct: 118 ---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 6/155 (3%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
++G G FG V+ G L ++VA+K + + ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
E+ L++E+M + L +L ++ + + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 652 DLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
DL A N L+ ++ K+SDFGM R D+ +T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 6/149 (4%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592
LG G FG V+ G+ +VA+K + + +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRD 652
Q ++ EYM N L +L +K LG + + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 653 LKASNILLDQHMNPKISDFGMARMFGGDE 681
L A N L+ + K+SDFG+AR D+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 17/175 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ I ++G+G FG VY R +G+ +K LSN S + ++ NE+ ++ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQL--RVRIIDGIAQ---GL 637
+++ E+G+ ++ EY L + KK + +I+D Q L
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI----KKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
YLH SR +I+HRD+K NI L + K+ DFG++++ T +VGT
Sbjct: 117 KYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 533 LGEGGFGPVYKGR---LLNGQE---VAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 585
+G+G FG V++ R LL + VAVK L + S +F+ E L+A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKH-LLGWQLRVRIIDG---------- 632
LLG C L++EYM L+ FL P + L R
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGN 685
+A G+ YL S + +HRDL N L+ ++M KI+DFG++R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 23/164 (14%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQHRNL 583
+ K+GEG +G VYK R L G+ VA+K++ + E+ L+ +L H N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTK-------KHLLGWQLRVRIIDGIAQG 636
++LL +G+ L++E+M + L + D + K L +Q + QG
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYL-YQ--------LLQG 110
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
L + H + I+HRDLK N+L++ K++DFG+AR FG
Sbjct: 111 LAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
+ LG+G G VYK R G+ A+K++ + + K+ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV--RIIDGIAQGLLYL 640
+V+ G ++GE ++ EYM SL L K + V I I +GL YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
H + IIHRD+K SN+L++ KI+DFG+++
Sbjct: 116 HT--KRHIIHRDIKPSNLLINSKGEVKIADFGISK 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 61/154 (39%), Positives = 77/154 (50%), Gaps = 15/154 (9%)
Query: 530 QSKLGEGGFGPV--YKGRLLN---GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 583
LGEG FG V Y N G+ VAVK L + GQ +K E+ ++ L H N+
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 584 VRLLGCCIEQGEKI--LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
V+ GCC EQG K LI EY+ SL +L KH L + I +G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
IHRDL A N+LLD KI DFG+A+
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 24/160 (15%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN-----EMMLIAKLQHRNLV 584
KLGEG + VYK R G+ VA+K++ + K+ N E+ L+ +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 585 RLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
LL + L++E+M V K + L K + LR GL
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLR---------GLE 116
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
YLH I+HRDLK +N+L+ K++DFG+AR FG
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 55/158 (34%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 533 LGEGGFGPVYKG--RLLNGQE--VAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LG G FG V KG + +G+E VAVK L G KEF E ++A+L H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 588 GCCIEQGEKILIYEYMVNK-SLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
G C +GE +++ + L +L L +V A G+ YL
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES- 113
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+HRDL A N+LL KISDFGM+R G
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 54/157 (34%), Positives = 86/157 (54%), Gaps = 22/157 (14%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 588
K+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIAQGLLYLH 641
+ + L++E+ LD+ L KK++ L L + + QG+ Y H
Sbjct: 66 VVHSENKLYLVFEF-----LDLDL----KKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+ R++HRDLK N+L+D+ K++DFG+AR FG
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 13/153 (8%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
K+GEG +G VYKGR GQ VA+K RL ++ E+ L+ +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 589 CCIEQGEKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
+++ LI+E++ + K LD P +++ ++ + I QG+L+ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSL---PKGQYMDAELVKSYLYQ-ILQGILFCH---S 119
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
R++HRDLK N+L+D K++DFG+AR FG
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 55/149 (36%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
K+G+G FG VYKG L EVAVK + LK F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDP----TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
+++ ++ E + SL FL T K LL L A G+ YL +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDA------AAGMEYLESKN-- 113
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMAR 675
IHRDL A N L+ ++ KISDFGM+R
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-19
Identities = 38/112 (33%), Positives = 57/112 (50%), Gaps = 10/112 (8%)
Query: 228 TGPWNGVAFGSAP-----SNTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLGQVQ 282
+GPWNG+ F P S + F +N +EVYY Y ++ I L ++ G ++
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYNF----TENNEEVYYTYRMTNNSIYSRLTLSSEGSLE 58
Query: 283 RLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQTSHCECLEGFKFKS 333
R W S W +F++AP C YG CGP C V+ + C C++GF K+
Sbjct: 59 RFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 48/154 (31%), Positives = 85/154 (55%), Gaps = 6/154 (3%)
Query: 528 SIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
+++ KLG G +G VY+G VAVK L + ++EF E ++ +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
LG C + +I E+M +L +L + ++ + L + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-LYMATQISSAMEYLEKKN-- 124
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
IHRDL A N L+ ++ K++DFG++R+ GD
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 58/162 (35%), Positives = 82/162 (50%), Gaps = 21/162 (12%)
Query: 532 KLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+LGEG FG V+ LL Q+ VAVK L S ++F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHL----------LGWQLRVRIIDGI 633
G C E ++++EYM + L+ FL P K L L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
A G++YL + L +HRDL N L+ Q + KI DFGM+R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 53/173 (30%), Positives = 92/173 (53%), Gaps = 15/173 (8%)
Query: 526 NFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+F I +K+G+G FG V+K R + + A+K+ LS + + +E +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL---LGWQLRVRIIDGIAQGLLY 639
++R +++G+ ++ EY N L L + L W+ ++I+ GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL----LGLAH 116
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
LH +I+HRD+K+ N+ LD + N KI D G+A++ + NT IVGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 58/159 (36%), Positives = 92/159 (57%), Gaps = 12/159 (7%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + E VA+K L+ +G + EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
LG C+ + L+ + M + L ++ + K +G QL + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
R++HRDL A N+L+ + KI+DFG+AR+ GDE + N
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 59/171 (34%), Positives = 92/171 (53%), Gaps = 16/171 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQH 580
I+ +G G FG V GRL L G+ VA+K L + + + ++F +E ++ + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH---LLGWQLRVRIIDGIAQGL 637
N++ L G + +++ EYM N SLD FL +KH QL V ++ GIA G+
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQL-VGMLRGIASGM 119
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
YL S + +HRDL A NIL++ ++ K+SDFG++R+ D T R
Sbjct: 120 KYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 54/156 (34%), Positives = 90/156 (57%), Gaps = 10/156 (6%)
Query: 530 QSKLGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 584
Q +G G FG V++G L + G++ VA+K L + + ++F +E ++ + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL G + ++I EYM N +LD +L D +QL V ++ GIA G+ YL S
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQL-VGMLRGIAAGMKYL---S 124
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
+ +HRDL A NIL++ ++ K+SDFG++R+ D
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 59/160 (36%), Positives = 85/160 (53%), Gaps = 11/160 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID---GIAQGLLYLH 641
RL ++ +I EYM SL FL K G L ++ID IA+G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
R IHRDL+A+N+L+ + + KI+DFG+AR+ +E
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 55/158 (34%), Positives = 87/158 (55%), Gaps = 22/158 (13%)
Query: 529 IQSKLGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNL 583
I+ +G G FG V +GRL L G+ VA+K L S + + ++F +E ++ + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGL 637
+ L G + ++I E+M N +LD FL F QL V ++ GIA G+
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI-------QL-VGMLRGIAAGM 119
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
YL S + +HRDL A NIL++ ++ K+SDFG++R
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 527 FSIQSKLGEGGFGPVYKGRL----LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQH 580
+ LGEG FG V +G+L + +VAVK +L + ++EF +E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 581 RNLVRLLGCCIEQGEK------ILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIID 631
N+++L+G C E ++I +M + L FL L Q ++ +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD 680
IA G+ YL S IHRDL A N +L + M ++DFG+++ ++ GD
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-18
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 582
F+ ++G G FG VY R + + VA+K++S QS + ++ E+ + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ GC + + L+ EY + + D+ + KK L ++ I G QGL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDIL--EVHKKPLQEVEIAA-ICHGALQGLAYLHS 133
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
+ R IHRD+KA NILL + K++DFG A +
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 8/156 (5%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 582
NF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+LL + + L++E++ ++ L F+ D + + L + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+ R++HRDLK N+L++ K++DFG+AR FG
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 55/168 (32%), Positives = 84/168 (50%), Gaps = 19/168 (11%)
Query: 523 ATENFSIQSKLGEGGFGPVYKG--RLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLI 575
++ ++ LG G FG VY+G R +G +VAVK L + S Q +F E +++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD----PTKKHLLGWQLRVRIID 631
+K H+N+VRL+G E+ + ++ E M L FL + P + L + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMAR 675
+A+G YL + IHRD+ A N LL P KI+DFGMAR
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 34/173 (19%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLN---GQEVAVKRL--SNQSGQGLKEFK-NEMMLIAKLQH 580
+ I+ +G G +G VYK + N G+E A+K+ + G+ + E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 581 RNLVRLLGCCIEQGEKI--LIYEYMVNKSLDVFLF----------DPTKKHLLGWQLRVR 628
N+V L+ +E +K L+++Y + + F K LL WQ
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-WQ---- 116
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMARMF 677
I G+ YLH ++HRDLK +NIL+ + KI D G+AR+F
Sbjct: 117 ----ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 55/169 (32%), Positives = 83/169 (49%), Gaps = 25/169 (14%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLN---GQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
N ++ +LGEG FG V+ N Q+ VAVK L + S K+F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF-------------DPTKKHLLGWQLR 626
H ++V+ G C+E I+++EYM + L+ FL P + L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE---LTQSQM 122
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ I IA G++YL + +HRDL N L+ +++ KI DFGM+R
Sbjct: 123 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 56/157 (35%), Positives = 83/157 (52%), Gaps = 20/157 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNL 583
+ ++ +GEG FG V +G GQ+VAVK + + + Q F E ++ KL H+NL
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNL 61
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLL 638
VRLLG + G I++ E M +L FL + LL + L V A+G+
Sbjct: 62 VRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV------AEGME 114
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
YL +++HRDL A NIL+ + K+SDFG+AR
Sbjct: 115 YLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 52/164 (31%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 531 SKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQH N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 586 LLGCCIEQGEK--ILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGL 637
G C G + L+ EY+ SL +L D K L Q I +G+
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGM 121
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
YL R +HRDL NIL++ KI DFG+ ++ D+
Sbjct: 122 EYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 16/152 (10%)
Query: 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRL 586
+LG G G V K G+ +AVK + + K + ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL---FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
G G+ + EYM SLD L + +LG +I + +GL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH-- 117
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ +IIHRD+K SNIL++ K+ DFG++
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 57/152 (37%), Positives = 86/152 (56%), Gaps = 18/152 (11%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVKRLS----NQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VY+G L +G AVK +S Q+GQ +K+ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 587 LGCCIEQGEKILIY-EYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
LG E + + I+ E + SL L + + ++ +L R I GL YLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVI--RLYTR---QILLGLEYLH-- 119
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
R +HRD+K +NIL+D + K++DFGMA+
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 50/172 (29%), Positives = 90/172 (52%), Gaps = 12/172 (6%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ + I +LG+G FG VYK + G A K + +S + L++F E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V L + + ++ E+ +LD + ++ L Q+R + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHS 121
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR--IVGT 692
+ ++IHRDLKA NILL + K++DFG++ LQ KR +GT
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ---KRDTFIGT 166
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 20/158 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E++ + ++G G +G VYK R + G+ VA+K + + G + + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA-------QG 636
V G + + + ++ EY SL ++ T+ L Q IA +G
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQ--------IAYVCRETLKG 113
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
L YLH+ IHRD+K +NILL + + K++DFG++
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 53/177 (29%), Positives = 93/177 (52%), Gaps = 30/177 (16%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQG---LKEFKNEMMLIAKLQHRNLVR 585
LG G F Y+ R + G +AVK+++ N S + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LG E L E+M S+ L + K+ ++ + + + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 644 SRLRIIHRDLKASNILLD---QHMNPKISDFGMA-----RMFGGDELQGNTKRIVGT 692
+IIHRD+K +N+L+D Q + +I+DFG A + G E QG +++GT
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---QLLGT 171
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 29/178 (16%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG------LKEFKNEMMLIAKL 578
+ I ++GEG G V+K + G+ VA+K+++ + +G L+E K +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
QH +V+LL +L+ EYM V + + L + K + L+
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK------ 110
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
G+ Y+H I+HRDLK +N+L+ KI+DFG+AR+F +E + + ++
Sbjct: 111 ---GVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 61/178 (34%), Positives = 91/178 (51%), Gaps = 26/178 (14%)
Query: 532 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 584
+LGE FG VYKG L Q VA+K L +++ L+E FK+E M+ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLF-------------DPTKKHLLGWQLRVRIID 631
LLG ++ +I+ Y + L FL D T K L V I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--ELQGNT 686
IA G+ +L S ++H+DL N+L+ +N KISD G+ R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 55/157 (35%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L E+ I + EYM SL FL K+L QL V + IA G+ Y+
Sbjct: 65 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 119
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 55/184 (29%), Positives = 81/184 (44%), Gaps = 32/184 (17%)
Query: 532 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNEMM 573
KLGEG FG V+ Q+ VAVK L + S ++F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKH---LLGWQL 625
++++L N+ RLLG C +I EYM N L+ FL L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--EL 682
+ + IA G+ YL L +HRDL N L+ ++ KI+DFGM+R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 683 QGNT 686
QG
Sbjct: 189 QGRA 192
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 53/162 (32%), Positives = 85/162 (52%), Gaps = 20/162 (12%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNL 583
NF KLGEG + VYKGR G+ VA+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 584 VRLLGCCIEQGEKILIYEYM---VNKSLDVF----LFDPTKKHLLGWQLRVRIIDGIAQG 636
VRL + + +L++EYM + K +D DP +QL +G
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL--------LKG 112
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+ + H+ R++HRDLK N+L+++ K++DFG+AR FG
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 36/170 (21%)
Query: 533 LGEGGFGPVYKGRLL------NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL-QHRNLV 584
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDP--------TKKHLLGWQL 625
LLG C ++G ++ EY + +L FL D T+K L+ +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+V A+G+ +L + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 140 QV------ARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ + +LG G FG V G+ +VA+K + S EF E ++ KL H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL--HQ 642
+L G C +Q ++ EYM N L +L + K QL + + + +G+ YL Q
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQL-LEMCKDVCEGMAYLESKQ 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ IHRDL A N L+D K+SDFG++R DE
Sbjct: 121 F-----IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 52/153 (33%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 533 LGEGGFGPVYKGRLL--NGQEV--AVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 587
+G+G FG VY G L+ +GQ++ AVK L+ + + +++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 588 GCCI-EQGEKILIYEYMVNKSLDVFLFD----PTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
G C+ +G +++ YM + L F+ PT K L+G+ L+V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ +HRDL A N +LD+ K++DFG+AR
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 35/180 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFK-----NEMMLIAKL 578
++F +GEG F V + +E A+K L + Q +KE K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 579 -QHRNLVRLLGCCIEQGEKILIYEYMVN----------KSLDVFLFDPTKKHLLGWQLRV 627
H +++L ++ + EY N SLD +
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE----KCTRFYAA----- 109
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
I+ + YLH IIHRDLK NILLD+ M+ KI+DFG A++ + + K
Sbjct: 110 EILLALE----YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 53/157 (33%), Positives = 86/157 (54%), Gaps = 21/157 (13%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 588
K+GEG +G VYK R + + +A+K++ Q +G+ E+ L+ ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 589 CCIEQGEKILIYEYM---VNKSLDV---FLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ L++EY+ + K +D F +P +Q I+ GIA Y H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----YCHS 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFG 678
+ R++HRDLK N+L+D+ N K++DFG+AR FG
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 58/158 (36%), Positives = 87/158 (55%), Gaps = 8/158 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 583
E+ + KLG+G FG V+ G +VA+K L + G + E F E ++ KL+H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V L E+ I + E+M SL FL + K+L QL V + IA G+ Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
R+ IHRDL+A+NIL+ ++ KI+DFG+AR+ +E
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 53/152 (34%), Positives = 68/152 (44%), Gaps = 16/152 (10%)
Query: 532 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
KLG+G FG V +G VAVK L + + +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID---GIAQGLLYLHQY 643
G + ++ E SL D +K LG L + D IA G+ YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
R IHRDL A NILL KI DFG+ R
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 23/161 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 579
+ + +GEG +G V K R G+ VA+K+ + + ++ K E+ ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIA 634
H N+V L +G L++EY+ L++ P WQL
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------L 110
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
Q + Y H IIHRD+K NIL+ + K+ DFG AR
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 7/172 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
+++ + +G G VY L N ++VA+KR+ + + E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+ + E L+ Y+ SL + + L + ++ + +GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGT 692
+ IHRD+KA NILL + + KI+DFG++ GGD + K VGT
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 55/159 (34%), Positives = 82/159 (51%), Gaps = 6/159 (3%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E+ + KLG G FG V+ G +VAVK L + + F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
LV+L E+ I + EYM SL FL D + L L V + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAAQVAAGMAYIE- 119
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
R+ IHRDL+++NIL+ + KI+DFG+AR+ +E
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 11/152 (7%)
Query: 533 LGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
LG+G +G VY R L+ Q +A+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 592 EQGEKILIYEYMVNKSLDVFL---FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
E G + E + SL L + P K + + I +GL YLH +I
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK---QILEGLKYLHD---NQI 129
Query: 649 IHRDLKASNILLDQHMNP-KISDFGMARMFGG 679
+HRD+K N+L++ + KISDFG ++ G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 49/150 (32%), Positives = 77/150 (51%), Gaps = 6/150 (4%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
+LG G FG V+ G+ +VA+K + N+ ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
+Q ++ E+M N L +L ++ L + + + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 652 DLKASNILLDQHMNPKISDFGMARMFGGDE 681
DL A N L+ K+SDFGM R DE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 51/157 (32%), Positives = 88/157 (56%), Gaps = 16/157 (10%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG-QGLKEFK-NEMMLIAKLQ---HRNLVRL 586
+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L+ H N+VRL
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 587 LGCC-IEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
L C + ++ L++E+ V++ L +L K L ++ ++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+ RI+HRDLK NIL+ KI+DFG+AR++
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 6e-16
Identities = 51/154 (33%), Positives = 83/154 (53%), Gaps = 10/154 (6%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 582
F+ ++G G FG VY R + EV A+K++S QS + ++ E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ GC + + L+ EY + + D L + KK L ++ I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHS 143
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
++ +IHRD+KA NILL + K++DFG A +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 6e-16
Identities = 51/160 (31%), Positives = 78/160 (48%), Gaps = 24/160 (15%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIAK 577
+ + +LG+G FG VY R G+ VA+K++ K+F + E+ + K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 578 LQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR-IIDGIAQ 635
L H N+V+L E E ++EYM +L + D K + +R II I Q
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS--ESVIRSIIYQILQ 110
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
GL ++H + HRDLK N+L+ KI+DFG+AR
Sbjct: 111 GLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 53/154 (34%), Positives = 84/154 (54%), Gaps = 10/154 (6%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 582
FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++ GC + + L+ EY + + D L + KK L ++ + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAYLHS 133
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
++ +IHRD+KA NILL + K+ DFG A +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 22/166 (13%)
Query: 529 IQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
++ +LGEG FG V+ N VAVK L + + K+F+ E L+ LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLF------------DPTK-KHLLGWQLRVRI 629
+V+ G C + I+++EYM + L+ FL P + K LG + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
IA G++YL + +HRDL N L+ ++ KI DFGM+R
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 31/184 (16%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQE---------------VAVKRL-SNQSGQGLKEFKNEM 572
++ KLGEG FG V+ E VAVK L ++ + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLL---------GW 623
++++L++ N++RLLG C+ +I EYM N L+ FL +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 624 QLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD-- 680
+ + IA G+ YL + L +HRDL N L+ H KI+DFGM+R ++ GD
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 681 ELQG 684
+QG
Sbjct: 186 RIQG 189
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 55/164 (33%), Positives = 82/164 (50%), Gaps = 23/164 (14%)
Query: 532 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVR 585
+LGE FG +YKG L + Q VA+K L + + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLF--------------DPTKKHLLGWQLRVRIID 631
LLG ++ +++EY+ L FL D T K L + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
IA G+ YL + +H+DL A NIL+ + ++ KISD G++R
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 40/192 (20%)
Query: 530 QSKLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNE 571
+ KLGEG FG V+ ++N Q+ VAVK L + + +F E
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTK 617
+ ++++L+ N++RLLG C+++ +I EYM N L+ FL P
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 618 KHLL--GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L + + + IA G+ YL S L +HRDL N L+ +++ KI+DFGM+R
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 676 -MFGGD--ELQG 684
++ GD +QG
Sbjct: 187 NLYAGDYYRIQG 198
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 49/151 (32%), Positives = 79/151 (52%), Gaps = 16/151 (10%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G FG VY ++ G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 587 LGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLHQYS 644
GC + E + I+ EYM S+ D K + L + + I +G+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTRKYTRQILEGVEYLH--- 121
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
I+HRD+K +NIL D N K+ DFG ++
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 55/160 (34%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 533 LGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLV 584
LG G FG VY+G + VAVK L + Q KEF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH----LLGWQLRVRIIDGIAQGLLYL 640
+LLG C+ + +I E M L +L D + LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNP-----KISDFGMAR 675
Q + IHRDL A N L+ + KI DFG+AR
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 16/159 (10%)
Query: 535 EGGFGPVYKGRLLNG-----QEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLG 588
EG FG ++ G L++ +EV VK + + + + + E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 589 CCIEQGEK-ILIYEYMVNKSLDVFLFDP-----TKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
CIE GE ++Y YM +L +FL L Q V + IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD 680
+ +IH+D+ A N ++D+ + KI+D ++R +F D
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 51/163 (31%), Positives = 89/163 (54%), Gaps = 18/163 (11%)
Query: 533 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LGEG FG V +G+L +VAVK +++ + +++F +E + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 588 GCCIEQGEK------ILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLL 638
G C++ E ++I +M + L FL L Q+ V+ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGD 680
YL S IHRDL A N +L+++MN ++DFG++ +++ GD
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 51/144 (35%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGCCI 591
LG+G FG V+KG L + VAVK Q LK +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
++ ++ E + D F KK L + V+ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 652 DLKASNILLDQHMNPKISDFGMAR 675
DL A N L+ ++ KISDFGM+R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 29/171 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 577
E ++ +LG+G FG VY+G VA+K ++ N S + EF NE ++ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------FD-PTKKHLLGWQ 624
++VRLLG +++ E M L +L PT + +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
IA G+ YL + +HRDL A N ++ + + KI DFGM R
Sbjct: 126 AE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 47/156 (30%), Positives = 82/156 (52%), Gaps = 21/156 (13%)
Query: 532 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 588
K+GEG +G V+K + E VA+KR+ + +G+ E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 589 CCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ L++EY ++ L + DP +QL +GL + H
Sbjct: 67 VLHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQL--------LKGLAFCHS 117
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+ ++HRDLK N+L++++ K++DFG+AR FG
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 9/150 (6%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLV 584
F++ +G+G FG VYK Q VA+K + ++ +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ G ++ + +I EY S D K L I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMA 674
IHRD+KA+NILL + + K++DFG++
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 30/173 (17%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLG 588
LG+G FG V R + G+ A+K L + KE E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG--------IAQGLLY 639
+ EK+ L+ EY L HL R + I L Y
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL--------FSHL---SKEGRFSEERARFYAAEIVLALEY 108
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
LH L II+RDLK NILLD + K++DFG+A+ + + NT GT
Sbjct: 109 LH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGL-KEFKNEMMLIAKLQHRN 582
E S+LGEG G V K RL N + A+K ++ L K+ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 583 LVRLLGCCIE--QGEKILIYEYMVNKSLDVFLFDPTKK------HLLGWQLRVRIIDGIA 634
+V+ G ++ + EY SLD K+ +LG +I + +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVL 115
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672
+GL YLH +IIHRD+K SNILL + K+ DFG
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 31/168 (18%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLK-EFKNEMMLIAKLQHRN 582
F +++GEG +G VY+ R +G+ VA+K++ + G+ E+ L+ L+H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLD-VFLFDPTKKHLLGWQL----------RVR-II 630
+V L E +V K LD +FL + L L +V+ ++
Sbjct: 68 IVELK-------------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLM 114
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+ +GL YLH+ IIHRDLK SN+LL KI+DFG+AR +G
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 21/162 (12%)
Query: 526 NFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+F + KLG+G +G VYK RL + Q A+K L + S + ++ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 583 LVR-----LLGC--CIEQGEKILIYEYMVNKSLDVFLFDPTK-KHLLGWQLRVRIIDGIA 634
++ L G CI + EY L + K + L+ Q RI +
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
+GL LH+ +I+HRDLK++NILL + KI D G++++
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 50/163 (30%), Positives = 85/163 (52%), Gaps = 25/163 (15%)
Query: 530 QSKLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQG-----LKEFKNEMMLIAKLQHRN 582
+K+G+G FG V+K R Q VA+K+ L +G L+E K ++ L+H N
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHEN 72
Query: 583 LVRLLGCCIEQGEK--------ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA 634
+V L+ C + L++E+ L L + K L +++ +++ +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEF-CEHDLAGLLSNKNVKFTLS-EIK-KVMKMLL 129
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
GL Y+H R +I+HRD+KA+NIL+ + K++DFG+AR F
Sbjct: 130 NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 60/174 (34%), Positives = 86/174 (49%), Gaps = 26/174 (14%)
Query: 525 ENFSIQSKLGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLI 575
+ + LGEG FG V K R VAVK L N + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTKKH--LL 621
+ +H+N++ LLG C ++G +I EY +L FL FD TK L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
++ V +A+G+ YL SR R IHRDL A N+L+ + KI+DFG+AR
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 49/156 (31%), Positives = 71/156 (45%), Gaps = 16/156 (10%)
Query: 533 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVR 585
LG G FG V+ + +E V VK L + EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
LLG C E +I EY L FL + K L + +V + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L S R +HRDL A N L+ K+S +++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 29/186 (15%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QH 580
T F + +GEG +G VYK R GQ VA+K + +E K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNH 62
Query: 581 RNLVRLLGCCIEQGEKI------LIYEY--------MVNKSLDVFLFDPTKKHLLGWQLR 626
N+ G I++ L+ E +V K+ + +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAY--- 117
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
I+ +GL YLH+ ++IHRD+K NILL ++ K+ DFG++ + NT
Sbjct: 118 --ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 687 KRIVGT 692
+GT
Sbjct: 173 --FIGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 51/151 (33%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 532 KLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG--LKEFKNEMMLIAKLQHRNLVRLLG 588
K+G G FG VY L+ E+ AVK + Q +KE +EM ++ L+H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 589 CCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRV--RIIDGIAQGLLYLHQYSR 645
+ + EK+ I+ EY +L+ L +H V + +GL YLH +
Sbjct: 67 VEVHR-EKVYIFMEYCSGGTLEELL-----EHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARM 676
I+HRD+K +NI LD + K+ DFG A
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 56/186 (30%), Positives = 86/186 (46%), Gaps = 47/186 (25%)
Query: 526 NFSIQSKLGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
N + LGEG FG V K L G+ VAVK L N S L++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----------------------FDPT 616
H ++++L G C + G +LI EY SL FL +P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 617 KKHL-------LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669
++ L WQ I++G+ YL + ++++HRDL A N+L+ + KIS
Sbjct: 121 ERALTMGDLISFAWQ--------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKIS 169
Query: 670 DFGMAR 675
DFG++R
Sbjct: 170 DFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 20/159 (12%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + E VA+K L S + KE +E ++A + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTK----KHLLGWQLRVRIIDGIAQGLLYLHQ 642
LG C+ + LI + M L ++ + ++LL W ++ IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
R++HRDL A N+L+ + KI+DFG+A++ G DE
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 56/169 (33%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QH 580
+ Q +GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------FDP-------TKKHLLGWQLR 626
N++ LLG C +G L EY + +L FL DP T L QL
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
D +A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG++R
Sbjct: 128 HFAAD-VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 54/180 (30%), Positives = 91/180 (50%), Gaps = 25/180 (13%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
F I ++GEG +G VYK R G+ VA+K RL N+ E+ ++ +L HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 584 VRLLGCCI----------EQGEKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRII 630
V L ++G L++EYM + L+ L ++ H+ +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------KSFM 122
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+ +GL Y H+ + L HRD+K SNILL+ K++DFG+AR++ +E + T +++
Sbjct: 123 KQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 48/151 (31%), Positives = 84/151 (55%), Gaps = 6/151 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E + I +LG+G FG VYK + G A K + +S + L+++ E+ ++A H +
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI 71
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG G+ ++ E+ ++D + + + L Q++V I + + L YLH
Sbjct: 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS- 128
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
++IIHRDLKA N+LL + K++DFG++
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 54/159 (33%), Positives = 83/159 (52%), Gaps = 17/159 (10%)
Query: 533 LGEGGFGPV----YKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
LGEG FG V Y N G++VAVK L +SG + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 587 LGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL--HQ 642
G C E G LI E++ + SL +L P K+ + + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
Y +HRDL A N+L++ KI DFG+ + D+
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62
Query: 585 RLLGCCIEQ-GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ G ++ EYM SL +L + L G L +D + + + YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD-VCEAMEYLEAN 121
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ +HRDL A N+L+ + K+SDFG+ +
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 36/187 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLKEFKNEMMLI 575
NF I+ K+G+G F VYK LL+G+ VA+K++ + LKE L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEY--------MVN--KSLDVFLFDPTKKHLLGWQL 625
+L H N+++ L IE E ++ E M+ K + + T W+
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-----WKY 111
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
V++ + H +S+ RI+HRD+K +N+ + K+ D G+ R F +
Sbjct: 112 FVQLCSALE------HMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 686 TKRIVGT 692
+ VGT
Sbjct: 165 SL--VGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 51/153 (33%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQG-------LKEFKNEMMLIAKLQHRN 582
+G G FG VY G +G+ +AVK+ L + S L E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+ LG ++ + EY+ S+ L L + I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+R IIHRD+K +NIL+D KISDFG+++
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 31/161 (19%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVK------RLSNQSGQGLKE----FKNEMMLIAKLQHR 581
+G+G +G VY + G+ +AVK ++ + K+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 582 NLVRLLGCCIEQGEKIL-IY-EYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIA 634
N+V+ LG E E+ L I+ EY+ S+ L F+ QL + +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE--------QLVRFFTEQVL 118
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+GL YLH I+HRDLKA N+L+D KISDFG+++
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 40/180 (22%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG------------------LKEFKNEMM 573
LGEG +G V K L G+ VA+K++ L+E K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLD--VFLFDPTKKHLLGWQLRVR 628
++ +++H N++ L+ +E L+ + M + K +D + L + K +L Q
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ---- 127
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
I GL LH++ +HRDL +NI ++ KI+DFG+AR +G +
Sbjct: 128 ----ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
|
Length = 335 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 52/163 (31%), Positives = 77/163 (47%), Gaps = 10/163 (6%)
Query: 517 FASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMM 573
F +V T + +G G FG V R L GQ VA+K++ + K E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
L+ L+H N++ L I E I Y V + L L L Q + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQI 117
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
+GL Y+H ++HRDLK SNIL++++ + KI DFG+AR+
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 50/147 (34%), Positives = 80/147 (54%), Gaps = 10/147 (6%)
Query: 532 KLGEGGFGPVYKGRLLNGQE-VAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG VY + E VAVK++S Q+ + ++ E+ + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647
GC +++ L+ EY + + D L + KK L ++ I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHSHN--- 141
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMA 674
+IHRD+KA NILL + K++DFG A
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 32/187 (17%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSNQSGQGLK-EF 568
+ + KLGEG FG V+ ++ VAVK L + + + +F
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 569 KNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------FDPTKKHL 620
E+ ++++L+ N++RLL CI +I EYM N L+ FL +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGG 679
+ + + + IA G+ YL S L +HRDL N L+ ++ KI+DFGM+R ++ G
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 680 D--ELQG 684
D +QG
Sbjct: 184 DYYRIQG 190
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 57/176 (32%), Positives = 88/176 (50%), Gaps = 43/176 (24%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIAK 577
+ + +++ EG +G VY+ R G+ VA+K+L + G L+E N ++ K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60
Query: 578 LQHRNLVRL----LGCCIEQGEKILIY---EYMVN--KSL-----DVFLFDPTKKHLLGW 623
LQH N+V + +G +++ IY EY+ + KSL FL K +L
Sbjct: 61 LQHPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML-- 113
Query: 624 QLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679
QL + G+A +LH I+HRDLK SN+LL+ KI DFG+AR +G
Sbjct: 114 QL----LSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 53/160 (33%), Positives = 83/160 (51%), Gaps = 12/160 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID---GIAQGLLYLH 641
+L + + +I E+M SL FL K Q ++ID IA+G+ ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
Q + IHRDL+A+NIL+ + KI+DFG+AR+ +E
Sbjct: 120 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 53/166 (31%), Positives = 85/166 (51%), Gaps = 30/166 (18%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG V+KG + + VA+K + ++SG Q +E + M+ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 587 LGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH--------LLGWQLRVRIIDGIAQGL 637
LG C G + L+ + SL D ++H LL W ++ IA+G+
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQ------IAKGM 122
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
YL ++ R++HR+L A NILL +I+DFG+A + D+ +
Sbjct: 123 YYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
E + +GEG +G V K + GQ VA+K+ S K E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
NLV L+ + L++E++ + LD P + L + + I +G+ + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCH 117
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
++ IIHRD+K NIL+ Q K+ DFG AR
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 51/146 (34%), Positives = 74/146 (50%), Gaps = 7/146 (4%)
Query: 532 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGC 589
++G G FG V+ GRL + VAVK LK +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649
C Q + I I +V D F T+ L + +++++ A G+ YL I
Sbjct: 62 CT-QKQPIYIVMELVQGG-DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 650 HRDLKASNILLDQHMNPKISDFGMAR 675
HRDL A N L+ + KISDFGM+R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 44/153 (28%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
++ + ++G G +G VYK R L G+ AVK + + G + E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSL-DVF-LFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
V G + + + + EY SL D++ + P + + + R + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
++ HRD+K +NILL + + K++DFG+A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 13/154 (8%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
SK+GEG +G V+K R GQ VA+K+ S K E+ ++ +L+H NLV L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGW--QLRVRIIDGIAQGLLYLHQYSR 645
+ + L++EY D + + +K+ G L +II Q + + H+++
Sbjct: 67 EVFRRKRKLHLVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN- 120
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679
IHRD+K NIL+ + K+ DFG AR+ G
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 533 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G FG VY GR L ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 587 LGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLHQY 643
GC ++ EK L EYM S+ D K + L + + I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
I+HRD+K +NIL D N K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 54/165 (32%), Positives = 84/165 (50%), Gaps = 28/165 (16%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + E VA+K L N S + KE +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH--------LLGWQLRVRIIDGIAQGLL 638
LG C+ + L+ + M L D +++ LL W ++ IA+G+
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQ------IAKGMS 123
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
YL + +R++HRDL A N+L+ + KI+DFG+AR+ DE +
Sbjct: 124 YLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 43/153 (28%), Positives = 83/153 (54%), Gaps = 11/153 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E+F + ++G G +G VYK R +N G+ A+K + + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSL-DVF-LFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
V G + + + + E+ SL D++ + P + + + R + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
+ +HRD+K +NILL + + K++DFG++
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVR 585
F + +G G +G VYKGR + ++A ++ + +G +E K E+ ++ K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 586 LLGCCIEQG------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
G I++ + L+ E+ S+ L TK + L + I I +GL +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
LHQ+ ++IHRD+K N+LL ++ K+ DFG++ D G +GT
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 16/157 (10%)
Query: 532 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR----NLV 584
+LG G FG V KG ++ Q +VA+K L N++ K ++EMM A++ H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
R++G C E +L+ E L+ FL KK + V ++ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+HRDL A N+LL KISDFG+++ G D+
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 25/173 (14%)
Query: 527 FSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH 580
F++ LG+G FG V + +L + Q+VAVK L S ++EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 581 RNLVRLLGCCIEQGEK------ILIYEYMVNKSLDVFLF------DPTKKHLLGWQLRVR 628
N+++L+G + K ++I +M + L FL +P L Q VR
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT---LPLQTLVR 117
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD 680
+ IA G+ YL S IHRDL A N +L+++M ++DFG+++ ++ GD
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 52/171 (30%), Positives = 92/171 (53%), Gaps = 13/171 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 582
E F+ ++G+G FG VYKG +EV A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ R G ++ + +I EY+ S LD+ P ++ + LR I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
R IHRD+KA+N+LL + + K++DFG+A +++ NT VGT
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 24/162 (14%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRN 582
+ I K+GEG FG +Y + + E V + + + +KE K E++L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEY--------MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA 634
+V E G ++ EY +N+ V ++ +L W ++ I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQ------IS 111
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMAR 675
GL ++H +I+HRD+K+ NI L ++ M K+ DFG+AR
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 52/153 (33%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
KLGEG + VYKGR L GQ VA+K RL ++ G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 589 CCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ L++EY+ L ++ L +QL +GL Y HQ
Sbjct: 71 IIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQL--------LRGLAYCHQ 121
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
R++HRDLK N+L+ + K++DFG+AR
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 33/167 (19%)
Query: 531 SKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS---GQGLKEFKNEMML--IAKLQHRNL 583
+++GEG +G V+K R L G+ VA+KR+ Q+ G L + +L + +H N+
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 584 VRLLGCCI-----EQGEKILIYEYMVNKSLDVFLF---DP-----TKKHLLGWQLRVRII 630
VRL C + + L++E+ V++ L +L +P T K ++ +QL
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMM-FQL----- 119
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
+GL +LH + R++HRDLK NIL+ K++DFG+AR++
Sbjct: 120 ---LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 51/155 (32%), Positives = 83/155 (53%), Gaps = 12/155 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + KLGEG + VYKGR L VA+K RL ++ G + E+ L+ L+H
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 64
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLRVRIIDGIAQGLLYL 640
N+V L + L++EY+ +K L +L D ++ +L + + +GL Y
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL---FLFQLLRGLNYC 120
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
H R +++HRDLK N+L+++ K++DFG+AR
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 21/169 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-Q 579
E+ + +GEG FG V + + A+K L + + ++F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------FDPT--KKH----LLGWQLR 626
H N++ LLG C +G + EY +L FL DP K+H L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
++ +A G+ YL S + IHRDL A N+L+ +++ KI+DFG++R
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 525 ENFSIQSKLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
N+ + LG G FG VY GR L ++V S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 579 QHRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQ 635
+H +V+ GC + EK L EYM S+ D K + L + R I Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN-TKRIVGT 692
G+ YLH I+HRD+K +NIL D N K+ DFG ++ + G K + GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 57/163 (34%), Positives = 84/163 (51%), Gaps = 23/163 (14%)
Query: 522 AATENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK--NEMMLIAKL 578
AAT +++ KLGEG + VYKG +NGQ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 579 QHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH-----LLGWQLRVRIIDG 632
+H N+V LL I E + ++EYM + P H L +QL
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL------- 112
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+GL Y+H I+HRDLK N+L+ K++DFG+AR
Sbjct: 113 -LRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 36/187 (19%)
Query: 527 FSIQSKLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH 580
+ + +G+G FG V K G++L +E+ ++ + Q L +E+ ++ +L+H
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKH 58
Query: 581 RNLVRLLGCCI-EQGEKILIY-EY--------MVNKSLDVFLFDPTKKHLLGWQLRVRII 630
N+VR I + + I EY ++ K + + I
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF----------IW 108
Query: 631 DGIAQGLLYLH-----QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
+ Q LL L+ ++HRDLK +NI LD + N K+ DFG+A++ G D
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSF 166
Query: 686 TKRIVGT 692
K VGT
Sbjct: 167 AKTYVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 47/151 (31%), Positives = 82/151 (54%), Gaps = 16/151 (10%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRL----SNQ--SGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G +G VY G GQ +AVK++ SN + + ++ + E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
LG C++ + E++ S+ L F P + + + +I+DG+A YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNNC 122
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
++HRD+K +N++L + K+ DFG AR
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 47/151 (31%), Positives = 82/151 (54%), Gaps = 6/151 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E + I +LG+G FG VYK + G A K + +S + L+++ E+ ++A H N+
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LL + ++ E+ ++D + + ++ L Q+RV + + L YLH+
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN 122
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
+IIHRDLKA NIL + K++DFG++
Sbjct: 123 ---KIIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 55/181 (30%), Positives = 89/181 (49%), Gaps = 30/181 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMML 574
+ I KLG+G +G V+K + VA+K++ F+N E+M
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMF 59
Query: 575 IAKL-QHRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
+ +L H N+V+LL + +K L++EYM + L + ++L + I+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMY 114
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ + L Y+H S +IHRDLK SNILL+ K++DFG+AR EL+ N + V
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVL 169
Query: 692 T 692
T
Sbjct: 170 T 170
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 8/150 (5%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLGC 589
+G G FG V+ R Q++ + + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649
+E +++ EY +L ++ L I+ Q LL LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD----EDTILHFFVQILLALHHVHTKLIL 123
Query: 650 HRDLKASNILLDQH-MNPKISDFGMARMFG 678
HRDLK NILLD+H M KI DFG++++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILS 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 54/167 (32%), Positives = 79/167 (47%), Gaps = 28/167 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSGQGLKE-FKNEMMLIAK 577
N S LG G FG V + L +VAVK L + +E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEY-----MVN---KSLDVFLFDPTKKHLLGWQLRVR 628
L H N+V LLG C G ++I EY ++N + + FL T + LL + +V
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL---TLEDLLSFSYQV- 150
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
A+G+ +L + IHRDL A N+LL KI DFG+AR
Sbjct: 151 -----AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 9e-12
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 47/179 (26%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMMLIA 576
+ + +G G +G V G++VA+K++SN F + E+ L+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLR 54
Query: 577 KLQHRNLVRLLGCCI-----EQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQL 625
L+H N++ LL + + ++ E M V KS + L
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS---------PQPLT--DD 103
Query: 626 RVRIIDGIAQ---GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
++ + Q GL YLH +IHRDLK SNIL++ + + KI DFG+AR DE
Sbjct: 104 HIQYF--LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 49/159 (30%), Positives = 87/159 (54%), Gaps = 18/159 (11%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQ---HRNL 583
+++G G +G VYK R +G VA+K + +N+ G L + E+ L+ +L+ H N+
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNI 64
Query: 584 VRLLGCC----IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
VRL+ C ++ K+ L++E+ V++ L +L L ++ ++ +GL
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIK-DLMRQFLRGLD 122
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
+LH I+HRDLK NIL+ K++DFG+AR++
Sbjct: 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRL-----SNQSGQGLKEFKNEMMLIAKLQ 579
N+ + LG+G FG VY + G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 580 HRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQG 636
H +V+ GC + E+ L E+M S+ D K + L + + I +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN-TKRIVGT 692
+ YLH I+HRD+K +NIL D N K+ DFG ++ L G K + GT
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 64
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V L L++EY+ +K L ++ D +++ + I +GL Y H
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH 121
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
R +++HRDLK N+L+++ K++DFG+AR
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 38/175 (21%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR 581
+F + +G+G FG V + + +++ A+K ++ Q ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG--------- 632
LV L Q E+ Y+V +D+ LLG LR +
Sbjct: 61 FLVNL--WYSFQDEE---NMYLV---VDL---------LLGGDLRYHLSQKVKFSEEQVK 103
Query: 633 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
I L YLH IIHRD+K NILLD+ + I+DF +A D L
Sbjct: 104 FWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 7/154 (4%)
Query: 527 FSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNL 583
+ S +G G +G V G++VA+K+LS QS K E+ L+ + H N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 584 VRLLGCCIEQGEKILIYE-YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ LL + Y+V + L + K L ++ I +GL Y+H
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS 136
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
IIHRDLK SNI +++ KI DFG+AR
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 20/154 (12%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQ-HRNLVRL 586
K+GEG F V K + G+ A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 587 LGCCIEQ--GEKILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVR-IIDGIAQGLLYLH 641
+ ++ G L++E M D+ L++ K K L + RV+ + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH 117
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
R I HRD+K NIL+ K++DFG R
Sbjct: 118 ---RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 17/151 (11%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGC 589
LG G +G V K R + G +AVKR+ + + Q K ++ + + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV------RIIDGIAQGLLYLHQY 643
+G+ + E M + SLD F K + L + +I I + L YLH
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVKALEYLH-- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
S+L +IHRD+K SN+L++++ K+ DFG++
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 48/171 (28%), Positives = 91/171 (53%), Gaps = 13/171 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 582
E F+ ++G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ + G ++ + +I EY+ S LD+ P + + L+ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ IHRD+KA+N+LL + + K++DFG+A +++ NT VGT
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 55/154 (35%), Positives = 80/154 (51%), Gaps = 24/154 (15%)
Query: 532 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
KLGEG + VYKG+ +NG+ VA+K RL + G + E L+ L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIV-LLH 69
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
I E + L++EY V+ L ++ P L +QL +GL Y+H
Sbjct: 70 DIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL--------LRGLSYIH 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
Q I+HRDLK N+L+ K++DFG+AR
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 54/165 (32%), Positives = 82/165 (49%), Gaps = 21/165 (12%)
Query: 527 FSIQSKLGEGGFGPVY---------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIA 576
+ +Q +LG+G FG VY + RL +E+ V L+ N++ Q E L++
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLS 57
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIA 634
KL H +V+ +E+ +I EY + LD L T K L Q + +
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ----VCEWFI 113
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679
Q LL +H + RI+HRDLKA NI L ++ KI DFG++R+ G
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 51/166 (30%), Positives = 85/166 (51%), Gaps = 26/166 (15%)
Query: 533 LGEGGFGPVYKGRLLNGQE--------VAVKRL-SNQSGQGLKEFKNEMMLIAKL-QHRN 582
LGEG FG V + + VAVK L S+ + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTK--KHLLGWQLRVRI 629
++ LLG C + G +I EY +L +L ++PT+ + L ++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 16/157 (10%)
Query: 532 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSNQSGQGLKEFKNEMMLIAK----LQHRNLV 584
+LG G FG V KG ++ ++ VAVK L N + K+E++ A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
R++G C E +L+ E L+ FL KH+ + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTEKNI-TELVHQVSMGMKYLEETN 115
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+HRDL A N+LL KISDFG+++ G DE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 50/171 (29%), Positives = 90/171 (52%), Gaps = 13/171 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 582
E F+ K+G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ + G ++ + +I EY+ S LD+ P + + LR I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ IHRD+KA+N+LL +H K++DFG+A +++ N VGT
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 525 ENFSIQSKLGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLI 575
+ ++ LGEG FG V K + VAVK L + + + L + +EM ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTK--KHLL 621
+ +H+N++ LLG C + G +I EY +L +L +D + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
++ V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 18/152 (11%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGC 589
+G G FG V K G +AVKR+ S + K ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 590 CIEQGEKILIYEYMVNKSLDVF---LFDPTKKHL----LGWQLRVRIIDGIAQGLLYLHQ 642
+G+ + E M + SLD F +++ K + LG +I + L YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLKE 125
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
L+IIHRD+K SNILLD++ N K+ DFG++
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 48/149 (32%), Positives = 69/149 (46%), Gaps = 9/149 (6%)
Query: 532 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG V G + +V VK L + S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV--RIIDGIAQGLLYLHQYSR 645
G C E +L+ E+ L +L K L+ R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMA 674
IH DL N LL + KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 46/176 (26%), Positives = 85/176 (48%), Gaps = 18/176 (10%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHR 581
NF I+ K+G G F VY+ LL+ + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLD-VFLFDPTKKHLLG----WQLRVRIIDGIAQG 636
N+++ L IE E ++ E L + + +K L+ W+ V++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
H +SR R++HRD+K +N+ + K+ D G+ R F ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 23/162 (14%)
Query: 533 LGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QHRNLVRLL 587
+GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFL-------FDP-------TKKHLLGWQLRVRIIDGI 633
G C +G L EY + +L FL DP T L QL + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL-LHFAADV 121
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFG++R
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHA 63
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V L + L++EY+ + L +L D + +++ + + +GL Y H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ +I+HRDLK N+L+++ K++DFG+AR
Sbjct: 121 ---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKG--RLLNGQE--VAVKRLSNQSGQGLKE-FKNEMMLIAKLQ 579
E+ ++ +GEG FG VY+G ++ VAVK N + ++E F E ++ +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E I + E L +L K+ L + ++ L Y
Sbjct: 66 HPHIVKLIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAY 122
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L R +HRD+ A N+L+ K+ DFG++R
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 51/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 533 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRN 582
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTK--KHLLGWQLRVRI 629
++ LLG C + G ++ EY +L +L FD K + L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 16/153 (10%)
Query: 528 SIQSKLGEGGFGPVYKG--RLLNGQE--VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
I+ LG G FG + +G +L + +E VA+ L + S + + F E + + + H N
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH---LLGWQLRVRIIDGIAQGLLY 639
+VRL G +++ EYM N +LD FL +KH L+ QL + ++ G+A G+ Y
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQL-MGMLPGLASGMKY 122
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672
L S + +H+ L A +L++ + KIS F
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 26/154 (16%)
Query: 532 KLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
++G G G VYK G+ A+K + N ++ E+ ++ + H N+V+
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 590 CIEQGEKILIYEYMVNKSLD-------VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
GE ++ E+M SL+ FL D ++ I+ GIA YLH
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA----YLH- 185
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
R I+HRD+K SN+L++ N KI+DFG++R+
Sbjct: 186 --RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
|
Length = 353 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 46/155 (29%), Positives = 67/155 (43%), Gaps = 21/155 (13%)
Query: 532 KLGEGGFGPVYKG---RLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG V G R ++ V VK L + F E+ +L H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFL--------FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
G CIE +L+ E+ L +L K L R+ +A GLL+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGLLW 115
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
LHQ IH DL N L ++ KI D+G+A
Sbjct: 116 LHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQHRN 582
E+ S LG G G V K + G +A K + + + K+ E+ ++ + +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+V G + + + E+M SLD P +LG +I + +GL YL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL 119
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
Y+ RI+HRD+K SNIL++ K+ DFG++
Sbjct: 120 --YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 13/173 (7%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVR 585
F + +G G +G VYKGR + ++A ++ + + +E K E+ ++ K HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 586 LLGCCIEQG------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
G I++ + L+ E+ S+ L TK + L I I +GL +
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
LH + ++IHRD+K N+LL ++ K+ DFG++ D G +GT
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 523 ATENFSIQSKLGEGGFGPVYKG---RLLNGQ---EVAVKRLSNQSGQGLK--EFKNEMML 574
+ E ++ +LG+G FG VY+G ++ G+ VAVK + N+S + EF NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEASV 62
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF-------DPTKKHLLGWQLRV 627
+ ++VRLLG + +++ E M + L +L + + Q +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
++ IA G+ YL+ + +HRDL A N ++ KI DFGM R
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 46/180 (25%), Positives = 89/180 (49%), Gaps = 10/180 (5%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 572
L + S+ + ++ K+G+G G V+ + GQEVA+K+++ Q + NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+++ +L++ N+V L + E ++ EY+ SL D + + +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
Q L +LH ++IHRD+K+ N+LL + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 14/182 (7%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK-NE 571
L + SV + ++ K+G+G G VY + GQEVA+K++ N Q KE NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINE 66
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRII 630
++++ + +H N+V L + E ++ EY+ SL DV T+ + Q+ +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAA-VC 121
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
Q L +LH ++IHRD+K+ NILL + K++DFG ++ + +T +V
Sbjct: 122 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MV 176
Query: 691 GT 692
GT
Sbjct: 177 GT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 46/168 (27%), Positives = 85/168 (50%), Gaps = 20/168 (11%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQH---RNLVRLL 587
+G G +G VY+G+ + G+ VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFL-FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
G ++ +I EY S+ + P + + II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALKYIHKVG-- 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI--VGT 692
+IHRD+KA+NIL+ N K+ DFG+A + Q ++KR VGT
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-09
Identities = 28/84 (33%), Positives = 46/84 (54%), Gaps = 8/84 (9%)
Query: 348 KSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK-NCSCRAYANSKVTDGGSGCLMW 406
KS D F +L + KLP + ++ +L+EC ++CL NCSCR++ + G GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 407 -FGDLIDLKKTDNHTNGVSIYIRV 429
L D + + GV +Y ++
Sbjct: 57 SESSLGDARLFPSG--GVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG+GGFG V ++ G+ A K+L + +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQL-RVRIIDG-IAQGLLYLHQYSRL 646
+ + L+ M L +++ + G+ R I GL +LHQ
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEP---GFPEARAIFYAAQIICGLEHLHQ---R 114
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
RI++RDLK N+LLD H N +ISD G+A G K GT
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 41/171 (23%)
Query: 525 ENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKL 578
+ S +GEG +G V G +VA+K++S Q L+E K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 579 QHRNLVRLLGC----CIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR----- 628
+H N++ +L E + ++ E M T + L ++ +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELM-----------ETDLYKL---IKTQHLSND 106
Query: 629 ----IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ I +GL Y+H + ++HRDLK SN+LL+ + + KI DFG+AR
Sbjct: 107 HIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 2e-09
Identities = 49/180 (27%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFKNEM 572
L S SV + ++ K+G+G G VY + GQEVA+K+++ Q + NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+++ + ++ N+V L + E ++ EY+ SL D + + +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
Q L +LH ++IHRD+K+ NILL + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 21/169 (12%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLLNG-------QEVAVKRLSNQSGQGLK-EFKNEMML 574
A E ++ +LG+G FG VY+G + G VA+K ++ + + EF NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 575 IAKLQHRNLVRLLGCCIEQGEKIL-IYEYMVNKSLDVFL--FDPTKKHLLGWQL-----R 626
+ + ++VRLLG + QG+ L I E M L +L P ++
Sbjct: 63 MKEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+++ IA G+ YL+ + +HRDL A N ++ + KI DFGM R
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
++ Q LG G G VYK LL + +AVK + + + + K+ +E+ ++ K
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++ G + + E+M SLDV+ P +H+LG RI + +GL YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIP--EHVLG-----RIAVAVVKGLTYLWS 113
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L+I+HRD+K SN+L++ K+ DFG++
Sbjct: 114 ---LKILHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 11/140 (7%)
Query: 530 QSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
++ + G G YKG+ + NG + VK +++ + E + + KLQH N+V+L+G
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIG 750
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
C + LI+EY+ K+L L + L W+ R +I GIA+ L +LH +
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 649 IHRDLKASNILLDQHMNPKI 668
+ +L I++D P +
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHR 581
NF I+ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLL-----GWQLRVRIIDGIAQG 636
N+++ IE E ++ E L + K+ L W+ V++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
H +SR R++HRD+K +N+ + K+ D G+ R F ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 10/180 (5%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 572
L S SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+++ + ++ N+V L + E ++ EY+ SL D + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
Q L +LH ++IHRD+K+ NILL + K++DFG + Q +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 36/175 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQGLKEFK-NEMMLIAKLQHR 581
+ + K+GEG +G VYK R G+ VA+K+ +G+ E+ L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 582 N-LVRLLGCCIEQGE----KILIY---EYMVNKSLDVFL----------FDPTKKHLLGW 623
+VRLL +E E K +Y EY+ + L F+ +
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 624 QLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMF 677
QL +G+ + H++ ++HRDLK N+L+D+ KI+D G+ R F
Sbjct: 118 QL--------LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 43/166 (25%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 533 LGEGGFGP--VYK----GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G FG +Y+ L+ +EV + RLS + ++ NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
++ ++ EY +L + K L ++ + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I+HRD+K NI L + K+ DFG++++ G + T +VGT
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 41/174 (23%), Positives = 72/174 (41%), Gaps = 46/174 (26%)
Query: 525 ENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSG------QGLKEFKNEMMLIAK 577
+ +G G +G V +G++VA+K++ + + L+E K ++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRH 60
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-FDPTKKHLLGWQLRVRIIDG---- 632
+H N++ + I DV++ D L+ L II
Sbjct: 61 FKHDNIIAIRD----------ILRPPGADFKDVYVVMD-----LMESDLH-HIIHSDQPL 104
Query: 633 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ +GL Y+H + +IHRDLK SN+L+++ +I DFGMAR
Sbjct: 105 TEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 12/180 (6%)
Query: 497 CEADGDGKDKSKDSSL-PLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVK 555
+ D D L P A A+ +++ L G G V+ GQ V
Sbjct: 37 DDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVV 95
Query: 556 RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP 615
Q G L E ML+ + H +++R+ + ++ + S D++ +
Sbjct: 96 LKIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY---SSDLYTYLT 148
Query: 616 TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ L + I I +GL YLH RIIHRD+K NI ++ I D G A+
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 10/162 (6%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V R +G++VAVK + + Q + NE++++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
+ E ++ E++ +L D + L + + + + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
RD+K+ +ILL K+SDFG D + K +VGT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGT 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 19/181 (10%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQE--VAVKRLSNQS---GQGLKE-------FKNEMM 573
+++ LG G FG VYK R N + +A+K ++ + G+ +E +E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 574 LIAK-LQHRNLVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIID 631
+I + L+H N+VR +E ++ + + L + F KK + I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ L YLH+ R I+HRDL +NI+L + I+DFG+A+ + +VG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVG 175
Query: 692 T 692
T
Sbjct: 176 T 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 55/186 (29%), Positives = 79/186 (42%), Gaps = 43/186 (23%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
++F LG G FG V R + A+K LS LK+ NE ++ ++H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----LFDPTKKHLLGWQLRV--RIIDGIA 634
LV L G Q + L Y+V ++ LF LR R + +A
Sbjct: 61 PFLVNLYGS--FQDDSNL---YLV---MEYVPGGELFS---------HLRKSGRFPEPVA 103
Query: 635 Q--------GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+ L YLH L I++RDLK N+LLD KI+DFG A+ ++G T
Sbjct: 104 RFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRT 155
Query: 687 KRIVGT 692
+ GT
Sbjct: 156 YTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 10/152 (6%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFK---NEMMLIAKLQHRN 582
F I +++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
LV+LL + L EY+ L L R + + + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALH- 118
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
L IHRDLK N L+D + K++DFG++
Sbjct: 119 --ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 23/160 (14%)
Query: 533 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSNQSGQGLKEFKNEMMLIAKLQHRN 582
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
LV+L G C+ E I++ EY+ LDVFL L W+L V +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 643 YSRLRIIHRDLKASNILLDQHMNP-------KISDFGMAR 675
+++H ++ NIL+ ++ K+SD G+
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 20/162 (12%)
Query: 533 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
+G G +G V Y RL Q+VAVK+LS QS + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 588 -----GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
IE ++ Y+V + L + K L + +I + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEV----YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
IIHRDLK SN+ +++ +I DFG+AR DE+ G
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG 174
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 10/165 (6%)
Query: 533 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLLG 588
LG+GGFG V ++ G+ A K+L+ + + K ++ M+ ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRLR 647
+ + L+ M L +++ +++ + R I GL +LHQ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
II+RDLK N+LLD N +ISD G+A + Q TK GT
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGT 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 27/62 (43%), Positives = 36/62 (58%), Gaps = 9/62 (14%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
IA GL +LH II+RDLK N++LD + KI+DFGM + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 691 GT 692
GT
Sbjct: 163 GT 164
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 37/153 (24%), Positives = 62/153 (40%), Gaps = 17/153 (11%)
Query: 528 SIQSKLGE----GGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHR 581
+ + +G+ + K + VAVK+ L + S + LK + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL---LGWQLRVRIIDGIAQGLL 638
N++ + I E ++ M S + L K H L I+ + L
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALD 115
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671
Y+H IHR +KAS+ILL +S
Sbjct: 116 YIHS---KGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 10/143 (6%)
Query: 532 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V + G++VAVK++ + Q + NE++++ QH N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 591 IEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649
+ E ++ E++ +L D+ T + Q+ + + + L +LH +I
Sbjct: 86 LVGDELWVVMEFLEGGALTDIV----THTRMNEEQI-ATVCLAVLKALSFLHAQ---GVI 137
Query: 650 HRDLKASNILLDQHMNPKISDFG 672
HRD+K+ +ILL K+SDFG
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 29/146 (19%)
Query: 549 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL--------------LGCCIEQG 594
+ VAVK++ Q +K E+ +I +L H N+V++ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 595 EKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
++ EYM + L+ L +QL +GL Y+H + ++HR
Sbjct: 90 SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL--------LRGLKYIHSAN---VLHR 138
Query: 652 DLKASNILLDQH-MNPKISDFGMARM 676
DLK +N+ ++ + KI DFG+AR+
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 38/153 (24%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 531 SKLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
K+GEG FG G+ +E+ + ++S + + E + E+ +++ ++H N+V
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ E G ++ +Y + D++ ++ +L + +I+D Q L L
Sbjct: 63 QYQESFEENGNLYIVMDYC--EGGDLYKKINAQRGVLFPE--DQILDWFVQICLALKHVH 118
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
+I+HRD+K+ NI L + K+ DFG+AR+
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 47/174 (27%), Positives = 73/174 (41%), Gaps = 30/174 (17%)
Query: 536 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCI 591
G +G V+ + G A+K + + + E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 592 EQGEK--ILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
QG+K L+ EY+ L L D + I I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLHSNG 113
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFG------MARMFGGDELQGNTKRIVGT 692
IIHRDLK NIL+D + + K++DFG + R ++ + KRIVGT
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 23/159 (14%)
Query: 533 LGEGGFGPVYKG--------RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
LG+G F ++KG L+ EV +K L + F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY-LHQY 643
G C+ E I++ EY+ SLD +L + W+L V A+ L + LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV------AKQLAWALHFL 116
Query: 644 SRLRIIHRDLKASNILL-----DQHMNP---KISDFGMA 674
+ H ++ A N+LL + NP K+SD G++
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSG-QGLKEFK-NEMMLIAKLQHRNL 583
F + +GEG +G V K R +E VA+K+ + + +KE E+ ++ L+ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V L +G+ L++EY+ L++ P ++ I Q + +H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV------PPEKVRSYIYQLIKAIHWC 116
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ I+HRD+K N+L+ + K+ DFG AR
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 45/154 (29%), Positives = 67/154 (43%), Gaps = 22/154 (14%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
+G G +G V G++VA+K+LS QS K E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 590 CIEQGEKILIYE-YMVNKSLDVFL-------FDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ Y+V + L K L +Q+ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKYIH 134
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
IIHRDLK N+ +++ KI DFG+AR
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/174 (32%), Positives = 79/174 (45%), Gaps = 40/174 (22%)
Query: 531 SKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
S +G G +G V G VAVK+LS QS K E+ L+ ++H N++ LL
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 588 GCCIEQGEKILIYEYMVNKSL----DVFLFDPTKKHLLGWQLR--VR-----------II 630
+ +SL DV+L HL+G L V+ +I
Sbjct: 83 DV------------FTPARSLEEFNDVYLV----THLMGADLNNIVKCQKLTDDHVQFLI 126
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
I +GL Y+H IIHRDLK SN+ +++ KI DFG+AR DE+ G
Sbjct: 127 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 176
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 44/175 (25%), Positives = 67/175 (38%), Gaps = 35/175 (20%)
Query: 533 LGEGGFGPVYKGRLLNGQEV-AVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LG GGFG V ++ + A+K + ++GQ + +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKL- 58
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR----------IIDGIAQGL 637
Y +K L + L LR R I +
Sbjct: 59 ------------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAF 106
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
YLH II+RDLK N+LLD + K+ DFG A+ + T GT
Sbjct: 107 EYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 20/153 (13%)
Query: 533 LGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLK-----EFKNEMMLIAKLQHRNL 583
LG+G FG V+ R + GQ A+K L + LK K E ++A++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLLYLHQ 642
V+L +G+ LI +++ L F K ++ + V+ + +A L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L II+RDLK NILLD+ + K++DFG+++
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 41/173 (23%)
Query: 527 FSIQSK------LGEGGFGPVYKGR-LLNGQEVAVKRLSN------QSGQGLKEFKNEMM 573
F + +K +G G +G V + ++VA+K+++N + + L+E K
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK---- 56
Query: 574 LIAKLQHRNLVRLLGC----CIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
L+ L H N++ + E + ++YE M + +S L D ++ L
Sbjct: 57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLY 115
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
LR GL Y+H + ++HRDLK SN+LL+ + + KI DFG+AR
Sbjct: 116 QLLR---------GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 28/165 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E F I + G FG VY GR N + AVK + + N+ M+ R+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDA 57
Query: 584 VRL--------LGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGW---QLRVRIID 631
+ L L ++ + L+ EY++ + L H+ G+ ++ V+ I
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL------HIYGYFDEEMAVKYIS 111
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
+A L YLH++ IIHRDLK N+L+ + K++DFG++++
Sbjct: 112 EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 517 FASVTAATENFSIQSK------LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKE 567
F SV F++ + +G G G V + GQ VA+K+LS Q+ K
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKR 61
Query: 568 FKNEMMLIAKLQHRNLVRLLGCCIEQ------GEKILIYEYMVNKSLDVFLFDPTKKHL- 620
E++L+ + H+N++ LL Q + L+ E M V D + +
Sbjct: 62 AYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS 121
Query: 621 -LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679
L +Q+ G+ +LH IIHRDLK SNI++ KI DFG+AR G
Sbjct: 122 YLLYQMLC--------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170
Query: 680 D 680
Sbjct: 171 S 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGCC 590
K+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 591 IEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY-----LHQY 643
+ ++ L+++Y + + F K + V++ G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 644 SRLRIIHRDLKASNILL----DQHMNPKISDFGMARMF 677
++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 39/159 (24%), Positives = 78/159 (49%), Gaps = 16/159 (10%)
Query: 526 NFSIQSKLGEGGFG-PVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNL 583
+++ +GEG FG + + + Q+ A+K + +S +++ + E +L+AK++H N+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP-----TKKHLLGWQLRVRIIDGIAQGLL 638
V G ++ EY L + + +L W ++ + G+
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQ 114
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
++H+ R++HRD+K+ NI L Q+ K+ DFG AR+
Sbjct: 115 HIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 25/177 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
++ +G G FG V+ R ++ A+K ++ LK+ NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQ 635
++RL +Q ++ EY+ L +L F + + I
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE--------IVC 112
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
L YLH I++RDLK NILLD+ + K++DFG A+ +L+ T + GT
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGCC 590
K+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 591 IEQGEK--ILIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDG----IAQGLLYLHQY 643
+ ++ L+++Y + + F +K + QL ++ I G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 644 SRLRIIHRDLKASNILL----DQHMNPKISDFGMARMF 677
++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 58/189 (30%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEM 572
+ S+ T+ + I +G+G +G VYK +G AVK L S +E + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 573 MLIAKL-QHRNLVRLLGCCIEQ-----GEKILIYEYMVNKSLDVFLFDPTKKHLL--GWQ 624
++ L H N+V+ G + G+ L+ E S+ + K LL G +
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 625 LRVRIIDGIAQG-LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
L +I I G LL L RIIHRD+K +NILL K+ DFG++ L+
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 684 GNTKRIVGT 692
NT VGT
Sbjct: 185 RNTS--VGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-06
Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 549 GQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLL--GCCIEQGEKILIYEYM 603
G EVA+K L + + + F+ E L A+L H N+V LL G G ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 604 VNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL-- 660
++L +V D +L ++++D +A +++ I+HRDLK NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALA------CAHNQ-GIVHRDLKPQNIMVSQ 114
Query: 661 -DQHMNPKISDFGMARMFGG 679
+ K+ DFG+ + G
Sbjct: 115 TGVRPHAKVLDFGIGTLLPG 134
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 20/152 (13%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL--LGWQLRVRIIDG--IAQGLLYLHQ 642
+ L+ M L ++ H+ G++ + I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-----HMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
RI++RDLK NILLD H + +ISD G+A
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 17/167 (10%)
Query: 533 LGEGGFGPVYK---GRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
+G G FG V+ R +G+ VA+K++ N Q+ K E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 588 GCCIEQGEKILIYE--YMVNKSL--DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
I Q I +E Y+V + + D+ + + L ++V + I +GL YLH
Sbjct: 66 D--ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQ-ILRGLKYLHS- 121
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
I+HRD+K N+L++ + KI DFG+AR+ DE + T+ +V
Sbjct: 122 --AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 31/150 (20%), Positives = 57/150 (38%), Gaps = 13/150 (8%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RL 586
S L G VY ++ +K ++ +E + ++ + + V ++
Sbjct: 1 SSIKLLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKV 58
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
L G L+ E++ ++LD + + I + +A+ L LHQ L
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDEVSEEE----------KEDIAEQLAELLAKLHQLPLL 108
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARM 676
+ H DL NIL+D I D+ A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 26/62 (41%), Positives = 34/62 (54%), Gaps = 9/62 (14%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I GL +LH+ II+RDLK N+LLD + KI+DFGM + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 691 GT 692
GT
Sbjct: 158 GT 159
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 52/176 (29%), Positives = 78/176 (44%), Gaps = 28/176 (15%)
Query: 517 FASVTAATENFSIQSK------LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKE 567
F SV A F++ + +G G G V + G VAVK+LS Q+ K
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR 66
Query: 568 FKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE-YMVNKSLDVFL-------FDPTKKH 619
E++L+ + H+N++ LL Q + Y+V + +D L D +
Sbjct: 67 AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS 126
Query: 620 LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L +Q + G+ +LH IIHRDLK SNI++ KI DFG+AR
Sbjct: 127 YLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 23/155 (14%)
Query: 533 LGEGGFGPV-YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
+G G +G V G +VA+K+L QS K E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL-- 80
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDP--------TKKHLLGWQLRVR-IIDGIAQGLLYL 640
+ + +++ D +L P KH + R++ ++ + +GL Y+
Sbjct: 81 ------DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
H IIHRDLK N+ +++ KI DFG+AR
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 28/158 (17%)
Query: 533 LGEGGFGPVYKGRLLNGQE----VAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLV 584
LG+GG+G V++ R + G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 585 RLLGCCIEQGEKILIYEYMVNKSL-------DVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L+ G+ LI EY+ L +F+ D +L I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL----------SEISLAL 113
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+LHQ II+RDLK NILLD + K++DFG+ +
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM--LIAKLQHR 581
+ ++G G G VYK R G +AVK++ + +E K +M + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHD 72
Query: 582 --NLVRLLGCCIEQGEKILIYEYMVN--KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+V+ G I + + E M L + P + +LG ++ V I+ + L
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-KMTVAIV----KAL 127
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
YL + + +IHRD+K SNILLD N K+ DFG++
Sbjct: 128 HYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 18/151 (11%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KRL +SG+ + + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ---GLLYLHQY 643
+ L+ M L +++ ++ G ++ R+I AQ G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGER---GLEME-RVIHYSAQITCGILHLHS- 113
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
+ I++RD+K N+LLD N ++SD G+A
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V + +G+ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
+ +K+ VN ++F ++ + R R IA L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGG-ELFFHLQRERSFP--EPRARFYAAEIASALGYLHS---L 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
II+RDLK NILLD + ++DFG+ + G E T GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 8/147 (5%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG V + VA VK L +N S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV-RIIDGIAQGLLYLHQYSRL 646
G C+E +L++EY L +L L + R+ IA G+ ++H +
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KH 118
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGM 673
+H DL N L + K+ D+G+
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 533 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V R +G AVK L ++ KE + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
+ EK+ VN ++F ++ L + R R +A + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGG-ELFFHLQRERCFL--EPRARFYAAEVASAIGYLHS---L 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
II+RDLK NILLD + ++DFG+ + G E + T GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 8/142 (5%)
Query: 532 KLGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V G++VAVK++ + Q + NE++++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
+ E ++ E++ +L D + + + + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 651 RDLKASNILLDQHMNPKISDFG 672
RD+K+ +ILL K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 22/58 (37%), Positives = 36/58 (62%), Gaps = 2/58 (3%)
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
VR+ IA+ +L L +L II+RD+K NILLD + ++DFG+++ F +E +
Sbjct: 106 EVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 31/174 (17%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL-------FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
+ L+ M L + FD + + I GL
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE--------ITCGLED 117
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGT 692
LH R RI++RDLK NILLD + + +ISD G+A + G+ ++G VGT
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGT 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 56/242 (23%), Positives = 93/242 (38%), Gaps = 47/242 (19%)
Query: 469 NETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATE--- 525
E +N DL A + ++ D D +PL A + E
Sbjct: 90 GELLVPRSNADLFASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQ-AKLKHDDEFLA 148
Query: 526 NFSIQSKLGEGGFGPVY--KGRLLNGQEVAVKRLSNQSGQGLKEFK-------------- 569
+F + L G FG ++ R + A +R N + QG + +
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEA-RRGVNSTNQGKPKCERLIAKRVKAGSRAA 207
Query: 570 ----NEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE---YMVNKSLDV----FLFDPT-- 616
NE++ + +L H N++++ E+IL E YM+ + D F++D
Sbjct: 208 IQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFD 259
Query: 617 -KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
K L Q R I+ + + Y+H ++IHRD+K NI L+ + DFG A
Sbjct: 260 WKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAM 315
Query: 676 MF 677
F
Sbjct: 316 PF 317
|
Length = 501 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 49/173 (28%), Positives = 67/173 (38%), Gaps = 36/173 (20%)
Query: 527 FSIQSKLGEGGFGPV----YKGRLLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIA 576
F + LG G FG V YK G+ A+K L + + L K
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL------DVFLFDPTKKHLLGWQLRVRII 630
+H LV L C + + EY L DVF + R
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-----------EPRAVFY 106
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGD 680
+ GL YLH+ +I++RDLK N+LLD KI+DFG+ + M GD
Sbjct: 107 AACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 38/142 (26%), Positives = 68/142 (47%), Gaps = 8/142 (5%)
Query: 532 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V + +G+ VAVK++ + Q + NE++++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
+ E ++ E++ +L D + + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 651 RDLKASNILLDQHMNPKISDFG 672
RD+K+ +ILL K+SDFG
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 26/178 (14%)
Query: 517 FASVTAATENFSIQSK------LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGL 565
F SV F++ + +G G G V Y L + VA+K+LS Q+
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 566 KEFKNEMMLIAKLQHRNLVRLLGC-----CIEQGEKILIYEYMVNKSLDVFLFDPTKKHL 620
K E++L+ + H+N++ LL +E+ + + Y+V + +D L + L
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV----YLVMELMDANLCQVIQMEL 116
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
++ + + G+ +LH IIHRDLK SNI++ KI DFG+AR G
Sbjct: 117 DHERMSYLLYQMLC-GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 533 LGEGGFGPV--YKGRLLNGQEVAVK-RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
+G+G +G V + R Q V K L N S + K + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 590 CIEQGEKILIYEYM-VNKSLDVF-LFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647
+GE L+Y M + D++ K LL V IA L YLH+
Sbjct: 68 W--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMARMF 677
I+HRDLK N+ L + K+ D G+AR+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 40/169 (23%)
Query: 526 NFSIQSKLGEGGFGPV----YKGRLLNGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKL 578
+F + LG G FG V +KG G+ A+K L + +K+ ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSL------------DVFLFDPTKKHLLGWQLR 626
H +V ++ ++ + E++V L DV F +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE--------- 126
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ YLH II+RDLK N+LLD + K++DFG A+
Sbjct: 127 ------LVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRN 582
++F S+LG G G V K + + ++L + + + E+ ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYL 640
+V G GE + E+M SLD L + + + +LG +V I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSI--AVLRGLAYL 119
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFG--------MARMFGGDELQGNTKRIVGT 692
+ + +I+HRD+K SNIL++ K+ DFG MA F G + +R+ GT
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
+LG+G +G VYK G +A+K RL + + E+ ++ K +V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
+G + EYM SLD + + RI + +GL +L + I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124
Query: 649 IHRDLKASNILLDQHMNPKISDFGMA 674
IHRD+K +N+L++ + K+ DFG++
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 25/57 (43%), Positives = 35/57 (61%), Gaps = 9/57 (15%)
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
G+ LHQ IIHRD+K N+L+DQ + K++DFG++R G E K+ VGT
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGT 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 44/149 (29%), Positives = 67/149 (44%), Gaps = 13/149 (8%)
Query: 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LG+G FG V RL +G+ AVK L Q + +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
CC + +++ VN +F +++ + R R I L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEITSALMFLHDKG-- 116
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMAR 675
II+RDLK N+LLD + K++DFGM +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 34/166 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIA 576
++F + +G G FG V+ R + +V A+K L NQ + E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILA 56
Query: 577 KLQHRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-- 632
+V+L Q E+ L + EYM L + +R +
Sbjct: 57 DADSPWIVKLY--YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEET 102
Query: 633 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
IA+ +L L +L IHRD+K NIL+D + K++DFG+
Sbjct: 103 ARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 48/178 (26%), Positives = 72/178 (40%), Gaps = 33/178 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGL--KEFKNEMMLIAKLQH 580
+ + I +G+GG G VY + + VA+K++ + S L K F E + A L H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLG--WQLRV----------- 627
+V + C G+ +Y M ++ T K LL WQ
Sbjct: 62 PGIVPVYSIC-SDGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSV 112
Query: 628 ----RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
I I + Y+H S+ ++HRDLK NILL I D+G A +E
Sbjct: 113 GAFLSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167
|
Length = 932 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 21/139 (15%)
Query: 550 QEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC-----CIEQGEKILIYEY 602
+ VA+K+LS Q+ K E++L+ + H+N++ LL +E+ + + I
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 603 MVNKSLDVFL---FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
+++ +L + D + L +Q+ G+ +LH IIHRDLK SNI+
Sbjct: 110 LMDANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHSAG---IIHRDLKPSNIV 158
Query: 660 LDQHMNPKISDFGMARMFG 678
+ KI DFG+AR G
Sbjct: 159 VKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 39/169 (23%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN------QSGQGLKEFKNEMMLIAKLQ 579
+ IQ +G+G +G V G++VA+K++++ + + L+E K L+ L+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK----LLRLLR 57
Query: 580 HRNLVRLLGCCI-----EQGEKILIYEYM------VNKSLDVFLFDPTKKH--LLGWQLR 626
H ++V + + E + +++E M V K+ D D T +H +QL
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND----DLTPEHHQFFLYQL- 112
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ L Y+H + + HRDLK NIL + KI DFG+AR
Sbjct: 113 -------LRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ + + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
+ L+ M L +++ G++ R + A+ L L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFE-EERALFYAAEILCGLEDLHRE 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGT 692
++RDLK NILLD + + +ISD G+A ++ G+ ++G VGT
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGT 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 46/183 (25%)
Query: 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFKN-EMMLIAKLQ 579
+ +++ + + +G G FG VY+ ++ E VA+K++ ++KN E++++ L
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLN 117
Query: 580 HRNLVRLLGC----CIEQGEKIL------------IYEYMV-----NKSLDVFLFDPTKK 618
H N++ L C ++ EK + +++YM N +L +FL
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK---- 173
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMAR-M 676
L +QL + L Y+H S+ I HRDLK N+L+D + + K+ DFG A+ +
Sbjct: 174 -LYSYQL--------CRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221
Query: 677 FGG 679
G
Sbjct: 222 LAG 224
|
Length = 440 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 45/168 (26%), Positives = 80/168 (47%), Gaps = 17/168 (10%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 577
NF + LG G +G V+ R ++G + A+K L Q + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 578 LQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQ 635
++ + L + K+ LI +Y+ L F + + V+I G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVL 116
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
L +LH +L II+RD+K NILLD + + ++DFG+++ F DE++
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 21/162 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQ--EVAVKRLSNQSGQGLKEFK---NEMMLIAKLQ 579
E+F+ LG G FG V N VA+KR K+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI-----A 634
H V L G ++ L+ E+++ FL + R + + A
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGCFYAA 138
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
Q +L L I++RDLK N+LLD+ K++DFG A++
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
+ L+ M L +++ G+ + R I A+ L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFDEQ-RAIFYAAELCCGLEDLQRE 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMA 674
RI++RDLK NILLD + +ISD G+A
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 37/113 (32%), Positives = 53/113 (46%), Gaps = 32/113 (28%)
Query: 594 GEKILIYEYMVNKSLDVFLFDPTKK------HLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647
GE + E+M SLD L KK ++LG +I + +GL YL + + +
Sbjct: 72 GEISICMEHMDGGSLDQVL----KKAGRIPENILG-----KISIAVLRGLTYLRE--KHK 120
Query: 648 IIHRDLKASNILLDQHMNPKISDFG--------MARMFGG-------DELQGN 685
I+HRD+K SNIL++ K+ DFG MA F G + LQG
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 173
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRN 582
++F S+LG G G V+K +G +A K + + ++ + E+ ++ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYL 640
+V G GE + E+M SLD L + + +LG +V I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 119
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFG--------MARMFGGDELQGNTKRIVGT 692
+ + +I+HRD+K SNIL++ K+ DFG MA F G + +R+ GT
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 48/149 (32%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 533 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V R L+G+ AVK L + KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLLYLHQYSRL 646
+ EK+ VN LF ++ + R R IA L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGYLHS---I 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMAR 675
I++RDLK NILLD + ++DFG+ +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 29/168 (17%)
Query: 526 NFSIQSKLGEGGFGPV----YKGRLLNGQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQ 579
+ + +LG+G +G V + VA+K+++N + + K E+ L+ +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 580 -HRNLVRLLGCCI---EQGEKILIYEYMVNKSL------DVFLFDPTKKHLLGWQLRVRI 629
H+N+ L I ++ +YE ++ L L D + + +Q
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQ----- 113
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
I GL Y+H + ++HRDLK N+L++ KI DFG+AR F
Sbjct: 114 ---ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 18/39 (46%), Positives = 28/39 (71%), Gaps = 3/39 (7%)
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L++LH++ +I+RDLK NILLD + K++DFGM +
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 18/41 (43%), Positives = 27/41 (65%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
IA+ +L + +L IHRD+K N+LLD + K+SDFG+
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 517 FASVTAATENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLI 575
F S ++ + I +G+G +G V+K NG + AVK L +E + E ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68
Query: 576 AKLQ-HRNLVRLLGCC----IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI 629
L H N+V+ G ++ G+++ L+ E S+ + K+ G ++ I
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR---GERMEEPI 125
Query: 630 IDGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
I I GL +LH + IHRD+K +NILL K+ DFG++ L+ N
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 686 TKRIVGT 692
T VGT
Sbjct: 183 TS--VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 40/162 (24%), Positives = 63/162 (38%), Gaps = 23/162 (14%)
Query: 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-------SGQGLKEFKNEM 572
+ ++I S L G G V+ V K Q + G K E+
Sbjct: 87 ASVVRMQYNILSSLTPGSEGEVF---------VCTKHGDEQRKKVIVKAVTGGKTPGREI 137
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
++ + HR ++ L+ K + M D+F + + L + + I
Sbjct: 138 DILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQRR 193
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
+ + L YLH IIHRD+K NI LD+ N + DFG A
Sbjct: 194 LLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
I+ GL +LH R II+RDLK N++LD + KI+DFGM +
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
I GL +LH+ II+RDLK N+LLD+ + KI+DFGM +
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
IA GL +LH II+RDLK N++LD + KI+DFGM +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 577
NF + LG G +G V+ R + G + A+K L Q + ++ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 578 LQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQ 635
++ + L + K+ LI +Y+ + L+ + + + VR G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFS--EDEVRFYSGEIIL 116
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
L +LH +L I++RD+K NILLD + ++DFG+++ F +E
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 25/60 (41%), Positives = 36/60 (60%), Gaps = 9/60 (15%)
Query: 616 TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
T + L+ + +V A+G+ +L SR + IHRDL A NILL ++ KI DFG+AR
Sbjct: 171 TLEDLISYSFQV------ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 15/166 (9%)
Query: 533 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V R ++ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
+ + +Y+ L F ++ + R R IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS---L 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I++RDLK NILLD + ++DFG+ + E G T GT
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 18/43 (41%), Positives = 28/43 (65%)
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
Q LL +H +IHRD+K++NILL + K+ DFG ++M+
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193
|
Length = 496 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 54/210 (25%), Positives = 76/210 (36%), Gaps = 69/210 (32%)
Query: 533 LGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRN 582
LG G FG V + + VAVK L + G E K M +LI H N
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKML--KEGATASEHKALMSELKILIHIGNHLN 72
Query: 583 LVRLLGCCIE-QGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQ 635
+V LLG C + G ++I E+ +L FL F P ++ + R R + ++
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 636 G-------------------------------------------LLYLHQYSR------- 645
+ Y Q +R
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ IHRDL A NILL ++ KI DFG+AR
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 18/45 (40%), Positives = 30/45 (66%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
+A+ +L + +L IHRD+K NIL+D+ + K+SDFG++ F
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 17/34 (50%), Positives = 27/34 (79%), Gaps = 1/34 (2%)
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
H ++R +++RDLK +NILLD+H + +ISD G+A
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 14/40 (35%), Positives = 28/40 (70%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672
+A+ +L + +L +HRD+K N+LLD++ + +++DFG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 17/43 (39%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
I L YLH +++RDLK N++LD+ + KI+DFG+ +
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 30/176 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMML----- 574
++F + KLGEG FG VYK L+N + +K+ + + G ++ + NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 575 -IAKLQHRNLVRLLGCCIEQGEKILIYEY---------MVNK----SLDVFLFDPTKKHL 620
A + L + ++ E L++ Y M +K +++ +L +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 621 LGWQLRVRIIDGIAQGLLY-LHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMA 674
G + +II I + +L+ L I+HRD+K NI+ + KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 6/58 (10%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE---LQGNTK 687
+A+G+ +L + IHRDL A NILL KI DFG+AR D ++GN +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 17/34 (50%), Positives = 27/34 (79%), Gaps = 1/34 (2%)
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
H ++R +++RDLK +NILLD+H + +ISD G+A
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 16/45 (35%), Positives = 27/45 (60%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
IA+ + ++ IHRD+K NIL+D+ + K++DFG+ F
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 21/43 (48%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
I GL +LH I++RDLK NILLD + KI+DFGM +
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 17/40 (42%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
L YLH Y I+HRDLK N+L+ + K++DFG++++
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 23/158 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSN-----QSGQGLKEFKNEMMLIAKL 578
E++ + +G G FG V R + Q+V A+K LS +S F E ++A
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFA 100
Query: 579 QHRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIA 634
+V+L C Q +K L + EYM L + +D +K W A
Sbjct: 101 NSPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TA 149
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672
+ +L L + +IHRD+K N+LLD+H + K++DFG
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+A+G+ +L SR + IHRDL A NILL ++ KI DFG+AR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 16/40 (40%), Positives = 28/40 (70%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672
IA+ +L +H +L +HRD+K N+LLD + + +++DFG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 24/87 (27%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
L++++ H +L + G C+ E I++ E++ + LDV L + + W++ V +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV--AQQL 126
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILL 660
A L YL + ++H ++ A NILL
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 19/54 (35%), Positives = 30/54 (55%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
A+ L L + +I+RDLK NILLD + + DFG+ ++ D+ + NT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
I GL +LH II+RDLK N++LD+ + KI+DFGM +
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 18/41 (43%), Positives = 27/41 (65%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
IA+ +L + +L IHRD+K N+LLD + K+SDFG+
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 19/43 (44%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+AQG+ +L + IHRD+ A N+LL KI DFG+AR
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 692 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.96 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.95 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.95 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.94 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.94 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.93 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.93 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.93 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.93 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.92 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.92 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.92 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.92 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.92 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.92 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.92 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.91 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.91 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.91 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.91 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.91 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.91 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.91 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.91 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.91 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.91 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.91 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.9 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.9 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.9 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.9 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.9 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.9 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.9 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.9 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.9 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.9 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.9 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.9 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.9 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.89 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.89 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.89 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.89 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.89 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.89 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.89 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.89 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.89 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.89 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.89 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.89 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.89 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.89 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.89 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.89 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.89 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.89 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.89 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.89 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.89 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.89 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.89 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.89 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.89 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.88 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.88 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.88 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.88 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.88 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.88 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.88 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.88 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.88 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.88 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.88 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.88 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.88 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.88 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.88 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.88 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.88 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.88 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.88 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.88 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.88 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.88 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.87 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.87 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.87 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.87 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.87 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.87 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.87 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.87 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.87 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.87 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.87 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.87 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.87 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.87 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.87 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.87 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.87 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.87 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.87 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.87 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.87 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.87 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.87 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.87 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.87 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.87 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.87 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.87 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.87 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.87 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.86 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.86 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.86 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.86 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.86 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.86 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.86 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.86 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.86 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.86 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.86 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.86 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.86 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.86 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.86 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.86 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.86 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.86 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.86 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.86 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.86 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.85 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.85 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.85 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.85 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.85 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.85 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.85 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.85 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.85 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.85 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.85 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.85 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.85 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.85 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.85 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.85 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.85 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.85 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.85 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.85 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.85 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.85 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.85 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.85 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.84 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.84 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.84 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.84 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.84 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.84 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.84 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.84 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.84 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.84 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.84 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.84 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.84 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.84 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.84 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.84 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.84 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.84 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.84 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.84 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.84 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.84 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.84 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.83 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.83 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.83 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.83 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.83 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.83 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.83 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.83 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.83 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.83 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.83 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.83 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.83 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.83 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.83 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.82 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.82 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.82 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.82 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.82 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.82 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.82 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.82 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.82 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.82 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.82 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.82 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.81 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.81 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.81 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.81 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.81 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.81 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.81 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.81 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.81 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.81 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.8 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.8 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.8 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.8 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.8 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.8 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.8 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.8 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.79 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.79 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.79 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.79 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.79 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.79 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.78 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.78 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.77 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.76 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.76 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.76 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.76 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.76 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.75 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.74 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.73 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.73 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.71 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.7 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.68 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.64 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.6 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.6 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.6 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.59 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.31 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.17 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.06 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.06 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.03 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.96 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.9 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.68 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.66 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.62 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.36 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.36 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.34 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.33 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.32 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.25 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.23 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.21 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.16 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.13 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.08 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.05 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.04 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.99 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 97.87 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.78 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.75 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.54 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.52 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.36 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.36 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.29 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.27 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.83 | |
| PLN02236 | 344 | choline kinase | 96.67 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.5 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.43 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.29 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.27 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.22 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.89 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.62 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.57 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.33 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.27 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.75 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.74 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.53 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.31 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.27 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.24 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=322.99 Aligned_cols=168 Identities=51% Similarity=0.838 Sum_probs=154.7
Q ss_pred CCCeeehhhHhhhcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEE
Q 005519 511 SLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590 (692)
Q Consensus 511 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 590 (692)
....|++.++..+|++|+..+.||+|+||.||+|.+.++..||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988765433267799999999999999999999999
Q ss_pred EeCC-eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEE
Q 005519 591 IEQG-EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (692)
Q Consensus 591 ~~~~-~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~ 669 (692)
.+.+ +++||||||++|+|+++|+..... .++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875444 78999999999999999999999988899999999999999999999999
Q ss_pred eeCCceecCC
Q 005519 670 DFGMARMFGG 679 (692)
Q Consensus 670 DFGlAk~~~~ 679 (692)
|||||+....
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999976644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=273.18 Aligned_cols=160 Identities=31% Similarity=0.555 Sum_probs=140.0
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
..+|.+.++||+|+|++||+|++. ++.+||||.+.+. .....+.+..|+.+|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888899999999999999875 4889999999765 3445677899999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC------CceEEEeeCCc
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH------MNPKISDFGMA 674 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~------~~~kI~DFGlA 674 (692)
|||.+|+|..||+ +...+++.+...++.|+|.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999994 3457999999999999999999999998 9999999999999764 45899999999
Q ss_pred eecCCCccccCccceecC
Q 005519 675 RMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 675 k~~~~~~~~~~~~~~~GT 692 (692)
|.+.+.... .+++||
T Consensus 163 R~L~~~~~a---~tlcGS 177 (429)
T KOG0595|consen 163 RFLQPGSMA---ETLCGS 177 (429)
T ss_pred hhCCchhHH---HHhhCC
Confidence 999866542 235554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=259.73 Aligned_cols=160 Identities=29% Similarity=0.465 Sum_probs=136.1
Q ss_pred cCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCc-------cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCe
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 595 (692)
.+.|.+.+.||+|+||.|-+|.- .+|+.||||.+.+.... ......+|+++|++++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35688889999999999999975 56999999999753211 23345799999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC---CceEEEeeC
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKISDFG 672 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kI~DFG 672 (692)
.||||||+++|.|.+++- ....+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999884 3445666677789999999999999999 9999999999999765 779999999
Q ss_pred CceecCCCccccCccceecC
Q 005519 673 MARMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 673 lAk~~~~~~~~~~~~~~~GT 692 (692)
|||..+... .+.+++||
T Consensus 325 lAK~~g~~s---fm~TlCGT 341 (475)
T KOG0615|consen 325 LAKVSGEGS---FMKTLCGT 341 (475)
T ss_pred hhhccccce---ehhhhcCC
Confidence 999987444 35568887
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=253.81 Aligned_cols=162 Identities=28% Similarity=0.425 Sum_probs=143.6
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
..++|++.++||+|+||+||+++..+ ++.+|+|.+++.. ....+..++|..++.+++||.||+++..|++.+++||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 34689999999999999999998655 8899999997642 2356778999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+||+.||.|..+| ++...+++..+..++.+|+.||.|||+.+ ||||||||+|||||++|+++|+||||+|...
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999998 44566888888889999999999999998 9999999999999999999999999999877
Q ss_pred CCccccCccceecC
Q 005519 679 GDELQGNTKRIVGT 692 (692)
Q Consensus 679 ~~~~~~~~~~~~GT 692 (692)
.++.. +.+++||
T Consensus 177 ~~~~~--t~tfcGT 188 (357)
T KOG0598|consen 177 KDGDA--TRTFCGT 188 (357)
T ss_pred cCCCc--cccccCC
Confidence 66543 4458888
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=264.50 Aligned_cols=152 Identities=39% Similarity=0.618 Sum_probs=133.8
Q ss_pred CcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCc--cHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-eEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-EKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~LV~Ey 602 (692)
.+.+.+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ...+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34445679999999999999965445999999754322 2569999999999999999999999999988 79999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC-ceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kI~DFGlAk~~~~~ 680 (692)
|++|+|..+|+.. ....+++..+++++.+||+||.|||++.. ||||||||+||||+.+. ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999764 46679999999999999999999999874 99999999999999997 9999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=263.02 Aligned_cols=160 Identities=31% Similarity=0.458 Sum_probs=144.7
Q ss_pred CCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
..|...+.||+|||..||+++. ..|+.||+|.+.+. .....+...+||++.+.|+|||||+++++|.+.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999987 67999999999763 3345677899999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
|+|++++|..++. +++.+++.++..+..||+.||.|||+++ |||||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999883 5677999999999999999999999998 999999999999999999999999999999877
Q ss_pred ccccCccceecC
Q 005519 681 ELQGNTKRIVGT 692 (692)
Q Consensus 681 ~~~~~~~~~~GT 692 (692)
+-+.. +++||
T Consensus 172 ~Erk~--TlCGT 181 (592)
T KOG0575|consen 172 GERKK--TLCGT 181 (592)
T ss_pred ccccc--eecCC
Confidence 54433 37887
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=226.83 Aligned_cols=109 Identities=52% Similarity=0.779 Sum_probs=81.5
Q ss_pred CceEEEccCCCCCCCC--CceEEEeeCCeEEEEeCCCCeEEEe-eccCCc-CCceEEEecCCCEEEEeCCCCCCCCccee
Q 005519 87 DTVVWVANRNSPIVDK--NGVLTVSNRGNLVLLNQSNGTIWSS-NVSREV-KNPVAQLLDNGNLVIRDNSGSNSTESYLW 162 (692)
Q Consensus 87 ~t~vW~anr~~p~~~~--~~~l~~~~~G~Lvl~~~~~~~~Wss-~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~W 162 (692)
+||||+|||+.|+... ..+|.|+.||+|+|++..++++|++ ++.+.. ....|.|+|+|||||+|.. +.+||
T Consensus 2 ~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~-----~~~lW 76 (114)
T PF01453_consen 2 RTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS-----GNVLW 76 (114)
T ss_dssp --------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT-----SEEEE
T ss_pred cccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec-----ceEEE
Confidence 6899999999999543 4899999999999999999999999 554322 5789999999999999964 58999
Q ss_pred eecCCCcccccccccccceeccCceeeEEecCCCCCCC
Q 005519 163 QSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPS 200 (692)
Q Consensus 163 qSFd~PTDTlLpgq~l~~~~~tg~~~~l~Sw~s~~dps 200 (692)
|||||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus 77 ~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 77 QSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp ESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred eecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999999988887777899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=255.67 Aligned_cols=161 Identities=30% Similarity=0.472 Sum_probs=138.5
Q ss_pred cCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKIL 598 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~L 598 (692)
.+.|+.+++||+|.||.||||+. .+|+.||+|++.... +....-..+||.||++|+||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35688889999999999999975 569999999986533 33455678999999999999999999999887 68999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+|||++ +|.-++. ...-.++..++..++.|++.||+|+|.++ |+|||||..|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999976 5555552 23446889999999999999999999998 9999999999999999999999999999999
Q ss_pred CCccccCcccee
Q 005519 679 GDELQGNTKRIV 690 (692)
Q Consensus 679 ~~~~~~~~~~~~ 690 (692)
.+.....|++++
T Consensus 270 ~~~~~~~T~rVv 281 (560)
T KOG0600|consen 270 PSGSAPYTSRVV 281 (560)
T ss_pred CCCCcccccceE
Confidence 888776777664
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=261.29 Aligned_cols=156 Identities=37% Similarity=0.593 Sum_probs=140.2
Q ss_pred hcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
..+.+++.++||+|-||.|+.|.+.....||||.++.. ....+.|.+|+.+|++|+|+|||+++|+|..++..+|||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 34456677899999999999999977779999999864 44568899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCcc
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~~ 682 (692)
|+.|+|.+||.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||.+.+++.
T Consensus 283 m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999999976 34566888999999999999999999998 99999999999999999999999999997776665
Q ss_pred c
Q 005519 683 Q 683 (692)
Q Consensus 683 ~ 683 (692)
.
T Consensus 359 ~ 359 (468)
T KOG0197|consen 359 T 359 (468)
T ss_pred e
Confidence 3
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=244.99 Aligned_cols=158 Identities=30% Similarity=0.410 Sum_probs=135.6
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-eEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-EKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~LV~Ey 602 (692)
+.+..+.||+|..|+|||++++ +++.+|+|.+.... +...+++.+|++++.+.+||+||+++|.|.... +..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3445579999999999999885 47889999995433 334678999999999999999999999999988 59999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCcc
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~~ 682 (692)
|++|||+.++.. ...+++...-+|+.+|++||.|||+.. +||||||||+|||++..|++||+|||.++.+.+.
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999843 255889999999999999999999732 4999999999999999999999999999988655
Q ss_pred ccCccceecC
Q 005519 683 QGNTKRIVGT 692 (692)
Q Consensus 683 ~~~~~~~~GT 692 (692)
..++++||
T Consensus 233 --~a~tfvGT 240 (364)
T KOG0581|consen 233 --IANTFVGT 240 (364)
T ss_pred --hccccccc
Confidence 23346776
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=239.81 Aligned_cols=148 Identities=29% Similarity=0.442 Sum_probs=131.3
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCC-cc-HHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QG-LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
++|+.+-++|+|+||.|||++.++ |+.||||++..... .. .+-.++|+++|+.++|+|+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457777899999999999999866 99999999875433 22 3557899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|++..-|+..- ...+.++.+...+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+.
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhc
Confidence 99988777654 23456888999999999999999999998 9999999999999999999999999999997
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=251.91 Aligned_cols=155 Identities=30% Similarity=0.404 Sum_probs=137.1
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeE
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 596 (692)
....+|.+.+.||+|+|++|++|+.. .++++|||++.+. .+...+-...|-.+|.+| .||.|++|+..|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34467999999999999999999864 4899999999763 233345567788899999 899999999999999999
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
|+|+||+++|+|.++|. +...++......++.+|+.||+|||+.| ||||||||+|||||+++.+||+|||-||.
T Consensus 150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999994 3466899999999999999999999998 99999999999999999999999999999
Q ss_pred cCCCcc
Q 005519 677 FGGDEL 682 (692)
Q Consensus 677 ~~~~~~ 682 (692)
+.+.+.
T Consensus 224 l~~~~~ 229 (604)
T KOG0592|consen 224 LSPSQK 229 (604)
T ss_pred CChhhc
Confidence 977543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-28 Score=251.20 Aligned_cols=160 Identities=33% Similarity=0.518 Sum_probs=139.1
Q ss_pred CCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHh--CCCCCcceeEEEEEeCC----eEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCIEQG----EKIL 598 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~L 598 (692)
...++.++||+|.||.||||.+. ++.||||++. .+....|++|-.|... ++|+||++++++-..+. +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34566689999999999999994 5999999985 4556778888877765 58999999999887665 8999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY------SRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
|+||+++|+|.+|| +.+.++|....+|+..+++||+|||+. .+++|+|||||++||||..|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 567899999999999999999999973 35689999999999999999999999999
Q ss_pred CceecCCCccccCccceecC
Q 005519 673 MARMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 673 lAk~~~~~~~~~~~~~~~GT 692 (692)
||.++.+...+..+..-+||
T Consensus 362 LAl~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred eeEEecCCCCCcchhhhhhh
Confidence 99999887766666556776
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=231.95 Aligned_cols=157 Identities=32% Similarity=0.432 Sum_probs=139.4
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCC---ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|+..+.||.|+||.|.+++.+. |..+|+|.+++... ...+...+|..+|..+.||++++|++.+.+..+++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 578888999999999999998754 88999999976422 34556789999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++|.|.++|+ +.+.++...+..++.||+.||+|||+.. |++|||||+|||||.+|.+||+|||+||.+.+.
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999994 3456889999999999999999999988 999999999999999999999999999998654
Q ss_pred ccccCccceecC
Q 005519 681 ELQGNTKRIVGT 692 (692)
Q Consensus 681 ~~~~~~~~~~GT 692 (692)
|-+++||
T Consensus 198 -----T~TlCGT 204 (355)
T KOG0616|consen 198 -----TWTLCGT 204 (355)
T ss_pred -----EEEecCC
Confidence 2347776
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=262.96 Aligned_cols=153 Identities=35% Similarity=0.574 Sum_probs=134.9
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 594 (692)
....+.+..++||+|+||+||+|+.. +.+.||||.++..... ...+|++|+++++.++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34566777799999999999999753 2457999999876554 6789999999999999999999999999999
Q ss_pred eEEEEEEccCCCCHhHHhcCCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC
Q 005519 595 EKILIYEYMVNKSLDVFLFDPT-------K----KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~-------~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~ 663 (692)
.++||+|||.+|+|.+||.... . ...|+..+.+.||.|||.||.||-++. +|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 9999999999999999996311 1 334889999999999999999999987 9999999999999999
Q ss_pred CceEEEeeCCceec
Q 005519 664 MNPKISDFGMARMF 677 (692)
Q Consensus 664 ~~~kI~DFGlAk~~ 677 (692)
..|||+||||+|-+
T Consensus 640 l~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 640 LVVKISDFGLSRDI 653 (774)
T ss_pred eEEEecccccchhh
Confidence 99999999999844
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=227.59 Aligned_cols=150 Identities=33% Similarity=0.555 Sum_probs=132.5
Q ss_pred CCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCC-cc-HHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QG-LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
.+|...++||+|.||.||+|+. ..|+.||||+++.... ++ .....+||+.|+.++|+||+.|++++-+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577789999999999999986 5599999999975422 22 3457899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+ -+|+..+++ +...+...+...++.++++||+|||.+. |+||||||.|+|+++++.+||+||||||.++..
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 995 478888865 4567889999999999999999999987 999999999999999999999999999999754
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=207.90 Aligned_cols=108 Identities=40% Similarity=0.876 Sum_probs=102.9
Q ss_pred eecCCCCCccccCCCCCc-ceeeecEEEEeCCeeEEEEEecCCCcEEEEEEccCCcEEEEEeeeCCCCeEEEEEeCCCCc
Q 005519 226 TCTGPWNGVAFGSAPSNT-TFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC 304 (692)
Q Consensus 226 w~~g~w~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~Ld~dG~l~~~~~~~~~~~W~~~~~~p~~~C 304 (692)
||+|+|||..|++.|++. ...+.+.|+.+++|.+++|...+.+.++|++||++|++++|.|++.+++|...|++|.+.|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 899999999999999988 6678888999999999999999999999999999999999999999999999999999999
Q ss_pred -cccccCCCccccCCCCCccccCCCcccCC
Q 005519 305 -HYGDCGPNSICSVDQTSHCECLEGFKFKS 333 (692)
Q Consensus 305 -~~g~CG~~g~C~~~~~~~C~C~~gf~~~~ 333 (692)
+|+.||+||+|+.+..+.|+|+|||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 99999999999888889999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=240.19 Aligned_cols=174 Identities=29% Similarity=0.437 Sum_probs=142.0
Q ss_pred CCCCCCeeehhhHhhhcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHh--CCCCCcce
Q 005519 508 KDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVR 585 (692)
Q Consensus 508 ~~~~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~ 585 (692)
..+++|.+-... ..+...+.+.||+|.||.||+|.+ .|+.||||.+.... ++.+.+|.++... |+|+||+.
T Consensus 197 SGSGlplLVQRT---iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 197 SGSGLPLLVQRT---IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred CCCCchhHhHHh---hhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhh
Confidence 445666554433 346788999999999999999999 57899999997543 3556667766654 69999999
Q ss_pred eEEEEEeCC----eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCceEecCCCCC
Q 005519 586 LLGCCIEQG----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-----YSRLRIIHRDLKAS 656 (692)
Q Consensus 586 l~g~~~~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-----~~~~~ivHrDlKp~ 656 (692)
+++.-..+. ++|||++|+++|||.+|| ....++....++++..+|.||++||. ++++.|.|||||+.
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 999876553 789999999999999999 44679999999999999999999994 78899999999999
Q ss_pred cEEEcCCCceEEEeeCCceecCCCcc--ccCccceecC
Q 005519 657 NILLDQHMNPKISDFGMARMFGGDEL--QGNTKRIVGT 692 (692)
Q Consensus 657 NILl~~~~~~kI~DFGlAk~~~~~~~--~~~~~~~~GT 692 (692)
|||+.+++.+.|+|+|||-....+.. ....+.-+||
T Consensus 346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGT 383 (513)
T KOG2052|consen 346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGT 383 (513)
T ss_pred cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccce
Confidence 99999999999999999998866532 2223334555
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-27 Score=239.35 Aligned_cols=151 Identities=26% Similarity=0.512 Sum_probs=137.7
Q ss_pred CCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
.+|++.+.||+|.||+|-++.. ..|++||||.+.+. +.+..-.+++||+||..++||||+.++.+|...+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5688899999999999999974 66999999998764 3455667899999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||..+|.|.+|+ .....|++.++.++++||..|+.|+|.++ ++|||||.+|||||.++++||+||||+.++..+
T Consensus 133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999 44566999999999999999999999987 999999999999999999999999999988655
Q ss_pred c
Q 005519 681 E 681 (692)
Q Consensus 681 ~ 681 (692)
.
T Consensus 207 k 207 (668)
T KOG0611|consen 207 K 207 (668)
T ss_pred c
Confidence 4
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-27 Score=235.33 Aligned_cols=166 Identities=28% Similarity=0.459 Sum_probs=140.0
Q ss_pred CCcceeeeecccCcEeEEEEE-ecCCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEE-EEEeCCe-EEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLG-CCIEQGE-KILI 599 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g-~~~~~~~-~~LV 599 (692)
.+|+++++||+|.||.|||+. +.+|..||.|.+.-. ..+.......|+.+|+.++|||||++++ .+.+..+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468888999999999999996 578999999988622 2344567899999999999999999998 5555555 8999
Q ss_pred EEccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 600 YEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYS-RLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|||+..|+|...+... ..++.+++++.++++.|+++||..+|.+= +-.|+||||||.||+|+.+|.+||.||||+|++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999888542 34567999999999999999999999831 123999999999999999999999999999999
Q ss_pred CCCccccCccceecC
Q 005519 678 GGDELQGNTKRIVGT 692 (692)
Q Consensus 678 ~~~~~~~~~~~~~GT 692 (692)
..+.+- +...+||
T Consensus 179 ~s~~tf--A~S~VGT 191 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGT 191 (375)
T ss_pred cchhHH--HHhhcCC
Confidence 877653 3457887
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=201.81 Aligned_cols=115 Identities=46% Similarity=0.757 Sum_probs=101.2
Q ss_pred CcccCCCEEEeCCCeEEEEEeCCCCCCCeEEEEEecCCCCceEEEccCCCCCCCCCceEEEeeCCeEEEEeCCCCeEEEe
Q 005519 48 TLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSS 127 (692)
Q Consensus 48 ~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~l~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~~Wss 127 (692)
+.|.+|++|+|+++.|++|||.+......+.+|||...+.++||.||++.| ....+.|.|+.||+|+|+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 568889999999999999999987543489999998766789999999998 4567899999999999999999999999
Q ss_pred eccCCcCCceEEEecCCCEEEEeCCCCCCCCcceeeecCCC
Q 005519 128 NVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYP 168 (692)
Q Consensus 128 ~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 168 (692)
++.+......|+|+|+||||||+.+ +.+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEEcCCCCC
Confidence 9874345678999999999999875 47899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-26 Score=240.20 Aligned_cols=151 Identities=25% Similarity=0.385 Sum_probs=136.9
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
..++|+++++||+|+||.||+++-++ |..+|+|++++.. ...++..+.|-.+|...++|.||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999998654 9999999998753 3456778999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||||++||++..+| .+...|+...+..++.+++.|++-||..+ +|||||||+|+|||..|++||+||||++-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999998 45677899999999999999999999998 9999999999999999999999999997554
Q ss_pred C
Q 005519 679 G 679 (692)
Q Consensus 679 ~ 679 (692)
.
T Consensus 293 ~ 293 (550)
T KOG0605|consen 293 K 293 (550)
T ss_pred h
Confidence 3
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=243.23 Aligned_cols=159 Identities=33% Similarity=0.505 Sum_probs=140.3
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
++|.+.+.||+|+||.||||+-+ +.+.||+|.+.+. .....+.+++|++++++++|||||.+++.|....+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788899999999999999764 4789999999764 33456789999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
|+.+ +|..+| .....+++..+..|+.+++.||.|||+.+ |+|||+||+|||+++++.+|++|||+||-+..+.
T Consensus 82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9977 999998 34566999999999999999999999987 9999999999999999999999999999887654
Q ss_pred cccCccceecC
Q 005519 682 LQGNTKRIVGT 692 (692)
Q Consensus 682 ~~~~~~~~~GT 692 (692)
. ..+++.||
T Consensus 155 ~--vltsikGt 163 (808)
T KOG0597|consen 155 S--VLTSIKGT 163 (808)
T ss_pred e--eeeeccCc
Confidence 3 34567776
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=245.32 Aligned_cols=154 Identities=36% Similarity=0.511 Sum_probs=134.9
Q ss_pred hHhhhcCCcceeeeecccCcEeEEEEEecC--C--cE-EEEEEccc---CCCccHHHHHHHHHHHHhCCCCCcceeEEEE
Q 005519 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLN--G--QE-VAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590 (692)
Q Consensus 519 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~--g--~~-VAVK~l~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 590 (692)
..+...++..+.++||+|+||.||+|++.. + .. ||||..+. .......+|.+|+++|..++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344555677777999999999999998643 2 23 89998874 2345678999999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEe
Q 005519 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (692)
Q Consensus 591 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~D 670 (692)
...+.++||||+|++|+|+++|... ...++..+++.++.+.|+||+|||+.+ +|||||.++|+|+..+..+||+|
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999543 225899999999999999999999998 99999999999999999999999
Q ss_pred eCCceec
Q 005519 671 FGMARMF 677 (692)
Q Consensus 671 FGlAk~~ 677 (692)
|||++.-
T Consensus 306 FGLs~~~ 312 (474)
T KOG0194|consen 306 FGLSRAG 312 (474)
T ss_pred cccccCC
Confidence 9998754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=233.04 Aligned_cols=149 Identities=29% Similarity=0.479 Sum_probs=128.2
Q ss_pred hhcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC--------------CccHHHHHHHHHHHHhCCCCCccee
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--------------GQGLKEFKNEMMLIAKLQHRNLVRL 586 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--------------~~~~~~f~~Ei~~l~~l~H~nIv~l 586 (692)
...+.|++.+.||+|.||+|-+|+. .+++.||||.+.+.. ....+..++||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3447899999999999999999985 458999999986531 1124578999999999999999999
Q ss_pred EEEEEeC--CeEEEEEEccCCCCHhHHhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC
Q 005519 587 LGCCIEQ--GEKILIYEYMVNKSLDVFLFDPTKKHL-LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (692)
Q Consensus 587 ~g~~~~~--~~~~LV~Ey~~~gsL~~~L~~~~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~ 663 (692)
+++-.+. +..|||+|||..|.+... ..... +...++.++++++..||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9998754 579999999999986432 22333 899999999999999999999999 9999999999999999
Q ss_pred CceEEEeeCCceec
Q 005519 664 MNPKISDFGMARMF 677 (692)
Q Consensus 664 ~~~kI~DFGlAk~~ 677 (692)
+++||+|||.+-..
T Consensus 247 g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 247 GTVKISDFGVSNEF 260 (576)
T ss_pred CcEEeeccceeeec
Confidence 99999999999877
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=237.57 Aligned_cols=162 Identities=29% Similarity=0.473 Sum_probs=138.5
Q ss_pred hhcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC----CC-ccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ----SG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQG 594 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~ 594 (692)
...++|.+.+.||+|+||+|+.|.. ..++.||||.+.+. .. ...+.+.+|+.++++++ ||||++++++.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999975 45899999977653 11 23456778999999998 999999999999999
Q ss_pred eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC-CceEEEeeCC
Q 005519 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGM 673 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kI~DFGl 673 (692)
..++||||+.+|+|.+++.+ ...+.+..+.+++.|++.|++|||..+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999944 455778999999999999999999998 9999999999999999 9999999999
Q ss_pred ceecC-CCccccCccceecC
Q 005519 674 ARMFG-GDELQGNTKRIVGT 692 (692)
Q Consensus 674 Ak~~~-~~~~~~~~~~~~GT 692 (692)
+.... .++. ....+||
T Consensus 168 s~~~~~~~~~---l~t~cGs 184 (370)
T KOG0583|consen 168 SAISPGEDGL---LKTFCGS 184 (370)
T ss_pred ccccCCCCCc---ccCCCCC
Confidence 99984 3332 3345665
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=250.53 Aligned_cols=153 Identities=34% Similarity=0.559 Sum_probs=137.2
Q ss_pred cCCcceeeeecccCcEeEEEEEecC----CcEEEEEEcccC-CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
....++.++||.|.||.|++|+++- ...||||.|+.. .+....+|+.|+.||++++||||++|.|+....+..++
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3457788999999999999998743 357999999865 34557889999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+|||+||+|+.||+.. ...+.+.+..-+.++||.||.||-+.+ .|||||.++|||++.+..+||+||||+|.+.
T Consensus 708 iTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999999653 345888899999999999999999988 9999999999999999999999999999886
Q ss_pred CCc
Q 005519 679 GDE 681 (692)
Q Consensus 679 ~~~ 681 (692)
++.
T Consensus 783 dd~ 785 (996)
T KOG0196|consen 783 DDP 785 (996)
T ss_pred cCC
Confidence 665
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=229.79 Aligned_cols=150 Identities=31% Similarity=0.479 Sum_probs=131.8
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--eEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG--EKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~LV~E 601 (692)
.++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457777999999999999998754 8999999987653333677899999999999999999999855554 6999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-CCceEEEeeCCceecCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGG 679 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kI~DFGlAk~~~~ 679 (692)
|+++|+|.+++..... .+++..+.++..||++||+|||+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999954322 6899999999999999999999998 999999999999999 79999999999998874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-26 Score=240.67 Aligned_cols=151 Identities=30% Similarity=0.455 Sum_probs=132.3
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHH--HHHHHHHHHhCC-CCCcceeEEEEEeCC-eEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKE--FKNEMMLIAKLQ-HRNLVRLLGCCIEQG-EKI 597 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~--f~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~ 597 (692)
..++|.+.++||.|.||.||+|+- ..+..||||++++.-. .+++ =++|+..|.+|. |||||+|.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 346799999999999999999974 5689999999986432 2333 367999999998 999999999999988 999
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
+|||||+. +|.+.+.+. .+.+++..+..|+.||++||+|+|.+| +.|||+||||||+.....+||+||||||.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999954 677777653 678999999999999999999999999 999999999999998889999999999988
Q ss_pred CCC
Q 005519 678 GGD 680 (692)
Q Consensus 678 ~~~ 680 (692)
...
T Consensus 161 ~Sk 163 (538)
T KOG0661|consen 161 RSK 163 (538)
T ss_pred ccC
Confidence 653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=236.29 Aligned_cols=161 Identities=32% Similarity=0.476 Sum_probs=143.9
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
....|...++||+|+.|.||.++. ..++.||||++........+-..+|+.+|+..+|+|||++++.+..++++|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 445677778999999999999974 5588999999987655556778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
||++|+|.+.+ ....+++.++..|++++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+..++
T Consensus 351 ym~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999998887 4455899999999999999999999998 9999999999999999999999999999998888
Q ss_pred cccCccceecC
Q 005519 682 LQGNTKRIVGT 692 (692)
Q Consensus 682 ~~~~~~~~~GT 692 (692)
.... .++||
T Consensus 424 ~KR~--TmVGT 432 (550)
T KOG0578|consen 424 SKRS--TMVGT 432 (550)
T ss_pred Cccc--cccCC
Confidence 6543 47887
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=223.92 Aligned_cols=150 Identities=33% Similarity=0.542 Sum_probs=127.7
Q ss_pred CCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCC-cc-HHHHHHHHHHHHhCCCCC-cceeEEEEEeCC------
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QG-LKEFKNEMMLIAKLQHRN-LVRLLGCCIEQG------ 594 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~------ 594 (692)
..|...++||+|+||+||+|+. .+|+.||+|++..... ++ -....+|+.++.+++|+| ||+|.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4566678899999999999985 4589999999875433 22 345678999999999999 999999998877
Q ss_pred eEEEEEEccCCCCHhHHhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 595 EKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
..+||+||+ .-+|..++...... ..++......++.|+++||+|||+++ |+||||||+||||++.+.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 789999999 45788888543322 45677888999999999999999998 99999999999999999999999999
Q ss_pred ceecC
Q 005519 674 ARMFG 678 (692)
Q Consensus 674 Ak~~~ 678 (692)
|+.+.
T Consensus 167 Ara~~ 171 (323)
T KOG0594|consen 167 ARAFS 171 (323)
T ss_pred HHHhc
Confidence 99775
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=233.49 Aligned_cols=155 Identities=30% Similarity=0.434 Sum_probs=130.7
Q ss_pred hhcCCcceeeeecccCcEeEEEEEe------cCCcEEEEEEcccCCC-ccHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 593 (692)
.+.++|++.++||+|+||.||+|.. ..++.||||.+..... ...+.+.+|+.++.++ +||||++++++|.+.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3457899999999999999999974 2246799999875332 3356789999999999 899999999998765
Q ss_pred C-eEEEEEEccCCCCHhHHhcCCCC-------------------------------------------------------
Q 005519 594 G-EKILIYEYMVNKSLDVFLFDPTK------------------------------------------------------- 617 (692)
Q Consensus 594 ~-~~~LV~Ey~~~gsL~~~L~~~~~------------------------------------------------------- 617 (692)
+ ..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 58999999999999999854211
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 618 ----KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 618 ----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 134788889999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=236.10 Aligned_cols=154 Identities=33% Similarity=0.523 Sum_probs=134.6
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
+.+.+...+.++||+|.||.|.++....+..||||.++..... ...+|..|+++|.+++|||||+|+|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 3455667778999999999999999977899999999865443 358899999999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+|||++|+|..||....... +.-....+|+.|||.||+||.+.. +|||||.++|+|++.++++||+|||++|-+-
T Consensus 614 ~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999995432222 455566789999999999999876 9999999999999999999999999999543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=227.46 Aligned_cols=153 Identities=32% Similarity=0.539 Sum_probs=131.6
Q ss_pred cCCcceeeeecccCcEeEEEEEecC-----------------CcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcce
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 585 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~ 585 (692)
.++|++.++||+|+||.||++...+ +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999997532 3369999887542 233567999999999999999999
Q ss_pred eEEEEEeCCeEEEEEEccCCCCHhHHhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceE
Q 005519 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPT----------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649 (692)
Q Consensus 586 l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~----------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv 649 (692)
+++++.+.+..++||||+++|+|.+++.... ....+++...++++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999884321 1134788899999999999999999987 99
Q ss_pred ecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 650 HRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 650 HrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||||||+|||+++++.+||+|||+++.+..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceeccc
Confidence 999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=237.27 Aligned_cols=163 Identities=26% Similarity=0.402 Sum_probs=141.4
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC---CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCe
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGE 595 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 595 (692)
....++|.+.++||+|.||+|+++.++. ++.+|||.+++.. ....+..+.|.+++... +||.|++|+.+++..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3445789999999999999999998754 7899999998753 34567788898888877 59999999999999999
Q ss_pred EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
+++||||+.+|++..++ ....++...+..++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||+|
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954433 4566899999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCccccCccceecC
Q 005519 676 MFGGDELQGNTKRIVGT 692 (692)
Q Consensus 676 ~~~~~~~~~~~~~~~GT 692 (692)
.-.....+ |.+++||
T Consensus 517 e~m~~g~~--TsTfCGT 531 (694)
T KOG0694|consen 517 EGMGQGDR--TSTFCGT 531 (694)
T ss_pred ccCCCCCc--cccccCC
Confidence 87655543 5569998
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=215.44 Aligned_cols=152 Identities=32% Similarity=0.416 Sum_probs=134.4
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
..++|++.+.||+|.||.||.|+.+. +-.||+|++.+. ..+-..++++|+++-..|+||||+++++++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34679999999999999999998644 678999999753 23446789999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
++||.++|+|...|.+. ....++......++.|+|.||.|+|..+ ||||||||+|+|++..+..||+|||-+..-.
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999653 3345778888899999999999999887 9999999999999999999999999998654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=232.25 Aligned_cols=153 Identities=24% Similarity=0.293 Sum_probs=134.4
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeE
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 596 (692)
....++|++.++||+|+||.||+++.. +++.+|+|.+.+. .......+.+|+.++..++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 345578999999999999999999875 4789999998642 223345688999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999998843 34788889999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 005519 677 FGGD 680 (692)
Q Consensus 677 ~~~~ 680 (692)
+...
T Consensus 192 ~~~~ 195 (370)
T cd05621 192 MDET 195 (370)
T ss_pred cccC
Confidence 7543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=191.34 Aligned_cols=113 Identities=49% Similarity=0.785 Sum_probs=99.0
Q ss_pred CcccCCCEEEeCCCeEEEEEeCCCCCCCeEEEEEecCCCCceEEEccCCCCCCCCCceEEEeeCCeEEEEeCCCCeEEEe
Q 005519 48 TLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSS 127 (692)
Q Consensus 48 ~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~l~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~~Wss 127 (692)
+.|..|+.|+|+++.|++|||.+.. ...+.+|||+..+.++||+|||+.|+.+ .+.|.|+.||+|+|++.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~-q~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIM-QNDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCC-CCCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 5678899999999999999998864 4689999998865689999999999764 4899999999999999999999999
Q ss_pred eccCCcCCceEEEecCCCEEEEeCCCCCCCCcceeeecCC
Q 005519 128 NVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (692)
Q Consensus 128 ~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 167 (692)
++........|+|+|+|||||++.. +.++||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSD-----GNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEeCCCCC
Confidence 9863345678999999999999875 4699999997
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=218.81 Aligned_cols=152 Identities=29% Similarity=0.431 Sum_probs=128.0
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC-cc-HHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QG-LKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKIL 598 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~L 598 (692)
.+.|+.+++|++|+||.||+|+.. +++.||+|+++-... .+ ----.+||.+|.+++|||||.+..+.... +..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356888999999999999999874 478999999974321 22 12357899999999999999999987754 57999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|||||++ +|...+.. ....+...+...+..|+++|++|||.+. |+||||||+|+|+...|.+||+||||||.++
T Consensus 155 VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999965 67777743 2356778888999999999999999986 9999999999999999999999999999997
Q ss_pred CCc
Q 005519 679 GDE 681 (692)
Q Consensus 679 ~~~ 681 (692)
..-
T Consensus 229 sp~ 231 (419)
T KOG0663|consen 229 SPL 231 (419)
T ss_pred CCc
Confidence 653
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=231.40 Aligned_cols=148 Identities=24% Similarity=0.348 Sum_probs=132.2
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||+||+++.. +++.||||.+.+.. ......+..|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46899999999999999999864 48899999986432 233467889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999843 346889999999999999999999988 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=232.10 Aligned_cols=147 Identities=26% Similarity=0.348 Sum_probs=131.0
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||.||+++.. +++.||||.+.+. .....+.+.+|+.++.+++||||+++++++.+....+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999764 5889999988642 2234567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
||+++|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999843 345788888899999999999999988 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=226.75 Aligned_cols=150 Identities=25% Similarity=0.388 Sum_probs=133.6
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.+.||+|+||.||+++.. +++.||||.+... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999875 4889999998643 2234567899999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999998843 345788888999999999999999988 999999999999999999999999999977543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=231.17 Aligned_cols=149 Identities=24% Similarity=0.351 Sum_probs=133.2
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||.||+++.. +++.||||.+... .......+.+|+.++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46899999999999999999874 4889999998643 1234566889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999843 345889999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=226.84 Aligned_cols=149 Identities=25% Similarity=0.398 Sum_probs=132.9
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||.||+|+..+ ++.||||.+.... ......+.+|+.++..++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468999999999999999998754 8899999987532 234567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999843 345788999999999999999999988 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-24 Score=231.31 Aligned_cols=146 Identities=23% Similarity=0.349 Sum_probs=130.4
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
.|++.++||+|+||+||+|+.. +++.||||.+.... ......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 47899999986532 2345678999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999843 345788888899999999999999987 999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=226.74 Aligned_cols=150 Identities=26% Similarity=0.381 Sum_probs=132.6
Q ss_pred cCCcceeeeecccCcEeEEEEEecC--CcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
.++|++.++||+|+||.||+|.... +..||+|.+... .......+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998643 368999988643 22345678899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||||+++|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999843 345889999999999999999999988 9999999999999999999999999999775
Q ss_pred C
Q 005519 679 G 679 (692)
Q Consensus 679 ~ 679 (692)
.
T Consensus 183 ~ 183 (340)
T PTZ00426 183 T 183 (340)
T ss_pred C
Confidence 3
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-24 Score=219.40 Aligned_cols=154 Identities=25% Similarity=0.366 Sum_probs=137.1
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC-CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
..+.|++.++||.|.-++||+|+. +.++.||||++... .....+.++.|+..|..++||||++++..|+.+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 447899999999999999999974 56899999999743 2334789999999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
.||.+||+.+.++..-. ..+++..+..|.+++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999865433 34889999999999999999999998 999999999999999999999999999777543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=232.09 Aligned_cols=152 Identities=34% Similarity=0.584 Sum_probs=135.1
Q ss_pred hhHhhhcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCe
Q 005519 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (692)
Q Consensus 518 ~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 595 (692)
.+..+..+.+.+.+.||+|.||+||+|++. ..||||.+.... ++..+.|++|+..+++.+|.||+-+.|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 455556677888899999999999999984 369999997543 3457889999999999999999999999998877
Q ss_pred EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
.+|+.+|++-+|..+|+.. +..++..+...|+.|||+||.|||.++ |||||||..||+|.++++|||+|||||.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999764 356888899999999999999999998 9999999999999999999999999996
Q ss_pred ec
Q 005519 676 MF 677 (692)
Q Consensus 676 ~~ 677 (692)
.-
T Consensus 537 vk 538 (678)
T KOG0193|consen 537 VK 538 (678)
T ss_pred ee
Confidence 43
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=218.87 Aligned_cols=150 Identities=27% Similarity=0.352 Sum_probs=131.5
Q ss_pred CcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
.|+..+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++.+++|+||+++.+++.+.+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999986 468999999886432 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999998887542 2345889999999999999999999987 99999999999999999999999999988644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=248.31 Aligned_cols=152 Identities=36% Similarity=0.626 Sum_probs=135.2
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC--Cc----EEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCe
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~--g~----~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 595 (692)
...+.++.+.||+|.||.||+|.+.+ +. .||||.+.+.. .+...+|.+|..+|++++|||||+++|.|.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 34567788999999999999998754 33 49999998753 4567899999999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEee
Q 005519 596 KILIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DF 671 (692)
.++++|||++|+|..||++.+ +...+...+.+.++.+||+|+.||+++. +|||||.++|+||++...+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence 999999999999999997642 2456889999999999999999999987 999999999999999999999999
Q ss_pred CCceec
Q 005519 672 GMARMF 677 (692)
Q Consensus 672 GlAk~~ 677 (692)
||||-+
T Consensus 847 GlArDi 852 (1025)
T KOG1095|consen 847 GLARDI 852 (1025)
T ss_pred chhHhh
Confidence 999933
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=228.78 Aligned_cols=151 Identities=25% Similarity=0.297 Sum_probs=132.9
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
..++|++.++||+|+||.||+++.. +++.||+|.+.+. .......+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999874 4889999998642 22334568899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||||+++|+|..++.. ..++...+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 34778888889999999999999987 9999999999999999999999999998875
Q ss_pred CC
Q 005519 679 GD 680 (692)
Q Consensus 679 ~~ 680 (692)
..
T Consensus 194 ~~ 195 (370)
T cd05596 194 AN 195 (370)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=224.01 Aligned_cols=141 Identities=26% Similarity=0.302 Sum_probs=125.7
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 606 (692)
+.||+|+||.||+++.. +++.||||.+.... ......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 58899999987532 233567889999999999999999999999999999999999999
Q ss_pred CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99988843 346889999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=222.96 Aligned_cols=149 Identities=26% Similarity=0.328 Sum_probs=132.4
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 58899999986432 234567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999843 345888999999999999999999988 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=230.04 Aligned_cols=146 Identities=25% Similarity=0.377 Sum_probs=129.9
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
.|++.++||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++.+++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999864 47899999986532 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|+++|+|..++.. ...++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999998843 345788888899999999999999988 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=228.80 Aligned_cols=147 Identities=23% Similarity=0.354 Sum_probs=130.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
.+|++.++||+|+||.||+++.. +++.||||.+.+.. ......+.+|+.++.+++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 48899999986421 234567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
||+++|+|.+++.. ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999843 345788888899999999999999988 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=222.09 Aligned_cols=149 Identities=30% Similarity=0.423 Sum_probs=120.7
Q ss_pred CcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----eEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EKILI 599 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~LV 599 (692)
.|...+++|.|+||.||+|.+.+ +++||||++-...+ .-.+|+.+|++++|||||+|+-++.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46777999999999999998754 78999998864322 2246899999999999999999987542 34689
Q ss_pred EEccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC-CceEEEeeCCceec
Q 005519 600 YEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMF 677 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kI~DFGlAk~~ 677 (692)
||||+. +|..+++.. ..+..++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ +.+||+|||.||++
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 677766532 12344566666778999999999999987 9999999999999976 89999999999999
Q ss_pred CCCcc
Q 005519 678 GGDEL 682 (692)
Q Consensus 678 ~~~~~ 682 (692)
..++-
T Consensus 177 ~~~ep 181 (364)
T KOG0658|consen 177 VKGEP 181 (364)
T ss_pred ccCCC
Confidence 87764
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=227.32 Aligned_cols=155 Identities=23% Similarity=0.276 Sum_probs=135.2
Q ss_pred hHhhhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 005519 519 SVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (692)
Q Consensus 519 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 594 (692)
++....++|++.+.||+|+||.||+++.. +++.+|+|.+... .......+.+|+.++..++||||+++++.+.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34455688999999999999999999875 4789999998642 2223456889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCc
Q 005519 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlA 674 (692)
..++||||+++|+|..++.. ..++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999998843 34788888899999999999999988 999999999999999999999999999
Q ss_pred eecCCC
Q 005519 675 RMFGGD 680 (692)
Q Consensus 675 k~~~~~ 680 (692)
+.+...
T Consensus 190 ~~~~~~ 195 (371)
T cd05622 190 MKMNKE 195 (371)
T ss_pred eEcCcC
Confidence 987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=222.63 Aligned_cols=151 Identities=24% Similarity=0.348 Sum_probs=133.0
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.+.||+|+||.||+++.. +++.||||.+.+. .....+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46899999999999999999864 4889999998642 2234566889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999843 2345888999999999999999999988 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=223.10 Aligned_cols=142 Identities=26% Similarity=0.297 Sum_probs=126.3
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 606 (692)
+.||+|+||.||+++.. +++.||||.+... .......+.+|+.++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 5889999998753 2234567889999999999999999999999999999999999999
Q ss_pred CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 99888843 345889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=222.56 Aligned_cols=152 Identities=22% Similarity=0.313 Sum_probs=133.3
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||.||+++.. +++.||+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 4788999998642 1223456888999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++|+|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 345788899999999999999999987 999999999999999999999999999887654
Q ss_pred c
Q 005519 681 E 681 (692)
Q Consensus 681 ~ 681 (692)
.
T Consensus 156 ~ 156 (331)
T cd05624 156 G 156 (331)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=233.22 Aligned_cols=153 Identities=18% Similarity=0.214 Sum_probs=133.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-C-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
..|.+.+.||+|+||.||++... + ++.||+|.+..........+.+|+.++++++||||+++++++.+.+..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34889999999999999999753 3 578899987654444456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++|+|.++|... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999888542 22345888999999999999999999987 999999999999999999999999999987544
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=222.91 Aligned_cols=152 Identities=22% Similarity=0.324 Sum_probs=134.4
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999864 58899999987532 234567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++|+|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998542 245889999999999999999999988 999999999999999999999999999987654
Q ss_pred c
Q 005519 681 E 681 (692)
Q Consensus 681 ~ 681 (692)
.
T Consensus 156 ~ 156 (330)
T cd05601 156 K 156 (330)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=221.08 Aligned_cols=141 Identities=23% Similarity=0.280 Sum_probs=125.5
Q ss_pred ecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCH
Q 005519 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (692)
Q Consensus 533 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 608 (692)
||+|+||.||+++.. +++.||+|.+... .......+..|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4789999998642 233456788999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 999843 345889999999999999999999988 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=228.55 Aligned_cols=155 Identities=32% Similarity=0.446 Sum_probs=132.6
Q ss_pred hcCCcceeeeecccCcEeEEEEEe------cCCcEEEEEEcccCC-CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 594 (692)
..++|++.++||+|+||.||+|+. ..+..||||.++... ....+.+.+|+.++..+ +||||++++++|.+++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345789999999999999999963 235689999987432 23456788999999999 8999999999999999
Q ss_pred eEEEEEEccCCCCHhHHhcCCC----------------------------------------------------------
Q 005519 595 EKILIYEYMVNKSLDVFLFDPT---------------------------------------------------------- 616 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~---------------------------------------------------------- 616 (692)
..++||||+++|+|..++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999885321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 617 --------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 617 --------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 0124788999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=222.40 Aligned_cols=142 Identities=25% Similarity=0.292 Sum_probs=125.9
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 606 (692)
+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999864 5899999998753 2234567788999999999999999999999999999999999999
Q ss_pred CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 99888843 346889999999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=220.87 Aligned_cols=149 Identities=26% Similarity=0.363 Sum_probs=130.1
Q ss_pred CcceeeeecccCcEeEEEEEe----cCCcEEEEEEcccC----CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~----~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 596 (692)
+|++.++||+|+||.||+++. .+++.||+|.+.+. .....+.+..|+.++.++ +|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999875 34789999998642 122345688899999999 599999999999999999
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998843 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCC
Q 005519 677 FGGD 680 (692)
Q Consensus 677 ~~~~ 680 (692)
+...
T Consensus 155 ~~~~ 158 (332)
T cd05614 155 FLSE 158 (332)
T ss_pred cccc
Confidence 6443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=224.05 Aligned_cols=151 Identities=25% Similarity=0.392 Sum_probs=134.9
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||.||+++.. +++.||||.+... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999875 5899999998643 2244677899999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998542 56889999999999999999999987 999999999999999999999999999877654
Q ss_pred c
Q 005519 681 E 681 (692)
Q Consensus 681 ~ 681 (692)
.
T Consensus 155 ~ 155 (350)
T cd05573 155 K 155 (350)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=219.60 Aligned_cols=142 Identities=25% Similarity=0.286 Sum_probs=125.2
Q ss_pred eeecccCcEeEEEEEe-cCCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCC
Q 005519 531 SKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 606 (692)
+.||+|+||.||++.. .+++.||+|.+... ......++..|+.++..++||||+++.+++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 45889999998753 2234567788999999999999999999999999999999999999
Q ss_pred CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||+++++.+||+|||+|+...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 99988843 3468899999999999999999997 56 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=229.15 Aligned_cols=151 Identities=29% Similarity=0.435 Sum_probs=134.7
Q ss_pred CCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
+-|++.+.||+|+-|.|-.|++ ..|+.+|||.+.+.. ........+||.+|+.+.|||+++|++++.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3488899999999999999986 569999999997642 223455778999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++|.|.++| ..+..++..++.+++.||+.|+.|+|..+ |+||||||+|+|||...++||+|||||.+-.++
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999998 45667889999999999999999999887 999999999999999999999999999876655
Q ss_pred c
Q 005519 681 E 681 (692)
Q Consensus 681 ~ 681 (692)
.
T Consensus 166 k 166 (786)
T KOG0588|consen 166 K 166 (786)
T ss_pred c
Confidence 4
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-24 Score=231.39 Aligned_cols=160 Identities=31% Similarity=0.489 Sum_probs=137.5
Q ss_pred cceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CeEEE
Q 005519 527 FSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------GEKIL 598 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~L 598 (692)
+...+.||+|+||.||+|+. ..|+.||||.+.... ....+....|++++++++|+|||++.+.-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44558899999999999995 559999999987632 34567788999999999999999999875543 36799
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEc--CCCc--eEEEeeCCc
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHMN--PKISDFGMA 674 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~--~~~~--~kI~DFGlA 674 (692)
|||||.+|||...|.+......|+..+.+.+..++..||.|||+++ |+||||||.||++- ++++ -||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998888888999999999999999999999988 99999999999994 3333 699999999
Q ss_pred eecCCCccccCccceecC
Q 005519 675 RMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 675 k~~~~~~~~~~~~~~~GT 692 (692)
|.+.+++ ..+.++||
T Consensus 172 rel~d~s---~~~S~vGT 186 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGT 186 (732)
T ss_pred ccCCCCC---eeeeecCc
Confidence 9998776 34568887
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=220.06 Aligned_cols=151 Identities=24% Similarity=0.329 Sum_probs=132.0
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||.||+++... ++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468999999999999999998754 778999998642 1223456889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 345888899999999999999999987 999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=223.09 Aligned_cols=148 Identities=24% Similarity=0.359 Sum_probs=132.0
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.+.||+|+||.||+++.. +++.||||.+... .......+.+|+.++..++||||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 4889999998642 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999843 345888999999999999999999988 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=226.39 Aligned_cols=155 Identities=30% Similarity=0.431 Sum_probs=132.3
Q ss_pred hhcCCcceeeeecccCcEeEEEEEecC------CcEEEEEEcccCCC-ccHHHHHHHHHHHHhCC-CCCcceeEEEEEeC
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQ 593 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~ 593 (692)
...++|.+.++||+|+||.||+|+... +..||||++..... ...+.|.+|+.++.++. ||||++++++|.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 445789999999999999999997521 34699999975432 33467999999999996 99999999999999
Q ss_pred CeEEEEEEccCCCCHhHHhcCCC---------------------------------------------------------
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPT--------------------------------------------------------- 616 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~--------------------------------------------------------- 616 (692)
...+|||||+++|+|.++|....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999998875321
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEE
Q 005519 617 ------------------------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (692)
Q Consensus 617 ------------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl 660 (692)
....+++..+..++.|+++||.|||+.+ |+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 0124788888999999999999999987 9999999999999
Q ss_pred cCCCceEEEeeCCceecCC
Q 005519 661 DQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 661 ~~~~~~kI~DFGlAk~~~~ 679 (692)
++++.+||+|||+++.+..
T Consensus 271 ~~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 271 AQGKIVKICDFGLARDIMH 289 (400)
T ss_pred eCCCEEEEEeCCcceeccc
Confidence 9999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=214.90 Aligned_cols=148 Identities=30% Similarity=0.457 Sum_probs=129.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|++.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++.+++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56999999999999999999864 58899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++ +|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 975 88888743 2345788899999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=223.85 Aligned_cols=143 Identities=23% Similarity=0.289 Sum_probs=126.4
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
...+|++.++||+|+||.||++... .++.||+|.... ..+.+|+.++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3467999999999999999999864 488999996532 356789999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
++. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 164 ~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 164 RYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 995 678877733 345889999999999999999999987 9999999999999999999999999998653
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=235.76 Aligned_cols=153 Identities=30% Similarity=0.467 Sum_probs=134.9
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEecCC-cEEEEEEcccCCCccHHHHHHHHHHHHhCC-CCCcceeEEE-EEe-----
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC-CIE----- 592 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~-~~~----- 592 (692)
.....++++.+.|.+|||+.||.+....+ .++|+|++-....+..+..++||.+|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34556788999999999999999998665 999999998777888999999999999997 9999999993 321
Q ss_pred -CCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEee
Q 005519 593 -QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (692)
Q Consensus 593 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DF 671 (692)
.-+.+|.||||++|+|-+++......+ |.+.++++|+.++++|+++||... ++|||||||.|||||..+++.|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 237899999999999999986544444 999999999999999999999974 78999999999999999999999999
Q ss_pred CCce
Q 005519 672 GMAR 675 (692)
Q Consensus 672 GlAk 675 (692)
|.|.
T Consensus 191 GSat 194 (738)
T KOG1989|consen 191 GSAT 194 (738)
T ss_pred cccc
Confidence 9995
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=218.70 Aligned_cols=145 Identities=28% Similarity=0.405 Sum_probs=125.7
Q ss_pred cceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHH---HhCCCCCcceeEEEEEeCCeEEEE
Q 005519 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLI---AKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
|++.++||+|+||.||++... +++.||||.+.... ....+.+..|+.++ .+++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999864 48899999987432 23345677776655 466899999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|||+++++|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999988873 245899999999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-23 Score=225.80 Aligned_cols=155 Identities=33% Similarity=0.496 Sum_probs=132.0
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 593 (692)
...++|++.+.||+|+||.||+++.. ++..||||++..... .....+.+|+.++..+ +|+||++++++|.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34467999999999999999998742 245799999975432 2345688999999999 899999999999999
Q ss_pred CeEEEEEEccCCCCHhHHhcCCC---------------------------------------------------------
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPT--------------------------------------------------------- 616 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~--------------------------------------------------------- 616 (692)
...++||||+++|+|.++++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 617 ----------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 617 ----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
....+++..+.+++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 1124788889999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=213.90 Aligned_cols=149 Identities=24% Similarity=0.411 Sum_probs=130.8
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999875 47899999987532 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|++++.+..+.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999988776542 2345888999999999999999999987 99999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=217.73 Aligned_cols=146 Identities=27% Similarity=0.348 Sum_probs=127.5
Q ss_pred CcceeeeecccCcEeEEEEEecC-CcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCC-CcceeEEEEEeCCeEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR-NLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~LV~ 600 (692)
+|++.+.||+|+||.||+|+..+ ++.||||.+... .....+.+..|+.++..+.|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47889999999999999998754 788999998753 233456788899999999765 5888999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 99999999988843 345788999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=218.58 Aligned_cols=142 Identities=30% Similarity=0.401 Sum_probs=124.6
Q ss_pred eeecccCcEeEEEEEe----cCCcEEEEEEcccC----CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 531 SKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++||+|+||.||+++. ..++.||||.+... .......+.+|+.++..++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 24789999998642 123345678999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++++|..++.. ...+.+..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 999999998843 345778888889999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-24 Score=195.92 Aligned_cols=148 Identities=28% Similarity=0.486 Sum_probs=126.5
Q ss_pred CcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|...++||+|.||+||||+..+ ++.||+|++.... +.--....+|+.+++.++|.||||+++....++.+-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45666899999999999998644 7889999886432 22235678999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+ ..+|..|... -...++.+....++.|+++||.|+|++. +.||||||+|.||+.+++.|++||||||-++-
T Consensus 83 c-dqdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 83 C-DQDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred h-hHHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9 4567776522 3456888999999999999999999987 99999999999999999999999999997753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=217.68 Aligned_cols=151 Identities=26% Similarity=0.343 Sum_probs=133.1
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
.++|++.++||+|+||.||+++.. ++..+|+|.+..... ....++.+|+.++.+++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999875 478899998875422 335679999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999843 345888999999999999999999853 399999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-24 Score=226.49 Aligned_cols=159 Identities=30% Similarity=0.504 Sum_probs=141.2
Q ss_pred hHhhhcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEE
Q 005519 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 519 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 597 (692)
+.+....++....+||-|.||.||.|.++. .-.||||.++.. ....++|+.|+.+|+.++|||+|+|+|+|......|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 344445567778999999999999999865 678999999864 457899999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
||+|||.+|+|.+||++..+ ..++.-..+.++.||+.||+||..+. +|||||..+|+|+.++..+||+||||+|++
T Consensus 340 IiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999977543 34666677899999999999999887 999999999999999999999999999999
Q ss_pred CCCcc
Q 005519 678 GGDEL 682 (692)
Q Consensus 678 ~~~~~ 682 (692)
.+|..
T Consensus 416 tgDTY 420 (1157)
T KOG4278|consen 416 TGDTY 420 (1157)
T ss_pred cCCce
Confidence 88865
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=212.34 Aligned_cols=149 Identities=28% Similarity=0.451 Sum_probs=131.5
Q ss_pred cCCcceeeeecccCcEeEEEEEec----CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... ...+.|.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356899999999999999999753 356899999876432 334679999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
||||+++|+|++++... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998542 346889999999999999999999987 999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=213.86 Aligned_cols=149 Identities=31% Similarity=0.432 Sum_probs=129.5
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
.++|++.++||+|+||.||+|+.. +++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 588999999875432 234567889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|++ ++|..++.. ....++...+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 577776643 2345788899999999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=217.20 Aligned_cols=154 Identities=31% Similarity=0.498 Sum_probs=131.7
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 607 (692)
++||.|.||+||-|+.+ .|+.||||.+.+. .......+++|+.||..++||.||.|...|...+..++|||-+.+.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 89999999999999874 5999999999763 34556889999999999999999999999999999999999996665
Q ss_pred HhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC---CceEEEeeCCceecCCCcccc
Q 005519 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKISDFGMARMFGGDELQG 684 (692)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kI~DFGlAk~~~~~~~~~ 684 (692)
|+-.|.. ....|+......++.||+.||.|||.++ |+||||||+||||.+. -.+||+|||+||+++..+.+.
T Consensus 650 LEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 650 LEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred HHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 6655532 3455788888889999999999999998 9999999999999654 469999999999998877643
Q ss_pred CccceecC
Q 005519 685 NTKRIVGT 692 (692)
Q Consensus 685 ~~~~~~GT 692 (692)
.++||
T Consensus 725 ---sVVGT 729 (888)
T KOG4236|consen 725 ---SVVGT 729 (888)
T ss_pred ---hhcCC
Confidence 46776
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=217.50 Aligned_cols=150 Identities=34% Similarity=0.574 Sum_probs=129.7
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCc----EEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
.+|++.+.||+|+||.||+|++. +++ .||||.+.... ....++|.+|+.++..++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56999999999999999999853 333 48999987543 23457899999999999999999999999864 5779
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998542 345788999999999999999999987 9999999999999999999999999999876
Q ss_pred CC
Q 005519 679 GD 680 (692)
Q Consensus 679 ~~ 680 (692)
.+
T Consensus 161 ~~ 162 (316)
T cd05108 161 AD 162 (316)
T ss_pred CC
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=216.55 Aligned_cols=147 Identities=27% Similarity=0.332 Sum_probs=127.6
Q ss_pred CcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC---CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
+|++.+.||+|+||.||+++... ++.||||.+.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47888999999999999998754 7899999987532 22345677788888777 6899999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||+++|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+...
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999988843 345888999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=217.69 Aligned_cols=141 Identities=26% Similarity=0.355 Sum_probs=124.2
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
+.||+|+||.||+++.. +++.||+|.+.+. .....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999864 4789999998753 223456678899888876 899999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999888743 345889999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=217.02 Aligned_cols=144 Identities=29% Similarity=0.344 Sum_probs=126.6
Q ss_pred eeecccCcEeEEEEEe----cCCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 531 SKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
+.||+|+||.||+++. .+++.||+|.+.... ......+..|+.++.+++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999864 347899999987532 2234567889999999999999999999999999999999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+|+|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 9999998843 345899999999999999999999988 999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=212.13 Aligned_cols=152 Identities=35% Similarity=0.528 Sum_probs=131.9
Q ss_pred CCcceeeeecccCcEeEEEEEe-----cCCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
+.|++.++||+|+||.||+|+. ..++.||+|.+.... .+...+|.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688889999999999999974 235789999997533 2345679999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC
Q 005519 599 IYEYMVNKSLDVFLFDPT--------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~ 664 (692)
||||+++++|.+++.... ....+++...+.++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 1235788999999999999999999987 99999999999999999
Q ss_pred ceEEEeeCCceecCC
Q 005519 665 NPKISDFGMARMFGG 679 (692)
Q Consensus 665 ~~kI~DFGlAk~~~~ 679 (692)
.+||+|||+++.+..
T Consensus 162 ~~kl~dfg~~~~~~~ 176 (283)
T cd05090 162 HVKISDLGLSREIYS 176 (283)
T ss_pred cEEeccccccccccC
Confidence 999999999987644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=216.96 Aligned_cols=142 Identities=26% Similarity=0.345 Sum_probs=124.5
Q ss_pred eeecccCcEeEEEEEecC-CcEEEEEEcccC---CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
++||+|+||.||+|+... ++.||||.+... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999998754 789999998753 233456678899988876 899999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 999988843 345888999999999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=221.82 Aligned_cols=145 Identities=28% Similarity=0.458 Sum_probs=126.6
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|+..++||+|+||.||+++.. +++.||||.+..... .....+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677789999999999999864 589999999865432 2356789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++++|... ....+..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999998543 23456777889999999999999988 99999999999999999999999999997754
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=207.91 Aligned_cols=152 Identities=31% Similarity=0.471 Sum_probs=136.4
Q ss_pred hcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
..++|++.+.||+|++|.||+|...+++.||+|.+... ....+++.+|+.++.+++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 34679999999999999999999877889999998753 33467899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999985432 346899999999999999999999987 99999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=216.00 Aligned_cols=143 Identities=27% Similarity=0.343 Sum_probs=122.5
Q ss_pred eeecccCcEeEEEEEecC-CcEEEEEEcccC---CCccHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
++||+|+||.||+|+..+ ++.||||.+... .....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999998754 788999998643 12334556667777765 4899999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|+|..++.. ...++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 999988843 345888899999999999999999987 99999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=219.67 Aligned_cols=160 Identities=30% Similarity=0.471 Sum_probs=139.7
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCc---cHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 597 (692)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|.++. |||||.+.+.+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44679999999999999999998765 999999999765433 3468999999999998 999999999999999999
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC----CceEEEeeCC
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH----MNPKISDFGM 673 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~----~~~kI~DFGl 673 (692)
+|||++.+|.|.+.+... . +++..+..++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998554 3 899999999999999999999988 9999999999999543 4799999999
Q ss_pred ceecCCCccccCccceecC
Q 005519 674 ARMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 674 Ak~~~~~~~~~~~~~~~GT 692 (692)
|+...+.+ ....++||
T Consensus 186 a~~~~~~~---~~~~~~Gt 201 (382)
T KOG0032|consen 186 AKFIKPGE---RLHTIVGT 201 (382)
T ss_pred ceEccCCc---eEeeecCC
Confidence 99998733 24456776
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=217.22 Aligned_cols=141 Identities=23% Similarity=0.332 Sum_probs=124.9
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
++||+|+||.||+++.. +++.||||.++.. .....+.+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999874 4889999999753 223456688999999998 799999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 999888743 346899999999999999999999988 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=217.39 Aligned_cols=150 Identities=27% Similarity=0.354 Sum_probs=132.1
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
.++|++.++||+|+||.||++... ++..+|+|.+..... .....+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999875 478899998865422 334678999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+++++|.+++.. ...+++.....++.+++.||.|||+.. .|+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999843 345788999999999999999999752 39999999999999999999999999998664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=216.78 Aligned_cols=146 Identities=25% Similarity=0.418 Sum_probs=126.1
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CeEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GEKI 597 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~ 597 (692)
+|++.++||+|+||.||+|+.. +++.||||++... ......++.+|+.++.+++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4888999999999999999864 5899999998643 223456788999999999999999999988643 2579
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
+||||++ ++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688888742 345889999999999999999999988 999999999999999999999999999865
Q ss_pred C
Q 005519 678 G 678 (692)
Q Consensus 678 ~ 678 (692)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=228.57 Aligned_cols=157 Identities=20% Similarity=0.272 Sum_probs=133.7
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC---
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG--- 594 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--- 594 (692)
....++|++.++||+|+||+||+++. .+++.||||.+... .......+.+|+.++..++|+||+++.+.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34557899999999999999999975 45899999998643 2334567889999999999999999988776432
Q ss_pred -----eEEEEEEccCCCCHhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEE
Q 005519 595 -----EKILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (692)
Q Consensus 595 -----~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI 668 (692)
..++||||+++|+|.++|.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3689999999999999986432 2356889999999999999999999987 999999999999999999999
Q ss_pred EeeCCceecCCC
Q 005519 669 SDFGMARMFGGD 680 (692)
Q Consensus 669 ~DFGlAk~~~~~ 680 (692)
+|||+++.+...
T Consensus 185 ~DFGls~~~~~~ 196 (496)
T PTZ00283 185 GDFGFSKMYAAT 196 (496)
T ss_pred EecccCeecccc
Confidence 999999987643
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=215.71 Aligned_cols=147 Identities=27% Similarity=0.349 Sum_probs=127.6
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~ 600 (692)
+|+..+.||+|+||.||++... +++.||||.+.+. .....+.+..|+.++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999864 5889999998743 2234566888999988885 577888999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||+++|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999998843 345889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=207.34 Aligned_cols=149 Identities=31% Similarity=0.494 Sum_probs=133.2
Q ss_pred CCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
+.|++.+.||+|+||.||++...++..+|+|.+... ....++|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458888999999999999999887888999988643 3345789999999999999999999999999999999999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 99999988542 235889999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=210.96 Aligned_cols=150 Identities=29% Similarity=0.356 Sum_probs=131.6
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
+|++.++||+|+||+||++... +++.||||.+.... ......+.+|+.++.+++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 58899999986432 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|+++|+|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999888543 2345899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=208.37 Aligned_cols=152 Identities=34% Similarity=0.517 Sum_probs=135.8
Q ss_pred cCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
.++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++.+++|+||+++++.+.+.+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3679999999999999999999878889999998653 334678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999998543 2345788899999999999999999987 999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=210.86 Aligned_cols=150 Identities=31% Similarity=0.537 Sum_probs=132.0
Q ss_pred CCcceeeeecccCcEeEEEEEec-----CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKI 597 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 597 (692)
++|++.+.||+|+||.||++... +++.||+|.+........+.|.+|+.++.+++||||+++.+++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888999999999999999742 4788999998766555677899999999999999999999987643 4689
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
+|+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998432 345899999999999999999999987 999999999999999999999999999977
Q ss_pred CC
Q 005519 678 GG 679 (692)
Q Consensus 678 ~~ 679 (692)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=211.51 Aligned_cols=152 Identities=29% Similarity=0.470 Sum_probs=130.2
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEe-----C
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-----Q 593 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~ 593 (692)
.....|...+.||+|+||.|..+... +|+.||||++... .....++-.+|++++++++|+||+.+.+.+.- -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34456776789999999999999864 5899999999732 33456788999999999999999999998865 3
Q ss_pred CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
+..|+|+|+| .-+|...+. ....|.......+++|+++||.|+|+.+ |+||||||.|+|++.+..+||+||||
T Consensus 99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 5789999999 667888873 3344888888999999999999999988 99999999999999999999999999
Q ss_pred ceecCCC
Q 005519 674 ARMFGGD 680 (692)
Q Consensus 674 Ak~~~~~ 680 (692)
||.....
T Consensus 172 AR~~~~~ 178 (359)
T KOG0660|consen 172 ARYLDKF 178 (359)
T ss_pred eeecccc
Confidence 9999654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=212.01 Aligned_cols=149 Identities=25% Similarity=0.307 Sum_probs=134.2
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++++.||+|.-|+||++++.+ +..+|+|.+.+.. .+...+...|-+||..++||.|+.|++.+...+..+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 568888999999999999999866 5889999997642 345667888999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|||++|+|...++. +..+.++...+..++.+|+.||+|||-.| ||.|||||+||||.++|++.|+||-|+...
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999997765 35566888999999999999999999998 999999999999999999999999999765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=222.44 Aligned_cols=162 Identities=26% Similarity=0.449 Sum_probs=140.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCe-EEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE-KILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~LV~ 600 (692)
++|..++++|+|+||.++..+.+ +++.+++|.+... .....+....|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999988754 4778999988643 33344568899999999999999999999999988 99999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+|++||+|.+.|.+. ++..++++....++.|++.|+.|||++. |+|||||+.||+++++..|||.|||+||.++.+
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999998654 3567899999999999999999999776 999999999999999999999999999999887
Q ss_pred ccccCccceecC
Q 005519 681 ELQGNTKRIVGT 692 (692)
Q Consensus 681 ~~~~~~~~~~GT 692 (692)
... ..+++||
T Consensus 160 ~~~--a~tvvGT 169 (426)
T KOG0589|consen 160 DSL--ASTVVGT 169 (426)
T ss_pred hhh--hheecCC
Confidence 632 3347776
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=215.29 Aligned_cols=141 Identities=27% Similarity=0.349 Sum_probs=121.4
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
++||+|+||+||+++.. +++.||||.+... ......++..|.. ++..++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 5899999998643 1223445566655 56778999999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|+|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99988874 3446889999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=215.09 Aligned_cols=142 Identities=27% Similarity=0.380 Sum_probs=124.6
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
+.||+|+||.||+++.. +++.||||.+.+. .....+.+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4789999998643 233456778888888876 699999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 999988843 345889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=223.00 Aligned_cols=145 Identities=26% Similarity=0.343 Sum_probs=127.6
Q ss_pred cCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
...|.+.+.||+|+||.||++.... ++.||||... ...+.+|+.++.+++|+|||++++++..++..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999998754 7889999542 23467899999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+. ++|..++.. ....+++..++.|+.|+++||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 95 688887743 2346899999999999999999999988 999999999999999999999999999987544
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=214.38 Aligned_cols=141 Identities=28% Similarity=0.353 Sum_probs=121.2
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
+.||+|+||+||+++.. +++.||||.+.... .....++..|.. ++..++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999874 58999999986431 223344555554 56789999999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|+|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999998843 346888899999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=207.85 Aligned_cols=147 Identities=42% Similarity=0.636 Sum_probs=127.3
Q ss_pred ceeeeecccCcEeEEEEEec-----CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 528 SIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 528 ~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
++.+.||.|.||.||+|.+. .+..|+||.++.... ...++|.+|+..+.+++||||++++|++.+.+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 45689999999999999876 256899999965332 347889999999999999999999999998888999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+++|+|.++|... ....+++..+..|+.||++||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 99999999999653 2356899999999999999999999987 9999999999999999999999999999883
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=209.91 Aligned_cols=145 Identities=30% Similarity=0.388 Sum_probs=126.5
Q ss_pred ecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCH
Q 005519 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (692)
Q Consensus 533 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 608 (692)
||+|+||+||++... +++.||||.+.... ....+.+..|+.++.+++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 58899999986432 22346678899999999999999999999999999999999999999
Q ss_pred hHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 609 DVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 609 ~~~L~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 98875422 3346899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=206.30 Aligned_cols=150 Identities=31% Similarity=0.503 Sum_probs=133.8
Q ss_pred CCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
++|++.+.||+|+||.||++...++..+|||.+... ....++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 468888999999999999998877778999998753 3345789999999999999999999999999999999999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..+
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 99999998542 235899999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=214.41 Aligned_cols=141 Identities=27% Similarity=0.337 Sum_probs=120.4
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
++||+|+||.||+++.. +++.||+|.+.+.. .....++..|.. ++..++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999874 48899999986432 222344555554 67889999999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
++|..++.. ...++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999888743 345778888899999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=221.09 Aligned_cols=155 Identities=30% Similarity=0.446 Sum_probs=131.7
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCCCc-cHHHHHHHHHHHHhCC-CCCcceeEEEEEeC
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQ 593 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~ 593 (692)
...++|.+.++||+|+||.||+|++. .++.||||++...... ..+.+..|+.++.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456888899999999999999853 2468999999754322 3457899999999997 99999999999999
Q ss_pred CeEEEEEEccCCCCHhHHhcCCC---------------------------------------------------------
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPT--------------------------------------------------------- 616 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~--------------------------------------------------------- 616 (692)
...++|+||+++|+|.++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999985421
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcE
Q 005519 617 --------------------------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNI 658 (692)
Q Consensus 617 --------------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NI 658 (692)
....+++...+.++.|+++||.|||+.+ |+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 1124677888999999999999999887 99999999999
Q ss_pred EEcCCCceEEEeeCCceecCC
Q 005519 659 LLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 659 Ll~~~~~~kI~DFGlAk~~~~ 679 (692)
|+++++.+||+|||+++.+..
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMR 291 (401)
T ss_pred EEeCCCEEEEEecCcceeccc
Confidence 999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=206.10 Aligned_cols=149 Identities=28% Similarity=0.461 Sum_probs=133.9
Q ss_pred cCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
.++|++.++||+|+||.||+|+. .+++.||+|.+..........+.+|+.++.+++||||+++++.+..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999986 45889999998755445566788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999998843 345789999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=214.45 Aligned_cols=141 Identities=26% Similarity=0.342 Sum_probs=124.7
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
++||+|+||+||+++.. +++.||||.+.... ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999874 47899999997532 23456688999999888 699999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|+|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 999888732 345899999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=209.06 Aligned_cols=154 Identities=29% Similarity=0.488 Sum_probs=131.9
Q ss_pred hcCCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCe
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 595 (692)
..++|++.++||+|+||.||+|... .+..||||++..... ....+|.+|+.++..++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999999753 246799998864322 335678999999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEE
Q 005519 596 KILIYEYMVNKSLDVFLFDPTK-------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI 668 (692)
.++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234678889999999999999999987 999999999999999999999
Q ss_pred EeeCCceecCC
Q 005519 669 SDFGMARMFGG 679 (692)
Q Consensus 669 ~DFGlAk~~~~ 679 (692)
+|||+|+.+..
T Consensus 161 ~dfg~~~~~~~ 171 (277)
T cd05062 161 GDFGMTRDIYE 171 (277)
T ss_pred CCCCCccccCC
Confidence 99999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=231.37 Aligned_cols=150 Identities=25% Similarity=0.350 Sum_probs=131.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC---ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||.||+|... .++.||||++..... ...++|.+|+.++.+++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999875 488999999875322 23467999999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 601 EYMVNKSLDVFLFDPT--------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
||+++++|.+++.... .....++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885311 1234567788899999999999999987 9999999999999999999999999
Q ss_pred Cceec
Q 005519 673 MARMF 677 (692)
Q Consensus 673 lAk~~ 677 (692)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99987
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=207.71 Aligned_cols=144 Identities=30% Similarity=0.420 Sum_probs=123.2
Q ss_pred eecccCcEeEEEEEecC---CcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCC
Q 005519 532 KLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (692)
Q Consensus 532 ~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 607 (692)
+||+|+||.||+|...+ ...+|+|.+.... ......|.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 69999999999997533 3468888876432 2335678999999999999999999999999999999999999999
Q ss_pred HhHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 608 LDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 608 L~~~L~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccc
Confidence 9999865322 234567888899999999999999987 9999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=210.02 Aligned_cols=142 Identities=20% Similarity=0.345 Sum_probs=125.3
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCcc---HHHHHHHHHHHHhCCCCCcceeEEEEEe----CCeEEEEEEcc
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILIYEYM 603 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~LV~Ey~ 603 (692)
..||+|++|.||+|.+ +++.||||.+....... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999997643333 5678899999999999999999999987 35789999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++|+|.+++.. ...+++....+++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+..
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999954 34688999999999999999999984 4 78999999999999999999999999997644
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=212.68 Aligned_cols=141 Identities=28% Similarity=0.379 Sum_probs=123.0
Q ss_pred eeecccCcEeEEEEEecC-CcEEEEEEcccCC---CccHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAK-LQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
+.||+|+||.||+|+... ++.||||.+.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998754 7899999987531 2334566778888876 4999999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|+|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999998843 345889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=209.87 Aligned_cols=153 Identities=34% Similarity=0.577 Sum_probs=133.9
Q ss_pred cCCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 597 (692)
.++|.+.+.||+|+||+||++... ++..+|+|.+..........+.+|+.++.+++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999742 24568999987655555678999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceE
Q 005519 598 LIYEYMVNKSLDVFLFDPT----------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 667 (692)
+|+||+++++|.+++.... +...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999985321 2235899999999999999999999987 99999999999999999999
Q ss_pred EEeeCCceecCC
Q 005519 668 ISDFGMARMFGG 679 (692)
Q Consensus 668 I~DFGlAk~~~~ 679 (692)
|+|||+++.+..
T Consensus 161 l~dfg~~~~~~~ 172 (288)
T cd05093 161 IGDFGMSRDVYS 172 (288)
T ss_pred eccCCccccccC
Confidence 999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=208.74 Aligned_cols=153 Identities=33% Similarity=0.543 Sum_probs=138.4
Q ss_pred hcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+..+|++.++||+|+||.||+|...+++.+|+|.+.........++..|+.++..++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568889999999999999999888899999999876555677899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++++|.+++.+.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999996542 345899999999999999999999988 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=210.32 Aligned_cols=148 Identities=29% Similarity=0.468 Sum_probs=129.1
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|.+.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56999999999999999999864 47889999987433 22345678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++ +|..++... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 975 787777432 345788889999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-22 Score=207.18 Aligned_cols=151 Identities=29% Similarity=0.490 Sum_probs=124.6
Q ss_pred CCcceeeeecccCcEeEEEEEec--CCcEEEEEEcccCC--CccHHHHHHHHHHHHhC---CCCCcceeEEEEEe-----
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCIE----- 592 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~----- 592 (692)
++|++.++||+|+||.||+++.. +++.||||.+.... ......+.+|+.++..+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 36789999886432 22234566787777665 69999999999863
Q ss_pred CCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 593 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
....++|+||++ ++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 6888888542 2345889999999999999999999988 9999999999999999999999999
Q ss_pred CceecCCC
Q 005519 673 MARMFGGD 680 (692)
Q Consensus 673 lAk~~~~~ 680 (692)
+|+.+...
T Consensus 156 ~~~~~~~~ 163 (290)
T cd07862 156 LARIYSFQ 163 (290)
T ss_pred ceEeccCC
Confidence 99877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=212.71 Aligned_cols=141 Identities=28% Similarity=0.372 Sum_probs=122.8
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
++||+|+||.||+++.. +++.||||.++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999875 47899999987531 23455677788887754 899999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|+|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999988843 345788899999999999999999988 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=213.14 Aligned_cols=142 Identities=27% Similarity=0.316 Sum_probs=119.9
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
+.||+|+||.||+++.. +++.||+|.+.... .....++..|.. ++..++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999875 47889999986432 222344444544 56778999999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
++|..++.. ...+.......++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999998843 345677888889999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=209.75 Aligned_cols=154 Identities=29% Similarity=0.485 Sum_probs=131.2
Q ss_pred hhcCCcceeeeecccCcEeEEEEEecC------CcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 594 (692)
...++|++.++||+|+||.||+|...+ +..||+|.+..... ....++.+|+.++.+++||||+++++++.++.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345789999999999999999996532 45799998864322 23456889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHhHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceE
Q 005519 595 EKILIYEYMVNKSLDVFLFDPT-------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 667 (692)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999985421 1234567888899999999999999987 99999999999999999999
Q ss_pred EEeeCCceecC
Q 005519 668 ISDFGMARMFG 678 (692)
Q Consensus 668 I~DFGlAk~~~ 678 (692)
|+|||+|+.+.
T Consensus 160 L~Dfg~~~~~~ 170 (288)
T cd05061 160 IGDFGMTRDIY 170 (288)
T ss_pred ECcCCcccccc
Confidence 99999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=205.62 Aligned_cols=149 Identities=35% Similarity=0.569 Sum_probs=132.3
Q ss_pred CCcceeeeecccCcEeEEEEEecC----CcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
++|++.+.||+|+||.||+|.... ...||||.+.... .....+|.+|+.++.+++||||+++++.+.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578999999999999999998642 3579999887543 23356799999999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998542 236889999999999999999999987 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=216.92 Aligned_cols=154 Identities=29% Similarity=0.442 Sum_probs=134.9
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCc--cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
.....|.+..+||+|.|++|.+++.. .+..||||.+++.... ....+.+|+++|..++|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567999999999999999999864 4889999999865332 34558899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||||+.+|.+.++|.. ........+..++.|+..|++|||+++ |+|||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999943 233444778889999999999999998 9999999999999999999999999999887
Q ss_pred CCc
Q 005519 679 GDE 681 (692)
Q Consensus 679 ~~~ 681 (692)
...
T Consensus 207 ~~~ 209 (596)
T KOG0586|consen 207 YGL 209 (596)
T ss_pred ccc
Confidence 554
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=230.43 Aligned_cols=150 Identities=28% Similarity=0.422 Sum_probs=133.3
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|.+.++||+|+||.||+|... +++.||||++.... ......+..|+.++..++||||+++++.+......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999875 58899999986532 223467889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++++|..++.. ...+++..++.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 99999999999843 335788889999999999999999987 999999999999999999999999999977544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=206.36 Aligned_cols=146 Identities=31% Similarity=0.392 Sum_probs=124.9
Q ss_pred eeecccCcEeEEEEEecC---CcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCC
Q 005519 531 SKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 606 (692)
+.||+|+||.||+|...+ +..+|+|.+..... .....|.+|+.++.+++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997643 45799998875432 33457899999999999999999999999999999999999999
Q ss_pred CHhHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 607 SLDVFLFDPT--KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 607 sL~~~L~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+|.+++.... .....++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccC
Confidence 9999986432 2234677888899999999999999987 99999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=210.52 Aligned_cols=152 Identities=32% Similarity=0.509 Sum_probs=130.3
Q ss_pred cCCcceeeeecccCcEeEEEEEecC---------------CcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLL 587 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~---------------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~ 587 (692)
.++|++.++||+|+||.||+++..+ ...||||.+.... ......|.+|+.++.+++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987532 2358999987542 23356799999999999999999999
Q ss_pred EEEEeCCeEEEEEEccCCCCHhHHhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcE
Q 005519 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPT---------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNI 658 (692)
Q Consensus 588 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NI 658 (692)
+++...+..++||||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999985321 1124788999999999999999999987 99999999999
Q ss_pred EEcCCCceEEEeeCCceecC
Q 005519 659 LLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 659 Ll~~~~~~kI~DFGlAk~~~ 678 (692)
++++++.+||+|||+++.+.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EEcCCCcEEecccccccccc
Confidence 99999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-23 Score=231.85 Aligned_cols=149 Identities=35% Similarity=0.536 Sum_probs=131.8
Q ss_pred eeeeecccCcEeEEEEEe-cCCc----EEEEEEcccC-CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 529 IQSKLGEGGFGPVYKGRL-LNGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 529 ~~~~LG~G~fG~Vykg~~-~~g~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
..++||+|+||+||||.+ ++|+ +||+|.+... ..+...++.+|+.+|++++||||+||+|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 347999999999999975 4443 6899988654 3445789999999999999999999999998766 8899999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCcc
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~~ 682 (692)
|+.|.|.+|++. .+..+..+..+.+..|||+||.|||++. ++||||..+||||.+...+||+|||+|+++.+++.
T Consensus 779 mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999965 3456788999999999999999999987 99999999999999999999999999999988876
Q ss_pred c
Q 005519 683 Q 683 (692)
Q Consensus 683 ~ 683 (692)
+
T Consensus 854 e 854 (1177)
T KOG1025|consen 854 E 854 (1177)
T ss_pred c
Confidence 4
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=216.71 Aligned_cols=148 Identities=28% Similarity=0.404 Sum_probs=128.0
Q ss_pred CcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----eEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EKI 597 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 597 (692)
+|++.++||+|+||.||++.. .+++.||||++.... ....+++.+|+.++..++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 458999999986532 234567889999999999999999999998776 789
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
+|+||+. ++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777763 2346889999999999999999999988 999999999999999999999999999876
Q ss_pred CCC
Q 005519 678 GGD 680 (692)
Q Consensus 678 ~~~ 680 (692)
...
T Consensus 154 ~~~ 156 (372)
T cd07853 154 EPD 156 (372)
T ss_pred ccC
Confidence 543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=207.23 Aligned_cols=150 Identities=33% Similarity=0.484 Sum_probs=127.2
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCc----EEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
++|++.+.||+|+||.||+|... +++ .+++|.+..... ....++..|+.+++++.||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999863 344 478888754322 23467888898999999999999999875 456789
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
++||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 345899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005519 679 GD 680 (692)
Q Consensus 679 ~~ 680 (692)
.+
T Consensus 161 ~~ 162 (279)
T cd05111 161 PD 162 (279)
T ss_pred CC
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=205.83 Aligned_cols=150 Identities=32% Similarity=0.596 Sum_probs=126.0
Q ss_pred cceeeeecccCcEeEEEEEecC-Cc--EEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeC------Ce
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------GE 595 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~ 595 (692)
|.+.++||+|+||.||+|...+ +. .||||.++.. .....+.|..|+.++.+++|+||+++++++.+. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3466899999999999998754 32 5899988653 233467789999999999999999999988643 24
Q ss_pred EEEEEEccCCCCHhHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 596 KILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
.++++||+++|+|..++... .....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887422 12345889999999999999999999987 9999999999999999999999999
Q ss_pred CceecCC
Q 005519 673 MARMFGG 679 (692)
Q Consensus 673 lAk~~~~ 679 (692)
+|+.+..
T Consensus 158 ~~~~~~~ 164 (272)
T cd05075 158 LSKKIYN 164 (272)
T ss_pred cccccCc
Confidence 9997754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=204.64 Aligned_cols=149 Identities=32% Similarity=0.512 Sum_probs=132.5
Q ss_pred CCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
.+|++.+.||+|+||.||++...++..+|+|.+... .....+|.+|+.++.+++||||+++++++.+.+..++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357788999999999999998877778999988643 2345678999999999999999999999999999999999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 99999998542 235889999999999999999999988 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=207.40 Aligned_cols=153 Identities=33% Similarity=0.571 Sum_probs=133.7
Q ss_pred cCCcceeeeecccCcEeEEEEEecC------CcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 596 (692)
.++|.+.+.||+|+||.||+|...+ ++.||||.+...... ..+.|.+|+.++.+++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999997633 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCc
Q 005519 597 ILIYEYMVNKSLDVFLFDP-----------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 665 (692)
++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 9999999999999998542 12345788999999999999999999987 999999999999999999
Q ss_pred eEEEeeCCceecCC
Q 005519 666 PKISDFGMARMFGG 679 (692)
Q Consensus 666 ~kI~DFGlAk~~~~ 679 (692)
+||+|||+++.+..
T Consensus 161 ~kl~d~g~~~~~~~ 174 (280)
T cd05049 161 VKIGDFGMSRDVYT 174 (280)
T ss_pred EEECCcccceeccc
Confidence 99999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=215.02 Aligned_cols=154 Identities=30% Similarity=0.463 Sum_probs=129.4
Q ss_pred hcCCcceeeeecccCcEeEEEEEe------cCCcEEEEEEcccCCC-ccHHHHHHHHHHHHhC-CCCCcceeEEEEEeC-
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ- 593 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~- 593 (692)
..++|++.++||+|+||.||+|.. ..++.||||.+..... .....+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346799999999999999999963 3467899999975432 3356788999999999 789999999988754
Q ss_pred CeEEEEEEccCCCCHhHHhcCCCC--------------------------------------------------------
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPTK-------------------------------------------------------- 617 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~~-------------------------------------------------------- 617 (692)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999998853210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 618 --------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 618 --------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~ 231 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 231 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEeccccccccc
Confidence 124688888999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=206.51 Aligned_cols=155 Identities=29% Similarity=0.471 Sum_probs=134.2
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC-----CcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCe
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGE 595 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~ 595 (692)
..++|++.+.||+|+||.||+|...+ +..|++|++.... ......+.+|+.++.+++||||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45689999999999999999998755 6789999887542 2345678999999999999999999999876 467
Q ss_pred EEEEEEccCCCCHhHHhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEe
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKK-----HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~D 670 (692)
.++++||+++++|..++...... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543222 56899999999999999999999987 99999999999999999999999
Q ss_pred eCCceecCCC
Q 005519 671 FGMARMFGGD 680 (692)
Q Consensus 671 FGlAk~~~~~ 680 (692)
||+++.+...
T Consensus 161 ~g~~~~~~~~ 170 (280)
T cd05043 161 NALSRDLFPM 170 (280)
T ss_pred CCCcccccCC
Confidence 9999976543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-22 Score=207.57 Aligned_cols=152 Identities=34% Similarity=0.566 Sum_probs=133.0
Q ss_pred CCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
++|.+.+.||+|+||.||+++.. +...+++|.+........+.+.+|+.++.+++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45888899999999999999742 345689999876555556789999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCc
Q 005519 599 IYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 665 (692)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985421 1234889999999999999999999988 999999999999999999
Q ss_pred eEEEeeCCceecCC
Q 005519 666 PKISDFGMARMFGG 679 (692)
Q Consensus 666 ~kI~DFGlAk~~~~ 679 (692)
+||+|||+|+....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=215.33 Aligned_cols=147 Identities=24% Similarity=0.368 Sum_probs=128.0
Q ss_pred hcCCcceeeeecccCcEeEEEEEec---CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
...+|++.++||+|+||.||++... .++.||||.+... +.+.+|+.++.+++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3467999999999999999999753 2578999988643 3456899999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|||+. ++|..++ .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99986 6787777 23456899999999999999999999988 99999999999999999999999999987755
Q ss_pred Cc
Q 005519 680 DE 681 (692)
Q Consensus 680 ~~ 681 (692)
..
T Consensus 238 ~~ 239 (392)
T PHA03207 238 HP 239 (392)
T ss_pred cc
Confidence 43
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=210.69 Aligned_cols=141 Identities=29% Similarity=0.379 Sum_probs=124.5
Q ss_pred eeecccCcEeEEEEEecC-CcEEEEEEcccC---CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
+.||+|+||+||+++... ++.||||.+.+. .......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999998754 789999998753 233456678899999888 799999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 999988843 345899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-22 Score=208.04 Aligned_cols=153 Identities=31% Similarity=0.514 Sum_probs=131.5
Q ss_pred cCCcceeeeecccCcEeEEEEEec-----------------CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcce
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 585 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-----------------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~ 585 (692)
.++|++.++||+|+||.||++... +...||+|.+.... .....+|.+|+.++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 467999999999999999998532 23468999987543 334568999999999999999999
Q ss_pred eEEEEEeCCeEEEEEEccCCCCHhHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCc
Q 005519 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPT--------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (692)
Q Consensus 586 l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~N 657 (692)
+++++...+..++||||+++++|..++.... ....+++.++..++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999985422 1234778899999999999999999988 9999999999
Q ss_pred EEEcCCCceEEEeeCCceecCC
Q 005519 658 ILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 658 ILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||+++++.+||+|||+|+.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred EEEcCCCCEEeccCcccccccC
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=212.18 Aligned_cols=145 Identities=23% Similarity=0.322 Sum_probs=126.0
Q ss_pred hhcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
....+|++.+.||+|+||.||+|+... ++.||+|..... ....|+.++.+++||||+++++++.++...++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 345679999999999999999998754 678999975432 2356999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||+. ++|..++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 678877743 3346899999999999999999999987 9999999999999999999999999998543
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=207.93 Aligned_cols=156 Identities=31% Similarity=0.520 Sum_probs=134.7
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEecC------CcEEEEEEcccC-CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 592 (692)
....++|++.+.||+|+||.||++.... ...+|+|.+... ..+...++.+|+.++.++ +|+||+++++++.+
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3455679999999999999999997632 367999988753 223456789999999999 89999999999999
Q ss_pred CCeEEEEEEccCCCCHhHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEE
Q 005519 593 QGEKILIYEYMVNKSLDVFLFDP-------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (692)
Q Consensus 593 ~~~~~LV~Ey~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NIL 659 (692)
++..+++|||+++|+|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999998532 22456889999999999999999999987 999999999999
Q ss_pred EcCCCceEEEeeCCceecCC
Q 005519 660 LDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 660 l~~~~~~kI~DFGlAk~~~~ 679 (692)
++.++.+||+|||+++.+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHH 184 (293)
T ss_pred EcCCCeEEeCcccccccccc
Confidence 99999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=204.26 Aligned_cols=150 Identities=31% Similarity=0.528 Sum_probs=128.5
Q ss_pred cceeeeecccCcEeEEEEEecC----CcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCe-----
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE----- 595 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 595 (692)
|++.+.||+|+||.||+|.... +..||||+++... .....++.+|+..+..++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 3679999987532 2335689999999999999999999999876554
Q ss_pred -EEEEEEccCCCCHhHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEee
Q 005519 596 -KILIYEYMVNKSLDVFLFDPT---KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (692)
Q Consensus 596 -~~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DF 671 (692)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999885432 2346899999999999999999999987 999999999999999999999999
Q ss_pred CCceecCC
Q 005519 672 GMARMFGG 679 (692)
Q Consensus 672 GlAk~~~~ 679 (692)
|+|+.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05035 158 GLSKKIYS 165 (273)
T ss_pred cceeeccc
Confidence 99997653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-23 Score=201.69 Aligned_cols=160 Identities=31% Similarity=0.439 Sum_probs=136.3
Q ss_pred cCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC----Ccc----HHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS----GQG----LKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~----~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 593 (692)
-++|...+.||+|..+.|.++.. ..+++.|+|++.... ... .+.-..|+.+|+++ -||+|+.|.+++...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35677778999999999998876 458899999886421 111 23456789999998 699999999999999
Q ss_pred CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
...++|+|.|+.|.|.++| .+.-.++++...+|+.|+..|+.|||... ||||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999 44567899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCccccCccceecC
Q 005519 674 ARMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 674 Ak~~~~~~~~~~~~~~~GT 692 (692)
|..+.+.+. ...++||
T Consensus 170 a~~l~~Gek---LrelCGT 185 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGT 185 (411)
T ss_pred eeccCCchh---HHHhcCC
Confidence 999988764 2345665
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=214.86 Aligned_cols=154 Identities=31% Similarity=0.481 Sum_probs=129.7
Q ss_pred hcCCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhC-CCCCcceeEEEEEeC-
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ- 593 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~- 593 (692)
+.++|++.+.||+|+||.||+|... .++.||+|++..... ...+.+..|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4467999999999999999999642 246899999875322 2345678899999999 899999999988754
Q ss_pred CeEEEEEEccCCCCHhHHhcCCCC--------------------------------------------------------
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPTK-------------------------------------------------------- 617 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~~-------------------------------------------------------- 617 (692)
...++++||+++++|..++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 568899999999999998853211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 618 --KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 618 --~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 125789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-22 Score=203.36 Aligned_cols=151 Identities=31% Similarity=0.547 Sum_probs=134.2
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
..|++.++||+|+||.||+|...+ ++.||+|.+... .....++.+|+.++.+++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 458888999999999999998654 788999998753 345678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+...
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999998543 2345899999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=203.45 Aligned_cols=151 Identities=32% Similarity=0.517 Sum_probs=131.8
Q ss_pred cCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
.++|++.++||+|+||.||+|+..+...||+|.+... ....++|.+|+.++.+++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 3569999999999999999998877778999999753 334568999999999999999999999874 45689999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
++|+|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999998542 2345789999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=205.83 Aligned_cols=152 Identities=36% Similarity=0.592 Sum_probs=131.3
Q ss_pred CCcceeeeecccCcEeEEEEEecC------CcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 597 (692)
++|++.+.||+|+||.||+|.... ...||+|.+..... ....+|.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999997643 25799999865432 33567999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC
Q 005519 598 LIYEYMVNKSLDVFLFDPTK-------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~ 664 (692)
++|||+++++|.+++..... ...+++.....++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999854211 145888999999999999999999987 99999999999999999
Q ss_pred ceEEEeeCCceecCC
Q 005519 665 NPKISDFGMARMFGG 679 (692)
Q Consensus 665 ~~kI~DFGlAk~~~~ 679 (692)
.+||+|||+++....
T Consensus 162 ~~~L~dfg~~~~~~~ 176 (283)
T cd05048 162 TVKISDFGLSRDIYS 176 (283)
T ss_pred cEEECCCcceeeccc
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-22 Score=202.84 Aligned_cols=145 Identities=34% Similarity=0.544 Sum_probs=129.1
Q ss_pred cceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccH--HHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~--~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
|++.+.||+|+||+||+++... ++.+|+|.+........ .....|+.++.+++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999998755 67899999976533222 23456999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
++++|..++. ....+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||++..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999985 3556899999999999999999999987 999999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-24 Score=208.62 Aligned_cols=159 Identities=30% Similarity=0.494 Sum_probs=140.4
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
+-|.++++||+|+||.|||+.++ .|+.||||++.. ...+.+...|+.+|...+.|++|+++|.+.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34778899999999999999875 499999999864 456789999999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCccc
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~~~ 683 (692)
..|+..+.++- ++.+|.+.++..++...++||+|||... -||||||+.||||+.+|.+||+|||.|-.+.+.-..
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999999853 4567999999999999999999999875 799999999999999999999999999988765444
Q ss_pred cCccceecC
Q 005519 684 GNTKRIVGT 692 (692)
Q Consensus 684 ~~~~~~~GT 692 (692)
.+ .++||
T Consensus 186 RN--TVIGT 192 (502)
T KOG0574|consen 186 RN--TVIGT 192 (502)
T ss_pred hC--ccccC
Confidence 34 36776
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=207.93 Aligned_cols=149 Identities=26% Similarity=0.328 Sum_probs=130.4
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|++.++||+|+||.||++... ++..+|+|.+..... ....++.+|++++.+++||||+++++++.+++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36899999999999999999864 478899998864322 2345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++++|.+++.. ...+++..+..++.|+++||.|||+.. +++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999999843 345788999999999999999999742 39999999999999999999999999998664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=203.02 Aligned_cols=156 Identities=29% Similarity=0.422 Sum_probs=133.9
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
+.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++.+++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445666666689999999999999864 4778999998766555677899999999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-CCceEEEeeCCceecC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFG 678 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kI~DFGlAk~~~ 678 (692)
+||+++++|..++.........++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999864322212377888899999999999999987 999999999999986 6789999999998764
Q ss_pred C
Q 005519 679 G 679 (692)
Q Consensus 679 ~ 679 (692)
.
T Consensus 161 ~ 161 (268)
T cd06624 161 G 161 (268)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-22 Score=204.19 Aligned_cols=151 Identities=33% Similarity=0.555 Sum_probs=131.9
Q ss_pred CCcceeeeecccCcEeEEEEEec-C---CcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-N---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~---g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
.+|++.+.||+|+||.||+|... . ...+|+|.++... ....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999763 2 3379999886532 23356799999999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|||+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998542 245789999999999999999999987 99999999999999999999999999997754
Q ss_pred C
Q 005519 680 D 680 (692)
Q Consensus 680 ~ 680 (692)
.
T Consensus 159 ~ 159 (267)
T cd05066 159 D 159 (267)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-22 Score=211.58 Aligned_cols=140 Identities=26% Similarity=0.330 Sum_probs=120.1
Q ss_pred ecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhC---CCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 533 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
||+|+||+||+++.. +++.||||.+.... ......+..|..++.+. +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 48899999986431 12334456677777665 699999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 999988843 445889999999999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9e-22 Score=208.11 Aligned_cols=154 Identities=31% Similarity=0.535 Sum_probs=132.7
Q ss_pred hcCCcceeeeecccCcEeEEEEEec--------CCcEEEEEEcccCC-CccHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 592 (692)
..++|++.+.||+|+||.||+++.. ++..||+|.+.... ....+++.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467889999999999999999641 24579999886432 34467899999999999 89999999999999
Q ss_pred CCeEEEEEEccCCCCHhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEE
Q 005519 593 QGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (692)
Q Consensus 593 ~~~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NIL 659 (692)
....++||||+++|+|..++.... ....+++.++..++.||++||.|||+.+ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999986432 1235788999999999999999999987 999999999999
Q ss_pred EcCCCceEEEeeCCceecCC
Q 005519 660 LDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 660 l~~~~~~kI~DFGlAk~~~~ 679 (692)
++.++.+||+|||+|+.+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 170 VTENNVMKIADFGLARDVNN 189 (304)
T ss_pred EcCCCcEEECCCccceeccc
Confidence 99999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-22 Score=206.71 Aligned_cols=153 Identities=32% Similarity=0.504 Sum_probs=132.9
Q ss_pred cCCcceeeeecccCcEeEEEEEecC-----------------CcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcce
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 585 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~ 585 (692)
.++|++.++||+|+||.||++...+ +..||+|.+.... ....+++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999987543 2458999987543 234678999999999999999999
Q ss_pred eEEEEEeCCeEEEEEEccCCCCHhHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCc
Q 005519 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPT--------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (692)
Q Consensus 586 l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~N 657 (692)
+++++......++++||+++++|..++.... ....+++..++.++.|+++||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1236899999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEeeCCceecCC
Q 005519 658 ILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 658 ILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|+++.++.+||+|||+++.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred eeecCCCceEEccccceeeccc
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=206.43 Aligned_cols=151 Identities=32% Similarity=0.534 Sum_probs=129.6
Q ss_pred CcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
+|++.+.||+|+||.||+|+.. ....+|+|.+..... ....++.+|+.++..++||||+++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999753 235789998865432 335679999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCc
Q 005519 599 IYEYMVNKSLDVFLFDPT---------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~N 657 (692)
++||+++++|.+++.... ....+++.+++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235889999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEeeCCceecCC
Q 005519 658 ILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 658 ILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||+++++.+||+|||+++.+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~ 179 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYE 179 (290)
T ss_pred EEEcCCCcEEeccccccccccC
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=201.47 Aligned_cols=152 Identities=36% Similarity=0.542 Sum_probs=136.5
Q ss_pred hcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
..++|++.++||+|+||.||++...+++.||||.+... ....+++.+|+.++.+++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 45689999999999999999999877889999998753 34567899999999999999999999999988999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++++|.+++... ....+++.++..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999998553 2345899999999999999999999987 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-22 Score=204.74 Aligned_cols=154 Identities=29% Similarity=0.465 Sum_probs=133.0
Q ss_pred cCCcceeeeecccCcEeEEEEEecC------CcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 596 (692)
.++|++.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678999999999999999997642 36899999865432 3356789999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEE
Q 005519 597 ILIYEYMVNKSLDVFLFDPTK-------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~ 669 (692)
++||||+++++|..++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999854221 234788999999999999999999987 9999999999999999999999
Q ss_pred eeCCceecCCC
Q 005519 670 DFGMARMFGGD 680 (692)
Q Consensus 670 DFGlAk~~~~~ 680 (692)
|||+++.+...
T Consensus 162 dfg~~~~~~~~ 172 (277)
T cd05032 162 DFGMTRDIYET 172 (277)
T ss_pred CcccchhhccC
Confidence 99999876443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=204.28 Aligned_cols=149 Identities=28% Similarity=0.343 Sum_probs=130.4
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
.|+..+.||+|+||+||++... +++.||+|.+.... ......+.+|+.++.+++|+||+++.+.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677789999999999999864 58899999986532 2234557889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999999888543 2345899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=203.42 Aligned_cols=150 Identities=33% Similarity=0.561 Sum_probs=131.6
Q ss_pred CCcceeeeecccCcEeEEEEEecC-C---cEEEEEEcccC-CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
..|++.+.||+|+||.||+|.... + ..||||.+... ......+|..|+.++++++||||+++.+++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998643 3 36999998754 233456899999999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|||+++++|..++... ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998542 345889999999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=203.79 Aligned_cols=154 Identities=31% Similarity=0.502 Sum_probs=133.3
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeC-----
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ----- 593 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~----- 593 (692)
+.+++.|++.+.||+|+||.||+|... +++.||+|.+... .....++..|+.++.++ +|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 346678999999999999999999864 4788999998653 34557789999999998 799999999998753
Q ss_pred -CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 594 -GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 594 -~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
...++||||+++++|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 4689999999999999988542 2346889999999999999999999987 9999999999999999999999999
Q ss_pred CceecCC
Q 005519 673 MARMFGG 679 (692)
Q Consensus 673 lAk~~~~ 679 (692)
+++.+..
T Consensus 157 ~~~~~~~ 163 (272)
T cd06637 157 VSAQLDR 163 (272)
T ss_pred Cceeccc
Confidence 9987643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=202.68 Aligned_cols=149 Identities=35% Similarity=0.565 Sum_probs=131.0
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|++.+.||+|++|.||+|+.. +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999874 58899999886432 22346788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
++ ++|..++........+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688888754444456899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=205.91 Aligned_cols=151 Identities=26% Similarity=0.413 Sum_probs=135.7
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
..++|++.++||+|+||.||++.. .+++.||+|.+........+.+.+|+.++..++|+||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 447899999999999999999986 4689999999976555556778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
|+++++|..++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....+
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999998832 34788999999999999999999987 999999999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=206.99 Aligned_cols=151 Identities=36% Similarity=0.534 Sum_probs=130.0
Q ss_pred CcceeeeecccCcEeEEEEEecC------CcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
+|++.++||+|+||.||+|...+ ++.||||++...... ..+.|.+|+.++..++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46777899999999999997532 478999999754332 24668899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCc
Q 005519 599 IYEYMVNKSLDVFLFDP-------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 665 (692)
++||+++++|..++... .....+++..+.+++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998421 11235788899999999999999999987 999999999999999999
Q ss_pred eEEEeeCCceecCC
Q 005519 666 PKISDFGMARMFGG 679 (692)
Q Consensus 666 ~kI~DFGlAk~~~~ 679 (692)
+||+|||+++.+..
T Consensus 163 ~kl~Dfg~~~~~~~ 176 (283)
T cd05091 163 VKISDLGLFREVYA 176 (283)
T ss_pred eEeccccccccccc
Confidence 99999999987644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=206.11 Aligned_cols=151 Identities=26% Similarity=0.417 Sum_probs=135.4
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
...+|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.++..+.|+||+++++.+..+...++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 446899999999999999999985 4588999999876555556789999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
|+++++|..++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 9999999998832 34788999999999999999999988 999999999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=204.93 Aligned_cols=152 Identities=34% Similarity=0.546 Sum_probs=133.0
Q ss_pred CCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
++|+..++||+|+||.||++... ++..+|+|.+..........|.+|+.++.+++|+||+++++++.++...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56778899999999999999642 356799999876655567789999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCce
Q 005519 599 IYEYMVNKSLDVFLFDPTK------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 666 (692)
++||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999854221 135789999999999999999999987 9999999999999999999
Q ss_pred EEEeeCCceecCC
Q 005519 667 KISDFGMARMFGG 679 (692)
Q Consensus 667 kI~DFGlAk~~~~ 679 (692)
||+|||+++.+..
T Consensus 162 kL~dfg~~~~~~~ 174 (280)
T cd05092 162 KIGDFGMSRDIYS 174 (280)
T ss_pred EECCCCceeEcCC
Confidence 9999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=205.92 Aligned_cols=142 Identities=27% Similarity=0.378 Sum_probs=121.0
Q ss_pred eecccCcEeEEEEEecC-------------------------CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCccee
Q 005519 532 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586 (692)
Q Consensus 532 ~LG~G~fG~Vykg~~~~-------------------------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l 586 (692)
+||+|+||.||+|.+.. ...||+|.+.........+|.+|+.++..++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589998875444445678999999999999999999
Q ss_pred EEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC--
Q 005519 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-- 664 (692)
Q Consensus 587 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~-- 664 (692)
++++.+....++||||+++|+|+.++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999988542 345789999999999999999999987 99999999999997643
Q ss_pred -----ceEEEeeCCceecC
Q 005519 665 -----NPKISDFGMARMFG 678 (692)
Q Consensus 665 -----~~kI~DFGlAk~~~ 678 (692)
.+|++|||+++...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~ 175 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTAL 175 (274)
T ss_pred cCccceeeecCCccccccc
Confidence 38999999987553
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=202.36 Aligned_cols=145 Identities=28% Similarity=0.409 Sum_probs=128.0
Q ss_pred CCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|++.++||+|+||.||+|.. .+++.||+|.+.... .....++.+|+.++.+++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3578889999999999999986 458899999886542 23456799999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999987653 3677888899999999999999988 99999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=201.12 Aligned_cols=151 Identities=36% Similarity=0.538 Sum_probs=133.5
Q ss_pred hcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
..++|++.++||+|+||.||+|...+++.||+|.+... .....+|.+|+.++.+++|+||+++++++ ..+..++++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 34678999999999999999999888899999998754 33457899999999999999999999886 45678999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.+..
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999988543 2346889999999999999999999887 99999999999999999999999999987763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=201.15 Aligned_cols=143 Identities=31% Similarity=0.503 Sum_probs=126.7
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCH
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 608 (692)
++||+|+||.||+|+.. +++.||+|.+.... ......|.+|+.++.+++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999874 58899999876432 23456799999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 999843 2345789999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=203.61 Aligned_cols=149 Identities=27% Similarity=0.484 Sum_probs=133.5
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
.++|++.++||+|+||.||+++.. +++.||+|.++.........+.+|+.++..++||||+++++.+..++..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999864 5889999998765445556788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++++|.+++.. ...+++.+...++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999998843 345889999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=200.97 Aligned_cols=149 Identities=31% Similarity=0.549 Sum_probs=134.0
Q ss_pred cCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
.++|++.+.||+|+||.||++... ++.||||.+..... ..+++.+|+.++.+++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888899999999999999874 78999999976533 5678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999985432 236899999999999999999999988 9999999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=217.98 Aligned_cols=150 Identities=23% Similarity=0.425 Sum_probs=122.9
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--------
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-------- 593 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-------- 593 (692)
..++|++.++||+|+||.||+|... .++.||||++.... ....+|+.++..++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999874 58899999885432 2345799999999999999999887532
Q ss_pred CeEEEEEEccCCCCHhHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC-ceEEEee
Q 005519 594 GEKILIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDF 671 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kI~DF 671 (692)
...++||||+++ +|..++.. ......+++..+..++.||++||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 56665532 223456889999999999999999999988 99999999999998664 7999999
Q ss_pred CCceecCCC
Q 005519 672 GMARMFGGD 680 (692)
Q Consensus 672 GlAk~~~~~ 680 (692)
|+|+.+...
T Consensus 216 Gla~~~~~~ 224 (440)
T PTZ00036 216 GSAKNLLAG 224 (440)
T ss_pred ccchhccCC
Confidence 999977543
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=205.08 Aligned_cols=150 Identities=32% Similarity=0.529 Sum_probs=130.7
Q ss_pred CCcceeeeecccCcEeEEEEEe-----cCCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 596 (692)
+.|++.++||+|+||.||+++. .++..||+|.+.... ......+.+|+.++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999974 247789999987543 33456799999999999999999999998875 568
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999998432 235899999999999999999999988 99999999999999999999999999987
Q ss_pred cCC
Q 005519 677 FGG 679 (692)
Q Consensus 677 ~~~ 679 (692)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=207.58 Aligned_cols=152 Identities=32% Similarity=0.524 Sum_probs=131.8
Q ss_pred cCCcceeeeecccCcEeEEEEEec--------CCcEEEEEEcccCC-CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 593 (692)
.++|.+.++||+|+||.||++... +...+|+|.+.... .....++..|+.++.++ +||||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999752 13469999987532 33456788999999999 799999999999999
Q ss_pred CeEEEEEEccCCCCHhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEE
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl 660 (692)
...++|+||+++|+|.+++.... ....+++.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999996432 1235889999999999999999999987 9999999999999
Q ss_pred cCCCceEEEeeCCceecC
Q 005519 661 DQHMNPKISDFGMARMFG 678 (692)
Q Consensus 661 ~~~~~~kI~DFGlAk~~~ 678 (692)
+.++.+||+|||+|+.+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 174 TEDNVMKIADFGLARDIH 191 (307)
T ss_pred cCCCcEEECCCccccccc
Confidence 999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=203.44 Aligned_cols=148 Identities=29% Similarity=0.463 Sum_probs=132.2
Q ss_pred CcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
.|++.++||+|+||.||++.... +..+++|.+........+.+.+|+.++..++||||+++++++..++..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36777899999999999998754 77889999876555567789999999999999999999999999999999999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++|..++.. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999988753 2346899999999999999999999987 9999999999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-23 Score=216.62 Aligned_cols=149 Identities=34% Similarity=0.490 Sum_probs=129.2
Q ss_pred cceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCC
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 606 (692)
+..++-||.|+-|.||+|++. +++||||++.... ..+|+-|++|+||||+.+.|+|....-+++|||||+.|
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 344578999999999999994 6899999886432 25788999999999999999999999999999999999
Q ss_pred CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCccccCc
Q 005519 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686 (692)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~~~~~~ 686 (692)
-|...|. .++.+.......+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++.+....+.
T Consensus 198 qL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk--- 268 (904)
T KOG4721|consen 198 QLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK--- 268 (904)
T ss_pred cHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhh---
Confidence 9999994 4556777888899999999999999987 999999999999999999999999999988765332
Q ss_pred cceecC
Q 005519 687 KRIVGT 692 (692)
Q Consensus 687 ~~~~GT 692 (692)
..+.||
T Consensus 269 MSFaGT 274 (904)
T KOG4721|consen 269 MSFAGT 274 (904)
T ss_pred hhhhhh
Confidence 246665
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=203.22 Aligned_cols=150 Identities=30% Similarity=0.360 Sum_probs=130.4
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC---ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
.|+..+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.++.+++|+|++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677899999999999999864 588999999865321 224567889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999988542 2335889999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=202.00 Aligned_cols=150 Identities=31% Similarity=0.452 Sum_probs=132.2
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++.+++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999875 48899999886432 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
|++++.|+.++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999998887632 335899999999999999999999987 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=205.62 Aligned_cols=151 Identities=28% Similarity=0.436 Sum_probs=135.3
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
+.++|++.++||+|+||.||++... +++.+|+|.+........+.|..|+.++.+++||||+++++.+..+...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 3467999999999999999999874 588999999876555566789999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+++++|..++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 83 FCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999988432 345889999999999999999999988 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=202.13 Aligned_cols=143 Identities=27% Similarity=0.389 Sum_probs=124.3
Q ss_pred ecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCH
Q 005519 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (692)
Q Consensus 533 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 608 (692)
||+|+||.||+++.. +++.+|+|.+.... ......+..|+.++.+++||||+++.+.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 48999999986421 12244566799999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 9887543 2345889999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=203.92 Aligned_cols=150 Identities=30% Similarity=0.412 Sum_probs=133.4
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999865 48899999886432 234567899999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++++|.+++.. ...++...+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999843 356889999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=200.85 Aligned_cols=152 Identities=24% Similarity=0.436 Sum_probs=132.8
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||.||+|+.. +++.||||.+... .......+.+|+.++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999864 5889999987542 2233457899999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 601 EYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||+++++|..++.... ....++...+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875322 2345788899999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-22 Score=214.45 Aligned_cols=158 Identities=28% Similarity=0.480 Sum_probs=135.9
Q ss_pred hHhhhcCCcceeeeecccCcEeEEEEEecC---C--cEEEEEEcccC-CCccHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 005519 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLN---G--QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (692)
Q Consensus 519 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~---g--~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 592 (692)
..+.+.+..++.+.||+|-||.||+|++.+ | -.||||..+.. .....+.|..|..+|+.++|||||+|+|.|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 334455667777899999999999998643 2 25899998864 44557889999999999999999999999986
Q ss_pred CCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 593 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
...|+|||.++.|.|..||.. +...|+..+...++.||..||+|||+.. +|||||..+|||+.....+||+|||
T Consensus 463 -~P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred -cceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccc
Confidence 578999999999999999943 4556888999999999999999999987 9999999999999999999999999
Q ss_pred CceecCCCcc
Q 005519 673 MARMFGGDEL 682 (692)
Q Consensus 673 lAk~~~~~~~ 682 (692)
|+|-+..+..
T Consensus 537 LSR~~ed~~y 546 (974)
T KOG4257|consen 537 LSRYLEDDAY 546 (974)
T ss_pred hhhhccccch
Confidence 9998866543
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=202.49 Aligned_cols=161 Identities=26% Similarity=0.370 Sum_probs=136.4
Q ss_pred eehhhHhhhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEEEEE-
Q 005519 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCI- 591 (692)
Q Consensus 515 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~- 591 (692)
..+..+..+.++|++.+.||+|+||.||++... +++.+|+|.+... .....++.+|+.++.++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666778899999999999999999999864 4789999987643 22346788999999999 6999999999885
Q ss_pred ----eCCeEEEEEEccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCce
Q 005519 592 ----EQGEKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (692)
Q Consensus 592 ----~~~~~~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 666 (692)
.++..++||||+++++|..++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999999887532 22346788899999999999999999987 9999999999999999999
Q ss_pred EEEeeCCceecCC
Q 005519 667 KISDFGMARMFGG 679 (692)
Q Consensus 667 kI~DFGlAk~~~~ 679 (692)
||+|||+++.+..
T Consensus 164 kl~dfg~~~~~~~ 176 (286)
T cd06638 164 KLVDFGVSAQLTS 176 (286)
T ss_pred EEccCCceeeccc
Confidence 9999999987654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=205.68 Aligned_cols=150 Identities=32% Similarity=0.552 Sum_probs=129.1
Q ss_pred CCcceeeeecccCcEeEEEEEecC-Cc--EEEEEEcccC-CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 599 (692)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998754 33 4788888743 233456799999999999 799999999999999999999
Q ss_pred EEccCCCCHhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCce
Q 005519 600 YEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 666 (692)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985421 1235889999999999999999999987 9999999999999999999
Q ss_pred EEEeeCCceec
Q 005519 667 KISDFGMARMF 677 (692)
Q Consensus 667 kI~DFGlAk~~ 677 (692)
||+|||+++..
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=201.25 Aligned_cols=142 Identities=30% Similarity=0.490 Sum_probs=122.9
Q ss_pred eeecccCcEeEEEEEecCCc-----------EEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 531 SKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~-----------~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++.+++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999875432 5788877654332 6889999999999999999999999988 778999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC-------ceEEEeeC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-------NPKISDFG 672 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~-------~~kI~DFG 672 (692)
+||+++|+|+.++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998543 226889999999999999999999987 99999999999999887 79999999
Q ss_pred CceecCC
Q 005519 673 MARMFGG 679 (692)
Q Consensus 673 lAk~~~~ 679 (692)
+|+.+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9987644
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=206.82 Aligned_cols=154 Identities=32% Similarity=0.532 Sum_probs=132.3
Q ss_pred hcCCcceeeeecccCcEeEEEEEec--------CCcEEEEEEcccCC-CccHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 592 (692)
..++|.+.++||+|+||.||+++.. ....+|+|.+.... .....++..|+.++.++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467889999999999999999642 24579999887532 33456789999999999 69999999999999
Q ss_pred CCeEEEEEEccCCCCHhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEE
Q 005519 593 QGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (692)
Q Consensus 593 ~~~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NIL 659 (692)
....++|+||+++|+|..++.... ....+++.++.+++.|++.||.|||+.+ |+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 999999999999999999985422 1245889999999999999999999987 999999999999
Q ss_pred EcCCCceEEEeeCCceecCC
Q 005519 660 LDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 660 l~~~~~~kI~DFGlAk~~~~ 679 (692)
++.++.+||+|||+++.+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~ 186 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHD 186 (314)
T ss_pred EcCCCcEEEccccccccccc
Confidence 99999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=206.85 Aligned_cols=150 Identities=35% Similarity=0.581 Sum_probs=129.3
Q ss_pred CCcceeeeecccCcEeEEEEEecC-Cc--EEEEEEcccCC-CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 599 (692)
++|++.+.||+|+||.||+|...+ +. .+|+|.+.... .....++.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578889999999999999998643 43 46888776432 33456789999999999 899999999999999999999
Q ss_pred EEccCCCCHhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCce
Q 005519 600 YEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 666 (692)
+||+++++|.+++.... ....+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235789999999999999999999987 9999999999999999999
Q ss_pred EEEeeCCceec
Q 005519 667 KISDFGMARMF 677 (692)
Q Consensus 667 kI~DFGlAk~~ 677 (692)
||+|||+++..
T Consensus 164 kl~dfg~~~~~ 174 (303)
T cd05088 164 KIADFGLSRGQ 174 (303)
T ss_pred EeCccccCccc
Confidence 99999999743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=204.02 Aligned_cols=150 Identities=31% Similarity=0.486 Sum_probs=134.5
Q ss_pred cCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
.+.|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+.++..++||||+++++.+......++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3678999999999999999998754 889999999766555677899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++++|..++... ...+++..+..++.|++++|.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999998887432 345889999999999999999999987 9999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=201.97 Aligned_cols=150 Identities=32% Similarity=0.501 Sum_probs=129.1
Q ss_pred cCCcceeeeecccCcEeEEEEEe-cCCc----EEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~----~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 597 (692)
.++|++.++||+|+||.||+|+. .+++ .||+|.+.... .....++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35688899999999999999975 3444 48999886533 2345678999999999999999999999875 4578
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998542 345889999999999999999999987 999999999999999999999999999987
Q ss_pred CC
Q 005519 678 GG 679 (692)
Q Consensus 678 ~~ 679 (692)
..
T Consensus 160 ~~ 161 (279)
T cd05109 160 DI 161 (279)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=198.37 Aligned_cols=151 Identities=29% Similarity=0.438 Sum_probs=134.0
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|++.+.||+|++|.||+++.. +++.|++|.+... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999874 5889999988643 234567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999998653 2356889999999999999999999987 999999999999999999999999999977554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=204.75 Aligned_cols=152 Identities=25% Similarity=0.411 Sum_probs=132.6
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC-CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|++.+.||+|+||.||++... .++.||+|.+... .......+.+|+.++.+++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35788899999999999999875 5889999988643 223356789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++++|..++........+++..+..++.+++.||.|||++. .|+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999998855333446899999999999999999999742 39999999999999999999999999998663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=203.05 Aligned_cols=142 Identities=27% Similarity=0.430 Sum_probs=120.8
Q ss_pred eecccCcEeEEEEEecCC---cEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCC
Q 005519 532 KLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (692)
Q Consensus 532 ~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 607 (692)
+||+|+||.||++...++ ..+++|.+.... ....+.|.+|+.++..++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975443 346677665432 2345789999999999999999999999999999999999999999
Q ss_pred HhHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 608 LDVFLFDPTK-KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 608 L~~~L~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
|..++..... ....++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 9999864321 234667778899999999999999987 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=206.01 Aligned_cols=153 Identities=33% Similarity=0.484 Sum_probs=132.3
Q ss_pred cCCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCC-CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCe
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGE 595 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 595 (692)
.++|.+.+.||+|+||.||++... .+..||||.++... ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356899999999999999999641 24579999887543 23346789999999999 79999999999999999
Q ss_pred EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
.++|+||+++|+|..++.... ...+++.++..++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999985422 234899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCC
Q 005519 676 MFGGD 680 (692)
Q Consensus 676 ~~~~~ 680 (692)
.+...
T Consensus 190 ~~~~~ 194 (302)
T cd05055 190 DIMND 194 (302)
T ss_pred cccCC
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=197.72 Aligned_cols=144 Identities=33% Similarity=0.480 Sum_probs=127.8
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCHh
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 609 (692)
++||+|+||.||+|...+++.+|+|.+...... ....|.+|+.++.+++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 379999999999999888899999998754332 2456899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 610 ~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
.++... ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccc
Confidence 988532 345789999999999999999999987 99999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-21 Score=198.58 Aligned_cols=152 Identities=27% Similarity=0.454 Sum_probs=134.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.++||+|+||.||+|... +++.||+|.++.. .....+.+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999875 6899999988632 2233678999999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||+++++|..++... .....+++..+..++.++++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988542 22455889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=202.35 Aligned_cols=146 Identities=38% Similarity=0.552 Sum_probs=127.1
Q ss_pred cceeeeecccCcEeEEEEEe-----cCCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeEEE
Q 005519 527 FSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKIL 598 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~L 598 (692)
|++.+.||+|+||+||++.. .+++.||+|.+..... .....|.+|+.++.+++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988653 3477899999875432 3457789999999999999999999998764 35899
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||||+++++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 34899999999999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 005519 679 G 679 (692)
Q Consensus 679 ~ 679 (692)
.
T Consensus 159 ~ 159 (283)
T cd05080 159 E 159 (283)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=200.48 Aligned_cols=151 Identities=33% Similarity=0.527 Sum_probs=132.6
Q ss_pred cCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
.++|++.++||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++.+++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 35688899999999999999998888889999987533 34567999999999999999999999874 45689999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
++++|.+++... ....+++.++..++.+++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999998543 2345789999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=198.83 Aligned_cols=150 Identities=33% Similarity=0.510 Sum_probs=130.9
Q ss_pred CCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
++|.+.++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++.+++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 568889999999999999999877778999988653 234567899999999999999999998875 456899999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999998543 2345789999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=201.79 Aligned_cols=151 Identities=31% Similarity=0.438 Sum_probs=132.1
Q ss_pred CCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 597 (692)
++|++.+.||+|+||.||+|+.. +.+.|++|.+...... ...++.+|+.++.+++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999853 2457999988754433 4578999999999999999999999999989999
Q ss_pred EEEEccCCCCHhHHhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEee
Q 005519 598 LIYEYMVNKSLDVFLFDPTKK------HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DF 671 (692)
+||||+++++|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643321 25899999999999999999999987 999999999999999999999999
Q ss_pred CCceecC
Q 005519 672 GMARMFG 678 (692)
Q Consensus 672 GlAk~~~ 678 (692)
|+++...
T Consensus 162 ~~~~~~~ 168 (275)
T cd05046 162 SLSKDVY 168 (275)
T ss_pred ccccccC
Confidence 9997543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=199.32 Aligned_cols=149 Identities=31% Similarity=0.482 Sum_probs=131.4
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-----CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
++|++.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56889999999999999999864 58899999876432 1234578899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 345788888999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 005519 679 G 679 (692)
Q Consensus 679 ~ 679 (692)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-22 Score=195.00 Aligned_cols=157 Identities=29% Similarity=0.352 Sum_probs=138.9
Q ss_pred HhhhcCCcceeeeecccCcEeEEEEE-ecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 005519 520 VTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG---- 594 (692)
Q Consensus 520 l~~~~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---- 594 (692)
+....++|.+.++||+|||..||.++ ..+++.+|+|++.....++.++.++|++..++++||||++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34566889999999999999999997 4568899999998877778899999999999999999999998876443
Q ss_pred -eEEEEEEccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 595 -EKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 595 -~~~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
..||++.|...|+|.+.+... .++..+++.+.++|+.+|++||++||+.. ++.+||||||.|||+.+.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 589999999999999888543 34557999999999999999999999986 579999999999999999999999999
Q ss_pred Cceec
Q 005519 673 MARMF 677 (692)
Q Consensus 673 lAk~~ 677 (692)
.+...
T Consensus 175 S~~~a 179 (302)
T KOG2345|consen 175 SATQA 179 (302)
T ss_pred Ccccc
Confidence 99755
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=213.82 Aligned_cols=148 Identities=30% Similarity=0.449 Sum_probs=128.5
Q ss_pred CcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhCC-C-----CCcceeEEEEEeCCeEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H-----RNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~L 598 (692)
+|.+.+.||+|+||+|.||.. ..++.||||.+++. ..-.++-..|+.+|..|+ | -|+|++++++...++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 799999999999999999975 45899999999864 344567788999999996 4 489999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC--CceEEEeeCCcee
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH--MNPKISDFGMARM 676 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~--~~~kI~DFGlAk~ 676 (692)
|+|.+ ..+|.++|... +...++......|+.||+.||.+||+.+ |||+|||||||||.+. ..+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99988 55888988653 4556899999999999999999999887 9999999999999753 3699999999986
Q ss_pred cCC
Q 005519 677 FGG 679 (692)
Q Consensus 677 ~~~ 679 (692)
...
T Consensus 341 ~~q 343 (586)
T KOG0667|consen 341 ESQ 343 (586)
T ss_pred cCC
Confidence 654
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=197.58 Aligned_cols=151 Identities=27% Similarity=0.496 Sum_probs=135.6
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
.++|++.++||+|+||.||++... +++.+|+|.+........+.+.+|+.++.+++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467999999999999999999864 4788999998765555678899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++++|..++... ...++...+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999988432 245889999999999999999999987 99999999999999999999999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=200.94 Aligned_cols=144 Identities=25% Similarity=0.402 Sum_probs=123.2
Q ss_pred eeecccCcEeEEEEEecC-------------CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEE
Q 005519 531 SKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-------------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 597 (692)
+.||+|+||.||+|+... ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2258899887654445567899999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCc-------eEEEe
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-------PKISD 670 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~-------~kI~D 670 (692)
+||||+++++|+.++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999998843 2345889999999999999999999987 999999999999987654 89999
Q ss_pred eCCceecCC
Q 005519 671 FGMARMFGG 679 (692)
Q Consensus 671 FGlAk~~~~ 679 (692)
||++..+..
T Consensus 156 ~g~~~~~~~ 164 (262)
T cd05077 156 PGIPITVLS 164 (262)
T ss_pred CCCCccccC
Confidence 999986643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=211.49 Aligned_cols=160 Identities=28% Similarity=0.412 Sum_probs=140.3
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
..|+..+.||+|.||.||||... .++.||+|.+.... ....++.+.|+.++..++|+||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777799999999999999864 48899999997543 34567889999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCcc
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~~ 682 (692)
|.+|++.+.| .....+++....-|.++++.||.|||.++ .+|||||+.|||+.+++.+||+|||.|..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999888 33444577777778999999999999998 99999999999999999999999999999988777
Q ss_pred ccCccceecC
Q 005519 683 QGNTKRIVGT 692 (692)
Q Consensus 683 ~~~~~~~~GT 692 (692)
+. ..++||
T Consensus 167 rr--~tfvGT 174 (467)
T KOG0201|consen 167 RR--KTFVGT 174 (467)
T ss_pred cc--cccccc
Confidence 65 358887
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=199.12 Aligned_cols=143 Identities=33% Similarity=0.539 Sum_probs=123.4
Q ss_pred eecccCcEeEEEEEec---CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCC
Q 005519 532 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (692)
Q Consensus 532 ~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 607 (692)
.||+|+||.||+|.+. .+..||+|.+..... ...++|.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 355799999875432 23467999999999999999999999875 457899999999999
Q ss_pred HhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
|.+++.. ....+++..+++++.|+++||.|||+++ ++||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999853 2346899999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=203.18 Aligned_cols=154 Identities=32% Similarity=0.533 Sum_probs=133.1
Q ss_pred hcCCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCe
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 595 (692)
..++|++.+.||+|+||.||++... ++..||+|.+.... .....+|.+|+.++.+++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467899999999999999999753 36789999987542 2345679999999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 005519 596 KILIYEYMVNKSLDVFLFDPT-------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~ 656 (692)
.++|+||+++++|..++.... ....+++..++.++.|++.||.|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999985321 1234788899999999999999999987 999999999
Q ss_pred cEEEcCCCceEEEeeCCceecCC
Q 005519 657 NILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 657 NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||++++++.+||+|||+++.+..
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~ 182 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYS 182 (288)
T ss_pred heEecCCCceEECccccceeccc
Confidence 99999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=203.55 Aligned_cols=151 Identities=26% Similarity=0.437 Sum_probs=135.6
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
...+|++.++||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 346799999999999999999985 4589999999876555556788999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
|+++++|..++.. ..+++.++..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..+
T Consensus 97 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 97 YLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred ecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999998832 35889999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=203.18 Aligned_cols=148 Identities=30% Similarity=0.464 Sum_probs=129.6
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|++.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++.+++||||+++++++......++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56899999999999999999864 47899999886432 23345678999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
++ ++|..++... ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 5888887542 345788999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=201.54 Aligned_cols=153 Identities=33% Similarity=0.515 Sum_probs=131.6
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC------CcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCe
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 595 (692)
..++|++.+.||+|+||.||+|...+ +..||+|.+.... ......|..|+.++.+++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34679999999999999999998743 5678999886433 2335679999999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC---ceEE
Q 005519 596 KILIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM---NPKI 668 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kI 668 (692)
.++||||+++++|.+++.... ....+++..+.+++.||++||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999985432 1235899999999999999999999987 99999999999998754 5999
Q ss_pred EeeCCceecC
Q 005519 669 SDFGMARMFG 678 (692)
Q Consensus 669 ~DFGlAk~~~ 678 (692)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05036 161 ADFGMARDIY 170 (277)
T ss_pred ccCccccccC
Confidence 9999998764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=199.96 Aligned_cols=151 Identities=33% Similarity=0.572 Sum_probs=132.2
Q ss_pred cCCcceeeeecccCcEeEEEEEecC-C---cEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
.++|+..+.||+|+||.||+|+... + ..+|+|.+.... ....+++.+|+.++.+++||||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3568888999999999999998743 3 379999987542 2345679999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||||+++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998542 345889999999999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 005519 679 G 679 (692)
Q Consensus 679 ~ 679 (692)
.
T Consensus 159 ~ 159 (268)
T cd05063 159 D 159 (268)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=209.41 Aligned_cols=148 Identities=30% Similarity=0.381 Sum_probs=125.3
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----- 594 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 594 (692)
..++|++.+.||+|+||.||++... .++.||||.+... ......++.+|+.++..++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999864 4889999998643 2234567889999999999999999999986543
Q ss_pred -eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 595 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
..++||||++++ |...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 579999999764 555542 23778888999999999999999988 99999999999999999999999999
Q ss_pred ceecCC
Q 005519 674 ARMFGG 679 (692)
Q Consensus 674 Ak~~~~ 679 (692)
|+....
T Consensus 170 a~~~~~ 175 (359)
T cd07876 170 ARTACT 175 (359)
T ss_pred cccccc
Confidence 986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=201.32 Aligned_cols=150 Identities=34% Similarity=0.564 Sum_probs=130.6
Q ss_pred CCcceeeeecccCcEeEEEEEecC-Cc----EEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
.+|++.+.||+|+||.||+|...+ ++ .+|+|.+..... ....++.+|+.++.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568888999999999999998643 33 589998875433 345678999999999999999999999987 78999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+||+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+|+.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998542 334889999999999999999999987 9999999999999999999999999998775
Q ss_pred CC
Q 005519 679 GD 680 (692)
Q Consensus 679 ~~ 680 (692)
..
T Consensus 161 ~~ 162 (279)
T cd05057 161 VD 162 (279)
T ss_pred Cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=197.82 Aligned_cols=149 Identities=34% Similarity=0.473 Sum_probs=131.7
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-----CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
+|+..+.||+|+||+||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++.+++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999875 68899999886432 22456799999999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 335789999999999999999999987 99999999999999999999999999987654
Q ss_pred C
Q 005519 680 D 680 (692)
Q Consensus 680 ~ 680 (692)
.
T Consensus 155 ~ 155 (258)
T cd06632 155 F 155 (258)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=198.39 Aligned_cols=151 Identities=31% Similarity=0.476 Sum_probs=133.4
Q ss_pred hcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
..++|++.++||+|+||.||++...++..+|+|.+... ....+.|.+|+.++++++|+||+++.+.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34679999999999999999999877788999988753 3345779999999999999999999999887 778999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999998543 2345788999999999999999999987 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=207.47 Aligned_cols=153 Identities=31% Similarity=0.518 Sum_probs=131.6
Q ss_pred cCCcceeeeecccCcEeEEEEEecC--------CcEEEEEEcccCC-CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 593 (692)
..+|++.+.||+|+||.||++.... ...||+|.+.... ....+++.+|+.++.++ +||||+++++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3568999999999999999996421 2368999887532 33467899999999999 899999999999999
Q ss_pred CeEEEEEEccCCCCHhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEE
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl 660 (692)
+..++++||+++|+|.+++.... ....+++.++..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999985421 2345889999999999999999999987 9999999999999
Q ss_pred cCCCceEEEeeCCceecCC
Q 005519 661 DQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 661 ~~~~~~kI~DFGlAk~~~~ 679 (692)
+.++.+||+|||+++.+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 168 TEDNVMKIADFGLARDVHN 186 (334)
T ss_pred cCCCcEEECCcccceeccc
Confidence 9999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=216.98 Aligned_cols=156 Identities=30% Similarity=0.458 Sum_probs=131.3
Q ss_pred eeeeecccCcEeEEEEEec-CCcEEEEEEccc----CCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCe--EEEEEE
Q 005519 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE--KILIYE 601 (692)
Q Consensus 529 ~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~----~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~LV~E 601 (692)
..++||+|+|-+||||... +|.+||--.++. ..+....+|..|+.+|+.|+|||||+++..+.+..+ ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3379999999999999864 377887543321 234556899999999999999999999999997765 789999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-CCceEEEeeCCceecCCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGD 680 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kI~DFGlAk~~~~~ 680 (692)
.+..|+|..|+. +.+.++.+...++++||++||.|||++. +||||||||.+||+|+. .|.|||+|.|||.++...
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999984 3455788899999999999999999986 78999999999999975 588999999999988655
Q ss_pred ccccCccceecC
Q 005519 681 ELQGNTKRIVGT 692 (692)
Q Consensus 681 ~~~~~~~~~~GT 692 (692)
.. +.++||
T Consensus 200 ~a----ksvIGT 207 (632)
T KOG0584|consen 200 HA----KSVIGT 207 (632)
T ss_pred cc----ceeccC
Confidence 43 347887
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=198.24 Aligned_cols=148 Identities=30% Similarity=0.465 Sum_probs=128.1
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-----CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 596 (692)
.+|++.++||+|+||.||++... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999864 48899999875321 12346788999999999999999999998764 467
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++++||+++++|.+++.. ...+++....+++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998843 234788888999999999999999988 99999999999999999999999999986
Q ss_pred cC
Q 005519 677 FG 678 (692)
Q Consensus 677 ~~ 678 (692)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=201.80 Aligned_cols=148 Identities=32% Similarity=0.465 Sum_probs=130.8
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCc-----cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
+|++.++||+|+||.||+|... +++.||||.+...... ....+..|+.++.+++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999864 5889999998754322 245577899999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|||+ +++|..++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985422 36899999999999999999999988 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=203.24 Aligned_cols=146 Identities=23% Similarity=0.395 Sum_probs=130.1
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.+.||+|+||.||++.... ++.||+|.+.... ......+.+|+.++..++||||+++++.+..+++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368899999999999999998744 7899999887542 233567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
||+++++|..++.. ...+++..+..++.++++||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999843 345888999999999999999999987 99999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=198.10 Aligned_cols=148 Identities=33% Similarity=0.528 Sum_probs=130.0
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCc---------cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCe
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ---------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 595 (692)
+|.+.+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 4789999988643221 23568899999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
.++|+||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 345788899999999999999999987 9999999999999999999999999998
Q ss_pred ecCC
Q 005519 676 MFGG 679 (692)
Q Consensus 676 ~~~~ 679 (692)
.+..
T Consensus 155 ~~~~ 158 (267)
T cd06628 155 KLEA 158 (267)
T ss_pred cccc
Confidence 8763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=196.18 Aligned_cols=152 Identities=23% Similarity=0.377 Sum_probs=133.8
Q ss_pred CcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|+..+.||+|+||.||.++. .+++.+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999875 45889999987643 234567789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999985432 346889999999999999999999987 9999999999999999999999999998775433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=196.52 Aligned_cols=147 Identities=41% Similarity=0.606 Sum_probs=130.9
Q ss_pred eeecccCcEeEEEEEecC----CcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
++||+|+||.||++.... +..||+|.+...... ..+.+.+|+.++.+++|+||+++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998753 778999998764333 367899999999999999999999999999999999999999
Q ss_pred CCHhHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 606 KSLDVFLFDPTK------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 606 gsL~~~L~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++|.+++..... ...+++..+..++.|+++||+|||+++ ++||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865321 366899999999999999999999987 99999999999999999999999999998865
Q ss_pred C
Q 005519 680 D 680 (692)
Q Consensus 680 ~ 680 (692)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=206.26 Aligned_cols=143 Identities=21% Similarity=0.243 Sum_probs=115.0
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec--CCcEEEEEEcccCC-----CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 594 (692)
...++|++.+.||+|+||+||+|... +++.||||++.... ....+.|.+|+.++.+++|+|++..+.. ..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 44578999999999999999999764 47778999875321 1235669999999999999999853322 24
Q ss_pred eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCC-CCCcEEEcCCCceEEEeeCC
Q 005519 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL-KASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl-Kp~NILl~~~~~~kI~DFGl 673 (692)
..+|||||+++++|.... ... ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 679999999999986321 111 1357889999999999988 999999 99999999999999999999
Q ss_pred ceecCCC
Q 005519 674 ARMFGGD 680 (692)
Q Consensus 674 Ak~~~~~ 680 (692)
|+.+...
T Consensus 159 A~~~~~~ 165 (365)
T PRK09188 159 ASVFRRR 165 (365)
T ss_pred ceecccC
Confidence 9988653
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=198.82 Aligned_cols=147 Identities=30% Similarity=0.440 Sum_probs=128.7
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC---c-------cHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---Q-------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~-------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 594 (692)
+|.+.+.||+|+||.||+|... +++.||+|.+..... . ..+.+..|+.++.+++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999764 588999998753211 1 1346888999999999999999999999999
Q ss_pred eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCc
Q 005519 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlA 674 (692)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 46888999999999999999999987 999999999999999999999999999
Q ss_pred eecC
Q 005519 675 RMFG 678 (692)
Q Consensus 675 k~~~ 678 (692)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=202.07 Aligned_cols=149 Identities=30% Similarity=0.419 Sum_probs=131.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
++|++.++||+|+||.||++... .++.||+|++..... ...+.+.+|+.++.+++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999875 488999998865322 234678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|+++++|+.+... ...+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999887632 234899999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=197.55 Aligned_cols=142 Identities=32% Similarity=0.518 Sum_probs=123.5
Q ss_pred eecccCcEeEEEEEe---cCCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCC
Q 005519 532 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (692)
Q Consensus 532 ~LG~G~fG~Vykg~~---~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 606 (692)
+||+|+||.||+|.+ .+++.+|+|.++.... ...+++.+|+.++.+++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 3478899999864332 23567999999999999999999999875 55779999999999
Q ss_pred CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99999843 345889999999999999999999988 999999999999999999999999999877544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=199.58 Aligned_cols=150 Identities=33% Similarity=0.515 Sum_probs=131.8
Q ss_pred CCcceeeeecccCcEeEEEEEec-----CCcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCeE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEK 596 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~ 596 (692)
+.|++.+.||+|+||.||+++.. .++.||||.+...... ..++|.+|+.++++++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999853 2678999998754332 46789999999999999999999999887 5678
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998542 235899999999999999999999987 99999999999999999999999999998
Q ss_pred cCC
Q 005519 677 FGG 679 (692)
Q Consensus 677 ~~~ 679 (692)
+..
T Consensus 159 ~~~ 161 (284)
T cd05038 159 LPE 161 (284)
T ss_pred ccc
Confidence 763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=208.34 Aligned_cols=149 Identities=29% Similarity=0.405 Sum_probs=127.5
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC------
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 593 (692)
..++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 447899999999999999999986 457899999986532 22345678999999999999999999987643
Q ss_pred CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
...++++|++ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999987 788888763 345889999999999999999999988 99999999999999999999999999
Q ss_pred ceecCC
Q 005519 674 ARMFGG 679 (692)
Q Consensus 674 Ak~~~~ 679 (692)
|+....
T Consensus 165 ~~~~~~ 170 (343)
T cd07878 165 ARQADD 170 (343)
T ss_pred ceecCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=215.87 Aligned_cols=156 Identities=35% Similarity=0.509 Sum_probs=132.8
Q ss_pred CCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
..|+.++.||.|+||.||-++. .+.+.||||++.-. +...+.++..|+..|.+++|||++.+.||+......||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4577778999999999999986 45788999999632 2334778999999999999999999999999998999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||| -||-.+.| ...+.++..-.+..|..+.+.||+|||+.+ .||||||+.||||.+.+.|||+|||.|.+..+.
T Consensus 106 EYC-lGSAsDll--eVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHH-hccHHHHH--HHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 999 55666665 223556778888899999999999999988 999999999999999999999999999988764
Q ss_pred ccccCccceecC
Q 005519 681 ELQGNTKRIVGT 692 (692)
Q Consensus 681 ~~~~~~~~~~GT 692 (692)
. .++||
T Consensus 180 n------sFvGT 185 (948)
T KOG0577|consen 180 N------SFVGT 185 (948)
T ss_pred h------cccCC
Confidence 4 36666
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=200.52 Aligned_cols=152 Identities=25% Similarity=0.443 Sum_probs=133.2
Q ss_pred CCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.+.||+|+||.||++.. .+++.+|||.+.... .....++.+|+.++..++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 468999999876432 223467899999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 22456899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=207.91 Aligned_cols=148 Identities=29% Similarity=0.380 Sum_probs=125.4
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC------
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 593 (692)
..++|++.+.||+|+||.||++... .++.||||++.... ......+.+|+.++..++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4478999999999999999999764 48899999987532 22356788999999999999999999988643
Q ss_pred CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
...++||||+++ +|...+. ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999975 5655552 23788888999999999999999988 99999999999999999999999999
Q ss_pred ceecCC
Q 005519 674 ARMFGG 679 (692)
Q Consensus 674 Ak~~~~ 679 (692)
|+....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=193.96 Aligned_cols=150 Identities=25% Similarity=0.410 Sum_probs=132.2
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC-CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
+|++.++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++.+++|+||+++++.+.++...++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999864 5889999988643 2334677889999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++++|..++... ....++......++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999887532 3345788999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=198.75 Aligned_cols=147 Identities=29% Similarity=0.504 Sum_probs=130.0
Q ss_pred CcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCC------ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
+|+..+.||+|+||.||+|...+++.+|||.+..... .....+.+|+.++.+++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3677889999999999999887889999998864321 2235688999999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999843 235788999999999999999999987 9999999999999999999999999998653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-21 Score=199.84 Aligned_cols=150 Identities=31% Similarity=0.412 Sum_probs=128.8
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++++|++.++||+|+||.||+|... +++.||+|.+..... .....+.+|+.++..++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 588999999865432 23346789999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||+. ++|..++... ...+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 6776666432 234678888899999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-21 Score=195.27 Aligned_cols=149 Identities=30% Similarity=0.541 Sum_probs=132.9
Q ss_pred CCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
.+|++.+.||+|+||.||++...++..+|+|.+... .....+|.+|+.++.+++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 468888999999999999998877889999988653 3345689999999999999999999999999999999999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++|.+++... ...+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999988532 235789999999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=199.16 Aligned_cols=151 Identities=26% Similarity=0.431 Sum_probs=129.9
Q ss_pred cCCcceeeeecccCcEeEEEEEecC----CcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
.++|++.++||+|+||.||+|...+ ...||||...... ....+.+.+|+.++.+++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999998643 2468999887544 3445689999999999999999999998865 56789
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||||+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998542 335899999999999999999999987 9999999999999999999999999998764
Q ss_pred CC
Q 005519 679 GD 680 (692)
Q Consensus 679 ~~ 680 (692)
..
T Consensus 159 ~~ 160 (270)
T cd05056 159 DE 160 (270)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.4e-21 Score=195.28 Aligned_cols=148 Identities=31% Similarity=0.546 Sum_probs=129.3
Q ss_pred CCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCeEEEEEEcc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEKILIYEYM 603 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV~Ey~ 603 (692)
++|++.+.||+|+||.||++... +..||+|.++.. ...+.|.+|+.++++++|+|++++++++.+ ++..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888999999999999999774 778999988643 345679999999999999999999998654 46789999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999998542 2335889999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.86 E-value=9e-21 Score=199.00 Aligned_cols=161 Identities=29% Similarity=0.407 Sum_probs=136.7
Q ss_pred eehhhHhhhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 005519 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (692)
Q Consensus 515 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 592 (692)
+...++..+.++|++.+.||+|+||.||++... +++.+|+|.+... .....++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344566677899999999999999999999874 5889999988653 22346678899999999 89999999999875
Q ss_pred C-----CeEEEEEEccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCce
Q 005519 593 Q-----GEKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (692)
Q Consensus 593 ~-----~~~~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 666 (692)
. ...++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3589999999999999987532 22346889999999999999999999987 9999999999999999999
Q ss_pred EEEeeCCceecCC
Q 005519 667 KISDFGMARMFGG 679 (692)
Q Consensus 667 kI~DFGlAk~~~~ 679 (692)
||+|||+++.+..
T Consensus 168 kl~dfg~~~~~~~ 180 (291)
T cd06639 168 KLVDFGVSAQLTS 180 (291)
T ss_pred EEeecccchhccc
Confidence 9999999987643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8e-21 Score=199.27 Aligned_cols=149 Identities=28% Similarity=0.363 Sum_probs=130.2
Q ss_pred CcceeeeecccCcEeEEEEEe----cCCcEEEEEEcccCC----CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 596 (692)
+|++.+.||+|+||.||+++. .+++.||+|.+.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999975 368899999986432 22346788999999999 699999999999999999
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++|+||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 345788888899999999999999987 99999999999999999999999999987
Q ss_pred cCCC
Q 005519 677 FGGD 680 (692)
Q Consensus 677 ~~~~ 680 (692)
+..+
T Consensus 155 ~~~~ 158 (290)
T cd05613 155 FHED 158 (290)
T ss_pred cccc
Confidence 7543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-21 Score=197.19 Aligned_cols=144 Identities=33% Similarity=0.436 Sum_probs=127.7
Q ss_pred eeecccCcEeEEEEEecC--C--cEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--g--~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
++||+|++|.||+|.+.. + ..||||.+..... ...++|.+|+.++.+++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998643 2 3699999986554 556789999999999999999999999988 889999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++|..++.+... ..+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999865332 46899999999999999999999987 99999999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=199.61 Aligned_cols=147 Identities=32% Similarity=0.470 Sum_probs=129.0
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|++.+.||+|++|.||+|... +++.||||.+..... .....+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999875 578999999865322 2235577899999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
+++ +|..++... ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 985 898887542 235788999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-21 Score=195.74 Aligned_cols=149 Identities=32% Similarity=0.509 Sum_probs=133.4
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|++.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++.+++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 588999999875443 2577899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++++|.+++.. ...+++..+..++.++++||.|||+.+ |+|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999843 345788899999999999999999988 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-21 Score=198.51 Aligned_cols=150 Identities=29% Similarity=0.445 Sum_probs=126.4
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHH-HHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMML-IAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
++|++.+.||+|+||.||+++.. +++.||+|++.... .....++..|+.+ ++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999875 58999999987542 2234456666665 566789999999999999999999999
Q ss_pred ccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 602 YMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 602 y~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|++ |+|..++... .....+++..+..++.|++.||+|||++ + ++||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 6887777432 2335689999999999999999999986 5 9999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-21 Score=206.67 Aligned_cols=148 Identities=28% Similarity=0.374 Sum_probs=125.6
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC------
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 593 (692)
..++|++.++||+|+||.||++... .++.||||++.... .....++.+|+.++..++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999864 47899999987532 23356788999999999999999999987643
Q ss_pred CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
...++||||+++ +|..++. ..+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 5666652 23788889999999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005519 674 ARMFGG 679 (692)
Q Consensus 674 Ak~~~~ 679 (692)
|+....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=197.45 Aligned_cols=149 Identities=32% Similarity=0.534 Sum_probs=131.1
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
+|++.++||+|++|.||+|+.. +++.||||.+..... .....+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999875 588999999875432 23567788999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
++ +|..++........+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 88888754433456899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-21 Score=194.34 Aligned_cols=143 Identities=35% Similarity=0.514 Sum_probs=128.2
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCHh
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 609 (692)
++||+|+||.||++...+++.||+|.+...... ....+.+|+.++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999866899999988764333 4568999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 610 ~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++... ...+++..+..++.+++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 998542 235788999999999999999999987 9999999999999999999999999998665
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-21 Score=203.06 Aligned_cols=148 Identities=26% Similarity=0.392 Sum_probs=130.4
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
+.|.....||+|+||.||++... ++..||||.+........+.+.+|+.++.+++|+||+++++.+..++..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34444568999999999999864 58899999987654555677999999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 99999998732 34788999999999999999999987 99999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=223.18 Aligned_cols=160 Identities=23% Similarity=0.359 Sum_probs=131.7
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--Ce
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GE 595 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~ 595 (692)
....++|++.++||+|+||.||++.... ++.||+|.+... .......|..|+.++.+++|||||++++++.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3445789999999999999999998744 778999988643 223456789999999999999999999988654 56
Q ss_pred EEEEEEccCCCCHhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CceEecCCCCCcEEEcCC-------
Q 005519 596 KILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSR----LRIIHRDLKASNILLDQH------- 663 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~ivHrDlKp~NILl~~~------- 663 (692)
.+|||||+++|+|..+|.... ....+++..++.|+.||+.||.|||..+. .+||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999885422 23468999999999999999999998542 349999999999999642
Q ss_pred ----------CceEEEeeCCceecCCC
Q 005519 664 ----------MNPKISDFGMARMFGGD 680 (692)
Q Consensus 664 ----------~~~kI~DFGlAk~~~~~ 680 (692)
..+||+|||+|+.+...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~ 195 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE 195 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc
Confidence 34899999999877543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-21 Score=201.75 Aligned_cols=144 Identities=28% Similarity=0.453 Sum_probs=118.7
Q ss_pred eeecccCcEeEEEEEec---CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~Ey~~~ 605 (692)
++||+|+||.||+|+.. +++.||+|.+... .....+.+|+.++.+++||||+++++++.. +...++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 68999999999999864 3578999998643 223567889999999999999999999864 4568999999864
Q ss_pred CCHhHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEE----cCCCceEEEeeCCce
Q 005519 606 KSLDVFLFDP------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMAR 675 (692)
Q Consensus 606 gsL~~~L~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kI~DFGlAk 675 (692)
+|..++... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 777666321 12235888999999999999999999988 9999999999999 456789999999999
Q ss_pred ecCCC
Q 005519 676 MFGGD 680 (692)
Q Consensus 676 ~~~~~ 680 (692)
.+...
T Consensus 161 ~~~~~ 165 (317)
T cd07868 161 LFNSP 165 (317)
T ss_pred ccCCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=193.85 Aligned_cols=153 Identities=27% Similarity=0.448 Sum_probs=135.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|++.+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|+.++..++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46899999999999999999864 57899999986432 33567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++++|..++........+++.....++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999865333356899999999999999999999987 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=199.75 Aligned_cols=150 Identities=27% Similarity=0.332 Sum_probs=133.3
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCC---ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|++.+.||+|+||.||++...+ ++.+|+|.+..... ...+.+..|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468899999999999999998754 88999999875432 24567899999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999988532 2356899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=201.81 Aligned_cols=151 Identities=36% Similarity=0.646 Sum_probs=127.6
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCc----EEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 597 (692)
.+.|+..+.||+|+||.||+|... +++ .||+|.+..... ....++.+|+.++.+++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999863 343 478898865432 2245789999999999999999999998754 567
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
+++||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998532 335788999999999999999999987 999999999999999999999999999977
Q ss_pred CCC
Q 005519 678 GGD 680 (692)
Q Consensus 678 ~~~ 680 (692)
...
T Consensus 160 ~~~ 162 (303)
T cd05110 160 EGD 162 (303)
T ss_pred cCc
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=197.36 Aligned_cols=149 Identities=30% Similarity=0.487 Sum_probs=123.3
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC--ccHHHHHHHHHHHHhC---CCCCcceeEEEEEeC-----C
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKL---QHRNLVRLLGCCIEQ-----G 594 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~-----~ 594 (692)
+|++.+.||+|+||.||+++.. +++.||+|.+..... .....+.+|+.++.++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999875 588999998865322 2234566777777665 699999999988642 4
Q ss_pred eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCc
Q 005519 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlA 674 (692)
..++|+||+++ +|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999974 788877542 2345889999999999999999999988 999999999999999999999999999
Q ss_pred eecCC
Q 005519 675 RMFGG 679 (692)
Q Consensus 675 k~~~~ 679 (692)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=199.17 Aligned_cols=150 Identities=27% Similarity=0.429 Sum_probs=134.0
Q ss_pred cCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
.++|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++.+++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36899999999999999999975 45789999998654444567789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++++|..++.. ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+...
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999843 34788999999999999999999988 999999999999999999999999999866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=200.04 Aligned_cols=150 Identities=28% Similarity=0.469 Sum_probs=127.3
Q ss_pred CcceeeeecccCcEeEEEEEec---CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKI 597 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 597 (692)
+|++.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999864 47899999987632 33356778899999999999999999999988 7899
Q ss_pred EEEEccCCCCHhHHhcCCC-C-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC----CCceEEEee
Q 005519 598 LIYEYMVNKSLDVFLFDPT-K-KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ----HMNPKISDF 671 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~-~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~----~~~~kI~DF 671 (692)
+||||+++ +|..++.... . ...++...+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5655553221 1 236888999999999999999999987 999999999999999 899999999
Q ss_pred CCceecCC
Q 005519 672 GMARMFGG 679 (692)
Q Consensus 672 GlAk~~~~ 679 (692)
|+++.+..
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=197.07 Aligned_cols=149 Identities=30% Similarity=0.487 Sum_probs=132.9
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++.+++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999864 58899999987543 23357799999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+ +++|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||+++.+...
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999988543 256899999999999999999999987 999999999999999999999999999977544
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-22 Score=227.10 Aligned_cols=169 Identities=25% Similarity=0.280 Sum_probs=145.8
Q ss_pred hhhHhhhcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 005519 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (692)
Q Consensus 517 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 592 (692)
..++....++|.++++||+|+||.|..+++.. ++.+|+|++.+. .......|..|-.+|..-+.+=|++|+..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34555667889999999999999999998855 788999999862 34456779999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 593 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
..++|||||||+||+|-..|.. ...++...+..++..|..||.-||+-| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999998843 336888888889999999999999988 9999999999999999999999999
Q ss_pred CceecCCCccccCccceecC
Q 005519 673 MARMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 673 lAk~~~~~~~~~~~~~~~GT 692 (692)
-+-.+..+.+-.. ...+||
T Consensus 221 sClkm~~dG~V~s-~~aVGT 239 (1317)
T KOG0612|consen 221 SCLKMDADGTVRS-SVAVGT 239 (1317)
T ss_pred hHHhcCCCCcEEe-ccccCC
Confidence 9998887765322 235776
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.8e-21 Score=196.93 Aligned_cols=143 Identities=36% Similarity=0.597 Sum_probs=123.3
Q ss_pred eeecccCcEeEEEEEecC-Cc--EEEEEEcccCC-CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
+.||+|+||.||+|+..+ +. .+|+|.+.... ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 57888887432 33456789999999999 899999999999999999999999999
Q ss_pred CCHhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 606 KSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 606 gsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985421 1234789999999999999999999987 9999999999999999999999999
Q ss_pred Ccee
Q 005519 673 MARM 676 (692)
Q Consensus 673 lAk~ 676 (692)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=199.64 Aligned_cols=149 Identities=26% Similarity=0.379 Sum_probs=130.9
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|++.++||+|+||+||++... +++.||+|.+.... ....+.+.+|+.++..++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999864 58899999876532 33467899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++++|..++.. ...+++..+..++.+++.||.|||+.. .++||||||+||++++++.++|+|||+++.+.
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 999999988743 345889999999999999999999742 39999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=195.57 Aligned_cols=150 Identities=31% Similarity=0.530 Sum_probs=126.2
Q ss_pred cceeeeecccCcEeEEEEEec----CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------
Q 005519 527 FSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 594 (692)
|++.+.||+|+||.||+|... .++.||||.+.... ....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999753 36789999886532 234667899999999999999999999887543
Q ss_pred eEEEEEEccCCCCHhHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEee
Q 005519 595 EKILIYEYMVNKSLDVFLFDPT---KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DF 671 (692)
..++++||+++|+|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998874321 2235788999999999999999999987 999999999999999999999999
Q ss_pred CCceecCC
Q 005519 672 GMARMFGG 679 (692)
Q Consensus 672 GlAk~~~~ 679 (692)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05074 158 GLSKKIYS 165 (273)
T ss_pred cccccccC
Confidence 99997753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=196.38 Aligned_cols=149 Identities=28% Similarity=0.383 Sum_probs=133.4
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
+|++.++||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999875 48899999886532 2346789999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
|+++++|..++.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999843 246889999999999999999999987 999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-23 Score=197.15 Aligned_cols=153 Identities=28% Similarity=0.437 Sum_probs=130.1
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEccc--CCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
.++.|++.++||+|.|+.||++.. +.|+.+|+|.+.. ....+.+++.+|+++-..++||||++|.....+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346788889999999999999964 5689999887753 2445778899999999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC---CCceEEEeeCCcee
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMARM 676 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kI~DFGlAk~ 676 (692)
+|+|.+++|-.-+ ..+...++..+-+.++||++||.|+|.++ |||||+||+|+||.. .--+||+|||+|+.
T Consensus 89 Fe~m~G~dl~~eI---V~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDI---VAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999986544 23345677778889999999999999998 999999999999953 44589999999999
Q ss_pred cCCCc
Q 005519 677 FGGDE 681 (692)
Q Consensus 677 ~~~~~ 681 (692)
+.+.+
T Consensus 163 l~~g~ 167 (355)
T KOG0033|consen 163 VNDGE 167 (355)
T ss_pred eCCcc
Confidence 98444
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=194.10 Aligned_cols=150 Identities=31% Similarity=0.472 Sum_probs=134.9
Q ss_pred cCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
.++|++.++||+|+||.||+++..+ ++.+++|.+..... .+++.+|+.++.+++||||+++++.+.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678899999999999999998765 78999999875422 67899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+...
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999999843 2456899999999999999999999987 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=194.09 Aligned_cols=146 Identities=34% Similarity=0.561 Sum_probs=128.0
Q ss_pred CCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
++|++.+.||+|+||.||++.. .++.||+|.+... .....+.+|+.++.+++||||+++++++.+. ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688999999999999999975 5788999988643 2346789999999999999999999998754 5799999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 99999998543 2345789999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=192.88 Aligned_cols=150 Identities=39% Similarity=0.608 Sum_probs=131.4
Q ss_pred cceeeeecccCcEeEEEEEecC-----CcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
|++.+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566899999999999998754 378999999754333 5678999999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854221 12899999999999999999999987 999999999999999999999999999877544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=194.60 Aligned_cols=148 Identities=30% Similarity=0.484 Sum_probs=128.2
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-----CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 596 (692)
.+|+..+.||+|+||.||++... .+..||+|++.... .+....+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 48899999886432 12345688999999999999999999988753 578
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 334788899999999999999999887 99999999999999999999999999986
Q ss_pred cC
Q 005519 677 FG 678 (692)
Q Consensus 677 ~~ 678 (692)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-21 Score=199.61 Aligned_cols=147 Identities=29% Similarity=0.449 Sum_probs=130.2
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4667789999999999999864 47889999886433 334567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++++|.+++. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999883 345788999999999999999999987 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-21 Score=196.36 Aligned_cols=149 Identities=29% Similarity=0.506 Sum_probs=130.3
Q ss_pred CcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCC------ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
+|+..+.||+|+||.||++.. .+++.||+|.+..... ...+.+..|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 5588999998864321 134678999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC-ceEEEeeCCceec
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMF 677 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kI~DFGlAk~~ 677 (692)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 345788999999999999999999987 99999999999998775 5999999999877
Q ss_pred CCC
Q 005519 678 GGD 680 (692)
Q Consensus 678 ~~~ 680 (692)
...
T Consensus 155 ~~~ 157 (268)
T cd06630 155 AAK 157 (268)
T ss_pred ccc
Confidence 543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-21 Score=200.60 Aligned_cols=146 Identities=28% Similarity=0.418 Sum_probs=129.2
Q ss_pred cceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
|+...+||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334458999999999999864 5889999998755445567789999999999999999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 99998773 245789999999999999999999987 99999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=195.06 Aligned_cols=148 Identities=26% Similarity=0.491 Sum_probs=131.6
Q ss_pred CcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC-CCccHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCeEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~LV~ 600 (692)
.|++.++||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++.+++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999986 45889999988653 2344677899999999996 999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++++|.+++.. ..+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++.+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998833 36889999999999999999999987 999999999999999999999999999887554
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-20 Score=198.22 Aligned_cols=144 Identities=28% Similarity=0.457 Sum_probs=118.6
Q ss_pred eeecccCcEeEEEEEecC---CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~Ey~~~ 605 (692)
.+||+|+||.||+|+..+ +..||+|.+... .....+.+|+.++.+++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 689999999999998643 568999988653 233567899999999999999999999864 4578999999875
Q ss_pred CCHhHHhcC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEE----cCCCceEEEeeCCce
Q 005519 606 KSLDVFLFD------PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMAR 675 (692)
Q Consensus 606 gsL~~~L~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kI~DFGlAk 675 (692)
+|..++.. ......+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 66665531 112335888999999999999999999987 9999999999999 566789999999999
Q ss_pred ecCCC
Q 005519 676 MFGGD 680 (692)
Q Consensus 676 ~~~~~ 680 (692)
.+...
T Consensus 161 ~~~~~ 165 (317)
T cd07867 161 LFNSP 165 (317)
T ss_pred ccCCC
Confidence 77543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-22 Score=213.18 Aligned_cols=153 Identities=35% Similarity=0.488 Sum_probs=133.9
Q ss_pred CCcceeeeecccCcEeEEEEEecC--Cc--EEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~--g~--~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
+...+.|+||+|.||.|++|.+.. |+ .||||.+...... ....|++|+.+|.+|+|+|++||+|...+ ...+||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 445566899999999999998743 44 5899999865443 67899999999999999999999999887 788999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+|.++.|||.+.|++ .....+-......++.|||.||.||..++ +|||||..+|+||.....+||+||||.|-++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 34455667788889999999999999987 99999999999999999999999999999987
Q ss_pred Ccc
Q 005519 680 DEL 682 (692)
Q Consensus 680 ~~~ 682 (692)
++.
T Consensus 265 ned 267 (1039)
T KOG0199|consen 265 NED 267 (1039)
T ss_pred CCc
Confidence 654
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=196.37 Aligned_cols=151 Identities=28% Similarity=0.428 Sum_probs=132.1
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
++|++.++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999875 47899999886532 2345778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
|++++.+..++. +...+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999887776653 2344889999999999999999999987 9999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=192.55 Aligned_cols=151 Identities=29% Similarity=0.423 Sum_probs=135.5
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|++.+.||+|++|.||+++... ++.|+||++..... ....++.+|+..+.+++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368888999999999999998764 89999999876433 3467899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
+++++|.+++.. ...++...+..++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999843 2568999999999999999999999 87 9999999999999999999999999999875443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=191.40 Aligned_cols=150 Identities=24% Similarity=0.399 Sum_probs=132.2
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|++.++||+|+||.||+++.. +++.||+|.+... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999864 5889999988643 233456899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999988542 2335788999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=201.40 Aligned_cols=145 Identities=20% Similarity=0.296 Sum_probs=125.1
Q ss_pred eeeeeccc--CcEeEEEEEe-cCCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 529 IQSKLGEG--GFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 529 ~~~~LG~G--~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
+.++||+| +|++||+++. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999986 458999999987532 223456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..+
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 9999999884322 234889999999999999999999987 999999999999999999999999876544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-21 Score=198.16 Aligned_cols=144 Identities=27% Similarity=0.428 Sum_probs=123.8
Q ss_pred eeecccCcEeEEEEEecC--------CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 531 SKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+.||+|+||.||+|.... ..+||+|.+........+++.+|+.++..++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997532 234888888655444567889999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCc--------eEEEeeCCc
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--------PKISDFGMA 674 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~--------~kI~DFGlA 674 (692)
+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998543 235789999999999999999999987 999999999999987765 699999999
Q ss_pred eecCC
Q 005519 675 RMFGG 679 (692)
Q Consensus 675 k~~~~ 679 (692)
..+..
T Consensus 156 ~~~~~ 160 (258)
T cd05078 156 ITVLP 160 (258)
T ss_pred cccCC
Confidence 76654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=194.34 Aligned_cols=148 Identities=29% Similarity=0.452 Sum_probs=130.8
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+-|++.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++.++...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34777889999999999999864 57899999876432 23456789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++++|..++. ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999999883 245789999999999999999999987 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-22 Score=196.85 Aligned_cols=160 Identities=28% Similarity=0.315 Sum_probs=136.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCc---cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
++|..+++||+|.||+|.+++-+ .++.+|+|++++.... ....-..|-++|...+||.+..|...++..+.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 57888899999999999999754 5899999999875433 3344567889999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||..+|.|.-+| .+.+.+++.....+-..|+.||.|||+++ ||.||||.+|.|||++|++||+||||+|.-...
T Consensus 248 eyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 999999997777 44566777777778889999999999987 999999999999999999999999999966544
Q ss_pred ccccCccceecC
Q 005519 681 ELQGNTKRIVGT 692 (692)
Q Consensus 681 ~~~~~~~~~~GT 692 (692)
.. .++.++||
T Consensus 322 g~--t~kTFCGT 331 (516)
T KOG0690|consen 322 GD--TTKTFCGT 331 (516)
T ss_pred cc--eeccccCC
Confidence 43 35568887
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=194.31 Aligned_cols=144 Identities=31% Similarity=0.541 Sum_probs=121.9
Q ss_pred eeecccCcEeEEEEEecC----CcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCeEEEEEEccC
Q 005519 531 SKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEKILIYEYMV 604 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV~Ey~~ 604 (692)
+.||+|+||.||+|...+ ...||+|++.... ....+.+.+|+.+++.++||||+++++++.. +...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999997532 3579999886432 3346788999999999999999999998764 456899999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++|.+++... ...+.+..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~ 150 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYD 150 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccC
Confidence 99999998542 234677888899999999999999987 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=212.42 Aligned_cols=154 Identities=21% Similarity=0.366 Sum_probs=119.8
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC--CcEEEEEE--------------ccc---CCCccHHHHHHHHHHHHhCCCCCc
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN--GQEVAVKR--------------LSN---QSGQGLKEFKNEMMLIAKLQHRNL 583 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~--------------l~~---~~~~~~~~f~~Ei~~l~~l~H~nI 583 (692)
..++|++.++||+|+||+||++.... +...++|. +.+ ........+.+|+.++.+++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 44789999999999999999986532 22222221 111 112234568899999999999999
Q ss_pred ceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEc
Q 005519 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661 (692)
Q Consensus 584 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~ 661 (692)
+++++++.+.+..++|+|++. ++|..++..... ...........|+.||+.||.|||+.+ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 566666643211 122335566789999999999999987 99999999999999
Q ss_pred CCCceEEEeeCCceecCCC
Q 005519 662 QHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 662 ~~~~~kI~DFGlAk~~~~~ 680 (692)
.++.+||+|||+|+.+...
T Consensus 302 ~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCEEEEeCCCceecCcc
Confidence 9999999999999987654
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=195.91 Aligned_cols=150 Identities=28% Similarity=0.420 Sum_probs=127.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCe-----
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGE----- 595 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~----- 595 (692)
++|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.++ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999864 58899999876432 22346788999999999 56999999999987665
Q ss_pred EEEEEEccCCCCHhHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-CCceEEEeeC
Q 005519 596 KILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFG 672 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kI~DFG 672 (692)
.++||||+++ +|..++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78888754322 346899999999999999999999987 999999999999998 8899999999
Q ss_pred CceecC
Q 005519 673 MARMFG 678 (692)
Q Consensus 673 lAk~~~ 678 (692)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998664
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=190.19 Aligned_cols=150 Identities=27% Similarity=0.402 Sum_probs=130.0
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC-CeEEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-GEKILIYE 601 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~LV~E 601 (692)
.|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|+.++.+++|+|++++.+.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999864 47889999986432 23456789999999999999999999887643 46789999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|+++++|.+++... ....+++.++..++.+++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999998642 2345899999999999999999999988 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.5e-21 Score=197.87 Aligned_cols=148 Identities=28% Similarity=0.479 Sum_probs=128.5
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|++.++||+|+||.||+++.. +|+.||+|.+.... ......+.+|+.++.+++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999874 58899999886432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++ ++|..++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 97 5777776432 345899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=192.39 Aligned_cols=143 Identities=37% Similarity=0.542 Sum_probs=124.1
Q ss_pred eeecccCcEeEEEEEecC----CcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.++.++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999875433 24567999999999999999999999875 5678999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.+...
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 9999999542 36889999999999999999999987 999999999999999999999999999877443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=194.85 Aligned_cols=149 Identities=28% Similarity=0.427 Sum_probs=133.3
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|++.+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999865 58899999986543 34456789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999843 26899999999999999999999987 999999999999999999999999999887643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=195.95 Aligned_cols=149 Identities=32% Similarity=0.516 Sum_probs=130.1
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999874 58899999886432 22346789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+. ++|..++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 96 6888887543 2346889999999999999999999987 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=192.47 Aligned_cols=148 Identities=32% Similarity=0.496 Sum_probs=128.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC-----CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 596 (692)
.+|++.+.||+|+||.||++... +++.||+|.+... ..+....+.+|+.++.+++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999864 4889999987432 123456789999999999999999999998764 468
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998843 234788889999999999999999988 99999999999999999999999999987
Q ss_pred cC
Q 005519 677 FG 678 (692)
Q Consensus 677 ~~ 678 (692)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=194.57 Aligned_cols=149 Identities=27% Similarity=0.429 Sum_probs=131.9
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
..|+..++||+|+||.||+|... .++.||+|.+.... ......+.+|+.++.++.||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777789999999999999874 47899999887532 34467799999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999998842 35788889999999999999999987 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=209.25 Aligned_cols=154 Identities=24% Similarity=0.393 Sum_probs=121.6
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-----------------cCCcEEEEEEcccCCCccHHH--------------HHHH
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSNQSGQGLKE--------------FKNE 571 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-----------------~~g~~VAVK~l~~~~~~~~~~--------------f~~E 571 (692)
..++|++.++||+|+||.||+|.. ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457899999999999999999964 234679999986533222233 3447
Q ss_pred HHHHHhCCCCCc-----ceeEEEEEe--------CCeEEEEEEccCCCCHhHHhcCCC---------------------C
Q 005519 572 MMLIAKLQHRNL-----VRLLGCCIE--------QGEKILIYEYMVNKSLDVFLFDPT---------------------K 617 (692)
Q Consensus 572 i~~l~~l~H~nI-----v~l~g~~~~--------~~~~~LV~Ey~~~gsL~~~L~~~~---------------------~ 617 (692)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++|+... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 678888763 356899999999999999886421 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 618 KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 618 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 361 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT 361 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence 123567888899999999999999987 99999999999999999999999999986543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-22 Score=213.75 Aligned_cols=163 Identities=26% Similarity=0.427 Sum_probs=140.2
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
+.+.+.++-.||.|+||+||++..++ +-..|.|.+...+...+++|.-||.||+..+||+||+|++.|...+.+++..|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 34567777899999999999998765 34457788887777888999999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
||.||-.+..+.+ -.+.|...++..++++++.||.|||++. |||||||+.|||++-+|.++|+|||.+.......
T Consensus 110 FC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred ecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 9999999998854 3567899999999999999999999998 9999999999999999999999999987655433
Q ss_pred cccCccceecC
Q 005519 682 LQGNTKRIVGT 692 (692)
Q Consensus 682 ~~~~~~~~~GT 692 (692)
.... .++||
T Consensus 185 qkRD--sFIGT 193 (1187)
T KOG0579|consen 185 QKRD--SFIGT 193 (1187)
T ss_pred hhhc--cccCC
Confidence 3222 36665
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=194.67 Aligned_cols=152 Identities=29% Similarity=0.471 Sum_probs=124.9
Q ss_pred CCcceeeeecccCcEeEEEEEecC-----CcEEEEEEcccCCC-cc-HHHHHHHHHHHHhCCCCCcceeEEEEEe-CCeE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSG-QG-LKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEK 596 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 596 (692)
..|+...+||+|.||.|||+.-.+ .+++|+|+++.... .+ .....+|+.+++.++||||+.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468888999999999999995432 33799999975422 12 2446789999999999999999999887 7789
Q ss_pred EEEEEccCCCCHhHHhc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC----CceEEEe
Q 005519 597 ILIYEYMVNKSLDVFLF--DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH----MNPKISD 670 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~--~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~----~~~kI~D 670 (692)
+|++||.++. |-..|+ +..+.+.++......|+.||+.|+.|||++= |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999774 444443 2334467888999999999999999999874 9999999999999776 8999999
Q ss_pred eCCceecCCC
Q 005519 671 FGMARMFGGD 680 (692)
Q Consensus 671 FGlAk~~~~~ 680 (692)
||+||++...
T Consensus 180 lGlaR~~~~p 189 (438)
T KOG0666|consen 180 LGLARLFNNP 189 (438)
T ss_pred ccHHHHhhcc
Confidence 9999998654
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=197.06 Aligned_cols=151 Identities=32% Similarity=0.485 Sum_probs=129.5
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC---ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
+.+.|++.++||+|+||.||+|+.. +++.||+|.+..... ...+++.+|+.++.+++||||+++.+++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3456888899999999999999864 588999998864322 234678899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+||++ |++.+++.. ....+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++...
T Consensus 93 v~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999997 566665532 2345899999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 005519 679 G 679 (692)
Q Consensus 679 ~ 679 (692)
.
T Consensus 167 ~ 167 (307)
T cd06607 167 P 167 (307)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-21 Score=192.64 Aligned_cols=141 Identities=29% Similarity=0.420 Sum_probs=127.4
Q ss_pred eeecccCcEeEEEEE-ecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEEEEccCCCCH
Q 005519 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 608 (692)
+.||+|+|+.|--++ +..+.++|||++.+.......+..+|++++...+ |+||++|+++|.+....|||||-|.+|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 789999999999886 5679999999999887777889999999999985 99999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCc---eEEEeeCCceec
Q 005519 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGMARMF 677 (692)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kI~DFGlAk~~ 677 (692)
..+|. +..-+++.++.++..+|+.||.|||.++ |.||||||+|||..+... +||+||.|+.-+
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence 98883 4556889999999999999999999998 999999999999976544 899999998644
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=194.72 Aligned_cols=158 Identities=28% Similarity=0.474 Sum_probs=133.9
Q ss_pred ehhhHhhhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEEEEEe-
Q 005519 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE- 592 (692)
Q Consensus 516 ~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~- 592 (692)
+..++..+.+.|++.+.||+|+||.||+|+.. +++.+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455567788999999999999999999874 4789999988653 23456788999999998 79999999999863
Q ss_pred -----CCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceE
Q 005519 593 -----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (692)
Q Consensus 593 -----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 667 (692)
....+++|||+++|+|..++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45789999999999999988542 2345788888999999999999999987 99999999999999999999
Q ss_pred EEeeCCceecC
Q 005519 668 ISDFGMARMFG 678 (692)
Q Consensus 668 I~DFGlAk~~~ 678 (692)
|+|||+++...
T Consensus 162 l~dfg~~~~~~ 172 (282)
T cd06636 162 LVDFGVSAQLD 172 (282)
T ss_pred EeeCcchhhhh
Confidence 99999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-20 Score=189.34 Aligned_cols=151 Identities=26% Similarity=0.412 Sum_probs=131.4
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|++.+.||+|+||.||++... +++.+|||.+... .......+.+|+.++++++||||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 5789999988643 233467899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC-CceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kI~DFGlAk~~~~~ 680 (692)
+++++|.+++... ....+++..+..++.+++++|+|||+++ |+|+||||+||+++.+ ..+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999998542 2345789999999999999999999987 9999999999999854 46899999999977543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.5e-20 Score=188.11 Aligned_cols=149 Identities=34% Similarity=0.515 Sum_probs=133.5
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|++.+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++.+++|+|++++++++.++...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 478999999876543 3567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999998843 256899999999999999999999987 999999999999999999999999999977543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=229.31 Aligned_cols=142 Identities=28% Similarity=0.502 Sum_probs=122.9
Q ss_pred CCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
..++..+.||+|+||.||+|+. .++..||||++...... ...|+.++++++|||||+++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778999999999999986 56899999998653221 235688999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
++|+|.++++ .++|..+.+|+.|+|+||+|||..+..+|+||||||+||+++.++.+++. ||++...
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 9999999983 27899999999999999999997656679999999999999999988885 7776544
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=195.72 Aligned_cols=150 Identities=29% Similarity=0.426 Sum_probs=129.6
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILI 599 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV 599 (692)
++|++.+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999875 478999999864322 2234677899999999999999999999877 889999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+||++ ++|..++... ...+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 4888877432 235899999999999999999999988 99999999999999999999999999997755
Q ss_pred C
Q 005519 680 D 680 (692)
Q Consensus 680 ~ 680 (692)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=208.43 Aligned_cols=152 Identities=24% Similarity=0.318 Sum_probs=122.2
Q ss_pred hhHhhhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCC------CCcceeEEEE
Q 005519 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH------RNLVRLLGCC 590 (692)
Q Consensus 518 ~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H------~nIv~l~g~~ 590 (692)
.++....++|++.++||+|+||+||++... .++.||||+++.. ....+++..|+.++.+++| ++++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344456788999999999999999999864 4788999998643 2234556778877777755 4588898888
Q ss_pred EeC-CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCcEEEcCCC----
Q 005519 591 IEQ-GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHM---- 664 (692)
Q Consensus 591 ~~~-~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDlKp~NILl~~~~---- 664 (692)
... .+.++|||++ +++|..++.. ...+++..+..|+.||+.||.|||++ + ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 754 5789999988 6778777743 34688999999999999999999974 6 99999999999998765
Q ss_pred ------------ceEEEeeCCceec
Q 005519 665 ------------NPKISDFGMARMF 677 (692)
Q Consensus 665 ------------~~kI~DFGlAk~~ 677 (692)
.+||+|||++...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cccccccCCCCceEEECCCCccccC
Confidence 4999999998643
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=191.91 Aligned_cols=154 Identities=31% Similarity=0.467 Sum_probs=133.4
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC-----
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG----- 594 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~----- 594 (692)
.++++|++.+.||+|+||.||+|... +++.+++|.+.... ...+++.+|+.++.++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45688999999999999999999874 47889999887543 3457799999999999 7999999999997644
Q ss_pred -eEEEEEEccCCCCHhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 595 -EKILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 595 -~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999885422 2356889999999999999999999987 9999999999999999999999999
Q ss_pred CceecCC
Q 005519 673 MARMFGG 679 (692)
Q Consensus 673 lAk~~~~ 679 (692)
++.....
T Consensus 159 ~~~~~~~ 165 (275)
T cd06608 159 VSAQLDS 165 (275)
T ss_pred cceeccc
Confidence 9986643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-21 Score=198.84 Aligned_cols=155 Identities=28% Similarity=0.355 Sum_probs=138.4
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
+.|+.-++||+||||.||-+... .|+.+|.|++.+. ..++.....+|-.++.+++.+.||.|-..+...+.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 55888899999999999999764 4899999988653 3456777899999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
..|.+|+|.-+|+... ...++++.+..++.+|+.||++||.+. ||.|||||+|||||+.|+++|+|.|||..+...
T Consensus 265 tlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 9999999999887643 357899999999999999999999987 999999999999999999999999999988776
Q ss_pred ccc
Q 005519 681 ELQ 683 (692)
Q Consensus 681 ~~~ 683 (692)
+..
T Consensus 341 ~~~ 343 (591)
T KOG0986|consen 341 KPI 343 (591)
T ss_pred Ccc
Confidence 653
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-21 Score=200.13 Aligned_cols=153 Identities=26% Similarity=0.361 Sum_probs=133.1
Q ss_pred CCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
.-|.+.+.||+|.|..|-++++ -.|..||||.+.+..- -....+..|++-|+.++|||||||+++...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4588889999999999999974 4699999999986532 234568889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEc-CCCceEEEeeCCceecCCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kI~DFGlAk~~~~~ 680 (692)
.-.+|+|.+||-.. ...+.+..+.+++.||+.|+.|+|+.. +|||||||+|+.+- +-|-+||+|||++..+.+.
T Consensus 98 LGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999543 345888899999999999999999865 99999999999875 5678999999999888776
Q ss_pred cc
Q 005519 681 EL 682 (692)
Q Consensus 681 ~~ 682 (692)
+.
T Consensus 173 ~k 174 (864)
T KOG4717|consen 173 KK 174 (864)
T ss_pred ch
Confidence 64
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-20 Score=193.51 Aligned_cols=151 Identities=30% Similarity=0.429 Sum_probs=129.9
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~ 600 (692)
++|+..++||.|++|.||++... +++.+|+|.+..... ....++.+|+.++.+++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36888899999999999999874 478999998875322 3457799999999999999999999998754 4689999
Q ss_pred EccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||+++++|.+++... .....++......++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999886432 23455788899999999999999999987 9999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=194.80 Aligned_cols=153 Identities=30% Similarity=0.493 Sum_probs=130.0
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG---- 594 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---- 594 (692)
...++|++.++||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999875 48899999986532 223456788999999999999999999987654
Q ss_pred ------eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEE
Q 005519 595 ------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (692)
Q Consensus 595 ------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI 668 (692)
..++|+||+++ ++..++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 66666633 2345899999999999999999999987 999999999999999999999
Q ss_pred EeeCCceecCCC
Q 005519 669 SDFGMARMFGGD 680 (692)
Q Consensus 669 ~DFGlAk~~~~~ 680 (692)
+|||+++.+...
T Consensus 158 ~dfg~~~~~~~~ 169 (302)
T cd07864 158 ADFGLARLYNSE 169 (302)
T ss_pred CcccccccccCC
Confidence 999999877543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=204.43 Aligned_cols=155 Identities=32% Similarity=0.490 Sum_probs=132.7
Q ss_pred eeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCHh
Q 005519 531 SKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 609 (692)
-+||+|.||+||-|+..+ ...+|||-+.....+....+.+||.+.++++|.|||+++|.+.+++..-+.||-+++|||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 379999999999999766 4579999998776677788899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-CCceEEEeeCCceecCCCccccCc
Q 005519 610 VFLFDPTKKHLL--GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGDELQGNT 686 (692)
Q Consensus 610 ~~L~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kI~DFGlAk~~~~~~~~~~~ 686 (692)
+.|.. +-.++ .+.+.-.+-.||++||.|||++. |||||||-+|+|++. .|.+||+|||-+|++-+-. ..|
T Consensus 661 sLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~T 733 (1226)
T KOG4279|consen 661 SLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCT 733 (1226)
T ss_pred HHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--ccc
Confidence 99953 33344 67778888999999999999987 999999999999975 7889999999999885422 234
Q ss_pred cceecC
Q 005519 687 KRIVGT 692 (692)
Q Consensus 687 ~~~~GT 692 (692)
.++.||
T Consensus 734 ETFTGT 739 (1226)
T KOG4279|consen 734 ETFTGT 739 (1226)
T ss_pred cccccc
Confidence 456665
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=184.77 Aligned_cols=151 Identities=34% Similarity=0.552 Sum_probs=135.5
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
.|+..+.||+|++|.||++... +++.+++|++........+++.+|+.++.+++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999875 588999999976554567889999999999999999999999999999999999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
+++|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 99999988542 246899999999999999999999977 9999999999999999999999999998876543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=184.55 Aligned_cols=141 Identities=18% Similarity=0.161 Sum_probs=108.6
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEcccCCCc--c-------HHHH-----------------HHHHHHHHhCCCCCc
Q 005519 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--G-------LKEF-----------------KNEMMLIAKLQHRNL 583 (692)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~-------~~~f-----------------~~Ei~~l~~l~H~nI 583 (692)
...||+|+||.||+|...+|+.||||.++..... . ...| ..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999878999999998653211 1 1222 349999999988776
Q ss_pred ceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceEecCCCCCcEEEcC
Q 005519 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL-HQYSRLRIIHRDLKASNILLDQ 662 (692)
Q Consensus 584 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDlKp~NILl~~ 662 (692)
....... ....+|||||++++++...+. ....++..+...++.|++.+|.|| |+.+ |+||||||+|||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence 4433222 223489999999887754431 234578899999999999999999 6777 999999999999984
Q ss_pred CCceEEEeeCCceecCC
Q 005519 663 HMNPKISDFGMARMFGG 679 (692)
Q Consensus 663 ~~~~kI~DFGlAk~~~~ 679 (692)
+.++|+|||+|.....
T Consensus 154 -~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 -GKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CcEEEEEccccccCCC
Confidence 6899999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=193.14 Aligned_cols=146 Identities=38% Similarity=0.548 Sum_probs=125.4
Q ss_pred eeecccCcEeEEEEEecC-------CcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 531 SKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+.||+|+||.||+|+..+ ++.+|||.+.... .....+|.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2579999886543 23467899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC-----ceEEEeeCC
Q 005519 603 MVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-----NPKISDFGM 673 (692)
Q Consensus 603 ~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~-----~~kI~DFGl 673 (692)
+++++|.+++.... ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986422 2245788999999999999999999887 99999999999999877 899999999
Q ss_pred ceecCC
Q 005519 674 ARMFGG 679 (692)
Q Consensus 674 Ak~~~~ 679 (692)
++.+..
T Consensus 158 ~~~~~~ 163 (269)
T cd05044 158 ARDIYK 163 (269)
T ss_pred cccccc
Confidence 986643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=191.20 Aligned_cols=153 Identities=27% Similarity=0.454 Sum_probs=128.5
Q ss_pred CcceeeeecccCcEeEEEEEecC--CcEEEEEEcccC----------CCccHHHHHHHHHHHHh-CCCCCcceeEEEEEe
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ----------SGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCIE 592 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~----------~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~ 592 (692)
+|++.+.||+|+||.||++.... ++.+|||.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998755 678999987532 12234567788888875 799999999999999
Q ss_pred CCeEEEEEEccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEee
Q 005519 593 QGEKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (692)
Q Consensus 593 ~~~~~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DF 671 (692)
++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.. .++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887431 23446888999999999999999999632 3999999999999999999999999
Q ss_pred CCceecCCC
Q 005519 672 GMARMFGGD 680 (692)
Q Consensus 672 GlAk~~~~~ 680 (692)
|+++.....
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999877554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=186.16 Aligned_cols=150 Identities=32% Similarity=0.488 Sum_probs=134.3
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILIY 600 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~ 600 (692)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|+.++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 588999999875432 4577899999999999999999999999988 8999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+++++|.+++... ..+++..+..++.++++||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998432 37899999999999999999999987 999999999999999999999999999988655
Q ss_pred c
Q 005519 681 E 681 (692)
Q Consensus 681 ~ 681 (692)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-20 Score=190.86 Aligned_cols=148 Identities=32% Similarity=0.517 Sum_probs=129.8
Q ss_pred cceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeEEEEEE
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILIYE 601 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~E 601 (692)
|++.++||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.++.+++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5678999999999999998754 7899999997653 33356788999999999999999999999988 89999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
|+++ +|..++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 888877432 246889999999999999999999987 999999999999999999999999999977654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-20 Score=192.10 Aligned_cols=143 Identities=31% Similarity=0.419 Sum_probs=124.9
Q ss_pred ecccCcEeEEEEEec-CCcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCH
Q 005519 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (692)
Q Consensus 533 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 608 (692)
||+|+||+||++... +++.||+|.+.... ......+.+|+.++.+++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 58899999886432 22345678899999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
..++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 99985432 245889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-20 Score=197.53 Aligned_cols=150 Identities=26% Similarity=0.405 Sum_probs=128.5
Q ss_pred hhcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG---- 594 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---- 594 (692)
...++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++.+++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999985 458899999986432 223456889999999999999999999987543
Q ss_pred --eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 595 --EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 595 --~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
..++|+||+ +++|..++. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 778888773 245889999999999999999999987 9999999999999999999999999
Q ss_pred CceecCC
Q 005519 673 MARMFGG 679 (692)
Q Consensus 673 lAk~~~~ 679 (692)
+++....
T Consensus 164 ~~~~~~~ 170 (343)
T cd07880 164 LARQTDS 170 (343)
T ss_pred ccccccc
Confidence 9987644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=190.48 Aligned_cols=149 Identities=30% Similarity=0.497 Sum_probs=126.5
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
++|++.++||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46899999999999999999875 58899999886432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-CCceEEEeeCCceecC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFG 678 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kI~DFGlAk~~~ 678 (692)
|++ ++|..++... ....+++.....++.||+.||+|||+.+ |+||||||+||++++ +..+||+|||+++...
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 5777776432 2233578888899999999999999987 999999999999985 5679999999998664
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-20 Score=191.02 Aligned_cols=141 Identities=26% Similarity=0.382 Sum_probs=125.9
Q ss_pred ecccCcEeEEEEEecC-CcEEEEEEcccCCC---ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCH
Q 005519 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (692)
Q Consensus 533 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 608 (692)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|+.++.+++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999865432 3467789999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
..++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 9998542 36899999999999999999999987 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=192.97 Aligned_cols=152 Identities=30% Similarity=0.444 Sum_probs=135.8
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
..++.|+..+.||+|+||.||++... +++.|++|.+..... ....+.+|+.++.+++|+|++++++.+......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888899999999999999875 588999999876433 5678899999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+..
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999985422 36899999999999999999999987 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.2e-20 Score=180.28 Aligned_cols=143 Identities=19% Similarity=0.217 Sum_probs=112.6
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEcccCCCc---------------------c-----HHHHHHHHHHHHhCCCCCc
Q 005519 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---------------------G-----LKEFKNEMMLIAKLQHRNL 583 (692)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~---------------------~-----~~~f~~Ei~~l~~l~H~nI 583 (692)
...||+|+||+||+|+..+|+.||||.+...... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754211 0 1124678999999999987
Q ss_pred ceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCcEEEcC
Q 005519 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQ 662 (692)
Q Consensus 584 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlKp~NILl~~ 662 (692)
.....+... ..+|||||++++++..... ....++......++.+++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444332 3489999999886543321 22346778889999999999999999 77 99999999999999
Q ss_pred CCceEEEeeCCceecCCCc
Q 005519 663 HMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 663 ~~~~kI~DFGlAk~~~~~~ 681 (692)
++.++|+|||+|+.+..+.
T Consensus 153 ~~~~~liDFG~a~~~~~~~ 171 (190)
T cd05145 153 DGKPYIIDVSQAVELDHPN 171 (190)
T ss_pred CCCEEEEEcccceecCCCC
Confidence 7899999999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=188.83 Aligned_cols=156 Identities=26% Similarity=0.470 Sum_probs=130.5
Q ss_pred CcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCeEEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKILIY 600 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~ 600 (692)
+|++.+.||.|+||.||++.. .+++.||+|.+... .....+++..|+.++.+++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999976 45789999988643 22345678899999999999999999998764 45679999
Q ss_pred EccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYS--RLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
||+++++|.+++... .....+++..++.++.++++||.|||..+ ...++|+||||+||+++.++.+||+|||+++.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998542 22456899999999999999999999332 234999999999999999999999999999987
Q ss_pred CCCc
Q 005519 678 GGDE 681 (692)
Q Consensus 678 ~~~~ 681 (692)
....
T Consensus 161 ~~~~ 164 (265)
T cd08217 161 GHDS 164 (265)
T ss_pred cCCc
Confidence 6543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.3e-20 Score=192.99 Aligned_cols=150 Identities=29% Similarity=0.488 Sum_probs=126.6
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 594 (692)
.++|++.++||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999864 58899999886432 222345678999999999999999999987654
Q ss_pred --eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 595 --EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 595 --~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
..++||||+.+ +|..++.. ....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 35999999965 77777633 2335889999999999999999999987 9999999999999999999999999
Q ss_pred CceecCC
Q 005519 673 MARMFGG 679 (692)
Q Consensus 673 lAk~~~~ 679 (692)
+++.+..
T Consensus 165 ~~~~~~~ 171 (310)
T cd07865 165 LARAFSL 171 (310)
T ss_pred CcccccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-20 Score=193.29 Aligned_cols=143 Identities=26% Similarity=0.398 Sum_probs=127.8
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCHh
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 609 (692)
.+||+|+||.||++... +++.||||++..........+.+|+.++.+++|+||+++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999874 58899999986554455677999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 610 ~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+..+
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 88732 34788999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-20 Score=198.29 Aligned_cols=150 Identities=31% Similarity=0.505 Sum_probs=128.2
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeC--CeE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ--GEK 596 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~ 596 (692)
..++|++.+.||+|+||.||+|... +++.+|||++... .......+..|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467899999999999999999875 4789999988542 223445678899999999 999999999998653 468
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++|+||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588888733 26789999999999999999999987 99999999999999999999999999987
Q ss_pred cCCC
Q 005519 677 FGGD 680 (692)
Q Consensus 677 ~~~~ 680 (692)
+...
T Consensus 157 ~~~~ 160 (337)
T cd07852 157 LSEL 160 (337)
T ss_pred cccc
Confidence 7543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.5e-20 Score=193.13 Aligned_cols=151 Identities=32% Similarity=0.470 Sum_probs=128.7
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CeEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKIL 598 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~L 598 (692)
.++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++.+++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999874 489999998864322 2234567899999999999999999998765 46899
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|+||+++ +|..++... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999974 787777432 256899999999999999999999988 9999999999999999999999999999875
Q ss_pred CC
Q 005519 679 GD 680 (692)
Q Consensus 679 ~~ 680 (692)
..
T Consensus 160 ~~ 161 (309)
T cd07845 160 LP 161 (309)
T ss_pred Cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=197.08 Aligned_cols=148 Identities=27% Similarity=0.432 Sum_probs=127.1
Q ss_pred cCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CeE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GEK 596 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~ 596 (692)
.++|++.++||+|+||.||+|+. .+++.||||.+.... ......+..|+.++.+++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999986 458899999986432 23456788999999999999999999987654 357
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++|+||+++ +|...+. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999974 7777662 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCC
Q 005519 677 FGG 679 (692)
Q Consensus 677 ~~~ 679 (692)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=202.48 Aligned_cols=170 Identities=28% Similarity=0.453 Sum_probs=144.3
Q ss_pred ehhhHhhhcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEEEEEe-
Q 005519 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE- 592 (692)
Q Consensus 516 ~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~- 592 (692)
.+..+..+++.|++.+.||.|.+|+||+++. ++++.+|||++... ....++...|..+++.. +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3455567788999999999999999999985 45888999988654 33456667788888887 79999999999974
Q ss_pred ----CCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEE
Q 005519 593 ----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (692)
Q Consensus 593 ----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI 668 (692)
++++|||||||.+||.-+.+.... ...+.|.....|++.+++||.+||... ++|||||-.|||+++++.+|+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 468999999999999999886644 677999999999999999999999887 999999999999999999999
Q ss_pred EeeCCceecCCCccccCccceecC
Q 005519 669 SDFGMARMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 669 ~DFGlAk~~~~~~~~~~~~~~~GT 692 (692)
.|||++..+....-+.+ ..+||
T Consensus 165 vDFGvSaQldsT~grRn--T~iGt 186 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRN--TFIGT 186 (953)
T ss_pred eeeeeeeeeeccccccc--CcCCC
Confidence 99999999876554444 36776
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=191.12 Aligned_cols=149 Identities=29% Similarity=0.401 Sum_probs=131.8
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
++|+..+.||+|+||.||++... +++.||+|.+.... ....+++.+|+.++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999875 58899999987643 23456789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++++|.+++.... ..++......++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999985422 568889999999999999999999 76 9999999999999999999999999997664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.6e-20 Score=191.16 Aligned_cols=141 Identities=29% Similarity=0.358 Sum_probs=118.1
Q ss_pred eecccCcEeEEEEEec-CCcEEEEEEcccCCC---ccHHHHHHHHHHHH---hCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 532 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIA---KLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 532 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~---~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..++. ..+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 488999998864321 22233455554433 3479999999999999999999999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 9999998843 345899999999999999999999988 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.6e-20 Score=188.20 Aligned_cols=151 Identities=27% Similarity=0.471 Sum_probs=131.4
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999875 4789999988643 123456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC-ceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kI~DFGlAk~~~~~ 680 (692)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||++..+...
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999988542 2335789999999999999999999987 99999999999998875 4699999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=190.43 Aligned_cols=146 Identities=25% Similarity=0.388 Sum_probs=129.6
Q ss_pred cceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 527 FSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
|...++||+|++|.||++.. .+++.+++|++........+.+.+|+.++..++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999986 45889999988654444566789999999999999999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 999998843 35788999999999999999999988 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-20 Score=192.57 Aligned_cols=150 Identities=30% Similarity=0.446 Sum_probs=133.4
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV 599 (692)
++|.+.+.||+|+||.||+++.. +++.||+|.+... .....+.+..|+.++.+++ ||||+++++.+..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999875 5899999988652 2233567889999999998 99999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999843 346899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005519 680 D 680 (692)
Q Consensus 680 ~ 680 (692)
.
T Consensus 155 ~ 155 (280)
T cd05581 155 N 155 (280)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-20 Score=197.82 Aligned_cols=149 Identities=23% Similarity=0.407 Sum_probs=128.7
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCeE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEK 596 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~ 596 (692)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++.+++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999864 58999999987532 2345678889999999999999999988763 3568
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++|+||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 688888743 345899999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 005519 677 FGG 679 (692)
Q Consensus 677 ~~~ 679 (692)
+..
T Consensus 157 ~~~ 159 (334)
T cd07855 157 LSS 159 (334)
T ss_pred ecc
Confidence 754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.9e-20 Score=191.54 Aligned_cols=149 Identities=28% Similarity=0.363 Sum_probs=129.1
Q ss_pred CcceeeeecccCcEeEEEEEe----cCCcEEEEEEcccCC----CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 596 (692)
+|++.+.||+|+||.||+++. .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999974 346789999886421 22346788999999999 699999999999999999
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++||||+++++|..++.. ...+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998843 345788999999999999999999987 99999999999999999999999999987
Q ss_pred cCCC
Q 005519 677 FGGD 680 (692)
Q Consensus 677 ~~~~ 680 (692)
+...
T Consensus 155 ~~~~ 158 (288)
T cd05583 155 FLAE 158 (288)
T ss_pred cccc
Confidence 6443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-21 Score=197.43 Aligned_cols=154 Identities=31% Similarity=0.430 Sum_probs=129.6
Q ss_pred CCcceeeeecccCcEeEEEEE-ecCCcEEEEEEcccCC-------CccHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCe
Q 005519 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS-------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCI-EQGE 595 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~-------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~ 595 (692)
++|-++..||+|||+.|||+. +...+.||||+-.... ..-.+...+|.+|.+.|+||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 567788999999999999996 4557889999653221 112344677889999999999999999986 4567
Q ss_pred EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC---CCceEEEeeC
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFG 672 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kI~DFG 672 (692)
.+-|+||+++.+|+.|| ...+.++++++..|+.||+.||.||.+.. ++|||-||||.||||.. -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 89999999999999999 34567899999999999999999999874 78999999999999964 4679999999
Q ss_pred CceecCCCcc
Q 005519 673 MARMFGGDEL 682 (692)
Q Consensus 673 lAk~~~~~~~ 682 (692)
|+|++.++..
T Consensus 619 LSKIMdddSy 628 (775)
T KOG1151|consen 619 LSKIMDDDSY 628 (775)
T ss_pred hhhhccCCcc
Confidence 9999987654
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=190.02 Aligned_cols=147 Identities=32% Similarity=0.526 Sum_probs=128.3
Q ss_pred cceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
|++.++||+|++|.||+|... ++..||+|++.... ......+.+|+.++.+++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999864 68999999886432 223467889999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+ ++|..++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 68988884422 235899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=196.20 Aligned_cols=149 Identities=30% Similarity=0.400 Sum_probs=126.8
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeC------
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 593 (692)
..++|++.+.||+|+||.||++... +++.||||.+... ......++.+|+.++.+++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999864 5889999998643 223346778899999999999999999988643
Q ss_pred CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
...++|+||+. ++|...+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999996 477777632 2788889999999999999999987 99999999999999999999999999
Q ss_pred ceecCCC
Q 005519 674 ARMFGGD 680 (692)
Q Consensus 674 Ak~~~~~ 680 (692)
++.....
T Consensus 165 ~~~~~~~ 171 (353)
T cd07850 165 ARTAGTS 171 (353)
T ss_pred ceeCCCC
Confidence 9977543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=187.73 Aligned_cols=142 Identities=27% Similarity=0.362 Sum_probs=126.2
Q ss_pred ecccCcEeEEEEEecC-CcEEEEEEcccCCC---ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCH
Q 005519 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (692)
Q Consensus 533 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 608 (692)
||+|+||.||+++... ++.+|+|.+..... ...+.+.+|+.++.+++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999998754 88999999865322 3456799999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 999843 334788999999999999999999987 999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=188.50 Aligned_cols=146 Identities=27% Similarity=0.385 Sum_probs=123.9
Q ss_pred cceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCC-CCCcceeEEEEEeC--CeEEEEEE
Q 005519 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQ--GEKILIYE 601 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~LV~E 601 (692)
|++.++||+|+||.||+++.. +++.||+|++.... .........|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567899999999999999864 58899999987532 222334557888898885 99999999999987 88999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|++ ++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++. +.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 5777777432 346899999999999999999999987 999999999999999 9999999999987744
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=215.52 Aligned_cols=149 Identities=34% Similarity=0.491 Sum_probs=120.3
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC-CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeC-------
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------- 593 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------- 593 (692)
-..+|+..+.||+||||.|||++. -||+.+|||++... .........+|+.++++|+||||||++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 446788889999999999999974 47999999999754 233456688999999999999999887533210
Q ss_pred --------------------------------------------------------------------------------
Q 005519 594 -------------------------------------------------------------------------------- 593 (692)
Q Consensus 594 -------------------------------------------------------------------------------- 593 (692)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005519 594 --------------------------------GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641 (692)
Q Consensus 594 --------------------------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH 641 (692)
.-+|+=||||+.-.+..++.+....+ .-...++++++|+.||+|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 01366788888887777774422211 35567889999999999999
Q ss_pred hcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 642 ~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
+++ ||||||||.||+|+++..|||+|||+|+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 998 99999999999999999999999999987
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=200.18 Aligned_cols=148 Identities=24% Similarity=0.374 Sum_probs=130.3
Q ss_pred cCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
..-|..++.||-|+||.|.+++-.| ...+|+|.|.+.+ .+.....+.|-.||+..+.+=||+|+..|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3458888999999999999997544 5678999997643 34566788999999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|||+++|++-.+|. +...+++..+..++.++..|+++.|..| +|||||||+|||||.+|.+||+||||+.-+
T Consensus 708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 99999999999883 4566888888888999999999999988 999999999999999999999999998633
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=189.35 Aligned_cols=141 Identities=29% Similarity=0.350 Sum_probs=118.3
Q ss_pred eecccCcEeEEEEEec-CCcEEEEEEcccCCC---ccHHHHHHHHHH---HHhCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 532 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMML---IAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 532 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~---l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
.||+|+||.||++... .++.||+|.+..... .....+..|..+ +....||||+++++++.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 488999998865321 222334455443 444579999999999999999999999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 9999988843 346899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=194.51 Aligned_cols=154 Identities=30% Similarity=0.400 Sum_probs=130.0
Q ss_pred hhHhhhcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC-
Q 005519 518 ASVTAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ- 593 (692)
Q Consensus 518 ~~l~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~- 593 (692)
.++...+++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++.+++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 35556778999999999999999999975 458899999987532 22346788899999999999999999988643
Q ss_pred -----CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEE
Q 005519 594 -----GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (692)
Q Consensus 594 -----~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI 668 (692)
...++++|++ +++|..++. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467888876 788888773 235889999999999999999999987 999999999999999999999
Q ss_pred EeeCCceecCC
Q 005519 669 SDFGMARMFGG 679 (692)
Q Consensus 669 ~DFGlAk~~~~ 679 (692)
+|||+++....
T Consensus 162 ~dfg~~~~~~~ 172 (345)
T cd07877 162 LDFGLARHTDD 172 (345)
T ss_pred ecccccccccc
Confidence 99999986543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-19 Score=183.24 Aligned_cols=152 Identities=24% Similarity=0.421 Sum_probs=134.9
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|++.+.||+|+||.||++... +++.+|+|++..... ...+++.+|++++..++|||++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999874 488999999875432 4567789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++++|..++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999885432 2366899999999999999999999987 999999999999999999999999999877554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=194.58 Aligned_cols=150 Identities=26% Similarity=0.446 Sum_probs=128.4
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----Ce
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GE 595 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 595 (692)
.++|++.+.||+|+||.||+++.. +++.||||.+... ......++.+|+.++.+++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999864 5889999998643 233456778899999999999999999988654 35
Q ss_pred EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
.++|+||+. ++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 688887743 345889999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCC
Q 005519 676 MFGGD 680 (692)
Q Consensus 676 ~~~~~ 680 (692)
.....
T Consensus 157 ~~~~~ 161 (337)
T cd07858 157 TTSEK 161 (337)
T ss_pred ccCCC
Confidence 77543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.5e-19 Score=190.82 Aligned_cols=149 Identities=32% Similarity=0.500 Sum_probs=128.1
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC---ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
+.|+..+.||+|+||.||+++.. +++.||+|.+..... ....++.+|+.++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777889999999999999864 588999999864322 23457889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||++ |+|.+.+.. ....+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 105 e~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9997 477666632 2345899999999999999999999987 99999999999999999999999999986644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=191.75 Aligned_cols=147 Identities=30% Similarity=0.415 Sum_probs=123.9
Q ss_pred CcceeeeecccCcEeEEEEEec-C--CcEEEEEEcccCC--CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeC----Ce
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-N--GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ----GE 595 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~--g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~ 595 (692)
+|++.+.||+|+||.||+++.. . +..||+|++.... ....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999864 3 6789999986432 22356788999999999 599999999976543 35
Q ss_pred EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
.++++||+. ++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788889886 68888873 3446889999999999999999999988 9999999999999999999999999998
Q ss_pred ecCC
Q 005519 676 MFGG 679 (692)
Q Consensus 676 ~~~~ 679 (692)
.+..
T Consensus 154 ~~~~ 157 (332)
T cd07857 154 GFSE 157 (332)
T ss_pred eccc
Confidence 7654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=185.80 Aligned_cols=142 Identities=25% Similarity=0.345 Sum_probs=120.0
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEcccCCC---ccHHHHHHHHHHH-HhCCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLI-AKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
+.||+|+||.||+|... +++.||||.+..... .....+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 488999999865321 2233445555444 455899999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999843 345788999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.8e-20 Score=196.66 Aligned_cols=158 Identities=26% Similarity=0.353 Sum_probs=131.6
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCC--------ccHHHHHHHHHHHHhCC---CCCcceeEEEEEe
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIE 592 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~ 592 (692)
..|+..+.+|+|+||+|..+.++. ..+|+||.+.+... ..+-..-.||.||+.++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458999999999999999998855 56899998875321 11223556999999997 9999999999999
Q ss_pred CCeEEEEEEccC-CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEee
Q 005519 593 QGEKILIYEYMV-NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (692)
Q Consensus 593 ~~~~~LV~Ey~~-~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DF 671 (692)
++..||+||-+. +-+|.+++ ..+..+++.++.-|+.||+-|+++||+++ |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999874 44777777 34556889999999999999999999999 999999999999999999999999
Q ss_pred CCceecCCCccccCccceecC
Q 005519 672 GMARMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 672 GlAk~~~~~~~~~~~~~~~GT 692 (692)
|.|......... .++||
T Consensus 715 gsaa~~ksgpfd----~f~gt 731 (772)
T KOG1152|consen 715 GSAAYTKSGPFD----VFVGT 731 (772)
T ss_pred cchhhhcCCCcc----eeeee
Confidence 999877655432 35665
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=191.54 Aligned_cols=150 Identities=31% Similarity=0.463 Sum_probs=128.8
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCeE
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEK 596 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 596 (692)
...+++|++.+.||+|+||.||++... +++.||||++... .....+.+..|+.++.+++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999854 6889999988642 22345678899999999999999999999876 5678
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++|+||+ +++|..++. ...+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 568888773 234778888899999999999999987 99999999999999999999999999986
Q ss_pred cC
Q 005519 677 FG 678 (692)
Q Consensus 677 ~~ 678 (692)
..
T Consensus 158 ~~ 159 (328)
T cd07856 158 QD 159 (328)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=185.59 Aligned_cols=152 Identities=30% Similarity=0.454 Sum_probs=132.9
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|++.++||+|+||.||+++.. +++.+|+|.+.... .....++..|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999754 57899999987532 23356788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 603 MVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++++|..++.+.. ....+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999885421 2356889999999999999999999987 999999999999999999999999999887554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=192.73 Aligned_cols=147 Identities=29% Similarity=0.402 Sum_probs=126.2
Q ss_pred CCcc-eeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCcc--------------HHHHHHHHHHHHhCCCCCcceeEE
Q 005519 525 ENFS-IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG--------------LKEFKNEMMLIAKLQHRNLVRLLG 588 (692)
Q Consensus 525 ~~f~-~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~--------------~~~f~~Ei~~l~~l~H~nIv~l~g 588 (692)
++|. +.+.||+|+||.||++... +++.||||.+....... ...+.+|+.++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 4477999999999999864 58899999886432211 125778999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEE
Q 005519 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (692)
Q Consensus 589 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI 668 (692)
++...+..++||||++ ++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 688888732 345888999999999999999999987 999999999999999999999
Q ss_pred EeeCCceecC
Q 005519 669 SDFGMARMFG 678 (692)
Q Consensus 669 ~DFGlAk~~~ 678 (692)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998776
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=192.87 Aligned_cols=148 Identities=31% Similarity=0.460 Sum_probs=130.2
Q ss_pred CcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----eEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EKI 597 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 597 (692)
+|++.+.||+|+||.||+++... ++.||||++.... ....+.+.+|+.++..++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58888999999999999998754 8899999987543 334578999999999999999999999998775 789
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
+||||++ ++|..++.. ...+++..+..++.+++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 478888743 336899999999999999999999988 999999999999999999999999999987
Q ss_pred CCC
Q 005519 678 GGD 680 (692)
Q Consensus 678 ~~~ 680 (692)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=217.27 Aligned_cols=165 Identities=30% Similarity=0.446 Sum_probs=136.8
Q ss_pred hhcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
..+-++.-..+||.|.||+||-+.. .+|...|||-+... .....+...+|+.++..++|||+|+.+|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3444566678999999999999975 45888999977532 34456778899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
.||||++|+|.+.+ ...+..++.....+-.|++.|++|||+++ ||||||||.||+|+.+|.+|+.|||.|+.+.
T Consensus 1312 FMEyC~~GsLa~ll---~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLL---EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHH---HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999988 33455666666678899999999999998 9999999999999999999999999999887
Q ss_pred CCc--cccCccceecC
Q 005519 679 GDE--LQGNTKRIVGT 692 (692)
Q Consensus 679 ~~~--~~~~~~~~~GT 692 (692)
++. .....+.+.||
T Consensus 1386 ~~~~~~~~el~~~~GT 1401 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGT 1401 (1509)
T ss_pred CchhcCCHHHHhhcCC
Confidence 652 12223345555
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=187.40 Aligned_cols=148 Identities=32% Similarity=0.453 Sum_probs=127.9
Q ss_pred cceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCC-ccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEEEEcc
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
|++.+.||+|+||.||+|+..+ ++.||||++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677999999999999999754 78899999865422 22334567999999999 999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+++|..++.... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 889988875432 346899999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.6e-19 Score=183.39 Aligned_cols=149 Identities=23% Similarity=0.322 Sum_probs=121.5
Q ss_pred hhhcCCcceeeee--cccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeE
Q 005519 521 TAATENFSIQSKL--GEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 521 ~~~~~~f~~~~~L--G~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 596 (692)
....++|++.+.+ |+|+||.||++... +++.+|+|.+........ |+.....+ +||||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344567776666 99999999999864 578899998864321111 22222222 799999999999999999
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC-ceEEEeeCCce
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMAR 675 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kI~DFGlAk 675 (692)
++||||+++++|..++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++
T Consensus 85 ~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999999843 237899999999999999999999988 99999999999999988 99999999998
Q ss_pred ecCCC
Q 005519 676 MFGGD 680 (692)
Q Consensus 676 ~~~~~ 680 (692)
.....
T Consensus 159 ~~~~~ 163 (267)
T PHA03390 159 IIGTP 163 (267)
T ss_pred ecCCC
Confidence 77543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.8e-19 Score=185.96 Aligned_cols=150 Identities=21% Similarity=0.316 Sum_probs=110.3
Q ss_pred hcCCcceeeeecccCcEeEEEEEecCC----cEEEEEEcccCCCccH-----------HHHHHHHHHHHhCCCCCcceeE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVRLL 587 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~g----~~VAVK~l~~~~~~~~-----------~~f~~Ei~~l~~l~H~nIv~l~ 587 (692)
..+.|++.++||+|+||.||+|...+. ..+|+|.......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346799999999999999999986543 4556664332211111 1122233445567899999999
Q ss_pred EEEEeCC----eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC
Q 005519 588 GCCIEQG----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (692)
Q Consensus 588 g~~~~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~ 663 (692)
+++.... ..++++|++.. ++...+.. ....++..+..|+.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9876544 34777887643 45554422 223567888899999999999999987 9999999999999999
Q ss_pred CceEEEeeCCceecCC
Q 005519 664 MNPKISDFGMARMFGG 679 (692)
Q Consensus 664 ~~~kI~DFGlAk~~~~ 679 (692)
+.+||+|||+|+.+..
T Consensus 163 ~~~~l~DFGla~~~~~ 178 (294)
T PHA02882 163 NRGYIIDYGIASHFII 178 (294)
T ss_pred CcEEEEEcCCceeecc
Confidence 9999999999998754
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=187.75 Aligned_cols=150 Identities=27% Similarity=0.413 Sum_probs=126.1
Q ss_pred cCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC-CccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~ 600 (692)
.++|++.+.||+|+||.||++...+ ++.||||.+.... .....++..|+.++.+.. ||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3678889999999999999999865 8899999987532 223456677887777775 999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||++ +++..++... ...+++..+..++.|+++||+|||+. + |+||||+|+||++++++.+||+|||+++.+..
T Consensus 94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 4666665332 23688999999999999999999974 5 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=190.94 Aligned_cols=146 Identities=30% Similarity=0.465 Sum_probs=124.6
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeC------C
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------G 594 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 594 (692)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999864 58999999986532 22345688999999999999999999998754 3
Q ss_pred eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCc
Q 005519 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlA 674 (692)
+.++|+||+.. +|..++ ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 56999999964 676654 234788999999999999999999987 999999999999999999999999999
Q ss_pred eecC
Q 005519 675 RMFG 678 (692)
Q Consensus 675 k~~~ 678 (692)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=188.46 Aligned_cols=150 Identities=34% Similarity=0.523 Sum_probs=126.4
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 594 (692)
.++|++.++||+|+||.||+|+.. +++.+|||++..... .....+.+|+.++.+++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999864 588999998864322 22346788999999999999999999876543
Q ss_pred --eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 595 --EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 595 --~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
..++|+||++. +|...+.. ....+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 56665533 2346899999999999999999999988 9999999999999999999999999
Q ss_pred CceecCC
Q 005519 673 MARMFGG 679 (692)
Q Consensus 673 lAk~~~~ 679 (692)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=189.56 Aligned_cols=145 Identities=23% Similarity=0.230 Sum_probs=123.4
Q ss_pred eeeeecccCcEeEEEEEecCCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCC
Q 005519 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (692)
Q Consensus 529 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 606 (692)
+.+.+|.|+++.|++++. +++.||||++... .....+.+..|+.++.+++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 334555566666666655 6899999998754 3345678999999999999999999999999999999999999999
Q ss_pred CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+|..++.... ...+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 9999986432 235788888999999999999999987 9999999999999999999999999997664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=9e-19 Score=182.84 Aligned_cols=149 Identities=33% Similarity=0.517 Sum_probs=125.3
Q ss_pred cceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCC--ccHHHHHHHHHHHHhC---CCCCcceeEEEEEeCCe-----
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKL---QHRNLVRLLGCCIEQGE----- 595 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~----- 595 (692)
|++.+.||+|+||.||+|+... ++.||+|.+..... .....+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778999999999999999764 88999999874322 1234567788777666 59999999999998776
Q ss_pred EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
.+++|||+. ++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999997 47888874422 235899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCC
Q 005519 676 MFGGD 680 (692)
Q Consensus 676 ~~~~~ 680 (692)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.3e-19 Score=186.10 Aligned_cols=146 Identities=33% Similarity=0.487 Sum_probs=125.4
Q ss_pred cceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC---ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
|...++||+|+||.||+|+.. +++.|++|.+..... .....+.+|+.++.+++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666688999999999999864 588999999864322 2345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+. +++..++.. ....+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 96 567666632 2345889999999999999999999987 9999999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=192.07 Aligned_cols=147 Identities=27% Similarity=0.414 Sum_probs=126.5
Q ss_pred cCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeC---------
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--------- 593 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------- 593 (692)
..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++.+++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999864 4889999998765556677899999999999999999999776543
Q ss_pred -----CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-CCceE
Q 005519 594 -----GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPK 667 (692)
Q Consensus 594 -----~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~k 667 (692)
...++|+||++ ++|..++. ...+++.....++.||+.||.|||+.+ |+||||||+||+++. +..+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 58888773 235788999999999999999999987 999999999999974 56789
Q ss_pred EEeeCCceecC
Q 005519 668 ISDFGMARMFG 678 (692)
Q Consensus 668 I~DFGlAk~~~ 678 (692)
|+|||+++.+.
T Consensus 156 l~dfg~~~~~~ 166 (342)
T cd07854 156 IGDFGLARIVD 166 (342)
T ss_pred ECCcccceecC
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=188.10 Aligned_cols=149 Identities=34% Similarity=0.519 Sum_probs=127.7
Q ss_pred CCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC---CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+.++..++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777789999999999999864 4788999988632 2233567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
||+. |++..++.. ....+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+..
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 577776633 2345788999999999999999999987 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-19 Score=184.92 Aligned_cols=149 Identities=33% Similarity=0.519 Sum_probs=129.6
Q ss_pred cceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
|++.+.||+|++|.||++... +++.+++|.+..... .....+..|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999864 588999999875432 24567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
++ +|..++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+..+....
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 75 787777432 246889999999999999999999988 9999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-19 Score=190.09 Aligned_cols=143 Identities=26% Similarity=0.314 Sum_probs=122.8
Q ss_pred eeeccc--CcEeEEEEEec-CCcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G--~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
+.||+| +||+||++... +++.||||.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467776 89999999864 68999999986432 22356789999999999999999999999999999999999999
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+...
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 99999885432 234888999999999999999999987 999999999999999999999999865433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-19 Score=184.88 Aligned_cols=147 Identities=35% Similarity=0.517 Sum_probs=129.4
Q ss_pred cceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC--CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
|+..++||+|+||.||+|+... ++.+|+|.+.... ....+.+..|+.++.+++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667899999999999998754 8999999987643 333567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
+ ++|.+++.... ..+++..+..++.++++||.|||+++ |+||||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 58999885421 46899999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.2e-19 Score=183.83 Aligned_cols=151 Identities=30% Similarity=0.446 Sum_probs=125.5
Q ss_pred CcceeeeecccCcEeEEEEEecC-CcEEEEEEcccC-----CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 599 (692)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++.+++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998643 444555555421 122345677899999999999999999999999999999
Q ss_pred EEccCCCCHhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 600 YEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||+++. ..+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888532 23456899999999999999999999987 999999999999976 469999999998775
Q ss_pred CC
Q 005519 679 GD 680 (692)
Q Consensus 679 ~~ 680 (692)
..
T Consensus 157 ~~ 158 (260)
T cd08222 157 GS 158 (260)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=186.36 Aligned_cols=149 Identities=29% Similarity=0.447 Sum_probs=123.9
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCC-CccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+|+..++||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556689999999999999864 48899999987532 234567899999999996 99999999999999999999999
Q ss_pred cCCCCHhHH---hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVF---LFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~---L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+.. ++..+ +.. .....+++.....++.+++.||+|||+. + |+||||||+||+++.++.+||+|||+|+.+.
T Consensus 85 ~~~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 44443 221 1235688999999999999999999975 5 9999999999999999999999999998664
Q ss_pred C
Q 005519 679 G 679 (692)
Q Consensus 679 ~ 679 (692)
.
T Consensus 160 ~ 160 (288)
T cd06616 160 D 160 (288)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-19 Score=191.52 Aligned_cols=164 Identities=26% Similarity=0.375 Sum_probs=138.2
Q ss_pred hhcCCcceeeeecccCcEeEEEEEecCCcEEEEEEccc--CCCccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEE
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~--~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~L 598 (692)
.....|++.++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+.+|.+++ |.+||+|++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 44566999999999999999999988888899987753 35566888999999999995 9999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
||||= .-+|..+|... .....+| .+..+..||++|+.++|+++ |||.||||.|+|+-++ .+||+|||+|+-+.
T Consensus 438 vmE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccC
Confidence 99975 56888888542 2233445 56778999999999999998 9999999999999876 79999999999998
Q ss_pred CCccccCccceecC
Q 005519 679 GDELQGNTKRIVGT 692 (692)
Q Consensus 679 ~~~~~~~~~~~~GT 692 (692)
.+.+.......+||
T Consensus 511 ~DTTsI~kdsQvGT 524 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGT 524 (677)
T ss_pred ccccceeeccccCc
Confidence 88776555556776
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-19 Score=178.84 Aligned_cols=142 Identities=29% Similarity=0.382 Sum_probs=126.1
Q ss_pred ecccCcEeEEEEEec-CCcEEEEEEcccCCC---ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCH
Q 005519 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (692)
Q Consensus 533 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 608 (692)
||+|+||.||++... +++.+|+|.+..... .....+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 488999998875422 2456899999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
.+++.. ...+++.....++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 999843 235889999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-19 Score=203.42 Aligned_cols=159 Identities=33% Similarity=0.488 Sum_probs=135.3
Q ss_pred HhhhcCCcceeeeecccCcEeEEEEEecC--------CcEEEEEEcccCCC-ccHHHHHHHHHHHHhC-CCCCcceeEEE
Q 005519 520 VTAATENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGC 589 (692)
Q Consensus 520 l~~~~~~f~~~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~ 589 (692)
.+...++.++.+.||+|.||+|++|.... ...||||.++.... ...+.+..|+.+|..+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34445556677899999999999997421 34799999986433 4567899999999998 79999999999
Q ss_pred EEeCCeEEEEEEccCCCCHhHHhcCCC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 005519 590 CIEQGEKILIYEYMVNKSLDVFLFDPT-----------KK--HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656 (692)
Q Consensus 590 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~-----------~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~ 656 (692)
|.++...++|.||+++|+|..||+... .. ..+...+.+.++.|||+||+||++.. +|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999997543 00 23888999999999999999999986 999999999
Q ss_pred cEEEcCCCceEEEeeCCceecCCCc
Q 005519 657 NILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 657 NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
|||+.++..+||+||||||....++
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~ 472 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKD 472 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCC
Confidence 9999999999999999999765544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=186.56 Aligned_cols=162 Identities=28% Similarity=0.351 Sum_probs=133.3
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCC---ccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 597 (692)
...+|..+.+||+|+||+|.++.-+. .+.+|||++++... ...+.-+.|-++|+.. +-|.+++|+.+++.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34568899999999999999997654 56799999987532 2334456677777776 5688999999999999999
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
+||||+.+|+|--.+ ++-..+-+..+..++.+||-||-+||+++ ||.||||.+|||||.++.+||+|||++|.-
T Consensus 427 FVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999998777 33445666778889999999999999998 999999999999999999999999999965
Q ss_pred CCCccccCccceecC
Q 005519 678 GGDELQGNTKRIVGT 692 (692)
Q Consensus 678 ~~~~~~~~~~~~~GT 692 (692)
.-+.. +|.+++||
T Consensus 501 i~~~~--TTkTFCGT 513 (683)
T KOG0696|consen 501 IFDGV--TTKTFCGT 513 (683)
T ss_pred ccCCc--ceeeecCC
Confidence 43332 35568887
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.6e-19 Score=189.32 Aligned_cols=149 Identities=30% Similarity=0.436 Sum_probs=128.3
Q ss_pred hcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCe----
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE---- 595 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---- 595 (692)
..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999875 4789999988643 12234667889999999999999999988776554
Q ss_pred --EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 596 --KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 596 --~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888743 45899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005519 674 ARMFGG 679 (692)
Q Consensus 674 Ak~~~~ 679 (692)
++.+..
T Consensus 165 ~~~~~~ 170 (343)
T cd07851 165 ARHTDD 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-19 Score=177.80 Aligned_cols=161 Identities=25% Similarity=0.353 Sum_probs=137.2
Q ss_pred cCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccC---CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 598 (692)
.++|.++++||+|+|.+|..+++.. .+.+|+|.+++. ..+.++-.+.|-.++... +||.+|.|..+++....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4679999999999999999998754 788999998753 344566677888887776 79999999999999999999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|.||+++|+|--++ ++.+.++++.+..+..+|..||.|||+.+ ||.||||.+|+|||.++.+||+|+|+.|.-.
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999986555 45567899999999999999999999998 9999999999999999999999999999654
Q ss_pred CCccccCccceecC
Q 005519 679 GDELQGNTKRIVGT 692 (692)
Q Consensus 679 ~~~~~~~~~~~~GT 692 (692)
++.. .|.+++||
T Consensus 403 ~~gd--~tstfcgt 414 (593)
T KOG0695|consen 403 GPGD--TTSTFCGT 414 (593)
T ss_pred CCCc--ccccccCC
Confidence 4432 24567887
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-20 Score=181.93 Aligned_cols=149 Identities=30% Similarity=0.583 Sum_probs=120.5
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEccc-CCCcc-HHHHHHHHHHHHhCCCCCcceeEEEEEeC--------
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSN-QSGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-------- 593 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~-~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-------- 593 (692)
..|.-..+||+|.||.||+++..+ ++.||+|++.- ....+ -....+|++++..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 456666899999999999998644 78899986632 22222 23457899999999999999999988643
Q ss_pred CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
...+||+.++++ +|.-.|.+ ....++..++.+++.++..||.|+|... |+|||+||+|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999965 56666633 2345788899999999999999999876 99999999999999999999999999
Q ss_pred ceecCC
Q 005519 674 ARMFGG 679 (692)
Q Consensus 674 Ak~~~~ 679 (692)
||.+.-
T Consensus 171 ar~fs~ 176 (376)
T KOG0669|consen 171 ARAFST 176 (376)
T ss_pred ccceec
Confidence 987743
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.9e-18 Score=168.96 Aligned_cols=149 Identities=36% Similarity=0.525 Sum_probs=132.7
Q ss_pred cceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|+..+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999998865 889999999765444 57889999999999999999999999999999999999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+++|.+++..... .+++.....++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999854221 1788999999999999999999987 999999999999999999999999999988654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.6e-18 Score=168.45 Aligned_cols=137 Identities=23% Similarity=0.266 Sum_probs=105.8
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhC-----CCCCcceeEEEEEeCC---e-EEEEE
Q 005519 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-----QHRNLVRLLGCCIEQG---E-KILIY 600 (692)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~-~~LV~ 600 (692)
.+.||+|+||.||. .++....+||++........+.+.+|+.++..+ .||||++++|++.+.. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 47899999999996 433233479988765445567899999999999 5799999999998763 3 34789
Q ss_pred Ec--cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCceEecCCCCCcEEEcC----CCceEEEeeCC
Q 005519 601 EY--MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL-LYLHQYSRLRIIHRDLKASNILLDQ----HMNPKISDFGM 673 (692)
Q Consensus 601 Ey--~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~ivHrDlKp~NILl~~----~~~~kI~DFGl 673 (692)
|| ++.++|.+++.+. .++.. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+-
T Consensus 85 e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 5589999999431 24444 35677888887 8999998 999999999999974 34799999544
Q ss_pred ceec
Q 005519 674 ARMF 677 (692)
Q Consensus 674 Ak~~ 677 (692)
++.+
T Consensus 156 ~~~~ 159 (210)
T PRK10345 156 ESTF 159 (210)
T ss_pred Ccce
Confidence 4444
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=196.08 Aligned_cols=149 Identities=25% Similarity=0.348 Sum_probs=106.2
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC-----CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEE------EE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC------CI 591 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~------~~ 591 (692)
..++|++.++||+|+||.||+|++.+ +..||||++..... .+.+.+| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998744 68999998864321 1112222 1122222333222211 24
Q ss_pred eCCeEEEEEEccCCCCHhHHhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCC
Q 005519 592 EQGEKILIYEYMVNKSLDVFLFDPTKK-----------------HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654 (692)
Q Consensus 592 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~-----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlK 654 (692)
+..+.+||+||+++++|.+++...... .......+..++.|++.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567899999999999999888542110 01122345578999999999999987 9999999
Q ss_pred CCcEEEcC-CCceEEEeeCCceecC
Q 005519 655 ASNILLDQ-HMNPKISDFGMARMFG 678 (692)
Q Consensus 655 p~NILl~~-~~~~kI~DFGlAk~~~ 678 (692)
|+|||++. ++.+||+|||+|+.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccc
Confidence 99999986 5789999999998664
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-19 Score=167.51 Aligned_cols=156 Identities=28% Similarity=0.408 Sum_probs=127.8
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCC-CccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEE
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 597 (692)
+.+.+...-.+.||+|++|.|-+-++ .+|...|||++.... .+..++...|+.+..+. ..|.+|+++|........+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 34445555568899999999988775 468999999997543 35567788899877665 7899999999999889999
Q ss_pred EEEEccCCCCHhHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 598 LIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
+.||.| ..||+.|-.+ ..+...+++.-.-+|+..|..||.|||++ +.+||||+||+|||++.+|.+||+|||++-.
T Consensus 122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccccccee
Confidence 999998 5577776432 12456688888889999999999999995 4799999999999999999999999999987
Q ss_pred cCC
Q 005519 677 FGG 679 (692)
Q Consensus 677 ~~~ 679 (692)
+.+
T Consensus 199 L~d 201 (282)
T KOG0984|consen 199 LVD 201 (282)
T ss_pred ehh
Confidence 754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-19 Score=172.56 Aligned_cols=147 Identities=24% Similarity=0.453 Sum_probs=125.8
Q ss_pred hcCCcceeeeecccCcEeEEEEE-ecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC--eEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQG--EKIL 598 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~~~L 598 (692)
..++|++.+++|+|.++.||.|. ..+.+.++||.++.. ..+...+|+.+|..+. ||||++|++...+.. -..|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 44789999999999999999997 456788999999753 3467889999999997 999999999988754 5689
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-CCceEEEeeCCceec
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMF 677 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kI~DFGlAk~~ 677 (692)
|+||+.+.+....- ..+....+..++.++++||.|+|+.| |+|||+||.|+++|. ...++|+|+|||.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876543 34666777889999999999999999 999999999999986 457999999999998
Q ss_pred CCCc
Q 005519 678 GGDE 681 (692)
Q Consensus 678 ~~~~ 681 (692)
.+..
T Consensus 184 Hp~~ 187 (338)
T KOG0668|consen 184 HPGK 187 (338)
T ss_pred CCCc
Confidence 7654
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-19 Score=177.02 Aligned_cols=148 Identities=26% Similarity=0.330 Sum_probs=122.8
Q ss_pred hcCCccee-eeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEEEEEe----CCe
Q 005519 523 ATENFSIQ-SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE----QGE 595 (692)
Q Consensus 523 ~~~~f~~~-~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~ 595 (692)
.+++|++. ++||-|--|+|..+..+ .++.+|+|.+... ...++|+++.-+. .|||||++++++.. ..-
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667765 67999999999999764 4888999988643 3456788877666 69999999998864 346
Q ss_pred EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC---CCceEEEeeC
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFG 672 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kI~DFG 672 (692)
+++|||.|++|.|...+.+. ....++++++..|+.||+.|+.|||+.. |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 78999999999999888543 3456899999999999999999999987 999999999999964 5569999999
Q ss_pred CceecCC
Q 005519 673 MARMFGG 679 (692)
Q Consensus 673 lAk~~~~ 679 (692)
+||.-..
T Consensus 210 FAK~t~~ 216 (400)
T KOG0604|consen 210 FAKETQE 216 (400)
T ss_pred cccccCC
Confidence 9997653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-18 Score=174.74 Aligned_cols=133 Identities=21% Similarity=0.162 Sum_probs=114.8
Q ss_pred cCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCHhHHhcC
Q 005519 536 GGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD 614 (692)
Q Consensus 536 G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~ 614 (692)
|.||.||+++.. +++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 789999999864 58899999986532 334555666667799999999999999999999999999999998843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 615 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||+++.+..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 234889999999999999999999987 99999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-20 Score=179.37 Aligned_cols=151 Identities=28% Similarity=0.423 Sum_probs=122.7
Q ss_pred eeeecccCcEeEEEEEe-cCCcEEEEEEcccCCC--ccHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CeEEEEEE
Q 005519 530 QSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GEKILIYE 601 (692)
Q Consensus 530 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~LV~E 601 (692)
.+-||-|+||.||..+. ++|+.||.|++...-. ...+++.+|++++.-++|.|++..++...-. ++.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 36899999999999986 4699999998864321 2357788999999999999999988775533 25678888
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
.|. -+|.+.+ .+...++.....-+.+||++||.|||+.+ |.||||||.|.|++.+...||+||||||.-..++
T Consensus 138 LmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 873 4666666 33455777777778999999999999988 9999999999999999999999999999888777
Q ss_pred cccCcc
Q 005519 682 LQGNTK 687 (692)
Q Consensus 682 ~~~~~~ 687 (692)
...+|.
T Consensus 211 ~~hMTq 216 (449)
T KOG0664|consen 211 RLNMTH 216 (449)
T ss_pred hhhhHH
Confidence 654443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.8e-18 Score=163.16 Aligned_cols=152 Identities=22% Similarity=0.362 Sum_probs=126.3
Q ss_pred hcCCcceeeeecccCcEeEEEEE-ecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCC-CCcceeEEEEEeCCeEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~LV~ 600 (692)
...+|.++++||.|+||.+|.|. ..+|++||||.-+.... ..++..|..+...++| ..|.++..+..++..-.|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 45789999999999999999997 46699999997664433 2456778999999976 78888888889999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC---CceEEEeeCCceec
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKISDFGMARMF 677 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kI~DFGlAk~~ 677 (692)
|.+ +-+|++.+.-. .+.++.++.+-++-|++.-++|+|.++ +|||||||+|+|+.-+ ..+.++||||||.+
T Consensus 91 dLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 987 77888866322 234778899999999999999999998 9999999999999654 35899999999988
Q ss_pred CCCcc
Q 005519 678 GGDEL 682 (692)
Q Consensus 678 ~~~~~ 682 (692)
.+..+
T Consensus 165 ~d~~t 169 (341)
T KOG1163|consen 165 RDIRT 169 (341)
T ss_pred ccccc
Confidence 66443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-19 Score=176.27 Aligned_cols=150 Identities=31% Similarity=0.453 Sum_probs=121.8
Q ss_pred CcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCC-ccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+.+.+..||.|+||+|+|-.++ .|+..|||++..... ...++++.|.+...+- +.||||+++|.+......|+-||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3444568999999999998764 499999999975433 5567888898866655 789999999999999999999999
Q ss_pred cCCCCHhHHh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 603 MVNKSLDVFL---FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 603 ~~~gsL~~~L---~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
| .-||+.+- ++ .+...+++.-.-+|...+++||.||.+. +.|||||+||+||||+..|.+||+|||++-.+.+
T Consensus 145 M-d~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred H-hhhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9 45666542 22 2344577777788888899999999985 4699999999999999999999999999876643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.2e-17 Score=158.19 Aligned_cols=143 Identities=39% Similarity=0.623 Sum_probs=126.8
Q ss_pred ecccCcEeEEEEEecC-CcEEEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCHhH
Q 005519 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDV 610 (692)
Q Consensus 533 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 610 (692)
||+|.+|.||++...+ ++++++|.+...... ..+.+.+|+..+.+++|++|+++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998854 889999998754332 35789999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-CCceEEEeeCCceecCCC
Q 005519 611 FLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGD 680 (692)
Q Consensus 611 ~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kI~DFGlAk~~~~~ 680 (692)
++.... ..+++..+..++.+++++|.|||+.+ ++|+||+|.||+++. +..++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 984321 35889999999999999999999987 999999999999999 899999999999977544
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-18 Score=189.17 Aligned_cols=149 Identities=31% Similarity=0.459 Sum_probs=117.6
Q ss_pred cceeeeecccCcEe-EEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEEEccC
Q 005519 527 FSIQSKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 527 f~~~~~LG~G~fG~-Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
|.-.+.+|.|+-|+ ||+|.+ ++++||||++-. ...+...+|+..+..- +||||||+++.-.+...+|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44447789999875 899999 678999999853 2345667899988877 6999999999888899999999998
Q ss_pred CCCHhHHhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC---C--CceEEEeeCCceecC
Q 005519 605 NKSLDVFLFDPTKK-HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---H--MNPKISDFGMARMFG 678 (692)
Q Consensus 605 ~gsL~~~L~~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~---~--~~~kI~DFGlAk~~~ 678 (692)
.-+|++++...... ....-.....+..|++.||++||+.+ ||||||||+||||+. + ..++|+|||++|.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 55899988542010 00111234567889999999999976 999999999999976 2 569999999999998
Q ss_pred CCccc
Q 005519 679 GDELQ 683 (692)
Q Consensus 679 ~~~~~ 683 (692)
.+..+
T Consensus 663 ~~~sS 667 (903)
T KOG1027|consen 663 GGKSS 667 (903)
T ss_pred CCcch
Confidence 87653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.7e-19 Score=186.48 Aligned_cols=159 Identities=25% Similarity=0.321 Sum_probs=136.0
Q ss_pred CCcceeeeecccCcEeEEEEEecCCc-EEEEEEcccCC---CccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLNGQ-EVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~g~-~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
.+++.+..||-|+||.|-++...... .+|+|.+++.. ....+....|-.+|...+.|.||+|+-.+.+.+..|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556678999999999998875433 48888887642 234566788999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
|-|-+|.|-..|++ +..++..+...++..+++|++|||.++ ||.|||||+|.||+.+|.+||.|||+||.++..
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999854 455778888889999999999999988 999999999999999999999999999999877
Q ss_pred ccccCccceecC
Q 005519 681 ELQGNTKRIVGT 692 (692)
Q Consensus 681 ~~~~~~~~~~GT 692 (692)
+. |-+++||
T Consensus 574 ~K---TwTFcGT 582 (732)
T KOG0614|consen 574 RK---TWTFCGT 582 (732)
T ss_pred Cc---eeeecCC
Confidence 64 4568887
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=166.61 Aligned_cols=151 Identities=17% Similarity=0.130 Sum_probs=115.1
Q ss_pred hhhcCCcceeeeecccCcEeEEEEE--ecCCcEEEEEEcccCCCc------------------------cHHHHHHHHHH
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQ------------------------GLKEFKNEMML 574 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~--~~~g~~VAVK~l~~~~~~------------------------~~~~f~~Ei~~ 574 (692)
......|++.+.||+|+||.||+|. ..+|+.||||.+...... ....+..|+.+
T Consensus 24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 3344458888999999999999998 567999999988643210 01235689999
Q ss_pred HHhCCCCC--cceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecC
Q 005519 575 IAKLQHRN--LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRD 652 (692)
Q Consensus 575 l~~l~H~n--Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrD 652 (692)
+.++.|.. +.+.++. ...+|||||+++.+|...+. ....+.......++.|++.+|.+||+.+ .|+|||
T Consensus 104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~D 174 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGD 174 (237)
T ss_pred HHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCC
Confidence 99997633 4444443 23589999999988765542 2223455666789999999999999876 499999
Q ss_pred CCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 653 LKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 653 lKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
|||+||+++ ++.++|+|||+|+......
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccCCcc
Confidence 999999999 8899999999999776543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-17 Score=162.63 Aligned_cols=136 Identities=19% Similarity=0.280 Sum_probs=114.3
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCc--------cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
+.||+|++|.||+|.. .+..|+||........ ....+.+|+.++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6678999976532211 124578899999999999998888887788889999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||+|+...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988331 12 77889999999999999988 99999999999999 7889999999998643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.9e-17 Score=161.83 Aligned_cols=142 Identities=13% Similarity=0.123 Sum_probs=115.9
Q ss_pred hhcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHH---H------HHHHHHHHHhCCCCCcceeEEEEEe
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK---E------FKNEMMLIAKLQHRNLVRLLGCCIE 592 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~---~------f~~Ei~~l~~l~H~nIv~l~g~~~~ 592 (692)
...++|+..+.||.|+||.||+... ++..+|||.+........+ . |.+|+..+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468899999999999999999755 5778999999754332222 2 6789999999999999999988664
Q ss_pred C--------CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC
Q 005519 593 Q--------GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (692)
Q Consensus 593 ~--------~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~ 664 (692)
. ...+|||||+++.+|.++. .++. ....+++.+|..+|..+ ++|||+||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 3579999999999997763 1222 24568999999999998 99999999999999988
Q ss_pred ceEEEeeCCceecCC
Q 005519 665 NPKISDFGMARMFGG 679 (692)
Q Consensus 665 ~~kI~DFGlAk~~~~ 679 (692)
++|+|||..+....
T Consensus 173 -i~liDfg~~~~~~e 186 (232)
T PRK10359 173 -LRIIDLSGKRCTAQ 186 (232)
T ss_pred -EEEEECCCcccccc
Confidence 99999999987743
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.1e-17 Score=163.00 Aligned_cols=138 Identities=33% Similarity=0.448 Sum_probs=123.8
Q ss_pred CcEeEEEEEecC-CcEEEEEEcccCCCcc-HHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCHhHHhcC
Q 005519 537 GFGPVYKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD 614 (692)
Q Consensus 537 ~fG~Vykg~~~~-g~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~ 614 (692)
+||.||+++..+ ++.+|+|.+....... .+.+.+|+..+.+++|+||+++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998764 8899999997654444 78999999999999999999999999999999999999999999999854
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 615 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
. ..+++..+..++.+++++|.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 2 22889999999999999999999987 999999999999999999999999999987653
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.8e-17 Score=185.43 Aligned_cols=142 Identities=18% Similarity=0.269 Sum_probs=114.9
Q ss_pred hhcCCcceeeeecccCcEeEEEEEecCCcEEEEEE-cccCCC-------ccHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQSG-------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ 593 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~-l~~~~~-------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 593 (692)
.....|...++||+|+||.||+|.+.... +++|+ +.+... ...+++.+|+.++.+++|++++....++.+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 33445566789999999999999875543 44443 222111 1235688999999999999999988888888
Q ss_pred CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
...++||||+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|||+ +++.++|+|||+
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 88899999999999998873 35678999999999999988 9999999999999 677999999999
Q ss_pred ceecCC
Q 005519 674 ARMFGG 679 (692)
Q Consensus 674 Ak~~~~ 679 (692)
|+....
T Consensus 474 a~~~~~ 479 (535)
T PRK09605 474 GKYSDL 479 (535)
T ss_pred cccCCc
Confidence 997644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6e-17 Score=160.59 Aligned_cols=146 Identities=18% Similarity=0.167 Sum_probs=113.0
Q ss_pred HhhhcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCC----------------------ccHHHHHHHHHHHHh
Q 005519 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG----------------------QGLKEFKNEMMLIAK 577 (692)
Q Consensus 520 l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~----------------------~~~~~f~~Ei~~l~~ 577 (692)
+......|.+.+.||+|+||.||++...+|+.||||++..... .....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3334445788899999999999999988899999998653210 001236778889999
Q ss_pred CCCCC--cceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCC
Q 005519 578 LQHRN--LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKA 655 (692)
Q Consensus 578 l~H~n--Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp 655 (692)
+.|++ +.+.++ ....++||||+++++|..... . .....++.++++++.++|+.+ |+||||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----~-----~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV----L-----EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc----c-----ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 98874 444444 245589999999999876531 0 234568899999999999987 99999999
Q ss_pred CcEEEcCCCceEEEeeCCceecCCCc
Q 005519 656 SNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 656 ~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
+||++++++.+||+|||+|..+..+.
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCCcc
Confidence 99999999999999999998776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.1e-18 Score=187.06 Aligned_cols=163 Identities=27% Similarity=0.450 Sum_probs=140.0
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
.+.++|.+...+|.|.||.|||++.. .++..|||.++........-.+.|+-+++..+|||||.++|-+...+.+++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 45578999999999999999999864 48899999998776677778889999999999999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
||+.+|+|++.-+ -...+.+.+.....+..++||+|||+++ -+|||||-.|||+++.+.+|++|||.+..++.-
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999987542 2345777788888999999999999998 799999999999999999999999999887654
Q ss_pred ccccCccceecC
Q 005519 681 ELQGNTKRIVGT 692 (692)
Q Consensus 681 ~~~~~~~~~~GT 692 (692)
-.+ .+.+.||
T Consensus 166 i~K--rksfiGt 175 (829)
T KOG0576|consen 166 IAK--RKSFIGT 175 (829)
T ss_pred hhh--hhcccCC
Confidence 332 2235555
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-16 Score=155.73 Aligned_cols=133 Identities=20% Similarity=0.206 Sum_probs=106.2
Q ss_pred eeeeecccCcEeEEEEEecCCcEEEEEEcccCCCc----cHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEEEEcc
Q 005519 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ----GLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 529 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~----~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
+...|++|+||+||.+.- ++..++.+.+.....- ....|.+|+++|.+++ |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997765 5677887777653221 1225889999999995 5889999886 4569999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCC-CCCcEEEcCCCceEEEeeCCceecCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL-KASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl-Kp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++.+|...+. . ....++.|++++|.++|+++ |+|||| ||+|||++.++.++|+|||+|+...+
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999865431 1 11357789999999999998 999999 79999999999999999999996654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.3e-18 Score=164.88 Aligned_cols=151 Identities=26% Similarity=0.402 Sum_probs=121.2
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCC-CccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E 601 (692)
+..+.+..||.|+-|.|++.+... |..+|||.+.+.. .+..++.+..+.++.+-+ .|.||+.+|+|+.....++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345556789999999999998754 8899999997643 334566777777766654 8999999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
.|. .-++..|.. ..+++++.-.-++...+++||.||.++. .|||||+||+|||+|+.|++|++|||++-++.+.
T Consensus 172 lMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 883 234444432 2345788888889999999999999854 6999999999999999999999999999877543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.2e-17 Score=161.93 Aligned_cols=151 Identities=23% Similarity=0.380 Sum_probs=125.6
Q ss_pred cCCcceeeeecccCcEeEEEEE-ecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEEEE
Q 005519 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 524 ~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E 601 (692)
.-+|++.++||+|+||.++.|+ +-+++.||||.-... ....++..|.+..+.|. .++|...+.+..++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3579999999999999999996 567899999965432 23356677888777774 6899999999999999999999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-----CCceEEEeeCCcee
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-----HMNPKISDFGMARM 676 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-----~~~~kI~DFGlAk~ 676 (692)
.+ +-||++.. +. -.+.++.++..-+|.|++.-++|+|++. +|.|||||+|+||.. ...+.|+||||||.
T Consensus 105 LL-GPSLEDLF-D~-CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLF-DL-CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHH-HH-hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 87 77888855 21 2456889999999999999999999987 999999999999964 34589999999999
Q ss_pred cCCCcc
Q 005519 677 FGGDEL 682 (692)
Q Consensus 677 ~~~~~~ 682 (692)
+.+..+
T Consensus 179 YrDp~T 184 (449)
T KOG1165|consen 179 YRDPKT 184 (449)
T ss_pred hcCccc
Confidence 977554
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=158.09 Aligned_cols=133 Identities=20% Similarity=0.320 Sum_probs=108.4
Q ss_pred eecccCcEeEEEEEecCCcEEEEEEcccCCC-c-------cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEcc
Q 005519 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-Q-------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 532 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~-------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
.||+|+||.||+|.. ++..|++|....... . ...++.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 568899998643211 1 1356788999999999887766666666777789999999
Q ss_pred CCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 604 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++++|.+++... . . .++.+++++|.+||+.+ ++|+|+||+||+++ ++.++++|||+|+....
T Consensus 80 ~g~~l~~~~~~~---~-~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~ 141 (199)
T TIGR03724 80 EGKPLKDVIEEG---N-D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE 141 (199)
T ss_pred CCccHHHHHhhc---H-H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence 999998887321 1 0 78899999999999988 99999999999999 78999999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.9e-17 Score=159.76 Aligned_cols=147 Identities=21% Similarity=0.396 Sum_probs=119.8
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEE-EEEeCCeEEEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLG-CCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g-~~~~~~~~~LV~E 601 (692)
+.|.+.+.||+|.||.+-+++++. ...+++|.+.. .....++|.+|..---.| .|.||+.-++ .++..+...+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 568888999999999999998865 66788888764 234578899998755555 5899987664 4556678889999
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEc--CCCceEEEeeCCceecCC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHMNPKISDFGMARMFGG 679 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~--~~~~~kI~DFGlAk~~~~ 679 (692)
|++.|+|.+-+ ....+.+....+++.|++.||.|+|++. +||||||.+||||- +...+||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999998876 2344667777889999999999999988 99999999999993 345799999999986643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.4e-17 Score=166.42 Aligned_cols=161 Identities=27% Similarity=0.395 Sum_probs=137.9
Q ss_pred hhhHhhhcCCcceeeeecccCcEeEEEEEec------CCcEEEEEEcccC-CCccHHHHHHHHHHHHhCCCCCcceeEEE
Q 005519 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589 (692)
Q Consensus 517 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 589 (692)
..++.....++++...+-+|.||.||+|.+. +.+.|-||.++.. ++.+...+..|..++..+.|||+..+.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4456666677888899999999999999653 3456888988754 34457889999999999999999999999
Q ss_pred EEeC-CeEEEEEEccCCCCHhHHhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC
Q 005519 590 CIEQ-GEKILIYEYMVNKSLDVFLF-----DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (692)
Q Consensus 590 ~~~~-~~~~LV~Ey~~~gsL~~~L~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~ 663 (692)
+.+. +..+++|.++.-|+|+.||. +....+.+.-.+...++.|++.|++|||.++ |||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9865 56789999999999999997 5555667788888999999999999999998 9999999999999999
Q ss_pred CceEEEeeCCceecCCC
Q 005519 664 MNPKISDFGMARMFGGD 680 (692)
Q Consensus 664 ~~~kI~DFGlAk~~~~~ 680 (692)
..+||+|-.|+|-+-+.
T Consensus 433 LqVkltDsaLSRDLFP~ 449 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPG 449 (563)
T ss_pred eeEEeccchhccccCcc
Confidence 99999999999966443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.6e-17 Score=176.73 Aligned_cols=147 Identities=24% Similarity=0.314 Sum_probs=123.1
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
.++.|.+...+|.|+|+.|-.+.. ..++..+||++.+.. .+-.+|+.++.+. +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356788888999999999999976 457899999997652 2334567665555 7999999999999999999999
Q ss_pred EccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEE-cCCCceEEEeeCCceecCC
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL-DQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl-~~~~~~kI~DFGlAk~~~~ 679 (692)
|++.++-+...++.. . .....+..|+.+|+.|+.|||+++ ||||||||+|||+ +..++++|+|||.++.+.+
T Consensus 396 e~l~g~ell~ri~~~---~-~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK---P-EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhc---c-hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999999887766432 2 222677789999999999999998 9999999999999 5899999999999998876
Q ss_pred C
Q 005519 680 D 680 (692)
Q Consensus 680 ~ 680 (692)
+
T Consensus 469 ~ 469 (612)
T KOG0603|consen 469 S 469 (612)
T ss_pred h
Confidence 6
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=5e-16 Score=165.87 Aligned_cols=145 Identities=26% Similarity=0.364 Sum_probs=120.4
Q ss_pred CcceeeeecccCcEeEEEEEecCC--cEEEEEEcccCCCccHHHHHHHHHHHHhCCC----CCcceeEEEE-EeCCeEEE
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLNG--QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH----RNLVRLLGCC-IEQGEKIL 598 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~g--~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~L 598 (692)
+|++.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986553 4788887665433332378889999998873 6888999888 47778899
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC-----CceEEEeeCC
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-----MNPKISDFGM 673 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~-----~~~kI~DFGl 673 (692)
||+.+ +.+|.++..... ...++..+.++|+.|++.+|.+||+.+ ++||||||+|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99976 788888664333 567899999999999999999999998 9999999999999754 4699999999
Q ss_pred ce
Q 005519 674 AR 675 (692)
Q Consensus 674 Ak 675 (692)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.4e-16 Score=160.09 Aligned_cols=154 Identities=23% Similarity=0.269 Sum_probs=126.9
Q ss_pred hhcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCC--C----CcceeEEEEEeCC
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--R----NLVRLLGCCIEQG 594 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~----nIv~l~g~~~~~~ 594 (692)
..+++|.+..++|+|.||+|-++.... +..||||+++.. ..-.+..+-|+.++.++.+ | -+|.+.+++...+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 347889999999999999999997643 688999998753 3334556789999999943 2 2788888899999
Q ss_pred eEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC------------
Q 005519 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ------------ 662 (692)
Q Consensus 595 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~------------ 662 (692)
+.++|+|.+ +-|+.++|... ....++..+...|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 999999987 55899999553 4556888999999999999999999987 999999999999931
Q ss_pred --------CCceEEEeeCCceecCCCc
Q 005519 663 --------HMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 663 --------~~~~kI~DFGlAk~~~~~~ 681 (692)
+..+||+|||-|..-....
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc
Confidence 3458999999999776554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.7e-16 Score=162.65 Aligned_cols=148 Identities=25% Similarity=0.463 Sum_probs=127.1
Q ss_pred hhcCCcceeeeecccCcEeEEEEEec----CCcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeE
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 596 (692)
...+.|..+++||+|.|++||++++. ..+.||+|.+...+ ...+..+|+++|..+ -|.||+++.+++...++.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34467899999999999999999753 36789999997543 346688999999999 589999999999999999
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC-CceEEEeeCCce
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMAR 675 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kI~DFGlAk 675 (692)
.+|+||+++-...++... ++...+..++..+.+||.++|.++ ||||||||.|+|.+.. +.-.|.|||||.
T Consensus 111 ~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 999999999999888743 567888889999999999999998 9999999999999864 567899999998
Q ss_pred ecCCC
Q 005519 676 MFGGD 680 (692)
Q Consensus 676 ~~~~~ 680 (692)
.....
T Consensus 182 ~~d~~ 186 (418)
T KOG1167|consen 182 RYDGY 186 (418)
T ss_pred HHHhh
Confidence 65433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.2e-15 Score=139.74 Aligned_cols=137 Identities=22% Similarity=0.216 Sum_probs=115.5
Q ss_pred eeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCC--CCcceeEEEEEeCCeEEEEEEccCCC
Q 005519 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQGEKILIYEYMVNK 606 (692)
Q Consensus 529 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~LV~Ey~~~g 606 (692)
+.+.||+|.++.||++...+ ..++||....... ...+..|+.++..++| .++.+++++...++..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999854 7899998865432 5678999999999976 58999999888888899999999888
Q ss_pred CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
.+..+ +......++.+++++|++||......++|+|+||+||++++.+.++++|||+++...
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 76432 456667889999999999998654569999999999999998999999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-15 Score=147.97 Aligned_cols=140 Identities=20% Similarity=0.220 Sum_probs=99.7
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEcccCCCc--cHHHH----------------------HHHHHHHHhCCCCC--c
Q 005519 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLKEF----------------------KNEMMLIAKLQHRN--L 583 (692)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~f----------------------~~Ei~~l~~l~H~n--I 583 (692)
.+.||+|+||.||++...+++.||||.+...... ....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3689999999999999878999999987643211 11111 34555666664433 4
Q ss_pred ceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCcEEEcC
Q 005519 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQ 662 (692)
Q Consensus 584 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlKp~NILl~~ 662 (692)
.+.+++ ...++||||++++.+....... .... .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~---~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD---VRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh---hhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 3468999999995432111000 0011 4567899999999999998 76 99999999999999
Q ss_pred CCceEEEeeCCceecCCCc
Q 005519 663 HMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 663 ~~~~kI~DFGlAk~~~~~~ 681 (692)
++.++|+|||+|..+...+
T Consensus 150 ~~~~~liDfg~a~~~~~~~ 168 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHPN 168 (187)
T ss_pred CCcEEEEECcccccccCcc
Confidence 8899999999998776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.6e-15 Score=160.43 Aligned_cols=157 Identities=24% Similarity=0.321 Sum_probs=132.5
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEec-CCcEEEEEEcccCCCccHHHHHHHHHHHHhCC------CCCcceeEEEEEeC
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ------HRNLVRLLGCCIEQ 593 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~------H~nIv~l~g~~~~~ 593 (692)
+....+|.+.-..|+|-|+.|.+|... .|++||||++.... ...+.=+.|+++|.+|+ .-++++|+-.|.+.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 344578999999999999999999864 48899999997642 23445578999999995 35899999999999
Q ss_pred CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC-ceEEEeeC
Q 005519 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFG 672 (692)
Q Consensus 594 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kI~DFG 672 (692)
.+++||+|-+ .-+|...|........|....+..++.|+.-||..|...+ |+|+||||+|||+++.. .+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999977 4578888866666667888899999999999999999887 99999999999998754 58999999
Q ss_pred CceecCCCcc
Q 005519 673 MARMFGGDEL 682 (692)
Q Consensus 673 lAk~~~~~~~ 682 (692)
.|-....++.
T Consensus 583 SA~~~~enei 592 (752)
T KOG0670|consen 583 SASFASENEI 592 (752)
T ss_pred cccccccccc
Confidence 9998887765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.7e-15 Score=157.12 Aligned_cols=136 Identities=25% Similarity=0.323 Sum_probs=110.5
Q ss_pred hcCCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhCC-----C---CCcceeEEEEEe-
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----H---RNLVRLLGCCIE- 592 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----H---~nIv~l~g~~~~- 592 (692)
...+|.+.++||-|.|++||++.. ...+.||+|+.+.. ..-.+....||++|.+++ | ..||+|++.|..
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 347899999999999999999975 34678999998753 334456788999999883 3 369999999985
Q ss_pred ---CCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC
Q 005519 593 ---QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (692)
Q Consensus 593 ---~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~ 663 (692)
+.+.+||+|++ +.+|..+|... ..+.++...+.+|++||+.||.|||.++ .|||-||||+|||+..+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 45899999999 44555555432 3456888999999999999999999987 69999999999999654
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-15 Score=122.39 Aligned_cols=66 Identities=56% Similarity=1.191 Sum_probs=57.4
Q ss_pred CCCCCceeEeecccCCCccceeeecccChhHHHHhhhcCCceEeeeeccccCCCcceEeeccccccc
Q 005519 347 CKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDL 413 (692)
Q Consensus 347 C~~~~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~~~~~~~~gC~~w~~~l~~~ 413 (692)
|+.+|+|++++++++|++.....+.+.++++|++.||+||||+||+|.+.. ++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 545799999999999999777666678999999999999999999997644 567899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.5e-16 Score=154.28 Aligned_cols=146 Identities=31% Similarity=0.409 Sum_probs=119.1
Q ss_pred CCcceeeeecccCcEeEEEEEe-cCCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeC------Ce
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------GE 595 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~ 595 (692)
.+|.-+..+|.|.- .|..+-. -.++.||+|++... ..+..++..+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888876 4544432 34789999988643 234567788999999999999999999998743 36
Q ss_pred EEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 596 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
.|+||||| ..+|...+. -.++..+...|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 79999999 556777663 34788888999999999999999988 9999999999999999999999999999
Q ss_pred ecCCC
Q 005519 676 MFGGD 680 (692)
Q Consensus 676 ~~~~~ 680 (692)
.-..+
T Consensus 167 ~e~~~ 171 (369)
T KOG0665|consen 167 TEDTD 171 (369)
T ss_pred ccCcc
Confidence 76555
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.1e-14 Score=147.93 Aligned_cols=150 Identities=36% Similarity=0.535 Sum_probs=128.3
Q ss_pred cceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCc---cHHHHHHHHHHHHhCCCC-CcceeEEEEEeCCeEEEEEEc
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQHR-NLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~LV~Ey 602 (692)
|.+.+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++++.+.+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999876 78899988754332 367899999999999988 799999999777778999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC-ceEEEeeCCceecCCCc
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGDE 681 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kI~DFGlAk~~~~~~ 681 (692)
+.++++..++........+.......++.|++.++.|+|..+ ++|||+||+||+++... .+|++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976633211136788899999999999999999998 99999999999999988 79999999999776544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3e-14 Score=145.23 Aligned_cols=136 Identities=21% Similarity=0.249 Sum_probs=105.5
Q ss_pred eeec-ccCcEeEEEEEecCCcEEEEEEcccCC-------------CccHHHHHHHHHHHHhCCCCCc--ceeEEEEEeCC
Q 005519 531 SKLG-EGGFGPVYKGRLLNGQEVAVKRLSNQS-------------GQGLKEFKNEMMLIAKLQHRNL--VRLLGCCIEQG 594 (692)
Q Consensus 531 ~~LG-~G~fG~Vykg~~~~g~~VAVK~l~~~~-------------~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~ 594 (692)
..|| .||.|+||+.... +..++||++.... ......+.+|+.++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 7888999998774 6788998775311 1223568889999999998875 67777654432
Q ss_pred ----eEEEEEEccCC-CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEE
Q 005519 595 ----EKILIYEYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (692)
Q Consensus 595 ----~~~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~ 669 (692)
..++|+||+++ .+|..++.+ ..++.. .+.+++++|.+||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 689888733 224433 3568999999999998 9999999999999998899999
Q ss_pred eeCCceecC
Q 005519 670 DFGMARMFG 678 (692)
Q Consensus 670 DFGlAk~~~ 678 (692)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998765
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.8e-13 Score=159.36 Aligned_cols=146 Identities=25% Similarity=0.348 Sum_probs=113.5
Q ss_pred hhhcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCeEE
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 521 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~ 597 (692)
+.-...|.+.+.||+|+||+||+|...+++.||+|.=+....- +|.-=..++.||+ -+.|+.+..+..-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3445679999999999999999999888999999976543221 1111122333343 234455555556667779
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-------CCceEEEe
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-------HMNPKISD 670 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-------~~~~kI~D 670 (692)
||+||.+.|+|.+++. ..+..+|.....++.|+++-++.||..+ |||+||||+|+||.. ..-++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999984 5667899999999999999999999998 999999999999942 34589999
Q ss_pred eCCce
Q 005519 671 FGMAR 675 (692)
Q Consensus 671 FGlAk 675 (692)
||-|-
T Consensus 845 fG~si 849 (974)
T KOG1166|consen 845 FGRSI 849 (974)
T ss_pred cccce
Confidence 99995
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.9e-13 Score=151.17 Aligned_cols=142 Identities=21% Similarity=0.243 Sum_probs=100.8
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCcc----------------------------------------HHHHHH
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG----------------------------------------LKEFKN 570 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~----------------------------------------~~~f~~ 570 (692)
+.||.|++|+||+|++.+|+.||||......... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999999999999999875432110 012455
Q ss_pred HHHHHHhC----CCCCcceeEEEEE-eCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 005519 571 EMMLIAKL----QHRNLVRLLGCCI-EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ-GLLYLHQYS 644 (692)
Q Consensus 571 Ei~~l~~l----~H~nIv~l~g~~~-~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~~ 644 (692)
|+..+.++ +|.+-+.+-..+. .....+|||||+++++|.+.+.... ... .+..++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 66555554 2333333323332 2345799999999999987653211 112 23456666666 477889887
Q ss_pred CCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 645 ~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
++|+|+||.||++++++.++++|||+++.+.++
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 999999999999999999999999999988654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.5e-12 Score=107.90 Aligned_cols=80 Identities=41% Similarity=0.887 Sum_probs=63.7
Q ss_pred CCCCCCC---CceeEeecccCCCccceeeecccChhHHHHhhhcCCceEeeeeccccCCCcceEeeccccccccccCCCC
Q 005519 344 SSDCKSG---DRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHT 420 (692)
Q Consensus 344 ~~~C~~~---~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~~~~~~~~gC~~w~~~l~~~~~~~~~~ 420 (692)
+++|... +.|..++++++|+..... ...++++|++.||+||+|+||+|.+ ++.+|++|.+.+.+.+... .
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~--~ 74 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLS--S 74 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeec--C
Confidence 3567543 689999999999876542 6679999999999999999999974 3456999999998876543 3
Q ss_pred CCeeEEEeec
Q 005519 421 NGVSIYIRVP 430 (692)
Q Consensus 421 ~~~~~ylrv~ 430 (692)
.+.++||||+
T Consensus 75 ~~~~~yiKv~ 84 (84)
T cd01098 75 GGGTLYLRLA 84 (84)
T ss_pred CCcEEEEEeC
Confidence 4578999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.8e-12 Score=106.32 Aligned_cols=71 Identities=24% Similarity=0.397 Sum_probs=59.7
Q ss_pred CCCCCceeEeecccCCCccceeeecccChhHHHHhhhc---CCceEeeeeccccCCCcceEeecccc-ccccccCCCCCC
Q 005519 347 CKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK---NCSCRAYANSKVTDGGSGCLMWFGDL-IDLKKTDNHTNG 422 (692)
Q Consensus 347 C~~~~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~---nCsC~A~~~~~~~~~~~gC~~w~~~l-~~~~~~~~~~~~ 422 (692)
|...+.|+++.++++|++.. .++++|++.|++ ||||.||+|.+. +.||++|.++| +|++... ..+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~--~~g 73 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEF--SHG 73 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhcc--CCC
Confidence 44467899999999998654 589999999999 999999999752 35899999999 9988765 457
Q ss_pred eeEEEe
Q 005519 423 VSIYIR 428 (692)
Q Consensus 423 ~~~ylr 428 (692)
.++|+|
T Consensus 74 ~~Ly~r 79 (80)
T cd00129 74 FDLYEN 79 (80)
T ss_pred ceeEeE
Confidence 899997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.6e-11 Score=118.06 Aligned_cols=131 Identities=23% Similarity=0.168 Sum_probs=97.8
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcc-eeEEEEEeCCeEEEEEEccCCCCHh
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCIEQGEKILIYEYMVNKSLD 609 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~LV~Ey~~~gsL~ 609 (692)
+.|+.|.++.||+++.. ++.+++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 67899999999999874 67899998754322 234567899999988665544 455443 33458999999998865
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS--RLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 610 ~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
.. . . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.|..-
T Consensus 80 ~~-------~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 80 TE-------D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cc-------c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 32 0 0 11235678999999999876 33469999999999999 668999999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.3e-11 Score=136.44 Aligned_cols=148 Identities=16% Similarity=0.223 Sum_probs=95.4
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCcc------------------------------H--------
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQG------------------------------L-------- 565 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~------------------------------~-------- 565 (692)
..|+. +.||.|++|+||+|++.+ |++||||.+.....+. .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999987 9999999986431100 0
Q ss_pred --HHHHHHHHHHHhC----CCCCcceeEEEEEe-CCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHH-H
Q 005519 566 --KEFKNEMMLIAKL----QHRNLVRLLGCCIE-QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG-L 637 (692)
Q Consensus 566 --~~f~~Ei~~l~~l----~H~nIv~l~g~~~~-~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~a-L 637 (692)
-+|.+|+..+.++ .+.+.+.+-..+.+ ....+|||||++++.+.+...- .....+.. .++...++. +
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTDMK---LLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCCHH---HHHHHHHHHHH
Confidence 1244455444444 24444443333332 3567899999999999764211 11112211 222222221 2
Q ss_pred HHHHhcCCCceEecCCCCCcEEEcCCC----ceEEEeeCCceecCCCc
Q 005519 638 LYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDFGMARMFGGDE 681 (692)
Q Consensus 638 ~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kI~DFGlAk~~~~~~ 681 (692)
.-++..+ ++|+|+||.||+++.++ .+++.|||++..+.++.
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~~ 318 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKED 318 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHHH
Confidence 2234455 99999999999999888 99999999999886543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.7e-11 Score=146.67 Aligned_cols=95 Identities=18% Similarity=0.247 Sum_probs=74.0
Q ss_pred hCCC-CCcceeEEEE-------EeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 005519 577 KLQH-RNLVRLLGCC-------IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648 (692)
Q Consensus 577 ~l~H-~nIv~l~g~~-------~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 648 (692)
.++| +||+++++.+ .+.+..++++||+ .++|.++|... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3445 5788888877 3334677889987 66999999542 345899999999999999999999988 9
Q ss_pred EecCCCCCcEEEcC-------------------CCceEEEeeCCceec
Q 005519 649 IHRDLKASNILLDQ-------------------HMNPKISDFGMARMF 677 (692)
Q Consensus 649 vHrDlKp~NILl~~-------------------~~~~kI~DFGlAk~~ 677 (692)
+||||||+||||+. ++.+||+|||+|+..
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~ 149 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRRE 149 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccc
Confidence 99999999999954 445666666666643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.3e-11 Score=138.97 Aligned_cols=143 Identities=24% Similarity=0.311 Sum_probs=109.0
Q ss_pred eeeeecccCcEeEEEEEec-CCcEEEEEEcc----cC-CC-ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS----NQ-SG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 529 ~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~----~~-~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
..+.+|.|++|.|+..... ..+..+.|... .. .. +....+..|..+-..++|||++..+....+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3478999999977777532 23333433322 11 11 111225667778888999999888777777766666799
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
|++. +|..++-. ...+...++..++.|++.|+.|||+.+ |.||||||+|+++..++.+||+|||.+..+.
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 9999 99888732 235777888899999999999999998 9999999999999999999999999998764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.5e-10 Score=110.61 Aligned_cols=143 Identities=17% Similarity=0.233 Sum_probs=110.3
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCC-ccHHHHHHHHHHHHhCCC--CCcceeEEEEEeCC---eEEEEEEccC
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQG---EKILIYEYMV 604 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~---~~~LV~Ey~~ 604 (692)
+.|+.|..+.||+++..+|+.+++|....... .....+..|+.++..+.+ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999886678899998764322 245678999999999976 45677887766542 5689999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS---------------------------------------- 644 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~---------------------------------------- 644 (692)
+.++...+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9887654411 34667777788888888888888421
Q ss_pred -------------CCceEecCCCCCcEEEcC--CCceEEEeeCCceec
Q 005519 645 -------------RLRIIHRDLKASNILLDQ--HMNPKISDFGMARMF 677 (692)
Q Consensus 645 -------------~~~ivHrDlKp~NILl~~--~~~~kI~DFGlAk~~ 677 (692)
...++|+|++|.||+++. +..+.|+||+.|..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 667899999988743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.2e-09 Score=105.27 Aligned_cols=137 Identities=14% Similarity=0.100 Sum_probs=98.7
Q ss_pred eeecccCcEeEEEEEecC-------CcEEEEEEcccCC------------C----------ccHHHHH----HHHHHHHh
Q 005519 531 SKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS------------G----------QGLKEFK----NEMMLIAK 577 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~------------~----------~~~~~f~----~Ei~~l~~ 577 (692)
..||.|--+.||.|...+ +..+|||..+... + ...+.+. .|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 4789999664210 0 0122333 78999998
Q ss_pred CCC--CCcceeEEEEEeCCeEEEEEEccCCCCHhH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceEecCC
Q 005519 578 LQH--RNLVRLLGCCIEQGEKILIYEYMVNKSLDV-FLFDPTKKHLLGWQLRVRIIDGIAQGLLYL-HQYSRLRIIHRDL 653 (692)
Q Consensus 578 l~H--~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~-~L~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDl 653 (692)
+.. -++.+.+++ ...+|||||+.+..+.. .|. ...++......+..+++.+|..| |..+ |||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 566677764 46689999997754422 221 12344455667889999999999 7776 999999
Q ss_pred CCCcEEEcCCCceEEEeeCCceecCC
Q 005519 654 KASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 654 Kp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
++.|||+++ +.++|+|||-|.....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCCC
Confidence 999999974 6799999999987754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.1e-11 Score=133.69 Aligned_cols=145 Identities=26% Similarity=0.305 Sum_probs=117.9
Q ss_pred eecccCcEeEEEEE----ecCCcEEEEEEcccCCCc--cHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEEEEccC
Q 005519 532 KLGEGGFGPVYKGR----LLNGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 532 ~LG~G~fG~Vykg~----~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~ 604 (692)
.+|+|.||.|+.++ .+.+..+|+|.+++.... .......|..++..++ ||.+|++...+......+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999774 233677888888653221 1225667888889997 9999999999999999999999999
Q ss_pred CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCcc
Q 005519 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (692)
Q Consensus 605 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~~ 682 (692)
+|.|...+. +....+......+...++.+++++|+.+ |+|||+|++||+++.+|.+|+.|||++|..-..+.
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999877763 3344566666677788999999999988 99999999999999999999999999998765443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-09 Score=112.55 Aligned_cols=151 Identities=22% Similarity=0.314 Sum_probs=100.2
Q ss_pred CCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccC---CCccHHHHHHHHHHHHhCCC----------CCcceeEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH----------RNLVRLLGCC 590 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H----------~nIv~l~g~~ 590 (692)
..+...+.||.|+++.||.++..+ ++++|||..... .....+++++|...+..+.+ -.++--++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 345667899999999999999865 899999977432 23457788888766665433 1222222221
Q ss_pred E---------eCC--------eEEEEEEccCCCCHhHHhc---C-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceE
Q 005519 591 I---------EQG--------EKILIYEYMVNKSLDVFLF---D-PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649 (692)
Q Consensus 591 ~---------~~~--------~~~LV~Ey~~~gsL~~~L~---~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv 649 (692)
. ... +.+++|+-+ .++|..++. . ......+....++.+-.|+++.+++||.++ ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 111 336677766 667776642 1 111233555666777899999999999998 99
Q ss_pred ecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 650 HRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 650 HrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
|+||||+|++++.+|.++|+||+.+...+.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCc
Confidence 999999999999999999999998887654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.1e-11 Score=116.98 Aligned_cols=137 Identities=25% Similarity=0.464 Sum_probs=114.4
Q ss_pred eeeeecccCcEeEEEEEecCCcEEEEEEcccC--CCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCC
Q 005519 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (692)
Q Consensus 529 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 606 (692)
+..+|.+...|..|+|++. |..+++|.+... .....++|..|.-.++.+.||||+.++|.|....++.++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 4468888999999999995 455667776532 2334578999999999999999999999999999999999999999
Q ss_pred CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEe-cCCCCCcEEEcCCCceEEE
Q 005519 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH-RDLKASNILLDQHMNPKIS 669 (692)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH-rDlKp~NILl~~~~~~kI~ 669 (692)
+|...|++. ..-..+..++.+++.+||+|++|||+.. +++- --|.+..+++|++.+++|+
T Consensus 273 slynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee
Confidence 999999875 3456788899999999999999999975 3443 3688999999999998874
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.9e-09 Score=98.57 Aligned_cols=136 Identities=21% Similarity=0.302 Sum_probs=101.9
Q ss_pred eeecccCcEeEEEEEecCCcEEEEE-EcccCCC-c------cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVK-RLSNQSG-Q------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK-~l~~~~~-~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
..+++|+-..+|.+.+.+ .++.+| ++.+.-. . ...+-.+|+.++.+++--.|..-.=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999997643 345555 3333211 1 123467899999998765555555566778888999999
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
+++..|.+.+... +..++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||++.-...+
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~E 145 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVE 145 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccHH
Confidence 9999999888332 2457777888889999998 99999999999998875 9999999999654443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2e-10 Score=131.94 Aligned_cols=142 Identities=21% Similarity=0.262 Sum_probs=112.5
Q ss_pred CcceeeeecccCcEeEEEEEecCCcEEEEEEcccCC-CccHHHHHHHHHH--HHhCCCCCcceeEEEEEeCCeEEEEEEc
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-GQGLKEFKNEMML--IAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~--l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 602 (692)
.+...+.||.+.|=+|.+++.++|. |+||.+.+.. ...++.|.++++- +..++|||++.+.-.-...+..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999998776 8899876544 4456666666554 4445899999877665555666788888
Q ss_pred cCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 603 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
..+ +|.+.| ..+..+..-+...|+.|++.||.-+|..+ |.|+|||.+||||+.-.-+.|+||.--|
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 744 455555 33556777778889999999999999988 9999999999999999999999997765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.8e-08 Score=92.46 Aligned_cols=149 Identities=23% Similarity=0.269 Sum_probs=105.6
Q ss_pred eeeeecccCcEeEEEEEecCCcEEEEE-EcccCCC-------ccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEE
Q 005519 529 IQSKLGEGGFGPVYKGRLLNGQEVAVK-RLSNQSG-------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 529 ~~~~LG~G~fG~Vykg~~~~g~~VAVK-~l~~~~~-------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 600 (692)
....|-+|+-+.|+++.+ .|+...|| ++.+.-. -..++.++|++++.+++--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 346888999999999988 46666666 3333211 12456788999999986544443333556666678999
Q ss_pred EccCC-CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCc---eEEEeeCCcee
Q 005519 601 EYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGMARM 676 (692)
Q Consensus 601 Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kI~DFGlAk~ 676 (692)
||+++ -++.+++.........+.. ...++..|-+.+.-||... |||+||..+||+|..++. +.++||||+-.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~-~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEG-LAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchh-HHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 4777777543333323322 2567888999999999988 999999999999976553 58999999976
Q ss_pred cCCCcc
Q 005519 677 FGGDEL 682 (692)
Q Consensus 677 ~~~~~~ 682 (692)
-...+.
T Consensus 166 s~~~ED 171 (229)
T KOG3087|consen 166 SRLPED 171 (229)
T ss_pred ccCccc
Confidence 544443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-07 Score=97.29 Aligned_cols=134 Identities=17% Similarity=0.143 Sum_probs=97.1
Q ss_pred EeEEEEEecCCcEEEEEEcccCCC-----------ccHHHHHHHHHHHHhCCCC--CcceeEEEEEe-----CCeEEEEE
Q 005519 539 GPVYKGRLLNGQEVAVKRLSNQSG-----------QGLKEFKNEMMLIAKLQHR--NLVRLLGCCIE-----QGEKILIY 600 (692)
Q Consensus 539 G~Vykg~~~~g~~VAVK~l~~~~~-----------~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~-----~~~~~LV~ 600 (692)
..|++..+ +|+.+.||+...... .....+.+|...+.++... ...+.+++... ....+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34666665 577899997643210 1122478999999888543 34455666543 23578999
Q ss_pred EccCCC-CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC-------CCceEEEeeC
Q 005519 601 EYMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-------HMNPKISDFG 672 (692)
Q Consensus 601 Ey~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~-------~~~~kI~DFG 672 (692)
|++++- +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+|+++.|||++. +..+.++||+
T Consensus 115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999986 8888874321 223455667789999999999999998 999999999999975 4679999999
Q ss_pred Cceec
Q 005519 673 MARMF 677 (692)
Q Consensus 673 lAk~~ 677 (692)
.++..
T Consensus 191 r~~~~ 195 (268)
T PRK15123 191 RAQIR 195 (268)
T ss_pred ccccc
Confidence 99653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.1e-08 Score=106.20 Aligned_cols=89 Identities=27% Similarity=0.465 Sum_probs=67.9
Q ss_pred CCCCcceeEEEEEe---------------------------CCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHH
Q 005519 579 QHRNLVRLLGCCIE---------------------------QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631 (692)
Q Consensus 579 ~H~nIv~l~g~~~~---------------------------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~ 631 (692)
+|||||++.++|.+ +..+||||.-. ..+|..+|.. +..+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc----CCCchHHHHHHHH
Confidence 58999998887753 22468888766 3477777732 2345556667889
Q ss_pred HHHHHHHHHHhcCCCceEecCCCCCcEEE--cCCC--ceEEEeeCCce
Q 005519 632 GIAQGLLYLHQYSRLRIIHRDLKASNILL--DQHM--NPKISDFGMAR 675 (692)
Q Consensus 632 ~ia~aL~yLH~~~~~~ivHrDlKp~NILl--~~~~--~~kI~DFGlAk 675 (692)
|+++|+.|||.++ |.|||+|++|||| |+|. ...|+|||.+-
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999998 9999999999999 3443 36899999874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.7e-08 Score=109.33 Aligned_cols=99 Identities=32% Similarity=0.518 Sum_probs=89.7
Q ss_pred HhCCCCCcceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCC
Q 005519 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKA 655 (692)
Q Consensus 576 ~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp 655 (692)
+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.-...++++|++||.|||.-. -..|+.+++
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 467899999999999999999999999999999999965 3456899999999999999999999854 239999999
Q ss_pred CcEEEcCCCceEEEeeCCceecC
Q 005519 656 SNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 656 ~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
.|+++|....+||+|||+..+..
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred ccceeeeeEEEEechhhhccccc
Confidence 99999999999999999998874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.2e-07 Score=92.50 Aligned_cols=127 Identities=25% Similarity=0.288 Sum_probs=82.2
Q ss_pred eEEEEEecCCcEEEEEEcccCC--------------C-------c-----cHHHHHHHHHHHHhCCCC--CcceeEEEEE
Q 005519 540 PVYKGRLLNGQEVAVKRLSNQS--------------G-------Q-----GLKEFKNEMMLIAKLQHR--NLVRLLGCCI 591 (692)
Q Consensus 540 ~Vykg~~~~g~~VAVK~l~~~~--------------~-------~-----~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~ 591 (692)
-||.|...++..+|||...... . . .....++|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998889999999764210 0 0 022467899999999765 566666542
Q ss_pred eCCeEEEEEEccC--CCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCceEecCCCCCcEEEcCCCceEE
Q 005519 592 EQGEKILIYEYMV--NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY-LHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (692)
Q Consensus 592 ~~~~~~LV~Ey~~--~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~y-LH~~~~~~ivHrDlKp~NILl~~~~~~kI 668 (692)
...|||||++ +..+.... +. .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DV----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HC----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHH-hc----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 3479999998 54444322 11 11123345577778876665 46766 9999999999999988 9999
Q ss_pred EeeCCceecCC
Q 005519 669 SDFGMARMFGG 679 (692)
Q Consensus 669 ~DFGlAk~~~~ 679 (692)
+|||.|.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.1e-07 Score=85.38 Aligned_cols=88 Identities=23% Similarity=0.266 Sum_probs=63.7
Q ss_pred eEEEeeCCeEEEEeCC-CCeEEEeeccCC-cCCceEEEecCCCEEEEeCCCCCCCCcceeeecCCCccccccccccccee
Q 005519 105 VLTVSNRGNLVLLNQS-NGTIWSSNVSRE-VKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (692)
Q Consensus 105 ~l~~~~~G~Lvl~~~~-~~~~Wss~~~~~-~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~ 182 (692)
.+.++.||+||+++.. +.++|++++... .....+.|+++|||||++.+ +.++|+| +|
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S-----~t----------- 81 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-----GRVVWSS-----NT----------- 81 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-----CCEEEEe-----cc-----------
Confidence 4556789999999875 589999998632 23367899999999999875 3689997 11
Q ss_pred ccCceeeEEecCCCCCCCCcceEEeecCCCCcEEEEEcCCeeeeecC
Q 005519 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTG 229 (692)
Q Consensus 183 ~tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~~g 229 (692)
....|.|.+.|+.+|+++++-. ...+.|.+.
T Consensus 82 ---------------~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 112 (114)
T smart00108 82 ---------------TGANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112 (114)
T ss_pred ---------------cCCCCceEEEEeCCCCEEEECC-CCCEEeCCC
Confidence 0134668899999999776532 235677654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.3e-09 Score=120.54 Aligned_cols=155 Identities=25% Similarity=0.344 Sum_probs=119.0
Q ss_pred CCcceeeeecccCcEeEEEEEecC--CcEEEEEEcccCC--CccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEE
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 525 ~~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV 599 (692)
..|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456667789999999998876533 4457777665432 222334445777777776 99999999999999999999
Q ss_pred EEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceEecCCCCCcEEEcCCC-ceEEEeeCCceec
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH-QYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMF 677 (692)
Q Consensus 600 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ivHrDlKp~NILl~~~~-~~kI~DFGlAk~~ 677 (692)
.||..++++...+.... ....+....-.++.|+..++.|+| +.+ +.||||||+|.+++..+ ..|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999877663211 112344555678899999999999 776 99999999999999999 9999999999988
Q ss_pred CC-Cccc
Q 005519 678 GG-DELQ 683 (692)
Q Consensus 678 ~~-~~~~ 683 (692)
.. +...
T Consensus 176 ~~~~g~~ 182 (601)
T KOG0590|consen 176 RNKNGAE 182 (601)
T ss_pred cccCCcc
Confidence 76 4433
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.6e-07 Score=83.26 Aligned_cols=88 Identities=23% Similarity=0.226 Sum_probs=64.0
Q ss_pred EEEee-CCeEEEEeCC-CCeEEEeeccC-CcCCceEEEecCCCEEEEeCCCCCCCCcceeeecCCCccccccccccccee
Q 005519 106 LTVSN-RGNLVLLNQS-NGTIWSSNVSR-EVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (692)
Q Consensus 106 l~~~~-~G~Lvl~~~~-~~~~Wss~~~~-~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~ 182 (692)
+.++. ||+||+++.. +.++|++++.. ......+.|+++|||||++.+ +.++|+|=-
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S~~---------------- 82 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-----GTVVWSSNT---------------- 82 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-----CcEEEEecc----------------
Confidence 45565 9999999865 57999999863 235667899999999999875 368998711
Q ss_pred ccCceeeEEecCCCCCCCCcceEEeecCCCCcEEEEEcCCeeeeecCC
Q 005519 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (692)
Q Consensus 183 ~tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~~g~ 230 (692)
....+.+.+.|+.+|+..++-.+ ..+.|.+..
T Consensus 83 ---------------~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 83 ---------------TRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred ---------------cCCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 01256788999999997765322 456787654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.5e-06 Score=86.75 Aligned_cols=108 Identities=22% Similarity=0.182 Sum_probs=85.8
Q ss_pred HHHHHHHHHHHHhCC--CCCcceeEEEEEeCC----eEEEEEEccCCC-CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 005519 565 LKEFKNEMMLIAKLQ--HRNLVRLLGCCIEQG----EKILIYEYMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637 (692)
Q Consensus 565 ~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~----~~~LV~Ey~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL 637 (692)
.....+|...+.++. .-...+.+++..... ..+||+|++++- +|.+++.... .++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 456788888888875 344566777766532 458999999884 8988884321 155566778999999999
Q ss_pred HHHHhcCCCceEecCCCCCcEEEcCCC---ceEEEeeCCceecC
Q 005519 638 LYLHQYSRLRIIHRDLKASNILLDQHM---NPKISDFGMARMFG 678 (692)
Q Consensus 638 ~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kI~DFGlAk~~~ 678 (692)
.-||+.+ |+|+|++|.|||++.+. .+.++||+.++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999998 99999999999999887 89999999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.8e-06 Score=91.86 Aligned_cols=140 Identities=20% Similarity=0.289 Sum_probs=110.7
Q ss_pred EeEEEEEe-cCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCeEEEEEEccCC-CCHhHHh
Q 005519 539 GPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILIYEYMVN-KSLDVFL 612 (692)
Q Consensus 539 G~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~LV~Ey~~~-gsL~~~L 612 (692)
.+.||+.. .||..++.|++.....+....-..-++..+++.|+|+|.+.+++.. +..++|||+|.++ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 46788864 5799999999954433333333455778899999999999998873 3578999999985 5666554
Q ss_pred cCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 613 FDP------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 613 ~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
+.. ......++...+.++.|+.-||.++|+.| +.-+-|.|.+||++.+..++|+..|...++..|
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 421 23345778899999999999999999998 777999999999999999999999999888766
Q ss_pred c
Q 005519 681 E 681 (692)
Q Consensus 681 ~ 681 (692)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 5
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=9.2e-06 Score=80.08 Aligned_cols=140 Identities=16% Similarity=0.157 Sum_probs=103.6
Q ss_pred ecccCcEeEEEEEecCCcEEEEEEcccC------CCccHHHHHHHHHHHHhCCC--CCcceeEEEEEeC----CeEEEEE
Q 005519 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQ------SGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQ----GEKILIY 600 (692)
Q Consensus 533 LG~G~fG~Vykg~~~~g~~VAVK~l~~~------~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~----~~~~LV~ 600 (692)
-|+||-+.|++-.+ +|+.+-+|+-... .+.+...|.+|+..|.++.. ..+.+...+.... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 35688888998776 3457888977622 14467889999999999853 3355555332222 2468999
Q ss_pred EccCC-CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCc--eEEEeeCCceec
Q 005519 601 EYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--PKISDFGMARMF 677 (692)
Q Consensus 601 Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~--~kI~DFGlAk~~ 677 (692)
|-+++ .+|.+++.+.. ....+...+..++.++++.+.-||..+ +.|+|+-+.||+++.++. ++++||--++..
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 97754 58888874321 224566777889999999999999998 999999999999986666 999999777643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.2e-06 Score=86.37 Aligned_cols=136 Identities=21% Similarity=0.201 Sum_probs=93.3
Q ss_pred cceeeeecccCcEeEEEEEecCCcEEEEEEcccC----------C-------C-----ccHHHHHHHHHHHHhCCCC--C
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----------S-------G-----QGLKEFKNEMMLIAKLQHR--N 582 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----------~-------~-----~~~~~f~~Ei~~l~~l~H~--n 582 (692)
..+.++||-|.-+.||.|..+.|.++|||.=... . . ......++|.+.|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4566899999999999999999999999943211 0 0 0123457788889888654 6
Q ss_pred cceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC
Q 005519 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662 (692)
Q Consensus 583 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~ 662 (692)
+.+-+++ +...+||||+++-.|...- -..-+... |+..|++-+.-+-..+ |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6665544 4568999999886653321 01122233 3333444443333445 999999999999999
Q ss_pred CCceEEEeeCCceec
Q 005519 663 HMNPKISDFGMARMF 677 (692)
Q Consensus 663 ~~~~kI~DFGlAk~~ 677 (692)
++.+.++||-=+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999766544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.3e-06 Score=97.85 Aligned_cols=143 Identities=15% Similarity=0.184 Sum_probs=93.1
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCc--------------------------c----HH----------HHHH
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------------------------G----LK----------EFKN 570 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--------------------------~----~~----------~f~~ 570 (692)
+-|+.++-|+||+|++++|++||||........ . .+ +|..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 678999999999999999999999987543211 0 01 1233
Q ss_pred HHHHHHhC----CCCCcceeEEEEE-eCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 005519 571 EMMLIAKL----QHRNLVRLLGCCI-EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG-LLYLHQYS 644 (692)
Q Consensus 571 Ei~~l~~l----~H~nIv~l~g~~~-~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~a-L~yLH~~~ 644 (692)
|..-+.++ ++..=+++=..+. -.....|+|||++|-.+.+...-. ....+. ..|+..++++ +.-+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~---k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDR---KELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCH---HHHHHHHHHHHHHHHHhcC
Confidence 44433333 2222223333333 345779999999999988774221 233442 2344444433 22222344
Q ss_pred CCceEecCCCCCcEEEcCCCceEEEeeCCceecCCCc
Q 005519 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 645 ~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~~ 681 (692)
+.|.|..|.||+++.++.+.+.|||+...+.+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~ 319 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence 9999999999999999999999999999886643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.7e-07 Score=101.60 Aligned_cols=148 Identities=24% Similarity=0.259 Sum_probs=117.9
Q ss_pred hcCCcceeeeecccCcEeEEEEEe--cCCcEEEEEEcccCCCccHH--HHHHHHHHHHhC-CCCCcceeEEEEEeCCeEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLK--EFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~~~~~~--~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 597 (692)
...+|.++..||.|.|+.|++... .++..+++|.+.+....... .-..|+.+...+ .|.++++....+.+-.+.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 456788999999999999999864 35778999988654332222 224456555555 5899999888888888889
Q ss_pred EEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCC-CceEEEeeCCcee
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARM 676 (692)
Q Consensus 598 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kI~DFGlAk~ 676 (692)
+=-||++++++...+ .-...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999987665 23345677778889999999999999876 9999999999999886 8889999999974
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.8e-06 Score=73.62 Aligned_cols=100 Identities=25% Similarity=0.405 Sum_probs=68.7
Q ss_pred CEEEeCCCeEEEEEeCCCCCCCeEEEEEecCCCCceEEEc-cCCCCCCCCCceEEEeeCCeEEEEeCCCCeEEEeeccCC
Q 005519 54 ETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVA-NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSRE 132 (692)
Q Consensus 54 ~~l~S~~g~f~lgf~~~~~~~~~~l~iw~~~~~~t~vW~a-nr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~~Wss~~~~~ 132 (692)
+.+.+.+|.+.|-|...|+ |-| |+. ..++||.. +...+.. ..+.+.|+.||||||+|..+.++|+|.. .
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~~-~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVL-YDS-NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD--Y 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEE-EET-TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--S
T ss_pred cccccccccccceECCCCe-----EEE-EcC-CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC--C
Confidence 4566655889999988875 333 332 25779999 5555432 5689999999999999999999999943 2
Q ss_pred cCCceEEEec--CCCEEEEeCCCCCCCCcceeeecCCCc
Q 005519 133 VKNPVAQLLD--NGNLVIRDNSGSNSTESYLWQSFDYPT 169 (692)
Q Consensus 133 ~~~~~a~l~d--~GNlvl~~~~~~~~~~~~~WqSFd~PT 169 (692)
...+.+..++ +||++ +... ..+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~~-----~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKND-----SLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EEST-----SSEEEESS----
T ss_pred CccEEEeccCcccCCCc-cccc-----eEEeECCCCCCC
Confidence 3567788888 99999 7542 357899877664
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.4e-06 Score=95.30 Aligned_cols=122 Identities=18% Similarity=0.244 Sum_probs=96.9
Q ss_pred ecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHH
Q 005519 546 LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQL 625 (692)
Q Consensus 546 ~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~ 625 (692)
..++.+|.|...+...........+.++.++.++||||++++.........|||+|-+. -|..++.. +.-..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34678899888876555334557778889999999999999999999999999999873 34444422 11233
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 626 ~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
....+.||+.||.|||+.+ .++|.+|.-..|++++.|.-||.+|-++...
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 3445789999999999876 5999999999999999999999999887544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=7.6e-07 Score=103.15 Aligned_cols=112 Identities=27% Similarity=0.433 Sum_probs=76.5
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 601 (692)
...+|..++.|..|++|.||..+++. .+.+|+| +.+..- -.++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc---cccccCCccee-----------------
Confidence 44678999999999999999998764 6678884 332110 0111 23333444444
Q ss_pred ccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 602 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
|+-...+. ....++- +++.+++|||+.+ |+|||+||+|.||+.-|.+|+.||||.++-
T Consensus 136 ----gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ----GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ----chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 22222231 1112221 2378999999988 999999999999999999999999999854
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.6e-06 Score=69.52 Aligned_cols=73 Identities=36% Similarity=0.798 Sum_probs=53.1
Q ss_pred CCceeEeecccCCCccceeeecccChhHHHHhhhc-CCceEeeeeccccCCCcceEeec-cccccccccCCCCCCeeEEE
Q 005519 350 GDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK-NCSCRAYANSKVTDGGSGCLMWF-GDLIDLKKTDNHTNGVSIYI 427 (692)
Q Consensus 350 ~~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~-nCsC~A~~~~~~~~~~~gC~~w~-~~l~~~~~~~~~~~~~~~yl 427 (692)
...|..++++.+++..... ....++++|++.|++ +|+|.||.|.. ++.+|.+|. +.+.+..... ..+.++|.
T Consensus 3 ~~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~--~~~~~~y~ 76 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFP--SGGVDLYE 76 (78)
T ss_pred CceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecc--cCCceeEE
Confidence 3568899999998654432 356799999999999 99999999964 345699999 6666665222 33445555
Q ss_pred e
Q 005519 428 R 428 (692)
Q Consensus 428 r 428 (692)
|
T Consensus 77 ~ 77 (78)
T smart00473 77 K 77 (78)
T ss_pred e
Confidence 4
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.6e-06 Score=82.13 Aligned_cols=62 Identities=23% Similarity=0.074 Sum_probs=53.9
Q ss_pred CCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceecCCC
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~~ 680 (692)
|+|.+++.. ....+++..++.|+.|+++||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 688888843 2446999999999999999999999875 999999999999999 9999987554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.6e-05 Score=77.85 Aligned_cols=138 Identities=19% Similarity=0.212 Sum_probs=85.3
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCC--cceeEEEEEeCCeEEEEEEccCCCC-
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCIEQGEKILIYEYMVNKS- 607 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~LV~Ey~~~gs- 607 (692)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999984 24456778765422 3455688999998886443 4677788777778889999999863
Q ss_pred HhHH---------------------hcCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHh-cCCCceEecCC
Q 005519 608 LDVF---------------------LFDPTKKHLLGWQLRV-RIID----------GIAQ-GLLYLHQ-YSRLRIIHRDL 653 (692)
Q Consensus 608 L~~~---------------------L~~~~~~~~l~~~~~~-~i~~----------~ia~-aL~yLH~-~~~~~ivHrDl 653 (692)
+... ||.. ........... ++.. .+.. ...+|.. .....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~-~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHST-KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCC-CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 1111 00011111100 0100 0111 1222221 12345789999
Q ss_pred CCCcEEEcCCCceEEEeeCCce
Q 005519 654 KASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 654 Kp~NILl~~~~~~kI~DFGlAk 675 (692)
.|.||++++++ +.|+||+.|.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999886
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.4e-06 Score=96.20 Aligned_cols=152 Identities=26% Similarity=0.317 Sum_probs=118.0
Q ss_pred CCcceeeeecc--cCcEeEEEEEe---cCCcEEEEEEcccC--CCccHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCeE
Q 005519 525 ENFSIQSKLGE--GGFGPVYKGRL---LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 525 ~~f~~~~~LG~--G~fG~Vykg~~---~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 596 (692)
..|.+...+|. |.+|.||.+.. .++..+|+|+-+.. .++....=.+|+...+++ .|+|.++....+..++.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34556688999 99999999976 34788999974322 223333335667666777 499999999999999999
Q ss_pred EEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCceEecCCCCCcEEEcCC-CceEEEee
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDF 671 (692)
Q Consensus 597 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kI~DF 671 (692)
++-+|++. .+|..+.+. ....++....+.+..+..+ ||..+|... |+|-|+||.||++.++ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 777777643 2233555666677777777 999999987 9999999999999998 88999999
Q ss_pred CCceecCCCcc
Q 005519 672 GMARMFGGDEL 682 (692)
Q Consensus 672 GlAk~~~~~~~ 682 (692)
|+...+.....
T Consensus 268 ~~v~~i~~~~~ 278 (524)
T KOG0601|consen 268 GLVSKISDGNF 278 (524)
T ss_pred ceeEEccCCcc
Confidence 99999877654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.13 E-value=9.8e-06 Score=79.41 Aligned_cols=106 Identities=21% Similarity=0.191 Sum_probs=84.0
Q ss_pred HHHHHHHHhCCC-CCcceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 005519 569 KNEMMLIAKLQH-RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647 (692)
Q Consensus 569 ~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 647 (692)
.+|..++..+++ +++.+++|.|- .++|.||...+++...-.....-...+|..|.+||.++++.+.+|++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888899976 69999999993 3789999988765321000012234689999999999999999999865445
Q ss_pred eEecCCCCCcEEEcCCCceEEEeeCCceecC
Q 005519 648 IIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 648 ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
+..+|++|+|+-+++++++|++|...+-...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999998886553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.08 E-value=8e-07 Score=96.38 Aligned_cols=148 Identities=22% Similarity=0.197 Sum_probs=99.6
Q ss_pred ceeeeecccCcEeEEEEEecC----CcEEEEEEcccCCCccHHHHHHHHHHHHhC-CCCCcceeE------EEEEe----
Q 005519 528 SIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLL------GCCIE---- 592 (692)
Q Consensus 528 ~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~------g~~~~---- 592 (692)
++.+..++.+++.++...... ...++.+..+............++-.+.-. +|+..+..- .....
T Consensus 247 ~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~ 326 (516)
T KOG1033|consen 247 SISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVG 326 (516)
T ss_pred cccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccc
Confidence 344566666777766654322 233444444433212222223334333333 344433221 01111
Q ss_pred -CCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEee
Q 005519 593 -QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (692)
Q Consensus 593 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DF 671 (692)
...+++.|+++...+|.++|.........++...+.++.|++.|+.| ++ .+|||+||.||+...+..+||.||
T Consensus 327 ~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 327 KKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred cccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhh
Confidence 23578999999999999999766666678889999999999999999 55 899999999999999999999999
Q ss_pred CCceecCCCc
Q 005519 672 GMARMFGGDE 681 (692)
Q Consensus 672 GlAk~~~~~~ 681 (692)
||........
T Consensus 401 gl~ts~~~~~ 410 (516)
T KOG1033|consen 401 GLVTSQDKDE 410 (516)
T ss_pred hheeecccCC
Confidence 9998886665
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.4e-05 Score=75.01 Aligned_cols=140 Identities=16% Similarity=0.179 Sum_probs=91.4
Q ss_pred hhcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHH---------HHHHHHHHhCCCCCcc---eeEEE
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEF---------KNEMMLIAKLQHRNLV---RLLGC 589 (692)
Q Consensus 522 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f---------~~Ei~~l~~l~H~nIv---~l~g~ 589 (692)
....+|+..+.+-......|.+-.. +++.+.+|..........+.| .+++..+.+++...+. .++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3456788888888777777777666 567888887764333222322 2333444444332222 22222
Q ss_pred EE-----eCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC
Q 005519 590 CI-----EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (692)
Q Consensus 590 ~~-----~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~ 664 (692)
.. -....+|+|||++|..|.+.. .++. .++..+++++.-||+.| +.|+|..|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 21 123557999999998875542 1221 24556778899999998 99999999999999664
Q ss_pred ceEEEeeCCceec
Q 005519 665 NPKISDFGMARMF 677 (692)
Q Consensus 665 ~~kI~DFGlAk~~ 677 (692)
++++||+..+..
T Consensus 173 -i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 -IRIIDTQGKRMS 184 (229)
T ss_pred -EEEEECcccccc
Confidence 999999988754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.3e-05 Score=89.66 Aligned_cols=141 Identities=18% Similarity=0.224 Sum_probs=88.7
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCcc-------------------------------------HHHHHHHHH
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-------------------------------------LKEFKNEMM 573 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~-------------------------------------~~~f~~Ei~ 573 (692)
+.||..+.|+||+|++++|+.||||.-...-... +-+|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999765421110 112444554
Q ss_pred HHHh----CCCCCcc---eeEEEEE-eCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcC
Q 005519 574 LIAK----LQHRNLV---RLLGCCI-EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY-LHQYS 644 (692)
Q Consensus 574 ~l~~----l~H~nIv---~l~g~~~-~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~y-LH~~~ 644 (692)
-..+ +.|-++. ++=.++. -...+.|+||||+|..+.+...- ....++... |+..+.++... +-..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~---i~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHD---ILNKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 3333 3455511 1222222 23478999999999887665321 223344443 33333333221 22234
Q ss_pred CCceEecCCCCCcEEEcC----CCceEEEeeCCceecCC
Q 005519 645 RLRIIHRDLKASNILLDQ----HMNPKISDFGMARMFGG 679 (692)
Q Consensus 645 ~~~ivHrDlKp~NILl~~----~~~~kI~DFGlAk~~~~ 679 (692)
++|+|-.|.||++.. +..+.+-|||+.+.+..
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67899999999987754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.5e-05 Score=76.33 Aligned_cols=141 Identities=14% Similarity=0.112 Sum_probs=86.4
Q ss_pred eecccCc-EeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCeEEEEEEccCCCCHh
Q 005519 532 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (692)
Q Consensus 532 ~LG~G~f-G~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 609 (692)
.|-.|.. ..||+.... +..+.||...... ......|+.++..+. +--+.+++++....+..++|||++++.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555655 689998764 4678888775432 345678888888873 445667888777666789999999998776
Q ss_pred HHh-------------------cCCCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----c
Q 005519 610 VFL-------------------FDPTK-KHLLG--WQLRVRIID--------------------GIAQGLLYLHQ----Y 643 (692)
Q Consensus 610 ~~L-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~aL~yLH~----~ 643 (692)
... +.... ..... ...+..-.. .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 11100 00111 000000000 01111222211 1
Q ss_pred CCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 644 ~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
..+.++|+|+.|.|||++.+..+.|+||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999987789999998863
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00011 Score=73.90 Aligned_cols=145 Identities=21% Similarity=0.188 Sum_probs=87.1
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCC--CcceeEEEEEeC---CeEEEEEEccC
Q 005519 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGCCIEQ---GEKILIYEYMV 604 (692)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~---~~~~LV~Ey~~ 604 (692)
++.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++...... ...+++||+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3689999999999999866 68999986543 3556788899888888533 356777755433 35799999999
Q ss_pred CCCHhH----------------Hh---cCC-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 005519 605 NKSLDV----------------FL---FDP-TKKHLLGWQLR---------VRI------------IDGIAQ-GLLYLHQ 642 (692)
Q Consensus 605 ~gsL~~----------------~L---~~~-~~~~~l~~~~~---------~~i------------~~~ia~-aL~yLH~ 642 (692)
+..+.. .+ +.. .......+... ... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111 01111111110 000 011222 2333332
Q ss_pred ----cCCCceEecCCCCCcEEEc-CCCceEEEeeCCceec
Q 005519 643 ----YSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMF 677 (692)
Q Consensus 643 ----~~~~~ivHrDlKp~NILl~-~~~~~kI~DFGlAk~~ 677 (692)
.....++|+|+.|.|||++ +++.+.|+||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2345699999999999999 6666789999988654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=8.4e-06 Score=83.51 Aligned_cols=95 Identities=29% Similarity=0.366 Sum_probs=78.5
Q ss_pred HHHhCCCCCcceeEEEEEeCC-----eEEEEEEccCCCCHhHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 005519 574 LIAKLQHRNLVRLLGCCIEQG-----EKILIYEYMVNKSLDVFLFDPTK-KHLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647 (692)
Q Consensus 574 ~l~~l~H~nIv~l~g~~~~~~-----~~~LV~Ey~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 647 (692)
-|-.+.|.|||+++.++.+.+ ...++.|||+-|+|..+|++..+ ...+......+++-||..||.|||+.. ++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 444557999999999987543 57899999999999999975332 234666777789999999999999964 78
Q ss_pred eEecCCCCCcEEEcCCCceEEE
Q 005519 648 IIHRDLKASNILLDQHMNPKIS 669 (692)
Q Consensus 648 ivHrDlKp~NILl~~~~~~kI~ 669 (692)
|+|+++..+-|++..++-+||.
T Consensus 199 iihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cccCCcchhheeecCCceEEec
Confidence 9999999999999999888874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00033 Score=84.34 Aligned_cols=78 Identities=19% Similarity=0.382 Sum_probs=57.2
Q ss_pred eeeecccCcEeEEEEEecCC---cEEEEEEcccCC-CccHHHHHHHHHHHHhCC-CCCc--ceeEEEEEeC---CeEEEE
Q 005519 530 QSKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNL--VRLLGCCIEQ---GEKILI 599 (692)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nI--v~l~g~~~~~---~~~~LV 599 (692)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+.++..+. |+++ .+++++|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47889999999999876553 356777654322 223457889999999995 6665 7888888764 357899
Q ss_pred EEccCCCC
Q 005519 600 YEYMVNKS 607 (692)
Q Consensus 600 ~Ey~~~gs 607 (692)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00028 Score=69.14 Aligned_cols=125 Identities=24% Similarity=0.401 Sum_probs=91.1
Q ss_pred CCcceeeeecccCc-EeEEEEEecCCcEEEEEEccc---C---------CC---------ccHHHHHHHHHHHHhCC---
Q 005519 525 ENFSIQSKLGEGGF-GPVYKGRLLNGQEVAVKRLSN---Q---------SG---------QGLKEFKNEMMLIAKLQ--- 579 (692)
Q Consensus 525 ~~f~~~~~LG~G~f-G~Vykg~~~~g~~VAVK~l~~---~---------~~---------~~~~~f~~Ei~~l~~l~--- 579 (692)
.+++..+.||.|.- |.|||+++ +|+.+|+|.... . .. .....|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 99999998 578999998321 0 00 11345889999999885
Q ss_pred CCCc--ceeEEEEEeC------------------CeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 005519 580 HRNL--VRLLGCCIEQ------------------GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639 (692)
Q Consensus 580 H~nI--v~l~g~~~~~------------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~y 639 (692)
+.++ |+.+|+..-. ....+|.||++... .+. .+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 3456 8999987422 12367777765432 111 2234567888889
Q ss_pred HHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCc
Q 005519 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (692)
Q Consensus 640 LH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlA 674 (692)
+|..+ |+-+|+|++|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999986 4689999864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0004 Score=69.67 Aligned_cols=152 Identities=20% Similarity=0.236 Sum_probs=95.9
Q ss_pred hhhHhhhcCCcceeeeec---ccCcEeEEEEEecCCcEEEEEEcccCCC---------ccHHH---------------HH
Q 005519 517 FASVTAATENFSIQSKLG---EGGFGPVYKGRLLNGQEVAVKRLSNQSG---------QGLKE---------------FK 569 (692)
Q Consensus 517 ~~~l~~~~~~f~~~~~LG---~G~fG~Vykg~~~~g~~VAVK~l~~~~~---------~~~~~---------------f~ 569 (692)
...+....++..+.+..| .|.-..||+|.-.++..+|||+...... ++..+ ..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 344444455555555555 5666689999887889999998854211 11111 23
Q ss_pred HHHHHHHhCC--CCCcceeEEEEEeCCeEEEEEEccCCCCH-hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 005519 570 NEMMLIAKLQ--HRNLVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646 (692)
Q Consensus 570 ~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL-~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 646 (692)
.|..-|.++. +-.+.+-+++ .+-.|||||+..... .-.| +.-.+.......+..++++.+.-|-...
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 3555555552 3444444444 245799999965521 1112 1122223355667778888888777632
Q ss_pred ceEecCCCCCcEEEcCCCceEEEeeCCceecCC
Q 005519 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 647 ~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~~~ 679 (692)
.+||+||..=|||+. ++.+.|+|||=|.....
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 399999999999999 78999999999876653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0015 Score=68.99 Aligned_cols=79 Identities=13% Similarity=0.111 Sum_probs=57.6
Q ss_pred cceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCC---CCcceeEEEEEeC---CeEEEEE
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGCCIEQ---GEKILIY 600 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~---~~~~LV~ 600 (692)
..-.+.||.|..+.||+....++ .+.+|..+. ......|..|...++.+.. ..+.++++.|... +..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34457899999999999876555 456666432 1133678899999988853 4678888887643 5689999
Q ss_pred EccCCCCH
Q 005519 601 EYMVNKSL 608 (692)
Q Consensus 601 Ey~~~gsL 608 (692)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00079 Score=66.40 Aligned_cols=128 Identities=17% Similarity=0.223 Sum_probs=88.0
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCC----------------CccHHHHHHHHHHHHhCC------CCCcceeEE
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------GQGLKEFKNEMMLIAKLQ------HRNLVRLLG 588 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----------------~~~~~~f~~Ei~~l~~l~------H~nIv~l~g 588 (692)
..||+|+.=.||. +++.....||...... ....++..+|+.-...+. +..|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 5799999988885 4555667888776543 123567777877666655 789999999
Q ss_pred EEEeCCeEEEEEEccCC--C----CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcC
Q 005519 589 CCIEQGEKILIYEYMVN--K----SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662 (692)
Q Consensus 589 ~~~~~~~~~LV~Ey~~~--g----sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~ 662 (692)
+.......-+|+|.+.+ | +|.+++. ...++. . +...+-+-..||-+.. |+.+|++|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEEe
Confidence 99998888999998743 2 4666662 233443 2 2233334455666655 999999999999954
Q ss_pred C--C--ceEEEee
Q 005519 663 H--M--NPKISDF 671 (692)
Q Consensus 663 ~--~--~~kI~DF 671 (692)
. + .+.|+|-
T Consensus 154 ~~~~~~~lvlIDG 166 (199)
T PF10707_consen 154 RDSGEFRLVLIDG 166 (199)
T ss_pred cCCCceEEEEEeC
Confidence 2 2 4677773
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00066 Score=69.02 Aligned_cols=140 Identities=16% Similarity=0.190 Sum_probs=76.7
Q ss_pred eeecccCcE-eEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCC---CcceeEEEEEeCC---eEEEEEEcc
Q 005519 531 SKLGEGGFG-PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCIEQG---EKILIYEYM 603 (692)
Q Consensus 531 ~~LG~G~fG-~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~~---~~~LV~Ey~ 603 (692)
+.|+.|+.. .||+. +..+.+|.... ......+..|..++..+... -+.+.++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467766665 58875 23466776443 22345788999999887532 3444454433322 348899999
Q ss_pred CCCCHhHH------------------hcCCCCCC-C------------C-CHHHHH--HHH-------HHHHHH-HH-HH
Q 005519 604 VNKSLDVF------------------LFDPTKKH-L------------L-GWQLRV--RII-------DGIAQG-LL-YL 640 (692)
Q Consensus 604 ~~gsL~~~------------------L~~~~~~~-~------------l-~~~~~~--~i~-------~~ia~a-L~-yL 640 (692)
++.++... |+...... . + .|.... .+. .+.+.. +. ++
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 98776321 11110000 0 0 111110 000 011111 11 11
Q ss_pred Hh--cCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 641 HQ--YSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 641 H~--~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
+. .....++|+|+.|.|||++.+....|+||+.|..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1234589999999999999876678999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0032 Score=68.76 Aligned_cols=75 Identities=13% Similarity=0.189 Sum_probs=54.7
Q ss_pred eeecccCcEeEEEEEecCC-cEEEEEEcccC-----C--CccHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCeEEEE
Q 005519 531 SKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ-----S--GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~-----~--~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~LV 599 (692)
+.||.|.+..||+....+| +.|.||.-... . +...+++..|.+.|..+. -..+.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6799999999999998776 58999974311 1 234567788888887762 2457777766 44567899
Q ss_pred EEccCCCC
Q 005519 600 YEYMVNKS 607 (692)
Q Consensus 600 ~Ey~~~gs 607 (692)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0022 Score=65.00 Aligned_cols=141 Identities=18% Similarity=0.243 Sum_probs=81.3
Q ss_pred eeecccCcEeEEEEEecC--CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCeEEEEEEccCCCC
Q 005519 531 SKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCIEQGEKILIYEYMVNKS 607 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~LV~Ey~~~gs 607 (692)
+.|..|-...+|+....+ ++.+++|....... ......+|+.++..+...+ ..++++... ..++|||+++..
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567778888999988654 56788887654322 1223347888888885433 344444332 248999999876
Q ss_pred HhHH-----------------hcCCCCC--------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 005519 608 LDVF-----------------LFDPTKK--------HLL-GWQLRVRIID----------------------GIAQGLLY 639 (692)
Q Consensus 608 L~~~-----------------L~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~aL~y 639 (692)
+... ++..... ... .+.....+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 1111111 011 1222111111 11111112
Q ss_pred H----Hhc-CCCceEecCCCCCcEEEcC-CCceEEEeeCCcee
Q 005519 640 L----HQY-SRLRIIHRDLKASNILLDQ-HMNPKISDFGMARM 676 (692)
Q Consensus 640 L----H~~-~~~~ivHrDlKp~NILl~~-~~~~kI~DFGlAk~ 676 (692)
| ... ....++|+|+.|.|||++. +..+.|+||-.|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 111 2346999999999999998 57899999988764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0016 Score=61.99 Aligned_cols=131 Identities=19% Similarity=0.233 Sum_probs=87.4
Q ss_pred ceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcce-eEEEEEeCCeEEEEEEccCCC
Q 005519 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR-LLGCCIEQGEKILIYEYMVNK 606 (692)
Q Consensus 528 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~~LV~Ey~~~g 606 (692)
...+.|++|.+|.||+|.+. +.++|+|.-.. +.....+..|++++..++-.++.. ++.+. +-.+.|||+.+-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34478999999999999984 45888887654 334577889999999998766643 44332 224559999988
Q ss_pred CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCC-CCcEEEcCCCceEEEeeCCceecC
Q 005519 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK-ASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlK-p~NILl~~~~~~kI~DFGlAk~~~ 678 (692)
.|.+.-.. .+-++.. .++.+---|-..+ |-|..|. |..++|..+..+.|+||--|++-.
T Consensus 98 ~L~~~~~~------~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 98 PLGKLEIG------GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred chhhhhhc------ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 88765311 1222222 3444433333334 7777765 666666666699999999998543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0018 Score=66.73 Aligned_cols=139 Identities=14% Similarity=0.075 Sum_probs=78.7
Q ss_pred eecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCeEEEEEEccCCCCHhH
Q 005519 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYEYMVNKSLDV 610 (692)
Q Consensus 532 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~LV~Ey~~~gsL~~ 610 (692)
.+..|-...+|+... +++.+++|........--....+|..++..+....+ .++++.+. ..+|+||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 345577778998874 566788887643322211235778888888864433 34444432 368999999876532
Q ss_pred H-----------------hcCCC-CCCCCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCceEecCCCCCc
Q 005519 611 F-----------------LFDPT-KKHLLGWQLR-VRIIDG---------IAQGLLYLHQY-----SRLRIIHRDLKASN 657 (692)
Q Consensus 611 ~-----------------L~~~~-~~~~l~~~~~-~~i~~~---------ia~aL~yLH~~-----~~~~ivHrDlKp~N 657 (692)
. ||... ....++...+ .....+ +.+.+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 12211 1111222211 111111 11112222111 13458999999999
Q ss_pred EEEcCCCceEEEeeCCcee
Q 005519 658 ILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 658 ILl~~~~~~kI~DFGlAk~ 676 (692)
|++++++ ++|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998863
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0011 Score=54.25 Aligned_cols=51 Identities=12% Similarity=0.304 Sum_probs=35.9
Q ss_pred EeecccCCCccceeeecccChhHHHHhhhcCCceEeeeeccccCCCcceEeeccc
Q 005519 355 KLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGD 409 (692)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~~~~~~~~gC~~w~~~ 409 (692)
.+.++.++..+.... ...+.++|++.|+.||+|.||.|.. +...|+++...
T Consensus 8 ~~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 8 QGSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred ccCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 335666665444322 3568999999999999999999974 23359986554
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.013 Score=61.57 Aligned_cols=142 Identities=18% Similarity=0.152 Sum_probs=85.6
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCC--CcceeEEE------EEeCCeEEEEEE
Q 005519 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGC------CIEQGEKILIYE 601 (692)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~------~~~~~~~~LV~E 601 (692)
.+.|..|....+|+....+ ..+++|.... ....+...|+.++..+.+. .+.+.+.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 3567777778999987644 4688887754 2345566788888877533 24444432 123446789999
Q ss_pred ccCCCCHhH----H----------hcCC----C----CCCCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 005519 602 YMVNKSLDV----F----------LFDP----T----KKHLLGWQLRV----------RIIDGIAQGLLYLHQ----YSR 645 (692)
Q Consensus 602 y~~~gsL~~----~----------L~~~----~----~~~~l~~~~~~----------~i~~~ia~aL~yLH~----~~~ 645 (692)
|+++..+.. . ||.. . ......|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 0 1110 0 01112232211 011223344555553 122
Q ss_pred CceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 646 LRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 646 ~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
..++|+|+.|.|||++++..+.|+||+.|.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 358999999999999998778999998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.02 Score=61.71 Aligned_cols=142 Identities=18% Similarity=0.229 Sum_probs=82.4
Q ss_pred eeecccCcEeEEEEEecC-----CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCcc-eeEEEEEeCCeEEEEEEccC
Q 005519 531 SKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCIEQGEKILIYEYMV 604 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~LV~Ey~~ 604 (692)
+.|-.|-.-.+|+....+ ++.|.+|..........+ -.+|..++..+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 455557777899886532 357888877654333333 36788888888654443 555655332 5899998
Q ss_pred CCCHhHH-----------------hcCCC-C--CCCCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 005519 605 NKSLDVF-----------------LFDPT-K--KHLLGWQLRVRIIDG-----------------IAQGLLYL----HQ- 642 (692)
Q Consensus 605 ~gsL~~~-----------------L~~~~-~--~~~l~~~~~~~i~~~-----------------ia~aL~yL----H~- 642 (692)
+.++... +|... . .....|.+..++..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 11111 0 111122322222211 11122222 21
Q ss_pred cCCCceEecCCCCCcEEEcC-CCceEEEeeCCceec
Q 005519 643 YSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMF 677 (692)
Q Consensus 643 ~~~~~ivHrDlKp~NILl~~-~~~~kI~DFGlAk~~ 677 (692)
.....++|+|+++.|||+++ +..++|+||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22346899999999999986 467999999988743
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.033 Score=59.29 Aligned_cols=141 Identities=17% Similarity=0.190 Sum_probs=76.4
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCC--CcceeEE------EEEeCCeEEEEEEc
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLG------CCIEQGEKILIYEY 602 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g------~~~~~~~~~LV~Ey 602 (692)
+.|+.|....+|+....+| .+++|+... ...+....|+.++..+... .+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777788999876555 678887752 1223344455555555322 2333332 11234567899999
Q ss_pred cCCCCHhH-----------H---hcCCC--------CCCCCCH-HHHHH------------HHHH-HHHHHHHHHhc---
Q 005519 603 MVNKSLDV-----------F---LFDPT--------KKHLLGW-QLRVR------------IIDG-IAQGLLYLHQY--- 643 (692)
Q Consensus 603 ~~~gsL~~-----------~---L~~~~--------~~~~l~~-~~~~~------------i~~~-ia~aL~yLH~~--- 643 (692)
+++..+.. . +|... ....+.| ..... ...+ +...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 98875411 1 11110 0111212 11111 1111 11122233211
Q ss_pred -CCCceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 644 -SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 644 -~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
-+..++|+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999977656899999885
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.038 Score=58.31 Aligned_cols=142 Identities=27% Similarity=0.327 Sum_probs=83.8
Q ss_pred eeecccCcEeEEEEEecC-------CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCeEEEEEEc
Q 005519 531 SKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~LV~Ey 602 (692)
+.|..|-...+|+....+ ++.+++|...... ....+..+|..++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456666677899887654 4788888865432 233455778888888753333 355555532 368999
Q ss_pred cCCCCHhHH-----------------hcCCCCCC------CC--CHHHHHH--------------------------HHH
Q 005519 603 MVNKSLDVF-----------------LFDPTKKH------LL--GWQLRVR--------------------------IID 631 (692)
Q Consensus 603 ~~~gsL~~~-----------------L~~~~~~~------~l--~~~~~~~--------------------------i~~ 631 (692)
+++..+... ||...... .. -|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 11111100 11 0111111 111
Q ss_pred HHHHHHHHHHh------cCCCceEecCCCCCcEEEcCC----CceEEEeeCCceec
Q 005519 632 GIAQGLLYLHQ------YSRLRIIHRDLKASNILLDQH----MNPKISDFGMARMF 677 (692)
Q Consensus 632 ~ia~aL~yLH~------~~~~~ivHrDlKp~NILl~~~----~~~kI~DFGlAk~~ 677 (692)
.+.+.+.+|.. .....++|+|+.|.|||++++ +.++++||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22223334432 234678999999999999984 78999999998743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.056 Score=57.26 Aligned_cols=142 Identities=19% Similarity=0.217 Sum_probs=81.3
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCC--CcceeEEEE------EeCCeEEEEEEc
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGCC------IEQGEKILIYEY 602 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~------~~~~~~~LV~Ey 602 (692)
+.++.|--..+|+....++ .+.+|..... ...++...|+.++..+.+. .+.+.+... ...+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 4567777788998876445 5667866432 1234555677777776432 234444321 123567899999
Q ss_pred cCCCCHhH-----------H---hcCCCC------C---CCCCHHHHHH------------HHHHHHHHHHHHHh----c
Q 005519 603 MVNKSLDV-----------F---LFDPTK------K---HLLGWQLRVR------------IIDGIAQGLLYLHQ----Y 643 (692)
Q Consensus 603 ~~~gsL~~-----------~---L~~~~~------~---~~l~~~~~~~------------i~~~ia~aL~yLH~----~ 643 (692)
+++..+.. . ++.... . ....|..... ....+.+.++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 98855320 0 111000 0 0112221110 11123345555543 2
Q ss_pred CCCceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 644 ~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 23469999999999999998777899999984
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.00048 Score=80.66 Aligned_cols=149 Identities=17% Similarity=0.179 Sum_probs=103.2
Q ss_pred hcCCcceeeeecccCcEeEEEEEecC-CcEEEEEEccc---CCCccHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEE
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 523 ~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 598 (692)
..+.+.+.+-+-+|.++.++.+.-.. |...++|.... ...+..+..+.+-.++...+||-+++...-+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 44567777788889999998775432 33333333321 112223333444444444566777766665667788999
Q ss_pred EEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCceec
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 599 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~~ 677 (692)
+++|+.+++|..-|+... .++..-....+..+.++++|||... ++|||+||.|+|...++..+++|||+.+..
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999988885432 2333334445666889999999865 899999999999999999999999966544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.03 Score=58.46 Aligned_cols=32 Identities=25% Similarity=0.446 Sum_probs=26.5
Q ss_pred CceEecCCCCCcEEEcCCCc-eEEEeeCCceec
Q 005519 646 LRIIHRDLKASNILLDQHMN-PKISDFGMARMF 677 (692)
Q Consensus 646 ~~ivHrDlKp~NILl~~~~~-~kI~DFGlAk~~ 677 (692)
..++|+|++|.|||+++++. .-|+||+.|..=
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997554 579999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.051 Score=56.93 Aligned_cols=76 Identities=16% Similarity=0.209 Sum_probs=48.5
Q ss_pred cceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCeEEEEEEcc
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 527 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~LV~Ey~ 603 (692)
.+..+.|+-|....+|+.. .+++.+.||.-. ......|..|..-|+.|. -..+.+.+++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4445778889999999887 567889999775 233467888888777773 445778888888777789999999
Q ss_pred CCC
Q 005519 604 VNK 606 (692)
Q Consensus 604 ~~g 606 (692)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.0013 Score=73.45 Aligned_cols=147 Identities=17% Similarity=0.102 Sum_probs=101.3
Q ss_pred hHhhhcCCcceeeeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCeEE
Q 005519 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCIEQGEKI 597 (692)
Q Consensus 519 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~ 597 (692)
.++..+..+...+.++++++++++|.+....+...++.+... ....-++++|.+++||| .++.++-+......+
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~ 310 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW 310 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence 344555566666788999999999997644444556655432 44567889999999999 777777777777889
Q ss_pred EEEEccCCC-CHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 598 LIYEYMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 598 LV~Ey~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
++++|+..+ +-..-. ......+...+...+.+.-.++|+|||+.. =+||| ||+..+ ...|..||+.+..
T Consensus 311 i~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred hhhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcc
Confidence 999999877 211101 011112233333445566678999999853 48998 777776 5799999999988
Q ss_pred cCCC
Q 005519 677 FGGD 680 (692)
Q Consensus 677 ~~~~ 680 (692)
+.+.
T Consensus 381 L~~~ 384 (829)
T KOG0576|consen 381 LTRT 384 (829)
T ss_pred cCcc
Confidence 7665
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.013 Score=61.14 Aligned_cols=131 Identities=15% Similarity=0.152 Sum_probs=87.2
Q ss_pred CcceeeeecccCcEeEEEEEecCCcEEEEEEcccC----------C------Cc------cHHHHHHHHHHHHhCCC--C
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----------S------GQ------GLKEFKNEMMLIAKLQH--R 581 (692)
Q Consensus 526 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----------~------~~------~~~~f~~Ei~~l~~l~H--~ 581 (692)
-+++.++||-|.-+-||.+...+|++.++|.=... . .+ ..-....|...|..+.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 36778999999999999999988999888832110 0 00 01124557777777743 2
Q ss_pred CcceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEc
Q 005519 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661 (692)
Q Consensus 582 nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~ 661 (692)
-+.+.+++ ...++|||++.+-.|... ....+..+... .+..-+--|-.+| +||+|..-=||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v------~~v~d~~~ly~---~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQV------RHVEDPPTLYD---DLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeee------eecCChHHHHH---HHHHHHHHHHHcC---ceecccchheeEEe
Confidence 34444444 456899999888765432 12233333333 3333344455666 99999999999999
Q ss_pred CCCceEEEeeC
Q 005519 662 QHMNPKISDFG 672 (692)
Q Consensus 662 ~~~~~kI~DFG 672 (692)
++..++++||-
T Consensus 237 dd~~i~vIDFP 247 (465)
T KOG2268|consen 237 DDDKIVVIDFP 247 (465)
T ss_pred cCCCEEEeech
Confidence 99999999994
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.15 Score=53.97 Aligned_cols=145 Identities=17% Similarity=0.246 Sum_probs=79.9
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcc-cCCCccHHHHHHHHHHHHhCCC--CCcceeEEEEEeCC--eEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQG--EKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~-~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~--~~~LV~Ey~~~ 605 (692)
+.+-.|---.+|..... +++.++.+-. ...........+|..+|+.+.- .-+.+.++.|.++. ..+.||+|+++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 34433333334444332 5666666221 1122344556778888887743 33455667777665 66999999988
Q ss_pred CCHhHH------------------h---cCC--------------CCCCCCCHHHHHHHH--------HHHHHHHHHHHh
Q 005519 606 KSLDVF------------------L---FDP--------------TKKHLLGWQLRVRII--------DGIAQGLLYLHQ 642 (692)
Q Consensus 606 gsL~~~------------------L---~~~--------------~~~~~l~~~~~~~i~--------~~ia~aL~yLH~ 642 (692)
..+... | |.- ...+.-.|....+.+ -...+-..||++
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 432111 1 100 000111122111100 012223445543
Q ss_pred c-----CCCceEecCCCCCcEEEcCCCceEEEeeCCcee
Q 005519 643 Y-----SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 643 ~-----~~~~ivHrDlKp~NILl~~~~~~kI~DFGlAk~ 676 (692)
+ ++..++|+|+.+.|++++.+.-+-|.||+++..
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 2 335799999999999999988899999999874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.15 Score=54.88 Aligned_cols=73 Identities=14% Similarity=0.170 Sum_probs=48.0
Q ss_pred eecccCcEeEEEEEecCC-cEEEEEEccc-------CCCccHHHHHHHHHHHHhCC--CC-CcceeEEEEEeCCeEEEEE
Q 005519 532 KLGEGGFGPVYKGRLLNG-QEVAVKRLSN-------QSGQGLKEFKNEMMLIAKLQ--HR-NLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 532 ~LG~G~fG~Vykg~~~~g-~~VAVK~l~~-------~~~~~~~~f~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~LV~ 600 (692)
.||.|....||++..+++ +.|+||.-.. .-+-..++...|...|.... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 5899995431 11334556667777776552 24 34455443 455667999
Q ss_pred EccCCC
Q 005519 601 EYMVNK 606 (692)
Q Consensus 601 Ey~~~g 606 (692)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.18 Score=54.05 Aligned_cols=141 Identities=16% Similarity=0.240 Sum_probs=79.6
Q ss_pred eeecccCcEeEEEEEecC----CcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCeEEEEEEccCC
Q 005519 531 SKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~LV~Ey~~~ 605 (692)
+.|..|=...+|+....+ +..|.+|........ .-.-.+|..++..+...++ .++++++..+ +|.||+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 445446667788886533 237888877554332 2233678888888866555 3566665322 58999977
Q ss_pred CCHhHH-----------------hcCCC-C-CC-CCCHHHHHHHHHH----------------------HHHHHHHHH--
Q 005519 606 KSLDVF-----------------LFDPT-K-KH-LLGWQLRVRIIDG----------------------IAQGLLYLH-- 641 (692)
Q Consensus 606 gsL~~~-----------------L~~~~-~-~~-~l~~~~~~~i~~~----------------------ia~aL~yLH-- 641 (692)
..|..- ||... . .. ...|....++..+ +.+-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665221 12211 0 11 1123332222211 111122221
Q ss_pred --h-cCCCceEecCCCCCcEEEcC-CCceEEEeeCCcee
Q 005519 642 --Q-YSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARM 676 (692)
Q Consensus 642 --~-~~~~~ivHrDlKp~NILl~~-~~~~kI~DFGlAk~ 676 (692)
. .....+.|.|+-+.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 12235799999999999975 57899999998864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.25 Score=54.03 Aligned_cols=73 Identities=11% Similarity=0.064 Sum_probs=49.3
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEcccC---CC----ccHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCeEEEE
Q 005519 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ---SG----QGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~---~~----~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~LV 599 (692)
.+.||.|....||+.... ++.++||.-... .. ....+-..|...|..+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 478999999999998764 456889966421 11 13344444566665543 357888888876 456889
Q ss_pred EEccCC
Q 005519 600 YEYMVN 605 (692)
Q Consensus 600 ~Ey~~~ 605 (692)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.75 E-value=0.55 Score=49.55 Aligned_cols=29 Identities=28% Similarity=0.361 Sum_probs=25.3
Q ss_pred CceEecCCCCCcEEEcCCCceEEEeeCCce
Q 005519 646 LRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 646 ~~ivHrDlKp~NILl~~~~~~kI~DFGlAk 675 (692)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46899999999999988 578999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.21 Score=53.24 Aligned_cols=140 Identities=18% Similarity=0.163 Sum_probs=92.7
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCC---------CccHH-----------------HHHHHHHHHHhCCCCCcc
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS---------GQGLK-----------------EFKNEMMLIAKLQHRNLV 584 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~---------~~~~~-----------------~f~~Ei~~l~~l~H~nIv 584 (692)
-.|..|--.-||.++-.+|..+|||+.+... ..+.- -...|++-|.+++.-.|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4567788888999998899999999775310 00111 123467777777654432
Q ss_pred eeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCC
Q 005519 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (692)
Q Consensus 585 ~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~ 664 (692)
----.. -....|||+|+.... +-....+.-.+....+..+-.++++-|.-|...+ ++||.||.--|+|+-++
T Consensus 230 ~PePIl--Lk~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~LyhdG- 301 (520)
T KOG2270|consen 230 CPEPIL--LKNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHDG- 301 (520)
T ss_pred CCCcee--eecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEECC-
Confidence 111111 124479999985332 2211223344666677888889999999998887 59999999999998765
Q ss_pred ceEEEeeCCceecC
Q 005519 665 NPKISDFGMARMFG 678 (692)
Q Consensus 665 ~~kI~DFGlAk~~~ 678 (692)
.+.|+|-+=+....
T Consensus 302 ~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEEccccccCC
Confidence 79999987765443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.35 Score=51.66 Aligned_cols=136 Identities=22% Similarity=0.276 Sum_probs=79.6
Q ss_pred CcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhCCCCC------cceeEEEEE--eC--CeEEEEEEccCCC
Q 005519 537 GFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCI--EQ--GEKILIYEYMVNK 606 (692)
Q Consensus 537 ~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~--~~--~~~~LV~Ey~~~g 606 (692)
.-..+|+....+|+. ++|..... ....+...|+..+..+.-.. |.++-|-.. -. ...+-++||++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 345688888777766 77777653 34566666777777663211 233322221 12 3778899999998
Q ss_pred CHhH-H--------------hc----CC-----CCCCCCCHHH---H----------HHHHHHHHHHHHHHHhc----CC
Q 005519 607 SLDV-F--------------LF----DP-----TKKHLLGWQL---R----------VRIIDGIAQGLLYLHQY----SR 645 (692)
Q Consensus 607 sL~~-~--------------L~----~~-----~~~~~l~~~~---~----------~~i~~~ia~aL~yLH~~----~~ 645 (692)
.+.. . |+ +. .......|.. . .....++...+..+.+. -.
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8762 1 01 11 1111234431 0 11223344445555431 11
Q ss_pred ---CceEecCCCCCcEEEcCCCc-eEEEeeCCce
Q 005519 646 ---LRIIHRDLKASNILLDQHMN-PKISDFGMAR 675 (692)
Q Consensus 646 ---~~ivHrDlKp~NILl~~~~~-~kI~DFGlAk 675 (692)
..+||+|+.|.||+++.+.. +.++||+-|.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22999999999999999885 8999999775
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.31 E-value=0.17 Score=50.14 Aligned_cols=101 Identities=17% Similarity=0.156 Sum_probs=67.0
Q ss_pred EEEEEcccCCCc-cHHHHHHHHHHHHhCCCCCcceeEEEEEeCCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHH
Q 005519 552 VAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRII 630 (692)
Q Consensus 552 VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~ 630 (692)
..+|++....-. ....|.++.+++++++ .|++|..- .+-..-++.|+|-.-. ... ..++
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------------i~~----~N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------------INF----SNFI 147 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------------cch----hHHH
Confidence 455666543333 5677899999999885 56666622 3335568888872211 111 1122
Q ss_pred HHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeCC
Q 005519 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 631 ~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFGl 673 (692)
.-=+++|.-.|+.. ...+|+|-.|+||+-|+.|.+||.|=+-
T Consensus 148 ~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 22246788889543 4699999999999999999999999754
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.48 Score=47.44 Aligned_cols=75 Identities=17% Similarity=0.244 Sum_probs=51.9
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEcccCCCccHHHHHHHHHHHHhC---CCCCcceeEEEEEeCCeEEEEEEccCCCC
Q 005519 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL---QHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (692)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 607 (692)
+++.-|.--..|.... +..++.||+-. ......|..|+.-|..+ +...+.+.+..-.+..+.+||+||++-|.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 4454444444454433 45678888653 33456788887655444 55678888988889999999999999877
Q ss_pred Hh
Q 005519 608 LD 609 (692)
Q Consensus 608 L~ 609 (692)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 75
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.13 Score=54.64 Aligned_cols=75 Identities=19% Similarity=0.137 Sum_probs=56.5
Q ss_pred CCeEEEEEEccCCCCHhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 005519 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 593 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kI~DFG 672 (692)
....|++|++. ++.+. ....-.|++.+.|+.+.+.-++-+... .+.-|||+.-.||||+ +|++-|+||-
T Consensus 298 ~~y~yl~~kdh-gt~is-------~ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 298 TLYLYLHFKDH-GTPIS-------IIKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred ceEEEEEEecC-Cceee-------eeecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEee
Confidence 34557777775 44432 233457888899988877777766653 4789999999999999 9999999999
Q ss_pred CceecC
Q 005519 673 MARMFG 678 (692)
Q Consensus 673 lAk~~~ 678 (692)
++|.-.
T Consensus 367 lsRl~~ 372 (488)
T COG5072 367 LSRLSY 372 (488)
T ss_pred eeeccc
Confidence 999443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 692 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 285 bits (733), Expect = 2e-91
Identities = 77/197 (39%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 506 KSKDSSLPLFSFASVTAATENFS------IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSN 559
+ D+ FSF + T NF +K+GEGGFG VYKG + N VAVK+L+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 560 ----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP 615
+ + ++F E+ ++AK QH NLV LLG + + L+Y YM N SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 616 TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L W +R +I G A G+ +LH+ IHRD+K++NILLD+ KISDFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 676 MFGGDELQGNTKRIVGT 692
T RIVGT
Sbjct: 182 ASEKFAQTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 1e-84
Identities = 77/180 (42%), Positives = 110/180 (61%), Gaps = 3/180 (1%)
Query: 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFKNEMM 573
FS + A++NFS ++ LG GGFG VYKGRL +G VAVKRL + QG + +F+ E+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-LGWQLRVRIIDG 632
+I+ HRNL+RL G C+ E++L+Y YM N S+ L + + L W R RI G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
A+GL YLH + +IIHRD+KA+NILLD+ + DFG+A++ + T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 5e-79
Identities = 70/179 (39%), Positives = 108/179 (60%), Gaps = 4/179 (2%)
Query: 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 574
+ AT NF + +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-LGWQLRVRIIDGI 633
++ +H +LV L+G C E+ E ILIY+YM N +L L+ + + W+ R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
A+GL YLH + IIHRD+K+ NILLD++ PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 4e-63
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 503 GKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG 562
G SS ++ + + G FG V+K +L + VAVK Q
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK 60
Query: 563 QGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILIYEYMVNKSLDVFLFDPTKK 618
Q + + E+ + ++H N+++ +G + LI + SL FL K
Sbjct: 61 QS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KA 115
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQ-------YSRLRIIHRDLKASNILLDQHMNPKISDF 671
+++ W I + +A+GL YLH+ + I HRD+K+ N+LL ++ I+DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 672 GMARMFGGDELQGNTKRIVGT 692
G+A F + G+T VGT
Sbjct: 176 GLALKFEAGKSAGDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-55
Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 23/195 (11%)
Query: 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 574
+ + + +N + +G G +G VYKG L + + VAVK S + Q K +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 575 IAKLQHRNLVRLLGCCIE-----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI 629
+ ++H N+ R + + E +L+ EY N SL +L H W R+
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116
Query: 630 IDGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG---- 679
+ +GL YLH + + I HRDL + N+L+ ISDFG++ G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 680 --DELQGNTKRIVGT 692
E VGT
Sbjct: 177 RPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 51/170 (30%), Positives = 90/170 (52%), Gaps = 6/170 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
+ +I+ K+G G FG V++ +G +VAVK L Q + + EF E+ ++ +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V +G + ++ EY+ SL L + L + R+ + +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I+HR+LK+ N+L+D+ K+ DFG++R+ L +K GT
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGT 202
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-45
Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 11/169 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ ++ +G G FG V K + ++VA+K++ ++S K F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C+ L+ EY SL L + +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 645 RLRIIHRDLKASNILLDQHMN-PKISDFGMARMFGGDELQGNTKRIVGT 692
+IHRDLK N+LL KI DFG A ++Q + G+
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGS 166
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 6/165 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ LG+G FG K G+ + +K L + + F E+ ++ L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
++ +G + I EY+ +L + + W RV IA G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS- 126
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
+ IIHRDL + N L+ ++ N ++DFG+AR+ ++ Q R
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 49/181 (27%), Positives = 91/181 (50%), Gaps = 23/181 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG-------LKEFKNEMMLIA 576
+ ++G+GGFG V+KGRL+ + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
L H N+V+L G ++ E++ L L D K H + W +++R++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQ-----HMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ Y+ I+HRDL++ NI L + K++DFG+++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 692 T 692
Sbjct: 189 N 189
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 7/157 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
+ + +KL E G ++KGR G ++ VK L + S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 583 LVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
++ +LG C I +M SL L + T ++ V+ +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFL 127
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
H L I L + ++++D+ M +IS + F
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 17/174 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRL----SNQSGQGLKEFKNEMMLIAKLQH 580
+++ +G GGFG VY+ G EVAVK Q ++ + E L A L+H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N++ L G C+++ L+ E+ L+ L + + V IA+G+ YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYL 121
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNP--------KISDFGMARMFGGDELQGNT 686
H + + IIHRDLK+SNIL+ Q + KI+DFG+AR +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-42
Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 10/170 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
++ ++G G FG VYKG+ +G +VAVK L+ + Q L+ FKNE+ ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++ +G I + ++ SL L K + + I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA 138
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
IIHRDLK++NI L + KI DFG+A +++ G+
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHR 581
+ ++ +G+G +G V++G G+ VAVK S++ K + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 582 NLVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
N++ + + LI Y SL +L + L +RI+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 638 LYLH-----QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIV 690
+LH + I HRDLK+ NIL+ ++ I+D G+A M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 691 GT 692
GT
Sbjct: 179 GT 180
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 10/166 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
E I +G+G FG VY GR +G EVA++ + + + LK FK E+M + +H N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V +G C+ +I ++L + D L +I I +G+ YLH
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHA 148
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
I+H+DLK+ N+ D + I+DFG+ + G + +
Sbjct: 149 ---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 21/181 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRN 582
+ + ++G+G +G V+ G+ G++VAVK + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 583 LVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
++ + I+ LI +Y N SL +L K L + +++ GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 639 YLH-----QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVG 691
+LH + I HRDLK+ NIL+ ++ I+D G+A F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 692 T 692
T
Sbjct: 209 T 209
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 15/165 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
LGEG FG V G+ VAVK L ++ Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 579 QHRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
H ++++ GCC + G L+ EY+ SL +L +H +G + I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ YLH IHRDL A N+LLD KI DFG+A+
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 585 RLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ + I EYM SL +L + L G L ++ + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-LKFSLDVCEAMEYL--- 133
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+HRDL A N+L+ + K+SDFG+ +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRNLVRL 586
+Q +G+G FG V++G+ G+EVAVK S++ + + E + L+H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 101
Query: 587 LGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ + L+ +Y + SL +L ++ + + +++ A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 643 -----YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGT 692
+ I HRDLK+ NIL+ ++ I+D G+A D + VGT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 12/164 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 580 HRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
H N+V+ G C G + LI EY+ SL +L K + ++ I +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
YL R IHRDL NIL++ KI DFG+ ++ D+
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 12/164 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 580 HRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
H N+V+ G C G + LI EY+ SL +L K + ++ I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
YL R IHRDL NIL++ KI DFG+ ++ D+
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
LGEG FG V R G++VAVK L G + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 579 QHRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
H N+V+ G C E G LI E++ + SL +L P K+ + + +++ I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ YL + +HRDL A N+L++ KI DFG+ + D+
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-36
Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 8/152 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 585 RLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ + ++ EYM SL +L + L G L ++ + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-LKFSLDVCEAMEYL--- 305
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+HRDL A N+L+ + K+SDFG+ +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 12/164 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
+ S+LG+G FG V R G VAVK+L + ++F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 580 HRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+V+ G G + L+ EY+ + L FL + L + I +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
YL R +HRDL A NIL++ + KI+DFG+A++ D+
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C+EQ L+ E+M + L +L + L + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETL-LGMCLDVCEGMAYL---E 121
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+IHRDL A N L+ ++ K+SDFGM R D+
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 7/159 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
E+ + ++G G FG V+ GRL + VAVK +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+VRL+G C ++ ++ E + FL T+ L + ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
IHRDL A N L+ + KISDFGM+R
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-35
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG G FG V+ +VAVK + ++ F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L ++ I I E+M SL FL +L + IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFI---E 301
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ IHRDL+A+NIL+ + KI+DFG+AR+ +E
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 48/158 (30%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ +++ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG C + +I E+M +L +L + ++ + L + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMATQISSAMEYL--- 127
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ IHRDL A N L+ ++ K++DFG++R+ GD
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 57/157 (36%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL ++ I I EYM N SL FL P+ L +L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIAEGMAFI---E 126
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 20/167 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP----TKKHLLGWQLRVRIIDGIA 634
+ ++ RLLG C+ ++ I + M L ++ + ++LL W + IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ G +E
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 21/169 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKEFKNEMMLIAKL 578
+ ++ +LGEG FG V+ N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------FDPTKKHLLGWQLR 626
QH+++VR G C E ++++EYM + L+ FL + LG
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ + +A G++YL + L +HRDL N L+ Q + KI DFGM+R
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 22/170 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
+ ++ +LGEG FG V+ N VAVK L + + K+F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------------FDPTKKHLLGWQL 625
QH ++V+ G C + I+++EYM + L+ FL K LG
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ I IA G++YL + +HRDL N L+ ++ KI DFGM+R
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 58/171 (33%), Positives = 79/171 (46%), Gaps = 23/171 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+LGE FG VYKG L Q VA+K L G +EF++E ML A+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------------FDPTKKHLLGWQ 624
LQH N+V LLG + +I+ Y + L FL D T K L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
V ++ IA G+ YL S ++H+DL N+L+ +N KISD G+ R
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKL-Q 579
+ Q +GEG FG V K R+ A+KR+ S ++F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTKKHLLGWQL 625
H N++ LLG C +G L EY + +L FL + T L QL
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ +A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFG++R
Sbjct: 145 -LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 6/157 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E ++ +LG G FG V G+ +VAVK + + EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ G C ++ ++ EY+ N L +L + L + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ IHRDL A N L+D+ + K+SDFGM R D+
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-34
Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ +++ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG C + +I E+M +L +L + ++ + L + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMATQISSAMEYL--- 334
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ IHR+L A N L+ ++ K++DFG++R+ GD
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKL 578
LG G FG V+KG + E V +K + ++SG Q + + M+ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP----TKKHLLGWQLRVRIIDGIA 634
H ++VRLLG C ++ + +Y+ SL + + LL W + IA
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIA 125
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+G+ YL ++HR+L A N+LL +++DFG+A + D+
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ + +LG G FG V G+ +VA+K + + EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C +Q +I EYM N L +L + + QL + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQL-LEMCKDVCEAMEYL---E 137
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ +HRDL A N L++ K+SDFG++R DE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 585 RLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
RL+G C Q E +++ E L FL ++ + + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNV-AELLHQVSMGMKYL--- 126
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+HRDL A N+LL KISDFG+++ G D+
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 52/162 (32%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
I+ +G G G V GRL VA+K L + + + ++F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N++RL G +++ EYM N SLD FL QL V ++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQL-VGMLRGVGAGMRY 166
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
L S L +HRDL A N+L+D ++ K+SDFG++R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 12/163 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
+ ++ RLLG C+ ++ I + M L ++ + K +G Q + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
YL R++HRDL A N+L+ + KI+DFG+A++ G +E
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
+G G FG VY G LL+ AVK L + +F E +++ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 583 LVRLLGCCIEQGEKIL-IYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQGL 637
++ LLG C+ L + YM + L F+ +PT K L+G+ L +A+G+
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL------QVAKGM 141
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
YL + + +HRDL A N +LD+ K++DFG+AR
Sbjct: 142 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-33
Identities = 56/157 (35%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L E+ I + EYM SL FL T K+L QL V + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYV---E 297
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 52/164 (31%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAK 577
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L HRNL+RL G + K+ + E SL L + H L L R +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH-QGHFLLGTL-SRYAVQVAEGM 134
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
YL R IHRDL A N+LL KI DFG+ R ++
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 19/166 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL--SNQSGQGLKEFKNEMMLIAKL 578
+ LGEG FG V +G L VAVK + N S + ++EF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 579 QHRNLVRLLGCCIEQG-----EKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRI 629
H N++RLLG CIE + ++I +M L +L + KH+ L ++
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL-LKF 152
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ IA G+ YL S +HRDL A N +L M ++DFG+++
Sbjct: 153 MVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 54/163 (33%), Positives = 85/163 (52%), Gaps = 11/163 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++RL G + ++I EYM N +LD FL + QL V ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQL-VGMLRGIAAGMK 161
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
YL + + +HRDL A NIL++ ++ K+SDFG++R+ D
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 56/162 (34%), Positives = 84/162 (51%), Gaps = 10/162 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
N SI +G G FG V GRL + VA+K L + + ++F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N++RL G + +++ EYM N SLD FL QL V ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQL-VGMLRGIASGMKY 162
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
L S + +HRDL A NIL++ ++ K+SDFG+ R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
E ++ +LG+G FG VY+G + VA+K + S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------FDPTKKHLLGWQLRVRI 629
++VRLLG + ++I E M L +L +P ++ +++
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM-IQM 143
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
IA G+ YL + + +HRDL A N ++ + KI DFGM R
Sbjct: 144 AGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
+G G FG VY G LL+ AVK L + +F E +++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 583 LVRLLGCCIEQGEKIL-IYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQGL 637
++ LLG C+ L + YM + L F+ +PT K L+G+ L +A+G+
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL------QVAKGM 205
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+L + + +HRDL A N +LD+ K++DFG+AR
Sbjct: 206 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
+G+G FG VY G ++ + A+K L Q ++ F E +L+ L
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 580 HRNLVRLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++ L+G + + YM + L F+ P +++ L + +A+G+
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDL-ISFGLQVARGME 138
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
YL + + +HRDL A N +LD+ K++DFG+AR
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-33
Identities = 56/157 (35%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L E+ I + EYM SL FL T K+L QL V + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYV---E 380
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 21/173 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL--------LNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 576
E+ LG+G F ++KG L+ EV +K L + F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
KL H++LV G C+ E IL+ E++ SLD +L + W+L + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAA 125
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNP--------KISDFGMARMFGGDE 681
+ +L +IH ++ A NILL + + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 525 ENFSIQSK-LGEGGFGPVYKGRLLNG---QEVAVKRL--SNQSGQGLKEFKNEMMLIAKL 578
+ +++ K LG G FG V KG + VAVK L E E ++ +L
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 579 QHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+ +VR++G C + E L+ E L+ +L +H+ + + ++ ++ G+
Sbjct: 76 DNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IELVHQVSMGM 130
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
YL +HRDL A N+LL KISDFG+++ DE
Sbjct: 131 KYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 20/167 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG----QEVAVKRL--SNQSGQGLKEFKNEMMLIAKL 578
+ F++ LG+G FG V + +L +VAVK L + ++EF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 579 QHRNLVRLLGCCIEQGEKI------LIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVR 628
H ++ +L+G + K +I +M + L FL +L L VR
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL-VR 141
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ IA G+ YL S IHRDL A N +L + M ++DFG++R
Sbjct: 142 FMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 51/179 (28%), Positives = 76/179 (42%), Gaps = 31/179 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
N +GEG FG V++ R VAVK L S +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL---------------------FDPT 616
+ N+V+LLG C L++EYM L+ FL
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 617 KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L ++ I +A G+ YL S + +HRDL N L+ ++M KI+DFG++R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 53/165 (32%), Positives = 77/165 (46%), Gaps = 17/165 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGI 633
H+N+VR +G ++ + ++ E M L FL P++ L + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMAR 675
A G YL IHRD+ A N LL KI DFGMAR
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E I I E L FL K L L + ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVR-KYSLDLASL-ILYAYQLSTALAY 131
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
L R +HRD+ A N+L+ + K+ DFG++R
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
E+ + LGEG FG VY+G N + VAVK + + ++F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQ 635
H ++V+L+G E+ I I E L +L L+ + L I +
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICK 124
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ YL + +HRD+ NIL+ K+ DFG++R ++
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 53/165 (32%), Positives = 77/165 (46%), Gaps = 17/165 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGI 633
H+N+VR +G ++ + ++ E M L FL P++ L + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMAR 675
A G YL IHRD+ A N LL KI DFGMAR
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 55/187 (29%), Positives = 83/187 (44%), Gaps = 47/187 (25%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+N + LGEG FG V K + VAVK L N S L++ +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------------------- 612
+ H ++++L G C + G +LI EY SL FL
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 613 --FDPTKKHLL--GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668
T L+ WQ I+QG+ YL + ++++HRDL A NIL+ + KI
Sbjct: 143 DERALTMGDLISFAWQ--------ISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKI 191
Query: 669 SDFGMAR 675
SDFG++R
Sbjct: 192 SDFGLSR 198
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ ++ LGEG FG V + VAVK L + + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTKKHL 620
+ +H+N++ LLG C + G +I EY +L +L ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR
Sbjct: 155 TFKDL-VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL+G C + + + E L FL ++ + + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVGK-REEIPVSNV-AELLHQVSMGMKYL---E 453
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+HR+L A N+LL KISDFG+++ G D+
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+ + LG G FG V + + VAVK L + + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 578 L-QHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFL-------------FDPTKKHLLG 622
+ H N+V LLG C + G + +I E+ +L +L + K L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ + +A+G+ +L + + IHRDL A NILL + KI DFG+AR
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ ++ LGEG FG V + VAVK L + + + L + +EM ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTKKHL 620
+ +H+N++ LLG C + G +I EY +L +L ++ +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR
Sbjct: 201 TFKDL-VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 49/174 (28%), Positives = 69/174 (39%), Gaps = 26/174 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
S LG G FG V + + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
L H N+V LLG C G ++I EY L FL + + D
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 633 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+A+G+ +L + IHRDL A NILL KI DFG+AR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 24/171 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
N LG G FG V + + VAVK L S + +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------FDPTKKHLLGWQ 624
L QH N+V LLG C G ++I EY L FL F
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L + +AQG+ +L + IHRD+ A N+LL KI DFG+AR
Sbjct: 166 L-LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E I I E L FL +K L + ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
L R +HRD+ A N+L+ + K+ DFG++R
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 26/174 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL---------FDPTKKHLLGWQL 625
+ +H+N++ LLG C + G +I EY +L +L + H QL
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 626 R----VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
V +A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 12/181 (6%)
Query: 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMM 573
F S++ +SI ++G GG V++ Q A+K L Q L ++NE+
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 574 LIAKLQHRNL--VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
+ KLQ + +RL I ++ E N L+ +L KK + R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWK 134
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ + + +HQ+ I+H DLK +N L+ K+ DFG+A D VG
Sbjct: 135 NMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 692 T 692
T
Sbjct: 191 T 191
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 9/162 (5%)
Query: 520 VTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
V +++ KLGEGGF V L +G A+KR+ Q +E + E +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 579 QHRNLVRLLGCCIEQGEK----ILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGI 633
H N++RL+ C+ + L+ + +L + K + L + ++ GI
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+GL +H HRDLK +NILL P + D G
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 41/171 (23%), Positives = 77/171 (45%), Gaps = 9/171 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + K+GEG FG + +G++ +K +S S + +E + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+ E G ++ +Y L + + K L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+I+HRD+K+ NI L + ++ DFG+AR+ +GT
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 48/179 (26%), Positives = 68/179 (37%), Gaps = 31/179 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
EN LG G FG V + VAVK L + +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRII 630
L H N+V LLG C G LI+EY L +L F + +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 631 DG--------------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
D +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 12/172 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+SI ++G GG V++ Q A+K L Q L ++NE+ + KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 583 L--VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+RL I ++ E N L+ +L KK + R + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
HQ+ I+H DLK +N L+ K+ DFG+A D VGT
Sbjct: 125 HQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 49/211 (23%), Positives = 80/211 (37%), Gaps = 14/211 (6%)
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
+ ++ G D +S SV +SI ++G GG V++
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG--RIYSILKQIGSGGSSKVFQVL 76
Query: 546 LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLLGCCIEQGEKILIYE 601
Q A+K L Q L ++NE+ + KLQ + +RL I ++ E
Sbjct: 77 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136
Query: 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661
N L+ +L KK + R + + + +HQ+ I+H DLK +N L+
Sbjct: 137 C-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 189
Query: 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
K+ DFG+A D VG
Sbjct: 190 D-GMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 9/163 (5%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
LG+G +G VY GR L N +A+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 592 EQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
E I I+ E + SL L Q I +GL YLH +I+H
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 651 RDLKASNILLDQHM-NPKISDFGMARMFGGDELQGNTKRIVGT 692
RD+K N+L++ + KISDFG ++ G + T+ GT
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGT 186
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 28/185 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+F +G GGFG V+K + ++G+ +KR+ + ++ + E+ +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 584 VRLLGCCIEQGEKI----------------LIYEYMVNKSLDVFLFDPTKKHLLGWQLRV 627
V GC + E+ +L+ ++ + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL- 125
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
+ + I +G+ Y+H ++I+RDLK SNI L KI DFG+ D G
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 688 RIVGT 692
R GT
Sbjct: 180 RSKGT 184
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 17/176 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
+F LG GGFG V++ + ++ A+KR+ ++ E+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 583 LVRLLGCCIE---------QGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRII 630
+VR +E K+ +Y + ++L ++ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
IA+ + +LH ++HRDLK SNI K+ DFG+ DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 18/170 (10%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
++G G F VYKG EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 589 CCIEQGEK----ILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLHQY 643
+ +L+ E M + +L +L K+ ++ ++ I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 644 SRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGDELQGNTKRIVGT 692
IIHRDLK NI + + KI D G+A + K ++GT
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 193
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQH 580
NF I+ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLY 639
N+++ IE E ++ E L + K+ L+ + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+H R++HRD+K +N+ + K+ D G+ R F ++ +VGT
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 16/166 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+F + LG+G FG V K R L+ + A+K++ + + L +E+ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVF---------LFD--PTKKHLLGWQLRVRIID 631
+VR +E+ + + KS L+D ++ R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
I + L Y+H IIHRDLK NI +D+ N KI DFG+A+
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 47/170 (27%), Positives = 88/170 (51%), Gaps = 8/170 (4%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E + I +LG+G FG VYK + G A K + +S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+LLG G+ ++ E+ ++D + + L Q++V + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
RIIHRDLKA N+L+ + +++DFG++ + ++ +GT
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 10/176 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E++ + +G G +G K R +G+ + K + + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 582 NLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKHLLGWQLRV-RIIDGIAQGLL 638
N+VR I++ L + EY L + TK+ + V R++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 639 YLHQ--YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
H+ ++HRDLK +N+ LD N K+ DFG+AR+ D T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 16/164 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 580
+ LG+GGF ++ + A K + +E E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH--LLGWQLRVRIIDGIAQGL 637
+++V G E + + ++ E +SL + K+ L + R + I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGC 154
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
YLH+ R+IHRDLK N+ L++ + KI DFG+A D
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 16/163 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 580
+ LG+GGF ++ + A K + +E E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH--LLGWQLRVRIIDGIAQGL 637
+++V G E + + ++ E +SL + K+ L + R + I G
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGC 128
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
YLH R R+IHRDLK N+ L++ + KI DFG+A D
Sbjct: 129 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 35/182 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 575
ENF K+GEG +G VYK R L G+ VA+K++ L E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM-------VNKSLDVFLFDPTKKHLLGWQLRVR 628
+L H N+V+LL + + L++E++ ++ S + P K L +QL
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-FQL--- 112
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
QGL + H + R++HRDLK N+L++ K++DFG+AR F G ++ T
Sbjct: 113 -----LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHE 163
Query: 689 IV 690
+V
Sbjct: 164 VV 165
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 44/170 (25%), Positives = 84/170 (49%), Gaps = 10/170 (5%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ ++ K+G+G G VY + GQEVA+++++ Q + NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V L + E ++ EY+ SL D + + + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
++IHRD+K+ NILL + K++DFG ++ + +T +VGT
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 13/167 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 582
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 583 LVRLLGCCIEQGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
+V+L E+ E+ SL L +P+ + L + ++ + G+ +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 640 LHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMARMFGGDEL 682
L + I+HR++K NI+ D K++DFG AR DE
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 33/180 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 576
E + K+GEG +G VYK + G+ VA+KR+ L E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRII 630
+L H N+V L+ + L++E+M V L D K L +QL
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL-YQL----- 128
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+G+ + HQ+ RI+HRDLK N+L++ K++DFG+AR F G ++ T +V
Sbjct: 129 ---LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 51/178 (28%), Positives = 88/178 (49%), Gaps = 18/178 (10%)
Query: 522 AATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLI 575
+++ F KLG G + VYKG G VA+K + S +G ++E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+L+H N+VRL + + L++E+M + K +D T + L ++
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQWQ 116
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+ QGL + H+ +I+HRDLK N+L+++ K+ DFG+AR F G + + +V
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 13/167 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 582
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 583 LVRLLGCCIEQGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
+V+L E+ E+ SL L +P+ + L + ++ + G+ +
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 640 LHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMARMFGGDEL 682
L + I+HR++K NI+ D K++DFG AR DE
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 34/181 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 575
+ + K+GEG +G V+K + + VA+KR+ L + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRI 629
+L+H+N+VRL + L++E+ S + L K L +QL
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL-FQL---- 110
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
+GL + H ++HRDLK N+L++++ K+++FG+AR F G ++ + +
Sbjct: 111 ----LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEV 162
Query: 690 V 690
V
Sbjct: 163 V 163
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 13/178 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRN 582
+++ +Q +G G V ++VA+KR++ + Q + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIA----QGL 637
+V + + E L+ + + S+ D+ K L I I +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM-ARMFGGDELQGNTKR--IVGT 692
YLH + IHRD+KA NILL + + +I+DFG+ A + G ++ N R VGT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 53/171 (30%), Positives = 83/171 (48%), Gaps = 34/171 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN--------EMM 573
+ + LGEG F VYK R Q VA+K +L ++S E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTALREIK 64
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRV 627
L+ +L H N++ LL + L++++M + K + L K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM-LMT-- 121
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
QGL YLHQ+ I+HRDLK +N+LLD++ K++DFG+A+ FG
Sbjct: 122 ------LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 33/180 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 576
E + K+GEG +G VYK + G+ A+K++ L++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRII 630
+L+H N+V+L + +L++E++ + + L T K L QL
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-LQL----- 109
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
G+ Y H R++HRDLK N+L+++ KI+DFG+AR F G ++ T IV
Sbjct: 110 ---LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 10/170 (5%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
K+GEG G V R +G++VAVK + + Q + NE++++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V + + E ++ E++ +L D + L + + + + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+IHRD+K+ +ILL K+SDFG D + + +VGT
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 53/155 (34%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 579
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N ++ GC + + L+ EY + + D L + KK L ++ + G QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
LH +IHRD+KA NILL + K+ DFG A
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 10/168 (5%)
Query: 519 SVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK 577
+V ++ L EGGF VY+ + + +G+E A+KRL + + + E+ + K
Sbjct: 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKK 81
Query: 578 LQ-HRNLVRLLGCCIEQGEK-------ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI 629
L H N+V+ E+ L+ + L FL + L ++I
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
+ + ++H + IIHRDLK N+LL K+ DFG A
Sbjct: 142 FYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 28/166 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLIAKL 578
E + KLGEG + VYKG+ L VA+K + + +G ++E L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+H N+V L + L++EY+ + K L +QL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL-FQL------- 109
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+GL Y H+ +++HRDLK N+L+++ K++DFG+AR
Sbjct: 110 -LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 580
E+F + + LG+G F VY+ + G EVA+K + ++ G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTK---KHLLGWQLRVRIIDGIAQG 636
+++ L E + L+ E N + K K + R + I G
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFMHQIITG 124
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
+LYLH + I+HRDL SN+LL ++MN KI+DFG+A
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 54/185 (29%), Positives = 82/185 (44%), Gaps = 38/185 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 575
+ + +KLGEG +G VYK + + VA+KR+ L+ + E+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLD--VFLFDPTKKHLLGWQLRVRII 630
+LQHRN++ L LI+EY + K +D + K L +QL
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL-YQL----- 141
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-----KISDFGMARMFGGDELQGN 685
G+ + H R +HRDLK N+LL KI DFG+AR F G ++
Sbjct: 142 ---INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 686 TKRIV 690
T I+
Sbjct: 195 THEII 199
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 51/231 (22%), Positives = 80/231 (34%), Gaps = 18/231 (7%)
Query: 466 RKENETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATE 525
+ + +D + L F + R F G+ + + S +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMHQLQPRRVSF---RGEASETLQSPGYDPSRPESFF--QQ 57
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKL-QHR 581
+F S+LG G +G V+K R +G+ AVK + + E+ K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
VRL E G L E SL L Q+ + D L +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRD-TLLALAHLH 174
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
++H D+K +NI L K+ DFG+ G + G
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGD 219
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 53/171 (30%), Positives = 87/171 (50%), Gaps = 12/171 (7%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E F + KLGEG +G VYK GQ VA+K++ + L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+V+ G + + ++ EY S+ D + K L ++ I+ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD--IIRLRNKTLTEDEIAT-ILQSTLKGLEYLH 142
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+R IHRD+KA NILL+ + K++DFG+A + NT ++GT
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 29/167 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLIAK 577
E + +GEG +G V K R G+ VA+K S+ K K E+ L+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLDVF--LFDPTK-KHLLGWQLRVRIID 631
L+H NLV LL C ++ L++E++ + L++F D + L +Q+
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL-FQI------ 133
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
G+ + H + IIHRD+K NIL+ Q K+ DFG AR
Sbjct: 134 --INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 46/181 (25%), Positives = 74/181 (40%), Gaps = 18/181 (9%)
Query: 518 ASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 576
+ Q ++G G FG V++ + G + AVK++ + + E++ A
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105
Query: 577 KLQHRNLVRLLGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
L +V L G E G + I+ E + SL + + L + + +
Sbjct: 106 GLSSPRIVPLYGAVRE-GPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALE 161
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTKR---IVG 691
GL YLH RI+H D+KA N+LL + + DFG A D L + I G
Sbjct: 162 GLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 692 T 692
T
Sbjct: 219 T 219
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 39/176 (22%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKE-FKN----EMMLIA 576
+ +K+G+G FG V+K R GQ+VA+K + N+ KE F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-----KEGFPITALREIKILQ 71
Query: 577 KLQHRNLVRLLGCCIEQGEKI--------LIYEYMVN------KSLDVFLFDPTKKHLLG 622
L+H N+V L+ C + L++++ + ++ V K ++
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM- 130
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
L GL Y+H+ +I+HRD+KA+N+L+ + K++DFG+AR F
Sbjct: 131 QML--------LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 33/169 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 575
E + K+GEG +G V+K R GQ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLDVF--LFDPTK-KHLLGWQLRVRI 629
+L+H NLV LL + L++EY V LD + K + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT-WQT---- 111
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
Q + + H++ IHRD+K NIL+ +H K+ DFG AR+
Sbjct: 112 ----LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 42/182 (23%), Positives = 77/182 (42%), Gaps = 27/182 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------NQSGQGLKE 567
++ I L +G F + + + A+K+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 568 FKNEMMLIAKLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSL-----DVFLFDPTKKHLL 621
FKNE+ +I +++ + G I +++ +IYEYM N S+ F+ D +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
Q+ II + Y+H + I HRD+K SNIL+D++ K+SDFG + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 682 LQ 683
++
Sbjct: 207 IK 208
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 16/169 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 583
+ ++ +LG GGFG V + G++VA+K+ + +E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 584 VRLLGCCIEQGEKI-------LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
V + +K+ L EY L +L L ++ I+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 637 LLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMARMFGGDEL 682
L YLH+ RIIHRDLK NI+L Q + KI D G A+ EL
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 11/171 (6%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 581
E F+ K+G+G FG V+KG + VA+K + + + +++ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ + G ++ + +I EY+ S D + L I+ I +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ IHRD+KA+N+LL +H K++DFG+A +++ NT VGT
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 43/177 (24%), Positives = 73/177 (41%), Gaps = 45/177 (25%)
Query: 529 IQSKLGEGGFGPVYKGR---LLNGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHR 581
K+G G +G VYK + + ++ A+K++ S E+ L+ +L+H
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHP 78
Query: 582 NLVRLLGCCIEQGEKI--LIYEYM--------------VNKSLDVFLFDPTKKHLLGWQL 625
N++ L + ++ L+++Y V L K LL +Q+
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQI 137
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
G+ YLH ++HRDLK +NIL+ KI+D G AR+F
Sbjct: 138 --------LDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 35/178 (19%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLI 575
AT + +++G G +G VYK R +G VA+K R+ N G G E+ L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65
Query: 576 AKLQ---HRNLVRLLGCCIEQGEKI-----LIYEYM-------VNKSLDVFLFDPTKKHL 620
+L+ H N+VRL+ C L++E++ ++K+ L T K L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+ Q +GL +LH I+HRDLK NIL+ K++DFG+AR++
Sbjct: 126 M-RQF--------LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 17/195 (8%)
Query: 507 SKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL 565
S SL +++ F + +G G +G VYKGR + GQ A+K + + +G
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEE 64
Query: 566 KEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI------LIYEYMVNKSL-DVFLFDPTK 617
+E K E+ ++ K HRN+ G I++ L+ E+ S+ D L TK
Sbjct: 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTK 122
Query: 618 KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
+ L + I I +GL +LHQ ++IHRD+K N+LL ++ K+ DFG++
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 678 GGDELQGNTKRIVGT 692
+ NT +GT
Sbjct: 180 DRTVGRRNT--FIGT 192
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 46/174 (26%), Positives = 89/174 (51%), Gaps = 33/174 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR--LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIA 576
+ + +++GEG +G V+K R G+ VA+KR+ + + G ++E + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69
Query: 577 KLQHRNLVRLL----GCCIEQGEKI-LIYEYM-------VNKSLDVFLFDPTKKHLLGWQ 624
+H N+VRL ++ K+ L++E++ ++K + + T K ++ +Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM-FQ 128
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
L +GL +LH + R++HRDLK NIL+ K++DFG+AR++
Sbjct: 129 L--------LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 519 SVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLI 575
S+ ++ +LG G +G V K R + +GQ +AVKR+ + + Q K ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA- 634
+ V G +G+ + E M + SLD F K G + I+ IA
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDK---GQTIPEDILGKIAV 116
Query: 635 ---QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ L +LH S+L +IHRD+K SN+L++ K+ DFG++ D++ + G
Sbjct: 117 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AG 171
Query: 692 T 692
Sbjct: 172 C 172
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 43/181 (23%), Positives = 78/181 (43%), Gaps = 11/181 (6%)
Query: 498 EADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKR 556
E + D + + + + ++F S+LG G G V+K +G +A K
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65
Query: 557 LS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--F 613
+ + E+ ++ + +V G GE + E+M SLD L
Sbjct: 66 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 125
Query: 614 DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
+ +LG ++ + +GL YL + +I+HRD+K SNIL++ K+ DFG+
Sbjct: 126 GRIPEQILG-----KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 674 A 674
+
Sbjct: 179 S 179
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 34/183 (18%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHRN 582
++ +G G FG V++ +L+ EVA+K++ K FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 583 LVRLLGCCIEQGEKI------LIYEYM---VNKSLDVFL-----FDPTKKHLLGWQLRVR 628
+V L G+K L+ EY+ V ++ + L +QL
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL--- 150
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTK 687
+ L Y+H + I HRD+K N+LLD K+ DFG A++ + N
Sbjct: 151 -----LRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 688 RIV 690
I
Sbjct: 201 YIC 203
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 36/186 (19%), Positives = 65/186 (34%), Gaps = 16/186 (8%)
Query: 518 ASVTAATENFSIQSKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEM 572
+S + + + +G+G V R G+ V V+R L S + + + E+
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIID 631
+ H N+V I E ++ +M S D L + I+
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQ 135
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT----- 686
G+ + L Y+H + +HR +KAS+IL+ +S +
Sbjct: 136 GVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 687 KRIVGT 692
K V
Sbjct: 193 KYSVKV 198
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 43/194 (22%), Positives = 70/194 (36%), Gaps = 35/194 (18%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKL-Q 579
T F K+G G FG V+K L+G A+KR + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGL 637
H ++VR E ++ EY SL + + +L+ ++ + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ-VGRGL 128
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNP-------------------KISDFGMARMFG 678
Y+H + ++H D+K SNI + + P KI D G
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 679 GDELQGNTKRIVGT 692
+ + G
Sbjct: 185 -----SSPQVEEGD 193
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 35/176 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 581
+++ +G G FG VY+ +L +G+ VA+K++ K FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 582 NLVRLLGCCIEQGEKI------LIYEYM---VNKSLDVF------LFDPTKKHLLGWQLR 626
N+VRL GEK L+ +Y+ V + + L K + +QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQL- 165
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDE 681
+ L Y+H I HRD+K N+LLD K+ DFG A+ E
Sbjct: 166 -------FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 6e-23
Identities = 18/199 (9%), Positives = 42/199 (21%), Gaps = 36/199 (18%)
Query: 513 PLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEF 568
+ ++ + L G V+ R + ++ A+K + S L+
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 569 KNEMMLIAKLQHRNLVRLLGCC--------------------------IEQGEKILIYEY 602
A+L + +L+
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 603 MV---NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
F + G + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLF 226
Query: 660 LDQHMNPKISDFGMARMFG 678
+ + D G
Sbjct: 227 IMPDGRLMLGDVSALWKVG 245
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLIAKLQHR 581
E+ ++G G +G V K +GQ +AVKR+ S + K+ ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA----QGL 637
+V+ G +G+ + E M + S D F +L + I+ I + L
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672
+L L+IIHRD+K SNILLD+ N K+ DFG
Sbjct: 139 NHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LGEG +G V + AVK L + G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 588 G-CCIEQGEKI-LIYEYMVNKSLDVFLFD-PTKKHLLGWQLR---VRIIDGIAQGLLYLH 641
E+ +K+ ++ EY V + + D +K Q ++IDG+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
I+H+D+K N+LL KIS G+A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 18/175 (10%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLV 584
+F + LG G G + + + ++VAVKR+ + E+ +L +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 585 RLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
R C + + + E +L ++ K + ++ GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIEL-CAATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 644 SRLRIIHRDLKASNILL-----DQHMNPKISDFGMARMFGGDEL-QGNTKRIVGT 692
L I+HRDLK NIL+ + ISDFG+ + + GT
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 579
E+F I LG+G FG VY R + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++RL G ++ LI EY ++ L K Q I +A L
Sbjct: 68 HPNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
Y H R+IHRD+K N+LL KI+DFG +
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 45/200 (22%), Positives = 79/200 (39%), Gaps = 19/200 (9%)
Query: 502 DGKDKSKDSSLPLFSFASVTAATENFS----IQSKLGEGGFGPVYKGR-LLNGQEVAVKR 556
+ DK + + V + I +LG G FG V++ G+ K
Sbjct: 24 NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 83
Query: 557 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD-- 614
++ KNE+ ++ +L H L+ L ++ E +LI E++ LFD
Sbjct: 84 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE----LFDRI 139
Query: 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFG 672
+ + + + + +GL ++H+ I+H D+K NI+ + KI DFG
Sbjct: 140 AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 673 MARMFGGDELQGNTKRIVGT 692
+A DE K T
Sbjct: 197 LATKLNPDE---IVKVTTAT 213
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 45/202 (22%), Positives = 80/202 (39%), Gaps = 37/202 (18%)
Query: 501 GDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSN 559
G G S +++ + + F ++ G+G FG V G+ G VA+K++
Sbjct: 1 GPGSMMSLNAAAA--ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ 58
Query: 560 QSGQGLKEFKN----EMMLIAKLQHRNLVRLLGCCIEQGEK-------ILIYEYM----- 603
F+N M +A L H N+V+L GE+ ++ EY+
Sbjct: 59 D-----PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLH 113
Query: 604 -VNKSLDVFLFDPTKKH--LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660
++ P + +QL + + LH S + + HRD+K N+L+
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFLFQL--------IRSIGCLHLPS-VNVCHRDIKPHNVLV 164
Query: 661 DQHMNP-KISDFGMARMFGGDE 681
++ K+ DFG A+ E
Sbjct: 165 NEADGTLKLCDFGSAKKLSPSE 186
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 35/172 (20%), Positives = 66/172 (38%), Gaps = 23/172 (13%)
Query: 529 IQSKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVR 585
++ + GG G +Y +NG+ V +K L + + E +A++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 586 LL--GCCIEQGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+ ++ + Y EY+ +SL L + + I L YL
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYL 198
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
H + +++ DLK NI+L + K+ D G + GT
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 18/168 (10%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--------RLSNQSGQGLKEFKNEMMLIA 576
+S S LG G FG V+ +EV VK L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 577 KLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIA 634
+++H N++++L E L+ E + LD LF + L L I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLD--LFAFIDRHPRLDEPLASYIFRQLV 140
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
+ YL IIHRD+K NI++ + K+ DFG A +L
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 41/180 (22%), Positives = 75/180 (41%), Gaps = 14/180 (7%)
Query: 501 GDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL-S 558
G K + A + ++G G G V+K R G +AVK++
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 559 NQSGQGLKEFKNEM-MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF---LFD 614
+ + + K ++ +++ +V+ G I + + E M + +
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG 119
Query: 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
P + +LG ++ I + L YL + +IHRD+K SNILLD+ K+ DFG++
Sbjct: 120 PIPERILG-----KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 3e-21
Identities = 28/194 (14%), Positives = 56/194 (28%), Gaps = 38/194 (19%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQH-------- 580
LG+ + G+ V +K+ K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 581 --------RNLVRLLGCC-----------IEQGEKILIYEYMVNKSLDVF--LFDPTKKH 619
+LV+ + + +Y M + L + H
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 620 -LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
L R+++ + + L LH ++H L+ +I+LDQ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 679 GDELQGNTKRIVGT 692
G R
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-21
Identities = 45/187 (24%), Positives = 70/187 (37%), Gaps = 29/187 (15%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLVR 585
+ LG G G V G+ VAVKR+ E+ +L H N++R
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 586 LLGCCIEQGEKI-LIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
C + + E N +L + L + ++ IA G+ +L
Sbjct: 74 YY-CSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 641 HQYSRLRIIHRDLKASNILLD-------------QHMNPKISDFGMARMFGGDE--LQGN 685
H L+IIHRDLK NIL+ +++ ISDFG+ + + + N
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 686 TKRIVGT 692
GT
Sbjct: 189 LNNPSGT 195
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 498 EADGDGKDKSKDSSLPLFSFASVTAATENFS------IQSKLGEGGFGPVYKGR-LLNGQ 550
+ F VTA + LG G FG V+K G
Sbjct: 56 SKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGL 115
Query: 551 EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDV 610
++A K + + + +E KNE+ ++ +L H NL++L + + +L+ EY+
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE--- 172
Query: 611 FLFD--PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-- 666
LFD + + L + + I +G+ ++HQ + I+H DLK NIL
Sbjct: 173 -LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQI 228
Query: 667 KISDFGMARMFGGDELQGNTKRIVGT 692
KI DFG+AR + E K GT
Sbjct: 229 KIIDFGLARRYKPRE---KLKVNFGT 251
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 4e-21
Identities = 28/171 (16%), Positives = 55/171 (32%), Gaps = 22/171 (12%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK 577
++ + LGEG F VY+ N Q+ +K + M +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD--VFLFDPTKKHLLGWQLRVRIIDGIAQ 635
++ + Q +L+ E +L + L+ T + ++ L + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNP-----------KISDFGMAR 675
+ +H IIH D+K N +L + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 16/166 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 579
++F I LG+G FG VY R N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGL 637
H N++R+ ++I L+ E+ L + K Q ++ +A L
Sbjct: 73 HPNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADAL 127
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
Y H ++IHRD+K N+L+ KI+DFG + +
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 11/168 (6%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLV 584
I KLG GG VY + +VA+K + + LK F+ E+ ++L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
++ E L+ EY+ +L ++ L + + I G+ + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH--- 128
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+RI+HRD+K NIL+D + KI DFG+A+ L T ++GT
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGT 175
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 8e-21
Identities = 41/196 (20%), Positives = 76/196 (38%), Gaps = 15/196 (7%)
Query: 502 DGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ 560
+ P +++ I +LG G FG V++ G A K +
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 193
Query: 561 SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKK 618
+ + E+ ++ L+H LV L + E ++IYE+M LF+ +
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEH 249
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMARM 676
+ + V + + +GL ++H+ +H DLK NI+ + K+ DFG+
Sbjct: 250 NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306
Query: 677 FGGDELQGNTKRIVGT 692
+ + K GT
Sbjct: 307 LDPKQ---SVKVTTGT 319
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 29/170 (17%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
N+ + +G+G F V R +L G+EVA+K + + L++ E+ ++ L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 583 LVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH---------LLGWQLRVRIIDG 632
+V+L IE + + LI EY + FD H Q I+
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQ----IVSA 126
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
+ Y H + RI+HRDLKA N+LLD MN KI+DFG + F
Sbjct: 127 VQ----YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 46/194 (23%), Positives = 69/194 (35%), Gaps = 48/194 (24%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+ + I +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
++ H N++ L + + +LI E + LFD +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFD-------------FLAQKESLS 113
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH +I H DLK NI+L P K+ DFG+A
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 679 GDELQGNTKRIVGT 692
K I GT
Sbjct: 171 DGVE---FKNIFGT 181
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 49/194 (25%), Positives = 76/194 (39%), Gaps = 48/194 (24%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+++ + +LG G F V K R G+E A K RLS+ +E + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
+++H N++ L + + +LI E + L FD + +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FD-------------FLAEKESLT 106
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH RI H DLK NI+L P K+ DFG+A
Sbjct: 107 EDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 679 GDELQGNTKRIVGT 692
K I GT
Sbjct: 164 AGN---EFKNIFGT 174
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 46/194 (23%), Positives = 69/194 (35%), Gaps = 48/194 (24%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+ + I +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
++ H N++ L + + +LI E + LFD +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFD-------------FLAQKESLS 113
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH +I H DLK NI+L P K+ DFG+A
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 679 GDELQGNTKRIVGT 692
K I GT
Sbjct: 171 DGVE---FKNIFGT 181
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 50/174 (28%), Positives = 74/174 (42%), Gaps = 32/174 (18%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 591 IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLG-----------WQLRVRIIDGIAQGLL 638
+G L EY LFD + Q ++ G+
Sbjct: 74 RREGNIQYLFLEYCSGGE----LFDRIEPD--IGMPEPDAQRFFHQ----LMAGVV---- 119
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
YLH + I HRD+K N+LLD+ N KISDFG+A +F + + ++ GT
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 27/180 (15%), Positives = 57/180 (31%), Gaps = 37/180 (20%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ--------- 579
LG+ + G+ V +K+ K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 580 ----------------HRNLVRLLGCC--IEQGEKILIYEYMVNKSLDVF--LFDPTKKH 619
+ ++R+ + + +Y M + L + H
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 620 -LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
L R+++ + + L LH Y ++H L+ +I+LDQ ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 41/183 (22%), Positives = 70/183 (38%), Gaps = 23/183 (12%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKEFKNEMMLIAK 577
+ + + +G+G F V + GQ+ AVK + ++ G ++ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGW---QLRVRIIDG 632
L+H ++V LL G +++E+M L + + +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRI 689
I + L Y H IIHRD+K +LL + K+ FG+A G
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGR 193
Query: 690 VGT 692
VGT
Sbjct: 194 VGT 196
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 50/174 (28%), Positives = 74/174 (42%), Gaps = 32/174 (18%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 591 IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLG-----------WQLRVRIIDGIAQGLL 638
+G L EY LFD + Q ++ G+
Sbjct: 74 RREGNIQYLFLEYCSGGE----LFDRIEPD--IGMPEPDAQRFFHQ----LMAGVV---- 119
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
YLH + I HRD+K N+LLD+ N KISDFG+A +F + + ++ GT
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 49/194 (25%), Positives = 72/194 (37%), Gaps = 48/194 (24%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+ + +LG G F V K R G + A K R + +E + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
++QH N++ L + + ILI E + L FD + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGEL----FD-------------FLAEKESLT 112
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH L+I H DLK NI+L P KI DFG+A
Sbjct: 113 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 679 GDELQGNTKRIVGT 692
K I GT
Sbjct: 170 FGNE---FKNIFGT 180
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 36/187 (19%), Positives = 66/187 (35%), Gaps = 42/187 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E + I LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---------- 632
++ L E ++I+E++ + F+ RI
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDI----FE-------------RINTSAFELNEREIV 105
Query: 633 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGN 685
+ + L +LH I H D++ NI+ + KI +FG AR +
Sbjct: 106 SYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-- 160
Query: 686 TKRIVGT 692
+ +
Sbjct: 161 -RLLFTA 166
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 42/173 (24%), Positives = 71/173 (41%), Gaps = 15/173 (8%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLV 584
+ LG GG V+ R L + ++VAVK L + F+ E A L H +V
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 585 RLLGCCIEQGEKILIY----EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+ + + EY+ +L + + + + + +I Q L +
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFS 132
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG-NTKRIVGT 692
H + IIHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 19/177 (10%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
E ++I LG+G FG V K + + QE AVK + ++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLL 638
N+++L + ++ E L FD +K RII + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 639 YLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
Y+H+ I+HRDLK NILL ++ + KI DFG++ F + K +GT
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 52/194 (26%), Positives = 83/194 (42%), Gaps = 19/194 (9%)
Query: 507 SKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQ 563
S + E ++I LG+G FG V K + + QE AVK + ++ +
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 564 GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLL 621
E+ L+ KL H N+++L + ++ E L FD +K
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFS 119
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFG 678
RII + G+ Y+H+ I+HRDLK NILL ++ + KI DFG++ F
Sbjct: 120 EHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 679 GDELQGNTKRIVGT 692
+ K +GT
Sbjct: 176 QNTKM---KDRIGT 186
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 53/166 (31%), Positives = 78/166 (46%), Gaps = 34/166 (20%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG G FG V G+ L G +VAVK L+ Q S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLG-----------WQLRVRIIDGIAQG 636
I I ++ EY+ L FD K+ G Q I+ G+
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKN--GRLDEKESRRLFQQ----ILSGVD-- 130
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
Y H R ++HRDLK N+LLD HMN KI+DFG++ M E
Sbjct: 131 --YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 53/166 (31%), Positives = 75/166 (45%), Gaps = 34/166 (20%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG G FG V G L G +VAVK L+ Q S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLG-----------WQLRVRIIDGIAQG 636
I ++ EY+ L FD KH G Q I+ +
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKH--GRVEEMEARRLFQQ----ILSAVD-- 125
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
Y H R ++HRDLK N+LLD HMN KI+DFG++ M E
Sbjct: 126 --YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 40/175 (22%), Positives = 72/175 (41%), Gaps = 17/175 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ +++++ +G G +G V A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLLYL 640
++RL + + L+ E LF+ K+ RI+ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 641 HQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
H+ L + HRDLK N L K+ DFG+A F ++ + VGT
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGT 171
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 45/174 (25%), Positives = 71/174 (40%), Gaps = 51/174 (29%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKE-FKNEMMLIAKLQHRNLVRLLG 588
LGEG FG V Q+VA+K +S Q + + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 589 CCIEQGEKILIYEYMVNKSLDVF---------LFDPTKKHLLG-----------WQLRVR 628
Y+ + + D+ LFD + Q
Sbjct: 75 -----------YDVITTPT-DIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQ---- 116
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
II I Y H R +I+HRDLK N+LLD ++N KI+DFG++ +
Sbjct: 117 IICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 41/179 (22%), Positives = 74/179 (41%), Gaps = 20/179 (11%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHR 581
+ F + KLG G FG V+ +G E +K ++ ++S +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD-----PTKKHLLGWQLRVRIIDGIAQG 636
N++++ + ++ E L + + L ++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 637 LLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
L Y H ++H+DLK NIL H KI DFG+A +F DE GT
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-19
Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 19/177 (10%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
+E + KLG G +G V R + E A+K + ++ S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLL 638
N+++L ++ L+ E L FD + II + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 639 YLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
YLH+ I+HRDLK N+LL ++ KI DFG++ +F + K +GT
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGT 201
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 4e-19
Identities = 43/179 (24%), Positives = 85/179 (47%), Gaps = 41/179 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + I+ +G G +G V + L + VA+K++ F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 574 LIAKLQHRNLVRLLGCCI----EQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ +L H ++V++L I E+ +++ ++ E + ++ V+L + K LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ + G+ Y+H S I+HRDLK +N L++Q + K+ DFG+AR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 40/239 (16%), Positives = 69/239 (28%), Gaps = 56/239 (23%)
Query: 504 KDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RL 557
S F S+ + + ++ +G+G +G V A+K ++
Sbjct: 5 HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI 64
Query: 558 SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC------------CIEQGEKILIYEYMVN 605
+ + ++ K E+ L+ KL H N+ RL G + + +
Sbjct: 65 RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGH---LLDKLNV 121
Query: 606 KSLDVFLFDPTKKHLLGWQLRV----------------------------RIIDGIAQGL 637
D I+ I L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 638 LYLHQYSRLRIIHRDLKASNILL--DQHMNPKISDFGMARMFGGDELQGNT--KRIVGT 692
YLH I HRD+K N L ++ K+ DFG+++ F GT
Sbjct: 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 47/192 (24%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-----------------NQSGQGLKE 567
++++ ++G+G +G V + A+K LS
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 568 FKNEMML------IA---KLQHRNLVRLLGCCIEQGEKILIY---EYMVNKSLDVFLFD- 614
+ + IA KL H N+V+L+ ++ + +Y E + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEV 128
Query: 615 PTKKHLLGWQLRV---RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671
PT K L Q R +I GI YLH +IIHRD+K SN+L+ + + KI+DF
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 672 GMARMF-GGDEL 682
G++ F G D L
Sbjct: 182 GVSNEFKGSDAL 193
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 39/169 (23%), Positives = 64/169 (37%), Gaps = 13/169 (7%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLV 584
++ +G GG G VY+ + + VA+K +S + E +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ G+ + + L L ++ L V I+ I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL-QGNTKRIVGT 692
HRD+K NIL+ + DFG+A ++L Q VGT
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGT 198
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 501 GDGKDKSKDSSLP-LFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS 558
G G + P +F S ++ + Q LG+G FG V + + GQE AVK +S
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 559 N---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD- 614
+ + E+ L+ +L H N+++L ++G L+ E L FD
Sbjct: 61 KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDE 116
Query: 615 -PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISD 670
++K RII + G+ Y+H+ +I+HRDLK N+LL + N +I D
Sbjct: 117 IISRKRFSEVDAA-RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIID 172
Query: 671 FGMARMFGGDELQGNTKRIVGT 692
FG++ F + K +GT
Sbjct: 173 FGLSTHFEASKKM---KDKIGT 191
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 40/195 (20%), Positives = 75/195 (38%), Gaps = 50/195 (25%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE---FKNEMML 574
+ + + LG G G V ++VA+K + + S + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-- 632
+ KL H ++++ + + ++ E M L FD +++
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FD-------------KVVGNKR 110
Query: 633 ------------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMF 677
+ + YLH IIHRDLK N+LL ++ KI+DFG +++
Sbjct: 111 LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 678 GGDELQGNTKRIVGT 692
G L + + GT
Sbjct: 168 GETSL---MRTLCGT 179
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 26/199 (13%)
Query: 507 SKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--------RL 557
++D++LP S EN+ + LG G V + +E AVK
Sbjct: 1 TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58
Query: 558 SNQSGQGLKE-FKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD- 614
S + Q L+E E+ ++ K+ H N+++L L+++ M L FD
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY 114
Query: 615 -PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
K L + R +I+ + + + LH+ L I+HRDLK NILLD MN K++DFG
Sbjct: 115 LTEKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 674 ARMFGGDELQGNTKRIVGT 692
+ E + + GT
Sbjct: 171 SCQLDPGEK---LREVCGT 186
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIAKL 578
+ + LG GGFG VY G + + VA+K + E++L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 579 QHR--NLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIA 634
++RLL E+ + LI E D LFD T++ L +L +
Sbjct: 104 SSGFSGVIRLLDW-FERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVL 159
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGDELQ 683
+ + + H ++HRD+K NIL+D K+ DFG +
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 206
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 42/177 (23%), Positives = 69/177 (38%), Gaps = 33/177 (18%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS----------NQSGQGLKEFKNEMML 574
+ + LG+GGFG V+ G L + +VA+K + + S E +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 575 IAKLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHL-------LGWQLR 626
A H ++RLL E E L+ E + + D+F + K L Q
Sbjct: 92 GAGGGHPGVIRLLDW-FETQEGFMLVLERPLP-AQDLFDYITEKGPLGEGPSRCFFGQ-- 147
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDEL 682
++ I + H ++HRD+K NIL+D K+ DFG + +
Sbjct: 148 --VVAAIQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY 195
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 41/183 (22%), Positives = 75/183 (40%), Gaps = 26/183 (14%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------NQSGQGLKEFKNEMML 574
+ + + LG G G V ++VA++ +S + + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDG 632
+ KL H ++++ + + ++ E M LFD K L +
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCK-LYFYQ 247
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRI 689
+ + YLH+ IIHRDLK N+LL ++ KI+DFG +++ G L + +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 690 VGT 692
GT
Sbjct: 302 CGT 304
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 44/189 (23%), Positives = 74/189 (39%), Gaps = 43/189 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-------- 632
N+VRL E+ L+++ + L F+ I+
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FE-------------DIVAREFYSEADA 107
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP---KISDFGMARMFGGDELQ 683
I + + Y H I+HR+LK N+LL K++DFG+A E
Sbjct: 108 SHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 163
Query: 684 GNTKRIVGT 692
GT
Sbjct: 164 --WHGFAGT 170
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 44/211 (20%), Positives = 81/211 (38%), Gaps = 47/211 (22%)
Query: 506 KSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-------RL 557
+S L +A+ + + + +G G V + G E AVK RL
Sbjct: 75 QSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL 134
Query: 558 SNQSGQGLKE-FKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP 615
S + + ++E + E ++ ++ H +++ L+ L+++ M L FD
Sbjct: 135 SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FD- 189
Query: 616 TKKHLLGWQLRVRIIDG--------------IAQGLLYLHQYSRLRIIHRDLKASNILLD 661
+ + + + + +LH I+HRDLK NILLD
Sbjct: 190 ------------YLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234
Query: 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+M ++SDFG + E + + GT
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEK---LRELCGT 262
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 41/187 (21%), Positives = 72/187 (38%), Gaps = 42/187 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ F LG G F V+ + L G+ A+K + +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---------- 632
+V L L+ + + L FD RI++
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FD-------------RILERGVYTEKDASL 110
Query: 633 ----IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGN 685
+ + YLH+ I+HRDLK N+L +++ I+DFG+++M +
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--- 164
Query: 686 TKRIVGT 692
GT
Sbjct: 165 -STACGT 170
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 44/189 (23%), Positives = 74/189 (39%), Gaps = 43/189 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-------- 632
N+VRL E+ L+++ + L F+ I+
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FE-------------DIVAREFYSEADA 130
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP---KISDFGMARMFGGDELQ 683
I + + Y H I+HR+LK N+LL K++DFG+A E
Sbjct: 131 SHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 186
Query: 684 GNTKRIVGT 692
GT
Sbjct: 187 --WHGFAGT 193
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 34/199 (17%), Positives = 74/199 (37%), Gaps = 49/199 (24%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 581
++ +S+ LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV-------------- 627
N+++L+ G++ + + + + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 628 -----RIIDG-------------------IAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663
+++ + + + ++H L I HRD+K N+L++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 664 MNP-KISDFGMARMFGGDE 681
N K+ DFG A+ E
Sbjct: 178 DNTLKLCDFGSAKKLIPSE 196
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 51/213 (23%), Positives = 73/213 (34%), Gaps = 47/213 (22%)
Query: 504 KDKSKDSSLPLFSFASVTAATENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVK--RLSN 559
D F S+ + + SK LG G F V + GQE A K +
Sbjct: 7 HSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR 66
Query: 560 QSGQGLKEFKNEMMLIAKLQHR-NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK 618
+ E +E+ ++ + ++ L E ILI EY + F
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS---- 118
Query: 619 HLLGWQLRVRIIDG----------------IAQGLLYLHQYSRLRIIHRDLKASNILL-- 660
+ I +G+ YLHQ I+H DLK NILL
Sbjct: 119 ---------LCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSS 166
Query: 661 -DQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ KI DFGM+R G + I+GT
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHAC---ELREIMGT 196
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 30/188 (15%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------NQSGQGLKEFK 569
E++ KLG G +G V + E A+K + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 570 NEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRV 627
NE+ L+ L H N+++L ++ L+ E+ L F+ +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQG 684
I+ I G+ YLH+ I+HRD+K NILL + +N KI DFG++ F D
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 685 NTKRIVGT 692
+ +GT
Sbjct: 206 --RDRLGT 211
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 51/185 (27%), Positives = 75/185 (40%), Gaps = 36/185 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQH 580
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----LFDPTKKHLLGWQLRVRIIDG---- 632
V+L Q ++ L Y L L ++ ++ D
Sbjct: 90 PFFVKLYFTF--QDDEKL---YFG---LSYAKNGELLK----YIR----KIGSFDETCTR 133
Query: 633 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
I L YLH IIHRDLK NILL++ M+ +I+DFG A++ + Q
Sbjct: 134 FYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 688 RIVGT 692
VGT
Sbjct: 191 SFVGT 195
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 44/234 (18%), Positives = 69/234 (29%), Gaps = 66/234 (28%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
+F +G GGFG V++ + ++ A+KR+ ++ E+ +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID----------- 631
+VR +E + E D P V+I
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 632 ----GIAQGLLY----------LHQYSRLR-----------------------------I 648
+ LY L + R +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK----------RIVGT 692
+HRDLK SNI K+ DFG+ DE + VGT
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-17
Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 42/189 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
TE + + +LG+G F V + +L GQE A + S + ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-------- 632
N+VRL E+G LI++ + L F+ I+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FE-------------DIVAREYYSEADA 112
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQ 683
I + +L+ HQ + ++HR+LK N+LL + K++DFG+A G+ Q
Sbjct: 113 SHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--Q 167
Query: 684 GNTKRIVGT 692
GT
Sbjct: 168 QAWFGFAGT 176
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 41/180 (22%), Positives = 67/180 (37%), Gaps = 34/180 (18%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE--FKN---------EM 572
+++Q + G +G V G G VA+KR+ N G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKI-----LIYEYM------VNKSLDVFLFDPTKKHLL 621
L+ H N++ L + E L+ E M V + + ++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ I GL LH+ ++HRDL NILL + + I DF +AR D
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 36/160 (22%), Positives = 75/160 (46%), Gaps = 23/160 (14%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR 581
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 582 NLVRLLGCCIEQGEK--ILIYEYMVNKSLDVF---LFDPTKKHLLGWQLRVRIIDGIAQG 636
N++ L + + L++E++ N L D + + +++ +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-YEI--------LKA 142
Query: 637 LLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMAR 675
L Y H S I+HRD+K N+++D +H ++ D+G+A
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 45/194 (23%), Positives = 66/194 (34%), Gaps = 45/194 (23%)
Query: 524 TENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H 580
+ + +Q LGEG V L+ QE AVK + Q G E+ ++ + Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID--------- 631
RN++ L+ E+ L++E M S+ I
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSI----LS-------------HIHKRRHFNELEA 113
Query: 632 -----GIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMF-----G 678
+A L +LH I HRDLK NIL +Q KI DF +
Sbjct: 114 SVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 679 GDELQGNTKRIVGT 692
G+
Sbjct: 171 SPISTPELLTPCGS 184
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 40/175 (22%), Positives = 63/175 (36%), Gaps = 54/175 (30%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
+G G FG R L + VAVK + G + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRF---- 81
Query: 591 IEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLG-----------WQLRVRI 629
E ++ + + L++ G Q +
Sbjct: 82 ---------KEVILTPT-HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQ----L 125
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH--MNPKISDFGMARMFGGDEL 682
+ G++ Y H ++I HRDLK N LLD KI DFG ++
Sbjct: 126 LSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 42/180 (23%), Positives = 78/180 (43%), Gaps = 43/180 (23%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+N+ I+ +G G +G VY + VA+K+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKI-----LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ +L+ ++RL I ++ E + K+ +FL + K +L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTIL- 135
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ L G ++H IIHRDLK +N LL+Q + K+ DFG+AR ++
Sbjct: 136 YNLLL---------GENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 17/152 (11%), Positives = 48/152 (31%), Gaps = 14/152 (9%)
Query: 529 IQSKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNL 583
+ G ++ L ++VA+ + Q L+E + + ++++ +
Sbjct: 35 LLIFHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
R+L + +++ E++ SL +R + +A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH-- 146
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
R + S + + + ++
Sbjct: 147 -RAGVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 24/169 (14%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 580
+ + + +G G +G V +G++VA+K+LS QS K E++L+ +QH
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 581 RNLVRLL-----GCCIEQGEKI-LIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIID 631
N++ LL + L+ +M + K + + + ++L+ +Q
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ------- 134
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
+ +GL Y+H ++HRDLK N+ +++ KI DFG+AR +
Sbjct: 135 -MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 41/176 (23%), Positives = 69/176 (39%), Gaps = 20/176 (11%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
T+ + ++ +G G + + E AVK + +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLLYL 640
++ L + ++ E M L D +K + ++ I + + YL
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEYL 132
Query: 641 HQYSRLRIIHRDLKASNILL-DQHMNP---KISDFGMARMFGGDELQGNTKRIVGT 692
H ++HRDLK SNIL D+ NP +I DFG A+ + G T
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYT 183
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.8 bits (188), Expect = 2e-15
Identities = 34/199 (17%), Positives = 57/199 (28%), Gaps = 46/199 (23%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRL--------SNQSGQGLKEFKNEMML 574
TE K+GEG FG V++ + VA+K + + + +E E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 575 IAKLQ---------HRNLVRLLGCCIEQGE--KILIYEYMVNKSLDVFLFDPTK------ 617
+L + L QG +L+ + S D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 618 ------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
L I+ + L LR HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 660 LDQHMNPKISDFGMARMFG 678
L + K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 45/187 (24%), Positives = 78/187 (41%), Gaps = 43/187 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
++ F ++S+LG G VY+ + + A+K L + K + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---------- 632
+++L E L+ E + L FD RI++
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FD-------------RIVEKGYYSERDAAD 152
Query: 633 ----IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGN 685
I + + YLH+ I+HRDLK N+L KI+DFG++++ L
Sbjct: 153 AVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--- 206
Query: 686 TKRIVGT 692
K + GT
Sbjct: 207 MKTVCGT 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 39/201 (19%), Positives = 69/201 (34%), Gaps = 67/201 (33%)
Query: 524 TENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H 580
T+++ + + LG G G V + GQ+ A+K L + + + E+ +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLGWQLRVRII 630
++V +L +YE M + + LF RI
Sbjct: 82 PHIVCILD----------VYENMHHGKRCLLIIMECMEGGELFS-------------RIQ 118
Query: 631 DG----------------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDF 671
+ I + +LH I HRD+K N+L ++ K++DF
Sbjct: 119 ERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDF 175
Query: 672 GMARMFGGDELQGNTKRIVGT 692
G A+ + LQ T
Sbjct: 176 GFAKETTQNALQT----PCYT 192
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 45/180 (25%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
++ S +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 574 LIAKLQHRNLVRLLGC----CIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ + +H N++ + IEQ + + ++ + M + K+ L + + L
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFL- 134
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+Q LR GL Y+H S ++HRDLK SN+LL+ + KI DFG+AR+ D
Sbjct: 135 YQILR---------GLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 40/179 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 574 LIAKLQHRNLVRLL-----GCCIEQGEKI-LIYEYM---VNKSLDVFLFDPTKKHLLGWQ 624
L+ + H+N++ LL +E+ + + ++ E M + + + + L +LL +Q
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135
Query: 625 -LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
L G+ +LH IIHRDLK SNI++ KI DFG+AR G +
Sbjct: 136 MLC---------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 38/177 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 574 LIAKLQHRNLVRLL-----GCCIEQGEKI-LIYEYM---VNKSLDVFLFDPTKKHLLGWQ 624
L+ + H+N++ LL +E+ + + L+ E M + + + + L +LL +Q
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL-YQ 172
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ G+ +LH IIHRDLK SNI++ KI DFG+AR G
Sbjct: 173 --------MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 41/180 (22%), Positives = 66/180 (36%), Gaps = 44/180 (24%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 589
LGEG F K + Q AVK +S + + E+ + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID--------------GIAQ 635
+Q L+ E + L F+ RI +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FE-------------RIKKKKHFSETEASYIMRKLVS 117
Query: 636 GLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ ++H + ++HRDLK N+L + ++ KI DFG AR+ D K T
Sbjct: 118 AVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFT 172
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 42/181 (23%), Positives = 77/181 (42%), Gaps = 38/181 (20%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ LG GG G V+ + VA+K++ Q +K E+ +I +L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 583 LVRLL-------------GCCIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
+V++ + + + ++ EYM V + L + + +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP--LLEEHARLFM- 126
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGD 680
+Q LR GL Y+H + ++HRDLK +N+ ++ + + KI DFG+AR+
Sbjct: 127 YQLLR---------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 681 E 681
Sbjct: 175 Y 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 29/172 (16%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 580
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 581 RNLVRLL-----GCCIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVR 628
N++ LL ++ L+ +M + K L + + L+ +Q
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLV-YQ---- 136
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
+ +GL Y+H IIHRDLK N+ +++ KI DFG+AR +
Sbjct: 137 ----MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 8e-14
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 12/174 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
+ F LG GGFG V+ ++ ++ A K+L+ + +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLL 638
R +V L E + L+ M + +++ + + + R I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+LHQ II+RDLK N+LLD N +ISD G+A + TK GT
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGT 352
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 49/185 (26%), Positives = 88/185 (47%), Gaps = 42/185 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + KLG+G +G V+K G+ VAVK++ + F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 574 LIAKLQ-HRNLVRLLGCCI-EQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLGWQ 624
++ +L H N+V LL + + L+++YM V ++ L K++++ +Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI--LEPVHKQYVV-YQ 117
Query: 625 -LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
++ + YLH S ++HRD+K SNILL+ + K++DFG++R F
Sbjct: 118 LIK---------VIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 684 GNTKR 688
N
Sbjct: 166 TNNIP 170
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 45/176 (25%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ +F ++S LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKI-----LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ +H N++ + + +I E M V + L D ++ +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM--LSDDHIQYFI- 118
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
+Q LR + LH + +IHRDLK SN+L++ + + K+ DFG+AR+
Sbjct: 119 YQTLR---------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-13
Identities = 25/126 (19%), Positives = 46/126 (36%), Gaps = 19/126 (15%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ LT + G++L + + Y T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNL------VLYD--HSTSVWASNTGIL-GK 50
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
K + + GN V+ + ++W+S+ R N V L ++GN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 162 WQSFDY 167
W + Y
Sbjct: 103 WSTGTY 108
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 31/182 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIA 576
+FS+ +G GGFG VY R + ++ A+K L L E + + L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 577 KLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQL----RVRI-I 630
+V + +K+ I + M L HL + +R
Sbjct: 248 TGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--------HYHLSQHGVFSEADMRFYA 298
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
I GL ++H +++RDLK +NILLD+H + +ISD G+A F + V
Sbjct: 299 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 351
Query: 691 GT 692
GT
Sbjct: 352 GT 353
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 36/192 (18%), Positives = 62/192 (32%), Gaps = 65/192 (33%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 589
LG G G V + ++ A+K L + + + E+ L + ++VR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 122
Query: 590 CIEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLGWQLRVRIIDG------- 632
+YE + + LF RI D
Sbjct: 123 ---------VYENLYAGRKCLLIVMECLDGGELFS-------------RIQDRGDQAFTE 160
Query: 633 ---------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGD 680
I + + YLH + I HRD+K N+L + K++DFG A+
Sbjct: 161 REASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 681 ELQGNTKRIVGT 692
+ T
Sbjct: 218 N---SLTTPCYT 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 43/174 (24%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
E + S +G G +G V G VAVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 574 LIAKLQHRNLVRLL-----GCCIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLL 621
L+ ++H N++ LL +E+ + L+ M + K L D + L+
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLI 138
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+Q I +GL Y+H IIHRDLK SN+ +++ KI DFG+AR
Sbjct: 139 -YQ--------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 50/174 (28%), Positives = 75/174 (43%), Gaps = 15/174 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
F LG+GGFG V ++ ++ A K+L + +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLL 638
R +V L E + + L+ M L ++ + + R I GL
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP--EARAVFYAAEICCGLE 300
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
LH R RI++RDLK NILLD H + +ISD G+A + K VGT
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-12
Identities = 25/123 (20%), Positives = 43/123 (34%), Gaps = 19/123 (15%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
++L+ + G +L + L + Y VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS--GKPVWASNTGGLGSG 52
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
L N GNLV+ +QSN IW + + + + V L + N+VI +
Sbjct: 53 CRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 162 WQS 164
W +
Sbjct: 103 WAT 105
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 38/178 (21%), Positives = 74/178 (41%), Gaps = 35/178 (19%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQ------EVAVKRLSNQSGQGLKEFKNEMML----- 574
+ + +G+GGFG +Y + + + VK + +G E K
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 575 IAKLQHRNLVRLLG-----CCIEQGEKILIYEYMV----NKSL-DVFLFDP---TKKHLL 621
I K ++ LG + Y +M+ L ++ + ++K +L
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI--SDFGMARMF 677
QL +RI+D + Y+H++ +H D+KASN+LL+ ++ D+G+A +
Sbjct: 156 --QLSLRILDILE----YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 34/160 (21%), Positives = 57/160 (35%), Gaps = 19/160 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LKEFKNEM-MLIA 576
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 577 KLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
H N+V LLG C + G + +I E+ +L +L R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
G + + I DLK + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+A+G+ +L + + IHRDL A NILL + KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 38/186 (20%), Positives = 67/186 (36%), Gaps = 63/186 (33%)
Query: 521 TAATENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
A +++ + S+ LG G G V + ++ A+K L + + + E+ L +
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRA 67
Query: 579 -QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLGWQLRV 627
Q ++VR++ +YE + + LF
Sbjct: 68 SQCPHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS------------- 104
Query: 628 RIIDG----------------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKI 668
RI D I + + YLH + I HRD+K N+L + K+
Sbjct: 105 RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKL 161
Query: 669 SDFGMA 674
+DFG A
Sbjct: 162 TDFGFA 167
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 52/225 (23%), Positives = 82/225 (36%), Gaps = 43/225 (19%)
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
N + +E +D + + TA + F LG G FG V +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 546 L-LNGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601
+G A+K L Q LK+ NE ++ + LV+L + L
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNSNL--- 116
Query: 602 YMVNKSLDVF----LFDPTKKHLLGWQLR-VRIIDG---------IAQGLLYLHQYSRLR 647
YMV ++ +F LR + I YLH
Sbjct: 117 YMV---MEYVAGGEMF---------SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--- 161
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+I+RDLK N+L+DQ +++DFG A+ ++G T + GT
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 29/179 (16%), Positives = 66/179 (36%), Gaps = 35/179 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR---------LLNGQEVAVKRLSNQSGQGLKEFK------ 569
+ ++S G +Y+ Q+ ++K L + G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 570 -----NEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV----NKSLDVFLFDPTKKHL 620
N+ + + +G + Q + Y ++V +SL D + KH+
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-ALDVSPKHV 155
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI--SDFGMARMF 677
L + +++ + L +LH+ +H ++ A NI +D ++ + +G A +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 8e-12
Identities = 29/124 (23%), Positives = 49/124 (39%), Gaps = 18/124 (14%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIV 100
+D L + G +L + + + Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCNL------VLYD--NNRAVWASGTNGK-- 48
Query: 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESY 160
VL + N GNLV+ + + IW+SN +R+ N L + N+VI DNS +
Sbjct: 49 ASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 161 LWQS 164
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-05
Identities = 17/72 (23%), Positives = 35/72 (48%), Gaps = 1/72 (1%)
Query: 96 NSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSN 155
+ + + + N NLVL + +N +W+S + + V ++ ++GNLVI S +
Sbjct: 13 GGSLAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAI 71
Query: 156 STESYLWQSFDY 167
+ Q+ +Y
Sbjct: 72 WASNTNRQNGNY 83
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 35/165 (21%), Positives = 63/165 (38%), Gaps = 27/165 (16%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
NF + K+G G FG + G+ L + VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIAQGL 637
++ ++ E + SL+ LFD + + QL R+
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQLISRME------- 119
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPK-----ISDFGMARMF 677
Y+H + +I+RD+K N L+ + N I DF +A+ +
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-11
Identities = 22/123 (17%), Positives = 40/123 (32%), Gaps = 20/123 (16%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ L + +L + + L + + YQ +W +N +
Sbjct: 3 NVLLSGQTLHADHSLQA--GAYTLTIQNKCNL------VKYQN--GRQIWASNTDRR--G 50
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
LT+ + GNLV+ + +N +W S + L +G VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 162 WQS 164
W
Sbjct: 103 WSL 105
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 5e-11
Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 45/187 (24%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 580
++F I LG G FG V+ R + A+K L + LK+ +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF-----LFDPTKKHLLGWQLR-VRIIDG-- 632
++R+ G Q + + +M+ +D + LF LR +
Sbjct: 66 PFIIRMWGTF--QDAQQI---FMI---MD-YIEGGELF---------SLLRKSQRFPNPV 107
Query: 633 -------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
+ L YLH II+RDLK NILLD++ + KI+DFG A+ +
Sbjct: 108 AKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDV 159
Query: 686 TKRIVGT 692
T + GT
Sbjct: 160 TYTLCGT 166
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 36/168 (21%), Positives = 72/168 (42%), Gaps = 31/168 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHR 581
++ + ++GEG FG +++G LLN Q+VA+K +S Q E++ +L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIA 634
+ + E +L+ + + SL+ L D + Q+ R+
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQ---- 120
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK-----ISDFGMARMF 677
+H+ S +++RD+K N L+ + + + DFGM + +
Sbjct: 121 ----SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 47/213 (22%), Positives = 84/213 (39%), Gaps = 33/213 (15%)
Query: 497 CEADGDGKDKSKDSSLPLFSFASVTAAT-----ENFSIQSKLGEGGFGPVYKGRLLNGQE 551
+ K+K+ D+ L + E++ + +G G FG V R + ++
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 552 V-AVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607
V A+K LS + F E ++A +V+L Q ++ L YMV
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--QDDRYL---YMV--- 147
Query: 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQ--------GLLYLHQYSRLRIIHRDLKASNIL 659
++ + P L+ + + A+ L +H + IHRD+K N+L
Sbjct: 148 ME---YMP-GGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNML 200
Query: 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
LD+ + K++DFG + + VGT
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGT 232
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 38/176 (21%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKN---EMMLIAKLQH 580
++F I +G+G FG V + + +++ A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLG----WQL---------RV 627
LV L Q E+ + +MV +D LLG + L V
Sbjct: 75 PFLVNLWYSF--QDEEDM---FMV---VD---------LLLGGDLRYHLQQNVHFKEETV 117
Query: 628 RI-IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
++ I + L YL RIIHRD+K NILLD+H + I+DF +A M +
Sbjct: 118 KLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 30/174 (17%)
Query: 526 NFSIQSKLGEGGFGPVYKG-RLLNGQEVA---VKRLSNQSGQGLKEFKNEMML-----IA 576
+ + K+G GGFG +Y ++ A VK ++G E K + I
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 577 KLQHRNLVRLLG-----CCIEQGEKILIYEYMV----NKSLDVFLFDPTKKHLLG--WQL 625
K R + LG K Y +MV L + QL
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQ-KISGQNGTFKKSTVLQL 156
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI--SDFGMARMF 677
+R++D + Y+H+ +H D+KA+N+LL ++ +D+G++ +
Sbjct: 157 GIRMLDVLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 42/182 (23%), Positives = 72/182 (39%), Gaps = 30/182 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
E+F I +G G FG V +L N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMV--------NKSLDVFLFDPTKKHLLGWQLRVRI-I 630
+ + L + + L+ +Y V +K D + R +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE-----------MARFYL 181
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+ + +HQ L +HRD+K NIL+D + + +++DFG D + V
Sbjct: 182 AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAV 237
Query: 691 GT 692
GT
Sbjct: 238 GT 239
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 27/165 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RN 582
+ + K+G G FG +Y G + G+EVA+K ++ E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIAQ 635
+ + C E +++ E + SL+ LF+ + L Q+ RI
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRKFSLKTVLLLADQMISRIE----- 119
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPK---ISDFGMARMF 677
Y+H + IHRD+K N L+ I DFG+A+ +
Sbjct: 120 ---YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 39/179 (21%), Positives = 71/179 (39%), Gaps = 34/179 (18%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFK-------NEMMLIAK 577
+ KLG G F V+ + ++N VA+K + E K +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 578 LQHRNLVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
+ ++++LL +G +++E L L KK+ + + + I
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHR-GIPLIYVKQI 136
Query: 634 AQ----GLLYLHQYSRLRIIHRDLKASNILLDQHMNP------KISDFGMARMFGGDEL 682
++ GL Y+H R IIH D+K N+L++ +P KI+D G A + +
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY 192
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 44/163 (26%), Positives = 66/163 (40%), Gaps = 25/163 (15%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 581
+ I S +G+G FG V K + + VA+K + N+ Q E + L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111
Query: 582 -----NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLR-VRII-DGI 633
+V L + + L++E L L+D + + G L R +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMA 674
LL+L L IIH DLK NILL KI DFG +
Sbjct: 167 CTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-10
Identities = 23/129 (17%), Positives = 43/129 (33%), Gaps = 19/129 (14%)
Query: 37 FSLAADTLTPTTLIRDGE-TLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANR 95
FS D P L ++ + + + + Y + +W N
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYDN--NNPIWATNT 56
Query: 96 NSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSN 155
+ G LV++ N T+W S V+ + + V L + N+VI ++
Sbjct: 57 GGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA--- 111
Query: 156 STESYLWQS 164
LW +
Sbjct: 112 -----LWAT 115
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 21/162 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHR 581
F + K+G G FG +Y G + +EVA+K + ++ Q L E K + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGG 62
Query: 582 NLV-RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLR--VRIIDGIAQGLL 638
+ + +E +L+ + + SL+ LF+ + L L+ + + D + +
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKL---SLKTVLMLADQMINRVE 117
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPK---ISDFGMARMF 677
++H S +HRD+K N L+ I DFG+A+ +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 4e-10
Identities = 28/123 (22%), Positives = 45/123 (36%), Gaps = 20/123 (16%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ L + GE L + R+ + Y D +W N D
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYDV--DKPIWATNTGGL--D 49
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
+ L++ + GNLV+ + N IW+SN E N V L + N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 162 WQS 164
W +
Sbjct: 102 WAT 104
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 39/182 (21%), Positives = 71/182 (39%), Gaps = 30/182 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
++F I +G G F V ++ +V A+K ++ E F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMV--------NKSLDVFLFDPTKKHLLGWQLRVRI-I 630
R + +L + + L+ EY V +K + + R +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-----------MARFYL 168
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
I + +H+ L +HRD+K NILLD+ + +++DFG D + V
Sbjct: 169 AEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAV 224
Query: 691 GT 692
GT
Sbjct: 225 GT 226
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 46/163 (28%), Positives = 72/163 (44%), Gaps = 27/163 (16%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 581
+ + +G+G FG V K Q VA+K + N+ Q +E + ++ L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQD 154
Query: 582 -----NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLR-VRII-DGI 633
N++ +L + + +E L + L++ KK G+ L VR I
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMA 674
Q L LH + RIIH DLK NILL Q K+ DFG +
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 7e-09
Identities = 24/126 (19%), Positives = 42/126 (33%), Gaps = 23/126 (18%)
Query: 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSP 98
L + L + L + F+L Y G W N+
Sbjct: 1 LGTNYLLSGQTLDTEGHLKN--GDFDLVMQDDCNLV-LYNGNWQS------------NTA 45
Query: 99 IVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTE 158
++ LT+++ G LV+ N T+W S N A + +G LV+ S
Sbjct: 46 NNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS------ 99
Query: 159 SYLWQS 164
+++
Sbjct: 100 --VFKI 103
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 8e-09
Identities = 17/125 (13%), Positives = 44/125 (35%), Gaps = 18/125 (14%)
Query: 40 AADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPI 99
+ L + ++ D L + + + L + + +VW + +
Sbjct: 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKGSKTNIVWESGTSGR- 55
Query: 100 VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTES 159
++ + + + G L + + T++ SN + + V L NG V+ +
Sbjct: 56 -GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPA------- 107
Query: 160 YLWQS 164
+W +
Sbjct: 108 -VWST 111
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 54/215 (25%), Positives = 82/215 (38%), Gaps = 43/215 (20%)
Query: 488 GITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL 547
GI+ + + L ++ A +F +G+G FG V R
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 548 NGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQHRNLVRLLGCCIEQGEKILIYEY 602
+ AVK L ++ KE K+ M L+ ++H LV L + +K+ Y
Sbjct: 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKL----Y 115
Query: 603 MVNKSLDVF-----LFDPTKKHLLGWQL---------RVRI-IDGIAQGLLYLHQYSRLR 647
V LD + LF + L R R IA L YLH L
Sbjct: 116 FV---LD-YINGGELF---------YHLQRERCFLEPRARFYAAEIASALGYLHS---LN 159
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMAR--MFGGD 680
I++RDLK NILLD + ++DFG+ + +
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-08
Identities = 21/112 (18%), Positives = 40/112 (35%), Gaps = 13/112 (11%)
Query: 37 FSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRN 96
+ L ++ L + +L + Y W +N +
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCNL------VLY---GGKYGWQSNTH 50
Query: 97 SPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVI 148
++ L ++++G L++ + TIWSS S + V L D+G VI
Sbjct: 51 G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 3e-07
Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 7/71 (9%)
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSG 153
+ + KN L + NLVL W SN ++ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVL--YGGKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 154 SNSTESYLWQS 164
+W S
Sbjct: 74 KT-----IWSS 79
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 43/175 (24%), Positives = 65/175 (37%), Gaps = 27/175 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 580
F LG+G FG V + A+K L + E E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSL-------DVFLFDPTKKHLLGWQLRVRI-ID 631
L L + +++ + EY L VF D R R
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----------RARFYGA 255
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
I L YLH S +++RDLK N++LD+ + KI+DFG+ + D T
Sbjct: 256 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 43/173 (24%), Positives = 68/173 (39%), Gaps = 33/173 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 579
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVN--------KSLDVFLFDPTKKHLLGWQLRVRII 630
L +L C + +++ + EY VN + + F
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEY-VNGGDLMYHIQQVGRFKEP-----------HAVFY 126
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGD 680
IA GL +L II+RDLK N++LD + KI+DFGM + ++ G
Sbjct: 127 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 43/173 (24%), Positives = 68/173 (39%), Gaps = 33/173 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 579
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVN--------KSLDVFLFDPTKKHLLGWQLRVRII 630
L +L C + +++ + EY VN + + F
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEY-VNGGDLMYHIQQVGRFKEP-----------HAVFY 447
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGD 680
IA GL +L II+RDLK N++LD + KI+DFGM + ++ G
Sbjct: 448 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 23/60 (38%), Positives = 35/60 (58%), Gaps = 4/60 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I L +LH+ L II+RD+K NILLD + + ++DFG+++ F DE + GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 19/50 (38%), Positives = 30/50 (60%), Gaps = 5/50 (10%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGD 680
I+ L +LHQ II+RDLK NI+L+ + K++DFG+ + + G
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 17/50 (34%), Positives = 29/50 (58%), Gaps = 5/50 (10%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGD 680
I L YLH +++RD+K N++LD+ + KI+DFG+ + + G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 46/173 (26%), Positives = 69/173 (39%), Gaps = 33/173 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQ 579
E+F + LG+G FG V+ + A+K L + + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVN--------KSLDVFLFDPTKKHLLGWQLRVRII 630
H L + C + E + + EY +N +S F R
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEY-LNGGDLMYHIQSCHKFDLS-----------RATFY 123
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGD 680
I GL +LH I++RDLK NILLD+ + KI+DFGM + M G
Sbjct: 124 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 20/50 (40%), Positives = 31/50 (62%), Gaps = 5/50 (10%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGD 680
+A L +LH L II+RDLK NILLD+ + K++DFG+++ +
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 21/50 (42%), Positives = 31/50 (62%), Gaps = 5/50 (10%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGD 680
I+ L YLH+ II+RDLK N+LLD + K++D+GM + + GD
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 21/50 (42%), Positives = 31/50 (62%), Gaps = 5/50 (10%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGD 680
I+ L YLH+ II+RDLK N+LLD + K++D+GM + + GD
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 20/50 (40%), Positives = 28/50 (56%), Gaps = 5/50 (10%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA--RMFGGD 680
I L++LH II+RDLK N+LLD + K++DFGM + G
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 6e-07
Identities = 75/513 (14%), Positives = 137/513 (26%), Gaps = 162/513 (31%)
Query: 245 FIFQPIVVQNKDEVYYMYESYSSPIIM------ILRV-NPLGQVQRLIW---HEMSTGWQ 294
+F+ V N D + + I+ I+ + + RL W + Q
Sbjct: 23 SVFEDAFVDNFD-CKDV-QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQ 80
Query: 295 VFFTAPDPFCHYGDCGPNSICSVDQTSHCECLEGF---KFKSQQNQTC------VRSHSS 345
F V + ++ F K++Q Q +
Sbjct: 81 KFVE-----------------EVLRINY-----KFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 346 DCKSGDRFKKLDDIKLPDLLDVSLNES-MNLKE-----------CEAECLKNCSCRAYAN 393
F K ++ L ++ + L+ + C +Y
Sbjct: 119 LYNDNQVFAKY-NVSRLQPYL-KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSY-- 174
Query: 394 SKVTDGGSGCLMW--FG-------DLIDLKK-----TDNHTNGVSIYIRVPAS-EQGNKK 438
KV + W L L+K N T+ + +
Sbjct: 175 -KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 439 LLWIIVILVLP--LVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVN--MGITTRTN 494
L ++ L++L V A+ W+ AF+++ + +TTR
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWN------------------AFNLSCKILLTTR-- 273
Query: 495 EFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVY-KGRLLNGQEVA 553
K + F S T I P K LL +
Sbjct: 274 ----------FKQ------VTDFLSAATTTH---ISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 554 VKRLSNQSGQGL--------KEFKNEMMLIAKLQHRN---LVRLLGCCIEQGEKILIYEY 602
+ L + + ++ + +H N L ++ + E +
Sbjct: 315 PQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
Query: 603 MVNKSLDVFLFD---PTKKHLLG--W-QLRVRIIDGIAQGLLYLHQYS---------RLR 647
L VF PT LL W + + + LH+YS +
Sbjct: 375 F--DRLSVFPPSAHIPTI--LLSLIWFDVIKSDVMVVVNK---LHKYSLVEKQPKESTIS 427
Query: 648 I--IHRDLKAS--------NILLDQHMNPKISD 670
I I+ +LK ++D + PK D
Sbjct: 428 IPSIYLELKVKLENEYALHRSIVDHYNIPKTFD 460
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 41/174 (23%), Positives = 66/174 (37%), Gaps = 24/174 (13%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 581
F + K+G+G FG V + + N + AVK + N E ++ K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92
Query: 582 ----NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRV--RIIDGIA 634
N+V+ G + LI+E L L++ ++ G+ + I
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
+ L YL ++ + H DLK NILLD K G TK
Sbjct: 148 KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 2e-06
Identities = 17/78 (21%), Positives = 27/78 (34%), Gaps = 8/78 (10%)
Query: 87 DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNL 146
D V + N+ + G + +L N +W+S SR V L + NL
Sbjct: 166 DRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNL 225
Query: 147 VIRDNSGSNSTESYLWQS 164
I + LW +
Sbjct: 226 AIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 4e-04
Identities = 24/146 (16%), Positives = 43/146 (29%), Gaps = 11/146 (7%)
Query: 87 DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNL 146
D VW +N + + + G LV+L N WSS + N V L + +
Sbjct: 44 DVRVWASNTAGATGCR---AVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 147 VIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTH 206
I LW S +++ L + S +
Sbjct: 101 TIYG--------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPY 152
Query: 207 RLDIHVLPQVCVYNGSAKYTCTGPWN 232
RL + + +++ + T
Sbjct: 153 RLSMETDCNLVLFDRDDRVWSTNTAG 178
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 38/165 (23%), Positives = 64/165 (38%), Gaps = 30/165 (18%)
Query: 527 FSIQSKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 581
+ I LGEG FG V + G+ VAVK + N E + ++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ----VLEHLNTT 71
Query: 582 ------NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQ-LRVRIIDGIA 634
V++L G +++E L + +D K++ G+ R+ I +A
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKEN--GFLPFRLDHIRKMA 124
Query: 635 QGLL----YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ +LH ++ H DLK NIL Q + + + R
Sbjct: 125 YQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 31/163 (19%), Positives = 56/163 (34%), Gaps = 26/163 (15%)
Query: 527 FSIQSKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 581
+ I LGEG FG V + +VA+K + N E ++ K++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76
Query: 582 ------NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRV--RIIDG 632
V + G + +E L F+ K++ + L +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ L +LH ++ H DLK NIL + + +
Sbjct: 132 LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.7 bits (112), Expect = 5e-06
Identities = 30/162 (18%), Positives = 52/162 (32%), Gaps = 22/162 (13%)
Query: 38 SLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNS 97
+ L + G+ L+SP+QRF+L G + VWVAN
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNL------VIQD--NGATVWVANEQQ 62
Query: 98 PIV------DKNGVLTVSNRGNLVLLNQSNGTIWSS-----NVSREVKNPVAQLLDNGNL 146
P +K L + L + S +W + + + L D+GN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 147 VIRDNSGSNSTESYLWQSFDYPTDTML---QGMKLGWDLRTG 185
V+ D+ + + +L + G G
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAG 164
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-05
Identities = 12/62 (19%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 99 IVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTE 158
+ ++ + NLVL N + SN + +L + G L I + +
Sbjct: 17 LSYESAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVW 74
Query: 159 SY 160
Y
Sbjct: 75 VY 76
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 41/161 (25%), Positives = 64/161 (39%), Gaps = 40/161 (24%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ + KLG G F V+ + + VA+K + + + +E I L+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDE---IRLLKS-- 89
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVF------------LFDPTKKHLLGWQLR---- 626
+ + MV + LD F +F+ HLL W ++
Sbjct: 90 --------VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQ 141
Query: 627 ------VR-IIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660
V+ II + QGL YLH ++ RIIH D+K NILL
Sbjct: 142 GLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILL 180
|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A Length = 99 | Back alignment and structure |
|---|
Score = 38.2 bits (88), Expect = 9e-04
Identities = 14/50 (28%), Positives = 21/50 (42%), Gaps = 5/50 (10%)
Query: 304 CHYGDCGPNSICSV--DQTSHCECLEGFKFKSQQNQTCVRSHSSDCKSGD 351
C C NS C D+ C+CL +K Q+ CV + + C +
Sbjct: 7 CVKKQCPQNSGCFRHLDEREECKCLLNYK---QEGDKCVENPNPTCNENN 53
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 692 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-24 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 7e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-19 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 7e-16 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 7e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 4e-09 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 9e-15 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-14 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 8e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-46
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 6/168 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ ++G G FG VYKG+ V + ++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+G + ++ ++ SL L K + I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA-- 122
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
IIHRDLK++NI L + + KI DFG+A + +++ G+
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-46
Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQH 580
++F S+LG G G V+K +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+V G GE + E+M SLD L K + Q+ ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ +I+HRD+K SNIL++ K+ DFG++ VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGT 166
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 5e-45
Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 6/164 (3%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ + I +LG+G FG VYK + A K + +S + L+++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+LL + ++ E+ ++D + + + L + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+IIHRDLKA NIL + K++DFG++ + ++
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 8e-45
Identities = 55/168 (32%), Positives = 81/168 (48%), Gaps = 7/168 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL + +I EYM N SL FL P+ L + + IA+G+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFP 173
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 4e-44
Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 16/173 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 579
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N ++ GC + + L+ EY + + D+ K L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
LH +IHRD+KA NILL + K+ DFG A + VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGT 174
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-44
Identities = 48/168 (28%), Positives = 84/168 (50%), Gaps = 7/168 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C+EQ L++E+M + L +L ++ L + + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+IHRDL A N L+ ++ K+SDFGM R D+ ++
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 7/168 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C +Q +I EYM N L +L + +H Q + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ +HRDL A N L++ K+SDFG++R DE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (394), Expect = 2e-43
Identities = 55/191 (28%), Positives = 87/191 (45%), Gaps = 19/191 (9%)
Query: 515 FSFASVTAATENFS---------IQSKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQ 560
F+F A F+ I+ +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 561 SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL 620
+ + ++F +E ++ + H N++ L G + ++I E+M N SLD FL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
V ++ GIA G+ YL +HRDL A NIL++ ++ K+SDFG++R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 681 ELQGNTKRIVG 691
+G
Sbjct: 182 TSDPTYTSALG 192
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (393), Expect = 3e-43
Identities = 47/163 (28%), Positives = 87/163 (53%), Gaps = 6/163 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ +++ KLG G +G VY+G VAVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG C + +I E+M +L +L + ++ + + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+ IHRDL A N L+ ++ K++DFG++R+ GD +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-42
Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 8/170 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
E++ + LGEG +G V + VAVK + ++ + K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+ G E + L EY L + + R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ I HRD+K N+LLD+ N KISDFG+A +F + + ++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-42
Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 8/170 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
E++ + +G G +G K R +G+ + K L + + + +E+ L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 582 NLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLL 638
N+VR I++ L + EY L + TK+ L + +R++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 639 YLHQYSR--LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
H+ S ++HRDLK +N+ LD N K+ DFG+AR+ D
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-42
Identities = 46/163 (28%), Positives = 80/163 (49%), Gaps = 8/163 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 585 RLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ + ++ EYM SL +L + +LG ++ + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+HRDL A N+L+ + K+SDFG+ + + G
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-42
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 6/162 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L + ++ EYM SL FL T K+L V + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+HRDL+A+NIL+ +++ K++DFG+AR+ +E
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 45/179 (25%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+Q +G+G FG V++G+ G+EVAVK S++ + + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60
Query: 585 RLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+ + L+ +Y + SL +L ++ + + +++ A GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 641 HQ-----YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGT 692
H + I HRDLK+ NIL+ ++ I+D G+A D + VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 10/178 (5%)
Query: 516 SFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMML 574
S SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA 634
+ + ++ N+V L + E ++ EY+ S L D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
Q L +LH ++IHRD+K+ NILL + K++DFG + Q +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (372), Expect = 3e-40
Identities = 49/196 (25%), Positives = 81/196 (41%), Gaps = 31/196 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-KEFKNEMMLIAK 577
N +GEG FG V++ R VAVK L ++ + +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL----------------- 620
+ N+V+LLG C L++EYM L+ FL + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 621 ----LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
L ++ I +A G+ YL + + +HRDL N L+ ++M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 677 FGGDELQGNTKRIVGT 692
+
Sbjct: 190 IYSADYYKADGNDAIP 205
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-40
Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 523 ATENFSIQS-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 577
+N I +LG G FG V +G +VA+K L + + +E E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L + +VRL+G C + +L+ E L FL K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR-IVGT 692
YL + +HRDL A N+LL KISDFG+++ G D+ +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-40
Identities = 50/191 (26%), Positives = 69/191 (36%), Gaps = 26/191 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 577
S LG G FG V + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL---------------L 621
L H N+V LLG C G ++I EY L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ + +A+G+ +L IHRDL A NILL KI DFG+AR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 682 LQGNTKRIVGT 692
Sbjct: 200 NYVVKGNARLP 210
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-40
Identities = 49/196 (25%), Positives = 75/196 (38%), Gaps = 31/196 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 577
EN LG G FG V +VAVK L ++ + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK------------------ 618
L H N+V LLG C G LI+EY L +L +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 619 --HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
++L ++ + +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 677 FGGDELQGNTKRIVGT 692
D
Sbjct: 214 IMSDSNYVVRGNARLP 229
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-39
Identities = 49/172 (28%), Positives = 74/172 (43%), Gaps = 14/172 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQH 580
E+F I LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N++RL G + LI EY ++ L +K Q I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
H R+IHRD+K N+LL KI+DFG + + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 143 bits (362), Expect = 2e-38
Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 8/170 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+++ I +LG G FG V++ G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V L + E ++IYE+M L + D + + + V + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 644 SRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGNTKRIVG 691
+H DLK NI+ + K+ DFG+ + T
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 3e-38
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 16/174 (9%)
Query: 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNL 583
++G G F VYKG EVA L ++ + + FK E ++ LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 584 VRLLGCCIEQGEK----ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
VR + +L+ E M + +L +L + ++ ++ I +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 640 LHQYSRLRIIHRDLKASNILL-DQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
LH + IIHRDLK NI + + KI D G+A + K ++GT
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 176
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-38
Identities = 44/171 (25%), Positives = 68/171 (39%), Gaps = 10/171 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
V+L + + Y N L ++ A+ + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYT---AEIVSAL 121
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
IIHRDLK NILL++ M+ +I+DFG A++ + Q VG
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 9e-38
Identities = 51/175 (29%), Positives = 73/175 (41%), Gaps = 13/175 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAK 577
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L HRNL+RL G + ++ E SL L LLG R +A+G+
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGT--LSRYAVQVAEGM 124
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
YL R IHRDL A N+LL KI DFG+ R ++ +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 12/174 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-NQSGQGLKEFKNEMMLIAKL 578
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
+ ++ RLLG C+ LI + M L + K +G Q + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
YL R++HRDL A N+L+ + KI+DFG+A++ G +E + + +
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 5/165 (3%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 581
++ S +GEG +G V +N VA+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N++ + + + Y+V + L+ K L + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
++HRDLK SN+LL+ + KI DFG+AR+ D
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 140 bits (354), Expect = 3e-37
Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 8/161 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ + I +LG G FG V++ G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+ L ++ E +LI E++ L + + + + + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 644 SRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDEL 682
I+H D+K NI+ + KI DFG+A DE+
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-37
Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 14/175 (8%)
Query: 525 ENFSIQSK-LGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQG--LKEFKNEMMLIAKL 578
+ +++ K LG G FG V KG + VAVK L N++ E E ++ +L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
+ +VR++G C E +L+ E L+ +L + + + + ++ ++ G+
Sbjct: 66 DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMK 121
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK-RIVGT 692
YL + +HRDL A N+LL KISDFG+++ DE +
Sbjct: 122 YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (352), Expect = 6e-37
Identities = 44/166 (26%), Positives = 70/166 (42%), Gaps = 13/166 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNE---MMLIAK 577
+FS+ +G GGFG VY R G+ A+K L + QG NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+V + + I + M L L + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
++H +++RDLK +NILLD+H + +ISD G+A F +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 24/186 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG---QEVAVKRLS-NQSGQGLKEFKNEMMLIAKL-Q 579
+ Q +GEG FG V K R+ + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------------FDPTKKHLLGWQLR 626
H N++ LLG C +G L EY + +L FL + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+ +A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG++R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 687 KRIVGT 692
Sbjct: 184 TMGRLP 189
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 12/173 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQ 579
E + +GEG FG V++G ++ VA+K N + ++E F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E +I E L F +K+ L + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
L R +HRD+ A N+L+ + K+ DFG++R +
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLP 172
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-36
Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 11/163 (6%)
Query: 532 KLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
+G G FG VY G LL+ AVK L+ + G + +F E +++ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 587 LGCCIE-QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
LG C+ +G +++ YM + L F+ + T + + + + +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLAS 148
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
+ +HRDL A N +LD+ K++DFG+AR E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 7e-35
Identities = 54/168 (32%), Positives = 82/168 (48%), Gaps = 11/168 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSGQG-LKEFKNEMMLIAKL 578
+ Q +G G FG VYKG L VA+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++RL G + ++I EYM N +LD FL + K V ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
YL + +HRDL A NIL++ ++ K+SDFG++R+ D T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 8e-35
Identities = 48/190 (25%), Positives = 75/190 (39%), Gaps = 25/190 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEM-MLIA 576
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 577 KLQHRNLVRLLGCCIEQGEKILI-YEYMVNKSLDVFLF-------------DPTKKHLLG 622
H N+V LLG C + G +++ E+ +L +L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
+ + +A+G+ +L + IHRDL A NILL + KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 683 QGNTKRIVGT 692
Sbjct: 190 YVRKGDARLP 199
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 17/182 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 577
E ++ +LG+G FG VY+G VA+K ++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRII 630
++VRLLG + ++I E M L +L +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
IA G+ YL+ + +HRDL A N ++ + KI DFGM R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 691 GT 692
Sbjct: 197 LP 198
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 131 bits (330), Expect = 2e-34
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 10/160 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
++F I LG G FG V+ R NG+ A+K L + + ++ +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
++R+ G + + +I +Y+ L L + + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
II+RDLK NILLD++ + KI+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 36/160 (22%), Positives = 67/160 (41%), Gaps = 9/160 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E + I LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+ L E ++I+E++ + + T L + V + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDE 681
I H D++ NI+ + KI +FG AR +
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-33
Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 15/169 (8%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+++ +G G FG VY+ +L +G+ VA+K++ + E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 585 RLLGCCIEQGEK------ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
RL GEK L+ +Y+ V K L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 639 YLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNT 686
Y+H I HRD+K N+LLD K+ DFG A+ E +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 128 bits (321), Expect = 2e-33
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 8/164 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E + K+GEG +G VYK + G+ A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+L + +L++E++ + + L + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
R++HRDLK N+L+++ KI+DFG+AR FG +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (321), Expect = 2e-33
Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 20/179 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL---------KEFKNEMML 574
EN+ + LG G V + +E AVK + G + E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 575 IAKLQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
+ K+ H N+++L L+++ M L +L T+K L + +I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ + LH +L I+HRDLK NILLD MN K++DFG + E + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 172
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-32
Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 26/191 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------------L 621
+ +H+N++ LLG C + G +I EY +L +L L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ V +A+G+ YL + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 682 LQGNTKRIVGT 692
T
Sbjct: 190 YYKKTTNGRLP 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 123 bits (310), Expect = 4e-32
Identities = 42/178 (23%), Positives = 73/178 (41%), Gaps = 15/178 (8%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQ 579
++ + + LG GG V+ R L ++VAVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 580 HRNLVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
H +V + + ++ EY+ +L + + + + +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG-GDELQGNTKRIVGT 692
L + H + IIHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-32
Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 8/160 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
ENF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+LL + + L++E++ D + + L + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ R++HRDLK N+L++ K++DFG+AR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (310), Expect = 9e-32
Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 14/174 (8%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 581
+ + + LG G F V + VA+K ++ ++ +G +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V L G LI + + L + +K + R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 642 QYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I+HRDLK N+L D+ ISDFG+++M + GT
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 9e-32
Identities = 44/173 (25%), Positives = 68/173 (39%), Gaps = 13/173 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 579
E+F + LG+G FG V+ Q A+K L + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H L + + + EY+ L + H I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
LH I++RDLK NILLD+ + KI+DFGM + + + NT GT
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 5e-31
Identities = 49/155 (31%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 532 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQHRNLVR 585
LGEG F VYK R N Q VA+K++ K+ E+ L+ +L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
LL + L++++M +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
I+HRDLK +N+LLD++ K++DFG+A+ FG
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQSGQG--LKEFKNE---MMLI 575
A + + +++GEG +G V+K R L G+ VA+KR+ Q+G+ E + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD---VFLFDPTKKHLLGWQLRVRIIDG 632
+H N+VRL C +V + +D D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ +GL +LH R++HRDLK NIL+ K++DFG+AR++ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 45/181 (24%), Positives = 85/181 (46%), Gaps = 19/181 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
+ +K+G+G FG V+K R GQ+VA+K++ N+ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 582 NLVRLLGCCIEQGEKI--------LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
N+V L+ C + L++++ + + K R++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR--IVG 691
GL Y+H+ +I+HRD+KA+N+L+ + K++DFG+AR F + + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 692 T 692
T
Sbjct: 184 T 184
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 8e-30
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 9/160 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
+ + K+GEG +G V+K + + VA+K RL + E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+VRL + L++E+ F G + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
++HRDLK N+L++++ K+++FG+AR FG
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 39/172 (22%), Positives = 66/172 (38%), Gaps = 12/172 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
+F LG+G FG V R G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
L L + EY L L + + + R R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEIVSAL 118
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+++RD+K N++LD+ + KI+DFG+ + D K GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 168
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 115 bits (289), Expect = 4e-29
Identities = 33/179 (18%), Positives = 74/179 (41%), Gaps = 18/179 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
++ + ++GEG FG +++G LLN Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+ + ++G ++ ++ SL+ L + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 644 SRLRIIHRDLKASNILLDQHMNP-----KISDFGMARMFGGDELQGN-----TKRIVGT 692
+++RD+K N L+ + + + DFGM + + + + K + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 7e-29
Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 7/160 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 582 NLVRLLGCCIEQGEKILIYE-YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N++ LL + Y+V + L K LG ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
H IIHRDLK N+ +++ KI DFG+AR +
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (288), Expect = 2e-28
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 10/160 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
+ F LG G FG V + +G A+K L Q + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
LV+L + ++ EY+ + L + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
H L +I+RDLK N+L+DQ +++DFG A+ G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (282), Expect = 3e-28
Identities = 37/175 (21%), Positives = 73/175 (41%), Gaps = 16/175 (9%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+ + K+G G FG +Y G + G+EVA+K ++ + E + +Q +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
+ C +G+ ++ ++ SL+ ++K + + + D + + Y+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---S 121
Query: 646 LRIIHRDLKASNIL---LDQHMNPKISDFGMARMFGGDELQGN-----TKRIVGT 692
IHRD+K N L + I DFG+A+ + + K + GT
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-28
Identities = 40/176 (22%), Positives = 67/176 (38%), Gaps = 19/176 (10%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE------FKNEMMLIAKLQ 579
+ + LG GGFG VY G + + VA+K + E E++L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 580 --HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
++RLL +LI E T++ L +L + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ H ++HRD+K NIL+D + K+ DFG + GT
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGT 172
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 7e-28
Identities = 46/179 (25%), Positives = 74/179 (41%), Gaps = 20/179 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLKEFKNEMMLIAK 577
+ + +LG G F V K R G + A K + S++ G ++ + E+ ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+QH N++ L + + ILI E + L +K L + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG- 125
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFGGDELQGNTKRIVGT 692
++ L+I H DLK NI+L P KI DFG+A K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 15/168 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLS----NQSGQGLKEFKNEMMLIA 576
ENF + LG G +G V+ R + G+ A+K L Q + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 577 KLQHR-NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
++ LV L + + LI +Y+ L L + Q+ + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
+L L +L II+RD+K NILLD + + ++DFG+++ F DE +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 3e-27
Identities = 34/167 (20%), Positives = 69/167 (41%), Gaps = 19/167 (11%)
Query: 525 ENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHR 581
+++ + S+ LG G G V + ++ A+K L + + + E+ L + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 582 NLVRLLGCC----IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
++VR++ + +++ E + L + D + + I+ I + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAI 124
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNP---KISDFGMARMFGGDE 681
YLH + I HRD+K N+L K++DFG A+
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (268), Expect = 4e-26
Identities = 36/173 (20%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN 582
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 583 LVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
++ L + + L++E++ N L + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 641 HQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
H + I+HRD+K N+++D +H ++ D+G+A + + V +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVAS 192
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 7e-26
Identities = 49/159 (30%), Positives = 70/159 (44%), Gaps = 7/159 (4%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 580
E + S +G G +G V G VAVK+LS QS K E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 581 RNLVRLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
N++ LL Y+V + L + K L +I I +GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+H IIHRDLK SN+ +++ KI DFG+AR
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (256), Expect = 8e-26
Identities = 31/158 (19%), Positives = 63/158 (39%), Gaps = 20/158 (12%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLK--------EFKNEMMLIAK 577
+I +GEG V+ E VK ++ + S + +K F + A+
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+ R L +L G + + +Y + N ++ + L D + + + + ++D I + +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ I+H DL N+L+ I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 6e-24
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 21/177 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHR 581
+ + +G G G V + + VA+K+LS Q+ K E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 582 NLVRLLGCCIEQG------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
N++ LL Q + L+ E M V + + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
G+ +LH IIHRDLK SNI++ KI DFG+AR G + V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVT 181
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 91.9 bits (228), Expect = 7e-23
Identities = 24/118 (20%), Positives = 49/118 (41%), Gaps = 13/118 (11%)
Query: 50 IRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVS 109
+ +GE L Q ++ + ++ + ++ T VW +N K +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGIL-GKKGCKAVLQ 58
Query: 110 NRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167
+ GN V+ + ++W+S+ R N V L ++GN+VI + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 88.6 bits (218), Expect = 2e-19
Identities = 35/171 (20%), Positives = 69/171 (40%), Gaps = 23/171 (13%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+ + KLG G F V+ + ++N VA+K + + ++E+ L+ ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73
Query: 586 LLGCCIEQGEKILIY-------------EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
K+L + + V + L + + +I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP------KISDFGMARMF 677
+ GL Y+H+ R IIH D+K N+L++ +P KI+D G A +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 71.6 bits (175), Expect = 7e-16
Identities = 27/126 (21%), Positives = 44/126 (34%), Gaps = 20/126 (15%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ L + GE L F + ++ D +W N
Sbjct: 2 NILYSGETLSTGEFLNY--GSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
++ L++ GNLV+ N SN IW+SN + N V L + N+VI
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 162 WQSFDY 167
W + +
Sbjct: 102 WATGTH 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 69.2 bits (169), Expect = 7e-15
Identities = 18/97 (18%), Positives = 34/97 (35%), Gaps = 9/97 (9%)
Query: 80 IWYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVA 138
I Y D + + L++ NLVL ++ + +WS+N + + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70
Query: 139 QLLDNGNLVIRDNSGSNSTESYLWQSFD--YPTDTML 173
L NG + + N +W S + +
Sbjct: 71 VLQPNGRMDVLTNQN-----IAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 52.6 bits (126), Expect = 4e-09
Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 5/110 (4%)
Query: 43 TLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDK 102
L T + + +Q +L + + + ++ + D VW N+
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR---DDRVWS--TNTAGKGT 66
Query: 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNS 152
+ G + +L N +W+S SR V L + NL I +
Sbjct: 67 GCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGA 116
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 68.7 bits (167), Expect = 9e-15
Identities = 29/130 (22%), Positives = 50/130 (38%), Gaps = 18/130 (13%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIV 100
+D L + G +L + + + Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCNL------VLYD--NNRAVWASGTNGKAS 50
Query: 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESY 160
VL + N GNLV+ + + IW+SN +R+ N L + N+VI DNS +
Sbjct: 51 GC--VLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 161 LWQSFDYPTD 170
+W + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 67.7 bits (165), Expect = 2e-14
Identities = 21/138 (15%), Positives = 43/138 (31%), Gaps = 22/138 (15%)
Query: 30 IFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTV 89
I + L T + ++ + + + + Y +
Sbjct: 3 IIFSKQPDDNHPQILHAT----ESLEILFGTHVYRFIMQTDCNL------VLYD--NNNP 50
Query: 90 VWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIR 149
+W N + G LV++ N T+W S V+ + + V L + N+VI
Sbjct: 51 IWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY 108
Query: 150 DNSGSNSTESYLWQSFDY 167
++ LW +
Sbjct: 109 GDA--------LWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 54.6 bits (131), Expect = 8e-10
Identities = 29/130 (22%), Positives = 43/130 (33%), Gaps = 22/130 (16%)
Query: 35 IKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVAN 94
I F L+ + P TL ++L S F S + ++ D VW +N
Sbjct: 3 ILFGLSHEGSHPQTLHAA-QSLELSS--FRFTMQSDCN-----LVLFD---SDVRVWASN 51
Query: 95 RNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGS 154
+ + G LV+L N WSS + N V L + + I
Sbjct: 52 TAG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPG-- 106
Query: 155 NSTESYLWQS 164
LW S
Sbjct: 107 ------LWDS 110
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 692 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.98 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.98 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.98 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.98 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.98 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.97 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.96 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.95 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.95 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.95 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.94 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.94 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.94 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.94 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.81 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.79 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.79 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.62 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.57 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.47 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.33 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.16 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.99 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.83 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.82 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.68 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.65 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.87 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.81 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.36 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-34 Score=244.12 Aligned_cols=162 Identities=29% Similarity=0.512 Sum_probs=142.6
Q ss_pred HHHHHHHCCCCCEEEEECCCCCEEEEEEEECC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 44376541895365564213827499999559-94999999045787458889999999982799980006889996995
Q 005519 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (692)
Q Consensus 517 ~~~l~~~~~~f~~~~~iG~G~fG~Vyk~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~ 595 (692)
+.+.+...++|++.++||+|+||+||+|.+.. ++.||||+++.. ....++|.+|+.++.+++|||||+++|+|.+.+.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CCCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCE
T ss_conf 765174579939865982088808999999999969999997776-1039999999999986799988267752745785
Q ss_pred EEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCE
Q ss_conf 99999736789976884299987778999999999999999999885699956843778996798699956997207723
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~ 675 (692)
.++||||+++|+|..++... ....+++..+..|+.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf 47876314676067775303-5541579999999999999788898789---3057604576899899928983244546
Q ss_pred ECCCCCCC
Q ss_conf 10898655
Q 005519 676 MFGGDELQ 683 (692)
Q Consensus 676 ~~~~~~~~ 683 (692)
.+..+...
T Consensus 164 ~~~~~~~~ 171 (287)
T d1opja_ 164 LMTGDTYT 171 (287)
T ss_dssp TCCSSSSE
T ss_pred ECCCCCCE
T ss_conf 53788722
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-33 Score=238.66 Aligned_cols=163 Identities=29% Similarity=0.408 Sum_probs=141.6
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 189536556421382749999955-99499999904578-7458889999999982799980006889996995999997
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 601 (692)
.++|++.++||+|+||+||+++.. +++.||||++.... ....+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCC
Q ss_conf 36789976884299987778999999999999999999885699956843778996798699956997207723108986
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~ 681 (692)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 4589808999753---799999999999999999999999759---8357546899788789987983231422404688
Q ss_pred CCCCCCCEECC
Q ss_conf 55686612159
Q 005519 682 LQGNTKRIVGT 692 (692)
Q Consensus 682 ~~~~~~~~~Gt 692 (692)
.....+..+||
T Consensus 158 ~~~~~~~~~GT 168 (271)
T d1nvra_ 158 RERLLNKMCGT 168 (271)
T ss_dssp EECCBCCCCSC
T ss_pred CCCCCCCEEEC
T ss_conf 65311132557
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-32 Score=234.40 Aligned_cols=160 Identities=26% Similarity=0.430 Sum_probs=140.3
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
Q ss_conf 189536556421382749999955-9949999990457874588899999999827999800068899969959999973
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 602 (692)
.++|++.++||+|+||+||++... +++.||||++........+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
T ss_conf 10538878981285829999999899989999998430172799999999999867999880585779889998999970
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 67899768842999877789999999999999999998856999568437789967986999569972077231089865
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (692)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~~ 682 (692)
+++|+|..++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..+..
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 379808988641----59999999999999999999999879---72267768886887899686425156413213666
Q ss_pred CCCCCCEECC
Q ss_conf 5686612159
Q 005519 683 QGNTKRIVGT 692 (692)
Q Consensus 683 ~~~~~~~~Gt 692 (692)
.. ...+||
T Consensus 172 ~~--~~~~gt 179 (293)
T d1yhwa1 172 KR--STMVGT 179 (293)
T ss_dssp CB--CCCCSC
T ss_pred CC--CCCCCC
T ss_conf 44--444447
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-33 Score=236.45 Aligned_cols=157 Identities=34% Similarity=0.530 Sum_probs=137.2
Q ss_pred HHHCCCCCEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 65418953655642138274999995599499999904578745888999999998279998000688999699599999
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 521 ~~~~~~f~~~~~iG~G~fG~Vyk~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 600 (692)
+...++|++.++||+|+||.||+|.+.++..||||+++.. ....++|.+|+.++.+++|||||+++|++.+ +..++||
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEE
T ss_conf 0388993886798107982899999999999999998647-6888999999999986799988578731045-9769999
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCC
Q ss_conf 73678997688429998777899999999999999999988569995684377899679869995699720772310898
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~ 680 (692)
||+++|+|.+++... ....+++..++.|+.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 87 Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EECCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCC
T ss_conf 957898288887514-7898878899999999999999997489---546756422515620244042341014773588
Q ss_pred CCC
Q ss_conf 655
Q 005519 681 ELQ 683 (692)
Q Consensus 681 ~~~ 683 (692)
...
T Consensus 163 ~~~ 165 (272)
T d1qpca_ 163 EYT 165 (272)
T ss_dssp CEE
T ss_pred CCC
T ss_conf 644
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-32 Score=234.30 Aligned_cols=153 Identities=31% Similarity=0.551 Sum_probs=138.5
Q ss_pred CCCCCEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
Q ss_conf 18953655642138274999995599499999904578745888999999998279998000688999699599999736
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 603 (692)
.++|++.++||+|+||.||+|.+.++..||||++... ....++|.+|+.++.+++|||||+++|+|.+.+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEEC
T ss_conf 6995888898208882999999889999999998788-676899999999999668997565352431599337999836
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 7899768842999877789999999999999999998856999568437789967986999569972077231089865
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (692)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~~ 682 (692)
++|+|.+++.. ....+++..++.++.|+|.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC
T ss_conf 99918997520--1347889999999999999877653164---31044315326666887768655321002368873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-32 Score=234.77 Aligned_cols=153 Identities=27% Similarity=0.437 Sum_probs=137.7
Q ss_pred HCCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 4189536556421382749999955-994999999045787458889999999982799980006889996995999997
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 523 ~~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 601 (692)
+.+.|++.++||+|+||+||+|... ++..||||++........+.+.+|+.++..++|||||++++++.+.+..++|||
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 10375984799307781999999999993999999872899999999999999986799998849889800995899996
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCC
Q ss_conf 3678997688429998777899999999999999999988569995684377899679869995699720772310898
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~ 680 (692)
|+++|+|..++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 90 y~~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 90 FCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred CCCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCC
T ss_conf 2799818899986--2899999999999999999999999889---887140700314878999899716123035778
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-31 Score=227.44 Aligned_cols=154 Identities=24% Similarity=0.405 Sum_probs=137.0
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
Q ss_conf 189536556421382749999955-9949999990457874588899999999827999800068899969959999973
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 602 (692)
-++|++.++||+|+||.||++... +++.||||++........+.+.+|+.++.+++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEEECCCEECCCC
Q ss_conf 678997688429998777899999999999999999988569995684377899679869--995699720772310898
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ--HMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~--~~~~ki~DFGla~~~~~~ 680 (692)
+++|+|.+++.. ....+++..+..|+.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 799889999976--2378999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CC
Q ss_conf 65
Q 005519 681 EL 682 (692)
Q Consensus 681 ~~ 682 (692)
..
T Consensus 180 ~~ 181 (350)
T d1koaa2 180 QS 181 (350)
T ss_dssp SC
T ss_pred CC
T ss_conf 43
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-32 Score=234.78 Aligned_cols=164 Identities=31% Similarity=0.473 Sum_probs=137.5
Q ss_pred HHHCCCCCEEEEECCCCCEEEEEEEECCCCEEEEEECCCC--CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 6541895365564213827499999559949999990457--87458889999999982799980006889996995999
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 521 ~~~~~~f~~~~~iG~G~fG~Vyk~~~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 598 (692)
+...++|++.++||+|+||+||+|+.. ..||||+++.. .....++|.+|+.++.+++|||||++++++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred CCCCCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEE
T ss_conf 315451899889830788589999999--989999997346998999999999999984799878645679715-58999
Q ss_pred EEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECC
Q ss_conf 99736789976884299987778999999999999999999885699956843778996798699956997207723108
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~ 678 (692)
||||+++|+|.+++... ...+++..+..|+.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 v~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEECCCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECC
T ss_conf 99658998889998523--578999999999999999988875099---9516147899798189978875002213335
Q ss_pred CCCCCCCCCCEECC
Q ss_conf 98655686612159
Q 005519 679 GDELQGNTKRIVGT 692 (692)
Q Consensus 679 ~~~~~~~~~~~~Gt 692 (692)
............||
T Consensus 156 ~~~~~~~~~~~~gt 169 (276)
T d1uwha_ 156 RWSGSHQFEQLSGS 169 (276)
T ss_dssp ----------CCCC
T ss_pred CCCCCCCCCCCCCC
T ss_conf 56776312566557
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-31 Score=227.01 Aligned_cols=154 Identities=25% Similarity=0.376 Sum_probs=136.8
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
Q ss_conf 189536556421382749999955-9949999990457874588899999999827999800068899969959999973
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 602 (692)
.++|++.++||+|+||+||+|... +++.||||++........+.+.+|+.++.+++|||||++++++.+....++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEEECCCEECCCC
Q ss_conf 67899768842999877789999999999999999998856999568437789967986--9995699720772310898
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~--~~~~~ki~DFGla~~~~~~ 680 (692)
+++|+|.+++.. ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+..+
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 899808888986--3899899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CC
Q ss_conf 65
Q 005519 681 EL 682 (692)
Q Consensus 681 ~~ 682 (692)
..
T Consensus 183 ~~ 184 (352)
T d1koba_ 183 EI 184 (352)
T ss_dssp SC
T ss_pred CC
T ss_conf 72
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.2e-33 Score=237.29 Aligned_cols=153 Identities=26% Similarity=0.340 Sum_probs=135.6
Q ss_pred HHCCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 54189536556421382749999955-99499999904578-74588899999999827999800068899969959999
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 522 ~~~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 599 (692)
...++|++.++||+|+||+||++... +++.||+|+++... ......+.+|+.++..++|||||+++++|.+..+.++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 87568889789712778099999998999699999987540978999999999999867999999499999989999999
Q ss_pred EECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEECCCCCCCEEECCCCCEEEEEECCCEECC
Q ss_conf 97367899768842999877789999999999999999998856-99956843778996798699956997207723108
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~-~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~ 678 (692)
|||+++|+|..++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 83 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EECCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 976799868998742---4999999999999999999999998599---9714457799468789989995487762567
Q ss_pred CC
Q ss_conf 98
Q 005519 679 GD 680 (692)
Q Consensus 679 ~~ 680 (692)
..
T Consensus 157 ~~ 158 (322)
T d1s9ja_ 157 DS 158 (322)
T ss_dssp HH
T ss_pred CC
T ss_conf 88
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.4e-32 Score=231.03 Aligned_cols=162 Identities=30% Similarity=0.417 Sum_probs=141.2
Q ss_pred CCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 89536556421382749999955-9949999990457---8745888999999998279998000688999699599999
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 600 (692)
++|++.+.||+|+||+||+|... +++.||||.+... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCC
Q ss_conf 73678997688429998777899999999999999999988569995684377899679869995699720772310898
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~ 680 (692)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 7048987777653---1599999999999999999997621650---884767741236688853886032102422567
Q ss_pred CCCCCCCCEECC
Q ss_conf 655686612159
Q 005519 681 ELQGNTKRIVGT 692 (692)
Q Consensus 681 ~~~~~~~~~~Gt 692 (692)
.........+||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CCCCCCCCCCCC
T ss_conf 764333555677
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.4e-32 Score=230.37 Aligned_cols=169 Identities=29% Similarity=0.418 Sum_probs=139.8
Q ss_pred HHHCCCCCEEEEECCCCCEEEEEEEECC-C-----CEEEEEECCCC-CCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEEE
Q ss_conf 6541895365564213827499999559-9-----49999990457-874588899999999827-99980006889996
Q 005519 521 TAATENFSIQSKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (692)
Q Consensus 521 ~~~~~~f~~~~~iG~G~fG~Vyk~~~~~-~-----~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~ 592 (692)
+...++|++.++||+|+||+||+|+... + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 57789939701983078819999998578855420499999966335878999999999999971589968687788862
Q ss_pred CCEEEEEEECCCCCCHHHHHCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
Q ss_conf 9959999973678997688429998--------------------77789999999999999999998856999568437
Q 005519 593 QGEKILIYEYMVNKSLDVFLFDPTK--------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRD 652 (692)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrD 652 (692)
.+..++||||+++|+|.++|..... ...+++..++.|+.|++.||.|||+++ |+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECC
T ss_conf 995899997279995999998625777510221000012220012577899999999999999999997399---05052
Q ss_pred CCCCCEEECCCCCEEEEEECCCEECCCCCCCCCCCCEECC
Q ss_conf 7899679869995699720772310898655686612159
Q 005519 653 LKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 653 ikp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~Gt 692 (692)
|||+|||++.++.+||+|||+|+...............||
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred CCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCC
T ss_conf 7032144345982898514222204577861562343578
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=2.2e-32 Score=233.02 Aligned_cols=154 Identities=32% Similarity=0.533 Sum_probs=134.6
Q ss_pred CCCCCEEEEECCCCCEEEEEEEECC-C---CEEEEEECCCC-CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 1895365564213827499999559-9---49999990457-87458889999999982799980006889996995999
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~~-~---~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 598 (692)
.++|.+.++||+|+||+||+|.+.. + ..||||++... .....++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 00427856980278829999999579978899999997844598999999999999985799888618999962887799
Q ss_pred EEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECC
Q ss_conf 99736789976884299987778999999999999999999885699956843778996798699956997207723108
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~ 678 (692)
||||+++|+|..++... ...+++..+..++.|+|.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 105 v~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEECCCCCCEEEECCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECC
T ss_conf 99722798530021045--679999999999999999889885279---8357615044898899919988844315756
Q ss_pred CCCC
Q ss_conf 9865
Q 005519 679 GDEL 682 (692)
Q Consensus 679 ~~~~ 682 (692)
.+..
T Consensus 180 ~~~~ 183 (299)
T d1jpaa_ 180 DDTS 183 (299)
T ss_dssp ----
T ss_pred CCCC
T ss_conf 7777
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.3e-31 Score=227.72 Aligned_cols=160 Identities=25% Similarity=0.315 Sum_probs=139.3
Q ss_pred CCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 89536556421382749999955-9949999990457---8745888999999998279998000688999699599999
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 600 (692)
++|.+.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCC
Q ss_conf 73678997688429998777899999999999999999988569995684377899679869995699720772310898
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~ 680 (692)
||+++|+|..++. ....+++.....++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 0357986055553---2567759999999999965211343159---622464777847658998888205652003567
Q ss_pred CCCCCCCCEECC
Q ss_conf 655686612159
Q 005519 681 ELQGNTKRIVGT 692 (692)
Q Consensus 681 ~~~~~~~~~~Gt 692 (692)
... ....+||
T Consensus 159 ~~~--~~~~~GT 168 (337)
T d1o6la_ 159 GAT--MKTFCGT 168 (337)
T ss_dssp TCC--BCCCEEC
T ss_pred CCC--CCCCEEC
T ss_conf 862--0551008
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.7e-32 Score=230.24 Aligned_cols=154 Identities=32% Similarity=0.523 Sum_probs=136.1
Q ss_pred HCCCCCEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
Q ss_conf 41895365564213827499999559949999990457874588899999999827999800068899969959999973
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 523 ~~~~f~~~~~iG~G~fG~Vyk~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 602 (692)
..++|++.+.||+|+||+||+|.+.++..||||+++.. ....++|.+|+.++.+++|||||+++|+|.+ +..++||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEE
T ss_conf 77997984699307980999999999999999998804-4888999999999986666788689999823-975999994
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 67899768842999877789999999999999999998856999568437789967986999569972077231089865
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (692)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~~ 682 (692)
+++|+|..++... ....++|..++.|+.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 93 ~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 93 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf 4799435420000-3553059999999999999999875411---43353123079998999299844255542568873
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.5e-31 Score=224.94 Aligned_cols=154 Identities=31% Similarity=0.503 Sum_probs=138.5
Q ss_pred CCCCCEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
Q ss_conf 18953655642138274999995599499999904578745888999999998279998000688999699599999736
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 603 (692)
.++|++.++||+|+||.||+|+.++++.||||.++.. ....++|.+|+.++.+++||||++++|+|.+.+..++|+||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf 6997996898207883999999889989999998747-577899999999999668986015889985078169999704
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCC
Q ss_conf 78997688429998777899999999999999999988569995684377899679869995699720772310898655
Q 005519 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (692)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~~~ 683 (692)
++|+|..++.. ....+++..+.+++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+......
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE
T ss_conf 89938886410--2467768999999999999999875468---434665413588769984798861442023578722
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.6e-31 Score=224.10 Aligned_cols=154 Identities=30% Similarity=0.513 Sum_probs=131.7
Q ss_pred HCCCCCEEE-EECCCCCEEEEEEEECC---CCEEEEEECCCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 418953655-64213827499999559---94999999045787-45888999999998279998000688999699599
Q 005519 523 ATENFSIQS-KLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 523 ~~~~f~~~~-~iG~G~fG~Vyk~~~~~---~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 597 (692)
..++|.+.+ +||+|+||.||+|.... +..||||.++.... ...++|.+|+.++.+++|||||+++|+|.. +..+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred CCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEE
T ss_conf 444718878487306080999999960897689999998820397899999999999986799888068656036-8079
Q ss_pred EEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEEC
Q ss_conf 99973678997688429998777899999999999999999988569995684377899679869995699720772310
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~ 677 (692)
+||||+++|+|..++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 85 lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf 99980789968997521--2569999999999999999878998688---105767646604546885420331342115
Q ss_pred CCCCC
Q ss_conf 89865
Q 005519 678 GGDEL 682 (692)
Q Consensus 678 ~~~~~ 682 (692)
.....
T Consensus 160 ~~~~~ 164 (285)
T d1u59a_ 160 GADDS 164 (285)
T ss_dssp TTCSC
T ss_pred CCCCC
T ss_conf 54343
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.4e-31 Score=227.57 Aligned_cols=151 Identities=32% Similarity=0.523 Sum_probs=133.0
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 189536556421382749999955-994999999045787---4588899999999827999800068899969959999
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 599 (692)
.+.|+..++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++.+++|||||++++++.+.+..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 78567627970188809999999899939999998444435889999999999999977899982389999989988999
Q ss_pred EECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCC
Q ss_conf 97367899768842999877789999999999999999998856999568437789967986999569972077231089
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~ 679 (692)
|||+++|+|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf 98069994578997---3799999999999999999999998689---76667884217987999789844365334677
Q ss_pred C
Q ss_conf 8
Q 005519 680 D 680 (692)
Q Consensus 680 ~ 680 (692)
.
T Consensus 168 ~ 168 (309)
T d1u5ra_ 168 A 168 (309)
T ss_dssp B
T ss_pred C
T ss_conf 8
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=225.71 Aligned_cols=151 Identities=30% Similarity=0.399 Sum_probs=134.9
Q ss_pred CCCCEEEEECCCCCEEEEEEEECC-CCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 895365564213827499999559-949999990457---8745888999999998279998000688999699599999
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 600 (692)
++|++.+.||+|+||+||+++... ++.||+|.+... .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCC
Q ss_conf 73678997688429998777899999999999999999988569995684377899679869995699720772310898
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~ 680 (692)
||+++|+|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 5047985898875---0489999999999999999999999889---465220234414668998711555633544888
Q ss_pred C
Q ss_conf 6
Q 005519 681 E 681 (692)
Q Consensus 681 ~ 681 (692)
.
T Consensus 160 ~ 160 (263)
T d2j4za1 160 R 160 (263)
T ss_dssp C
T ss_pred C
T ss_conf 5
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.6e-31 Score=227.22 Aligned_cols=165 Identities=30% Similarity=0.486 Sum_probs=141.8
Q ss_pred HHHHHHHCCCCCEEEEECCCCCEEEEEEEEC------CCCEEEEEECCCCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEE
Q ss_conf 4437654189536556421382749999955------9949999990457874-58889999999982799980006889
Q 005519 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGC 589 (692)
Q Consensus 517 ~~~l~~~~~~f~~~~~iG~G~fG~Vyk~~~~------~~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~ 589 (692)
+.+++.+.++|++.++||+|+||+||+|+.. ++..||||++...... ..++|.+|+.++..++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 33113898893886798207883999999888765778829999998821085799999999999996689976552466
Q ss_pred EEECCEEEEEEECCCCCCHHHHHCCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 996995999997367899768842999---------------------87778999999999999999999885699956
Q 005519 590 CIEQGEKILIYEYMVNKSLDVFLFDPT---------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648 (692)
Q Consensus 590 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~i 648 (692)
|.+....++++||+++|+|.++++... ....+++..++.|+.|++.||.|||+.+ +
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---E
T ss_conf 6059803899981589929999985275542100001110012103467889899999999999999855413578---6
Q ss_pred EECCCCCCCEEECCCCCEEEEEECCCEECCCCCCCC
Q ss_conf 843778996798699956997207723108986556
Q 005519 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (692)
Q Consensus 649 vHrDikp~NILl~~~~~~ki~DFGla~~~~~~~~~~ 684 (692)
+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~ 197 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCC
T ss_conf 854884011689899928983314421136776411
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=8.3e-31 Score=222.38 Aligned_cols=151 Identities=29% Similarity=0.424 Sum_probs=134.3
Q ss_pred CCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 89536556421382749999955-9949999990457---8745888999999998279998000688999699599999
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 600 (692)
++|++.++||+|+||+||+++.. +++.||||++... .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCC
Q ss_conf 73678997688429998777899999999999999999988569995684377899679869995699720772310898
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~ 680 (692)
||+++|+|..++. ....+++.....++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 5037863223432---2221110079999999987655412476---770556810503868998898317521671245
Q ss_pred C
Q ss_conf 6
Q 005519 681 E 681 (692)
Q Consensus 681 ~ 681 (692)
.
T Consensus 158 ~ 158 (316)
T d1fota_ 158 T 158 (316)
T ss_dssp B
T ss_pred C
T ss_conf 6
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=2.4e-31 Score=226.06 Aligned_cols=155 Identities=25% Similarity=0.366 Sum_probs=135.4
Q ss_pred HHCCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 54189536556421382749999955-99499999904578-74588899999999827999800068899969959999
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 522 ~~~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 599 (692)
...+.|++.+.||+|+||+||++... +++.||||.+.... ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 77666699889940658399999999999899999981577312899999999999867998999198999989988898
Q ss_pred EECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEEECCCEE
Q ss_conf 97367899768842999877789999999999999999998856999568437789967986---999569972077231
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMARM 676 (692)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~---~~~~~ki~DFGla~~ 676 (692)
|||+++|+|.++|.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+. +++.+||+|||+|+.
T Consensus 86 mE~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp ECCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEE
T ss_conf 852689848886530---367887899999999999987524130---55687046300110468882499831543587
Q ss_pred CCCCCC
Q ss_conf 089865
Q 005519 677 FGGDEL 682 (692)
Q Consensus 677 ~~~~~~ 682 (692)
...+..
T Consensus 160 ~~~~~~ 165 (307)
T d1a06a_ 160 EDPGSV 165 (307)
T ss_dssp ------
T ss_pred CCCCCE
T ss_conf 258970
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.9e-30 Score=217.14 Aligned_cols=154 Identities=29% Similarity=0.411 Sum_probs=135.0
Q ss_pred HCCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCC------CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 4189536556421382749999955-99499999904578------7458889999999982799980006889996995
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (692)
Q Consensus 523 ~~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~ 595 (692)
..+.|.+.++||+|+||+||+|... +++.||||.+.... ....+.+.+|+.++.+++|||||++++++.+...
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred EEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEEE
Q ss_conf 999997367899768842999877789999999999999999998856999568437789967986999----5699720
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDF 671 (692)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~----~~ki~DF 671 (692)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+|++||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEECCCCCCCCCHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCH
T ss_conf 9999986778643100103---564215578999999999987666254---2211333012798258986664696433
Q ss_pred CCCEECCCCCC
Q ss_conf 77231089865
Q 005519 672 GMARMFGGDEL 682 (692)
Q Consensus 672 Gla~~~~~~~~ 682 (692)
|+|+.+.....
T Consensus 162 G~a~~~~~~~~ 172 (293)
T d1jksa_ 162 GLAHKIDFGNE 172 (293)
T ss_dssp TTCEECTTSCB
T ss_pred HHHHHCCCCCC
T ss_conf 44210577763
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.4e-31 Score=223.64 Aligned_cols=155 Identities=34% Similarity=0.535 Sum_probs=134.5
Q ss_pred HCCCCCEEEEECCCCCEEEEEEEECCC-----CEEEEEECCCCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 418953655642138274999995599-----499999904578-74588899999999827999800068899969959
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 523 ~~~~f~~~~~iG~G~fG~Vyk~~~~~~-----~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 596 (692)
..+.|+..+.||+|+||.||+|.+... ..||||++.... ....++|.+|+.++.+++|||||+++|+|.+.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 88996861598117790999999968998787999999988445968999999999999856898783236778338803
Q ss_pred EEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf 99997367899768842999877789999999999999999998856999568437789967986999569972077231
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~ 676 (692)
++|+||+.++++..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEECCCCCCHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 899972135740222102--3454208999999999998541212123---42576564427888998499845510300
Q ss_pred CCCCCC
Q ss_conf 089865
Q 005519 677 FGGDEL 682 (692)
Q Consensus 677 ~~~~~~ 682 (692)
+..+..
T Consensus 160 ~~~~~~ 165 (283)
T d1mqba_ 160 LEDDPE 165 (283)
T ss_dssp ------
T ss_pred CCCCCC
T ss_conf 357876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=1.4e-30 Score=220.79 Aligned_cols=152 Identities=28% Similarity=0.351 Sum_probs=130.2
Q ss_pred CCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHH---HHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 89536556421382749999955-9949999990457---8745888999---999998279998000688999699599
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKN---EMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~---~~~~~~~f~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~ 597 (692)
++|++.+.||+|+||.||+++.. +++.||||++... .......+.+ |+.++..++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEEC
Q ss_conf 99973678997688429998777899999999999999999988569995684377899679869995699720772310
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (692)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~ 677 (692)
+||||+++|+|..+|.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 99991489838999873---255327899999999999999999779---622044422167858896798220102333
Q ss_pred CCCCC
Q ss_conf 89865
Q 005519 678 GGDEL 682 (692)
Q Consensus 678 ~~~~~ 682 (692)
.....
T Consensus 158 ~~~~~ 162 (364)
T d1omwa3 158 SKKKP 162 (364)
T ss_dssp SSSCC
T ss_pred CCCCC
T ss_conf 78864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-30 Score=221.57 Aligned_cols=145 Identities=30% Similarity=0.477 Sum_probs=126.0
Q ss_pred EEECCCCCEEEEEEEECC---CCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCCC
Q ss_conf 564213827499999559---9499999904578--74588899999999827999800068899969959999973678
Q 005519 531 SKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (692)
Q Consensus 531 ~~iG~G~fG~Vyk~~~~~---~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 605 (692)
++||+|+||+||+|.+.. ++.||||+++... ....++|.+|+.++.+++|||||+++|+|. .+..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEC-CCCEEEEEECCCC
T ss_conf 783458782999999816973859999998801089899999999999998679989852777750-5977999974788
Q ss_pred CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 99768842999877789999999999999999998856999568437789967986999569972077231089865
Q 005519 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (692)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~~ 682 (692)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCC
T ss_conf 968999752---257899999999999999976687479---55677761131023567512341345331343234
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.1e-30 Score=215.68 Aligned_cols=153 Identities=23% Similarity=0.331 Sum_probs=134.4
Q ss_pred HCCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 4189536556421382749999955-994999999045787458889999999982799980006889996995999997
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 523 ~~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 601 (692)
..++|++.++||+|+||+||+|... +++.||||.++.. ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 701058878983177839999999899969999997578-6659999999999985799798909899988998899995
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEEECCCEECCC
Q ss_conf 3678997688429998777899999999999999999988569995684377899679869--99569972077231089
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ--HMNPKISDFGMARMFGG 679 (692)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~--~~~~ki~DFGla~~~~~ 679 (692)
|+++|+|.+++.. ....+++.....++.|++.||.|||+.+ |+||||||+|||++. ...+||+|||+|+....
T Consensus 82 ~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf 3899808899875--3899999999999999999999998769---9751355444344378851899764411100346
Q ss_pred CC
Q ss_conf 86
Q 005519 680 DE 681 (692)
Q Consensus 680 ~~ 681 (692)
..
T Consensus 157 ~~ 158 (321)
T d1tkia_ 157 GD 158 (321)
T ss_dssp TC
T ss_pred CC
T ss_conf 77
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=1.9e-30 Score=219.94 Aligned_cols=150 Identities=25% Similarity=0.336 Sum_probs=134.9
Q ss_pred CCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 89536556421382749999955-9949999990457---8745888999999998279998000688999699599999
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 600 (692)
++|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|+.++..++||||+++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCC
Q ss_conf 73678997688429998777899999999999999999988569995684377899679869995699720772310898
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (692)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~ 680 (692)
||+.+|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 23346622666751---589899999999999999899998599---861767999936077897886101033322566
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-30 Score=220.38 Aligned_cols=162 Identities=32% Similarity=0.510 Sum_probs=136.3
Q ss_pred CCCCEEEEECCCCCEEEEEEEECC-CC----EEEEEECCCC-CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 895365564213827499999559-94----9999990457-87458889999999982799980006889996995999
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~~-~~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 598 (692)
++|++.++||+|+||+||+|.... ++ .||+|+++.. .....++|.+|+.++.+++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECC
Q ss_conf 99736789976884299987778999999999999999999885699956843778996798699956997207723108
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (692)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~ 678 (692)
++||+.+|+|..++.. ....+++..+++++.|+|.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEECCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf 9984268740101113--3457999999999999999999998769---5047621203116799875860255222335
Q ss_pred CCCCCCCCCCEECC
Q ss_conf 98655686612159
Q 005519 679 GDELQGNTKRIVGT 692 (692)
Q Consensus 679 ~~~~~~~~~~~~Gt 692 (692)
.......+....||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred CCCCCCCCCCCCCC
T ss_conf 44453223651058
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=4.5e-30 Score=217.41 Aligned_cols=153 Identities=28% Similarity=0.366 Sum_probs=135.0
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCC---------CHHHHHHHHHHHHHCC-CCCCCEEEEEEEE
Q ss_conf 189536556421382749999955-9949999990457874---------5888999999998279-9980006889996
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ---------GLKEFKNEMMLIAKLQ-HRNLVRLLGCCIE 592 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~---------~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~ 592 (692)
.++|++.+.||+|+||+||+++.. +++.||||++...... ..+.+.+|+.++.+++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEEC
Q ss_conf 99599999736789976884299987778999999999999999999885699956843778996798699956997207
Q 005519 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFG 672 (692)
++..++||||+++|+|.++|.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCCEEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCH
T ss_conf 7605999976898668999986---599999999999999999999998759---9432346254898689983871240
Q ss_pred CCEECCCCCC
Q ss_conf 7231089865
Q 005519 673 MARMFGGDEL 682 (692)
Q Consensus 673 la~~~~~~~~ 682 (692)
+|+.+.....
T Consensus 156 ~a~~~~~~~~ 165 (277)
T d1phka_ 156 FSCQLDPGEK 165 (277)
T ss_dssp TCEECCTTCC
T ss_pred HEEECCCCCC
T ss_conf 3167268872
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-30 Score=220.05 Aligned_cols=151 Identities=29% Similarity=0.428 Sum_probs=128.5
Q ss_pred CCEEEEECCCCCEEEEEEEECC-CCEEEEEECCCC--CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEE----CCEEEEE
Q ss_conf 5365564213827499999559-949999990457--87458889999999982799980006889996----9959999
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILI 599 (692)
Q Consensus 527 f~~~~~iG~G~fG~Vyk~~~~~-~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV 599 (692)
|.+.++||+|+||+||+|.... +..||+|++... .....+.|.+|+.++.+++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEEECCCEECC
Q ss_conf 97367899768842999877789999999999999999998856999568437789967986-99956997207723108
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFG 678 (692)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~-~~~~~ki~DFGla~~~~ 678 (692)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ .+|+||||||+|||++ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf 957898948999751---355469999999999999999999789-9799687674351166799988980057654236
Q ss_pred CCC
Q ss_conf 986
Q 005519 679 GDE 681 (692)
Q Consensus 679 ~~~ 681 (692)
...
T Consensus 167 ~~~ 169 (270)
T d1t4ha_ 167 ASF 169 (270)
T ss_dssp TTS
T ss_pred CCC
T ss_conf 876
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=225.72 Aligned_cols=158 Identities=27% Similarity=0.452 Sum_probs=134.7
Q ss_pred CCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEEE
Q ss_conf 89536556421382749999955-99499999904578--7458889999999982799980006889996--9959999
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKILI 599 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 599 (692)
++|++.+.||+|+||+||+++.. +++.||+|.+.... ....+.+.+|+.++.+++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EECCCCCCHHHHHCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf 97367899768842999-87778999999999999999999885699--9568437789967986999569972077231
Q 005519 600 YEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSR--LRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~al~yLH~~~~--~~ivHrDikp~NILl~~~~~~ki~DFGla~~ 676 (692)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+. .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCC
Q ss_conf 089865
Q 005519 677 FGGDEL 682 (692)
Q Consensus 677 ~~~~~~ 682 (692)
+..+..
T Consensus 164 ~~~~~~ 169 (269)
T d2java1 164 LNHDTS 169 (269)
T ss_dssp C-----
T ss_pred CCCCCC
T ss_conf 245777
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.8e-30 Score=215.80 Aligned_cols=160 Identities=26% Similarity=0.380 Sum_probs=135.4
Q ss_pred CCCCEEEEECCCCCEEEEEEEECC-CCEEEEEECCCC---CCCCHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 895365564213827499999559-949999990457---8745888999999998-27999800068899969959999
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIA-KLQHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 599 (692)
++|.+.++||+|+||+||+|+... ++.||||++... .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCC
Q ss_conf 97367899768842999877789999999999999999998856999568437789967986999569972077231089
Q 005519 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (692)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~ 679 (692)
|||+++|+|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 750379808998640---478999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCCEECC
Q ss_conf 8655686612159
Q 005519 680 DELQGNTKRIVGT 692 (692)
Q Consensus 680 ~~~~~~~~~~~Gt 692 (692)
..... +...||
T Consensus 156 ~~~~~--~~~~gt 166 (320)
T d1xjda_ 156 GDAKT--NTFCGT 166 (320)
T ss_dssp TTCCB--CCCCSC
T ss_pred CCCCC--CCCCCC
T ss_conf 65334--545787
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-30 Score=220.91 Aligned_cols=169 Identities=27% Similarity=0.410 Sum_probs=139.8
Q ss_pred HHHHCCCCCEEEEECCCCCEEEEEEEEC------CCCEEEEEECCCCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 7654189536556421382749999955------99499999904578-7458889999999982799980006889996
Q 005519 520 VTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (692)
Q Consensus 520 l~~~~~~f~~~~~iG~G~fG~Vyk~~~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~ 592 (692)
.+...++|++.++||+|+||.||+|.+. .+..||||+++... ......|.+|+.++.+++||||++++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred EEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 04268991883598207881899999878644778968999998701286899999999999997699988412547842
Q ss_pred CCEEEEEEECCCCCCHHHHHCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCC
Q ss_conf 99599999736789976884299-------98777899999999999999999988569995684377899679869995
Q 005519 593 QGEKILIYEYMVNKSLDVFLFDP-------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (692)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~ 665 (692)
....++|+||+++|+|..++... .....+++..+..++.|+|.||.|||+++ |+||||||+|||+++++.
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCE
T ss_conf 88106777604899889998750332113444688799999999999999999876479---654328677540359964
Q ss_pred EEEEEECCCEECCCCCCCCCCCCEEC
Q ss_conf 69972077231089865568661215
Q 005519 666 PKISDFGMARMFGGDELQGNTKRIVG 691 (692)
Q Consensus 666 ~ki~DFGla~~~~~~~~~~~~~~~~G 691 (692)
+||+|||+|+.+.............|
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~ 197 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLL 197 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEE
T ss_pred EEEEECCCCEECCCCCCEEECCCEEC
T ss_conf 99942454202357763031340231
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.2e-30 Score=218.46 Aligned_cols=172 Identities=27% Similarity=0.393 Sum_probs=139.1
Q ss_pred HHHHHHCCCCCEEEEECCCCCEEEEEEEECC------CCEEEEEECCCCC-CCCHHHHHHHHHHHHHC-CCCCCCEEEEE
Q ss_conf 4376541895365564213827499999559------9499999904578-74588899999999827-99980006889
Q 005519 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGC 589 (692)
Q Consensus 518 ~~l~~~~~~f~~~~~iG~G~fG~Vyk~~~~~------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~g~ 589 (692)
.+.+...++|++.++||+|+||.||+|.... ++.||||+++... ....+++..|+..+.++ +|+||++++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf 25261679979844984167839999998677755578399999986001717899999999998861499849974115
Q ss_pred EEECC-EEEEEEECCCCCCHHHHHCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 99699-5999997367899768842999-------------877789999999999999999998856999568437789
Q 005519 590 CIEQG-EKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKA 655 (692)
Q Consensus 590 ~~~~~-~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp 655 (692)
+.+.+ ..++||||+++|+|.++|.... ....+++..+..++.|++.||.|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred ECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCC
T ss_conf 404797579999845899299999853666665322202332146899999999999999999887379---71786773
Q ss_pred CCEEECCCCCEEEEEECCCEECCCCCCCCCCCCEECC
Q ss_conf 9679869995699720772310898655686612159
Q 005519 656 SNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 656 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~Gt 692 (692)
+|||+++++.+||+|||+|+...............||
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred CCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEEC
T ss_conf 1065779982898457520011356652224751667
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-29 Score=214.43 Aligned_cols=153 Identities=31% Similarity=0.477 Sum_probs=132.4
Q ss_pred CCCCEEEEECCCCCEEEEEEEE-CCCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 8953655642138274999995-599499999904578--7458889999999982799980006889996995999997
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~-~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 601 (692)
++|++.++||+|+||+||+|.. .+++.||||+++... ....+++.+|+.++++++||||+++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCC
Q ss_conf 36789976884299987778999999999999999999885699956843778996798699956997207723108986
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~ 681 (692)
|+.++.+...... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.+..+||+|||+|+....+.
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 2377445554420--2568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred C
Q ss_conf 5
Q 005519 682 L 682 (692)
Q Consensus 682 ~ 682 (692)
.
T Consensus 157 ~ 157 (298)
T d1gz8a_ 157 R 157 (298)
T ss_dssp B
T ss_pred C
T ss_conf 4
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-29 Score=214.59 Aligned_cols=153 Identities=35% Similarity=0.561 Sum_probs=134.1
Q ss_pred CCCCEEEEECCCCCEEEEEEEECC-CC--EEEEEECCCC-CCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCEEEEE
Q ss_conf 895365564213827499999559-94--9999990457-874588899999999827-999800068899969959999
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~~-~~--~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 599 (692)
++|++.++||+|+||.||+|++.+ +. .||||++... .....++|.+|+.++.++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EECCCCCCHHHHHCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 9736789976884299-------------987778999999999999999999885699956843778996798699956
Q 005519 600 YEYMVNKSLDVFLFDP-------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (692)
Q Consensus 600 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ 666 (692)
+||+++|+|.++|+.. .....+++..+..++.|+|.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEEECCCEECCCC
Q ss_conf 99720772310898
Q 005519 667 KISDFGMARMFGGD 680 (692)
Q Consensus 667 ki~DFGla~~~~~~ 680 (692)
||+|||+|+.....
T Consensus 167 kl~DfG~a~~~~~~ 180 (309)
T d1fvra_ 167 KIADFGLSRGQEVY 180 (309)
T ss_dssp EECCTTCEESSCEE
T ss_pred EECCCCCCCCCCCC
T ss_conf 87434432244422
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.8e-30 Score=216.67 Aligned_cols=170 Identities=29% Similarity=0.383 Sum_probs=141.5
Q ss_pred HHHHCCCCCEEEEECCCCCEEEEEEEEC------CCCEEEEEECCCCCC-CCHHHHHHHHHHHHHC-CCCCCCEEEEEEE
Q ss_conf 7654189536556421382749999955------994999999045787-4588899999999827-9998000688999
Q 005519 520 VTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCI 591 (692)
Q Consensus 520 l~~~~~~f~~~~~iG~G~fG~Vyk~~~~------~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~ 591 (692)
.+...++|++.++||+|+||.||+|++. .+..||||+++.... ....+|.+|+.++.++ +|||||+++|+|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE
T ss_conf 63778996985498206882999999806644778869999998742487799999999999876269998878998983
Q ss_pred ECCEEEEEEECCCCCCHHHHHCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCC
Q ss_conf 6995999997367899768842999---------------8777899999999999999999988569995684377899
Q 005519 592 EQGEKILIYEYMVNKSLDVFLFDPT---------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656 (692)
Q Consensus 592 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~ 656 (692)
+....++||||+++|+|..+++... ....+++..+..++.|++.||.|||+++ ++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred ECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCC
T ss_conf 19978999973799879999985356654444453322233458899999999999999999887579---266624102
Q ss_pred CEEECCCCCEEEEEECCCEECCCCCCCCCCCCEECC
Q ss_conf 679869995699720772310898655686612159
Q 005519 657 NILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692 (692)
Q Consensus 657 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~Gt 692 (692)
|||++.++.+|++|||+|+.+.............||
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred CCCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCC
T ss_conf 100002575210234010233678861586201359
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.5e-29 Score=211.36 Aligned_cols=149 Identities=30% Similarity=0.535 Sum_probs=128.8
Q ss_pred EEEEECCCCCEEEEEEEECCC----CEEEEEECCCC-CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-CEEEEEEEC
Q ss_conf 655642138274999995599----49999990457-874588899999999827999800068899969-959999973
Q 005519 529 IQSKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-GEKILIYEY 602 (692)
Q Consensus 529 ~~~~iG~G~fG~Vyk~~~~~~----~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 602 (692)
+.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+.++.+++||||++++|+|.+. ...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 66698136880999999977998799999999884369789999999999998678999867867898069943899987
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 67899768842999877789999999999999999998856999568437789967986999569972077231089865
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (692)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~~ 682 (692)
+++|+|.+++... ....++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 111 ~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EECCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCC
T ss_conf 4067414421013--454048999999999887652003367---62577668757677999889910652322556655
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.9e-29 Score=213.25 Aligned_cols=160 Identities=28% Similarity=0.398 Sum_probs=129.1
Q ss_pred CCCCEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHH--HHHHHHHHCCCCCCCEEEEEEEECC----EEEE
Q ss_conf 895365564213827499999559949999990457874588899--9999998279998000688999699----5999
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK--NEMMLIAKLQHRNLVRLLGCCIEQG----EKIL 598 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~~~~~VAVK~l~~~~~~~~~~f~--~Ei~~l~~l~H~niv~l~g~~~~~~----~~~l 598 (692)
+.|.+.++||+|+||.||+|++ +++.||||++... ..+++. .|+..+..++||||++++++|.+.. ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 6899988982078819999999-9989999998720---04679999999999627998683268899837986048999
Q ss_pred EEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEEEEECC
Q ss_conf 997367899768842999877789999999999999999998856-----999568437789967986999569972077
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~-----~~~~ivHrDikp~NILl~~~~~~ki~DFGl 673 (692)
||||+++|+|..+|.. ..++|..+++++.|+|.||.|||.. ...+|+||||||+|||++.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEECCCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCC
T ss_conf 9964669898999865----899989999999999999999887665204689866153173135786887768876386
Q ss_pred CEECCCCCC--CCCCCCEECC
Q ss_conf 231089865--5686612159
Q 005519 674 ARMFGGDEL--QGNTKRIVGT 692 (692)
Q Consensus 674 a~~~~~~~~--~~~~~~~~Gt 692 (692)
|+.+..... ........||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt 175 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp CEEEETTTTEECC----CCSC
T ss_pred CCCCCCCCCCEECCCCCEECC
T ss_conf 623467776200135525035
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-29 Score=214.88 Aligned_cols=155 Identities=25% Similarity=0.408 Sum_probs=132.8
Q ss_pred HHCCCCCEEEEECCCCCEEEEEEEECC----CCEEEEEECCCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 541895365564213827499999559----94999999045787-4588899999999827999800068899969959
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 522 ~~~~~f~~~~~iG~G~fG~Vyk~~~~~----~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 596 (692)
...++|++.+.||+|+||.||+|++.. +..||||.++.... ...+.|.+|+.++.+++||||++++|++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEE
T ss_conf 688996987799307882999999936996449999999365668799999999999998689999856988995-3747
Q ss_pred EEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf 99997367899768842999877789999999999999999998856999568437789967986999569972077231
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~ 676 (692)
++||||+++|+|..++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 999984069807765422--4789999999999999987752302267---44141026553206789678765034213
Q ss_pred CCCCCC
Q ss_conf 089865
Q 005519 677 FGGDEL 682 (692)
Q Consensus 677 ~~~~~~ 682 (692)
+.....
T Consensus 158 ~~~~~~ 163 (273)
T d1mp8a_ 158 MEDSTY 163 (273)
T ss_dssp ------
T ss_pred CCCCCC
T ss_conf 367762
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9e-29 Score=208.61 Aligned_cols=150 Identities=23% Similarity=0.311 Sum_probs=126.9
Q ss_pred CCCCCEEE-EECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEEE----CCEE
Q ss_conf 18953655-6421382749999955-9949999990457874588899999999827-99980006889996----9959
Q 005519 524 TENFSIQS-KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE----QGEK 596 (692)
Q Consensus 524 ~~~f~~~~-~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~ 596 (692)
.++|.+.. .||+|+||+||+|... +++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEEECC
Q ss_conf 999973678997688429998777899999999999999999988569995684377899679869---99569972077
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGM 673 (692)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~---~~~~ki~DFGl 673 (692)
++||||+++|+|.++|... ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 9999778998499999862-7877579999999999999999999769---86444100220113555566311354551
Q ss_pred CEECCCCCC
Q ss_conf 231089865
Q 005519 674 ARMFGGDEL 682 (692)
Q Consensus 674 a~~~~~~~~ 682 (692)
|+.+.....
T Consensus 161 a~~~~~~~~ 169 (335)
T d2ozaa1 161 AKETTSHNS 169 (335)
T ss_dssp CEECCCCCC
T ss_pred EEECCCCCC
T ss_conf 233368886
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.96 E-value=3.1e-29 Score=211.78 Aligned_cols=151 Identities=26% Similarity=0.423 Sum_probs=135.0
Q ss_pred CCCCEEEEECCCCCEEEEEEEECCCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
Q ss_conf 8953655642138274999995599499999904578--74588899999999827999800068899969959999973
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 602 (692)
++|++.++||+|+||+||+|+..+++.||||++.... ....+.+.+|+.++.+++||||+++++.+.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCC
Q ss_conf 6789976884299987778999999999999999999885699956843778996798699956997207723108986
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~ 681 (692)
+.++.+..+.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+|..+....
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EHHHHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 00456789986---0477514456899999999999860574---8826787750568689978732366430114676
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=212.29 Aligned_cols=148 Identities=32% Similarity=0.416 Sum_probs=127.5
Q ss_pred EEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
Q ss_conf 6556421382749999955-9949999990457874-----588899999999827999800068899969959999973
Q 005519 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (692)
Q Consensus 529 ~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 602 (692)
..++||+|+||+||+|... +++.||||+++..... ..+.+.+|+.++..++|||||++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 67899768842999877789999999999999999998856999568437789967986999569972077231089865
Q 005519 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (692)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~~ 682 (692)
+.++++...+. ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+..+..
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred HCCHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf 34507765541---2667789999999999999998863163---55035776258853778411465761000578755
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.3e-29 Score=211.56 Aligned_cols=167 Identities=29% Similarity=0.442 Sum_probs=139.7
Q ss_pred HHCCCCCEEEEECCCCCEEEEEEEECC--------CCEEEEEECCCCCC-CCHHHHHHHHHHHHHC-CCCCCCEEEEEEE
Q ss_conf 541895365564213827499999559--------94999999045787-4588899999999827-9998000688999
Q 005519 522 AATENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCI 591 (692)
Q Consensus 522 ~~~~~f~~~~~iG~G~fG~Vyk~~~~~--------~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~ 591 (692)
...++|.+.++||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCC
T ss_conf 25899697009851678289999985787555667549999998811286889999999999998139996973465220
Q ss_pred ECCEEEEEEECCCCCCHHHHHCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCE
Q ss_conf 6995999997367899768842999-------------877789999999999999999998856999568437789967
Q 005519 592 EQGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNI 658 (692)
Q Consensus 592 ~~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NI 658 (692)
+....++||||+++|+|.++|.... ....+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCE
T ss_conf 188689999736999099999860677643222334574346799999999999999998766379---78630221022
Q ss_pred EECCCCCEEEEEECCCEECCCCCCCCCCCCEEC
Q ss_conf 986999569972077231089865568661215
Q 005519 659 LLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691 (692)
Q Consensus 659 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~G 691 (692)
|++.++.+||+|||+++..........+....|
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred EECCCCCEEECCCHHHCCCCCCCCCCCCCCCCC
T ss_conf 454789767622111011355555431466788
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=212.28 Aligned_cols=153 Identities=31% Similarity=0.432 Sum_probs=131.1
Q ss_pred CCCCCEEEEECCCCCEEEEEEEECC--C--CEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 1895365564213827499999559--9--49999990457---874588899999999827999800068899969959
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~~--~--~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 596 (692)
.++|++.+.||+|+||.||+|+... + ..||||+++.. .....++|.+|+.++.+++||||++++|+|.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf 4891997898038883999999988999079999999983555798999999999999986899998789877740-100
Q ss_pred EEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf 99997367899768842999877789999999999999999998856999568437789967986999569972077231
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~ 676 (692)
++|+||+++|++.+++.. ....+++..++.++.|+|.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred HEEEEEECCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHH
T ss_conf 114654238612544421--2689999999999999999998752178---75205668881565565433256115553
Q ss_pred CCCCCC
Q ss_conf 089865
Q 005519 677 FGGDEL 682 (692)
Q Consensus 677 ~~~~~~ 682 (692)
+.....
T Consensus 161 ~~~~~~ 166 (273)
T d1u46a_ 161 LPQNDD 166 (273)
T ss_dssp CCC-CC
T ss_pred CCCCCC
T ss_conf 035887
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.96 E-value=1.9e-28 Score=206.38 Aligned_cols=151 Identities=26% Similarity=0.378 Sum_probs=132.2
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----E
Q ss_conf 189536556421382749999955-994999999045787---45888999999998279998000688999699----5
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----E 595 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~----~ 595 (692)
.++|++.+.||+|+||.||++... +++.||||.++.... ...+.|.+|+.++..++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCE
Q ss_conf 99999736789976884299987778999999999999999999885699956843778996798699956997207723
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~ 675 (692)
.++||||+++++|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.+...+++|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 999997788987101120---3589999999999999999999998579---5276346755665754320100344432
Q ss_pred ECCCC
Q ss_conf 10898
Q 005519 676 MFGGD 680 (692)
Q Consensus 676 ~~~~~ 680 (692)
.+...
T Consensus 160 ~~~~~ 164 (277)
T d1o6ya_ 160 AIADS 164 (277)
T ss_dssp ECC--
T ss_pred HHCCC
T ss_conf 21235
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.7e-28 Score=206.83 Aligned_cols=150 Identities=28% Similarity=0.414 Sum_probs=124.2
Q ss_pred CCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEC------CEEEE
Q ss_conf 9536556421382749999955-9949999990457874588899999999827999800068899969------95999
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------GEKIL 598 (692)
Q Consensus 526 ~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 598 (692)
.|+..++||+|+||+||+|+.. +++.||||++..... .+.+|+.++.+++||||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEEECCCEEC
Q ss_conf 997367899768842999877789999999999999999998856999568437789967986999-5699720772310
Q 005519 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMF 677 (692)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~-~~ki~DFGla~~~ 677 (692)
||||++++.+............+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCC
Q ss_conf 89865
Q 005519 678 GGDEL 682 (692)
Q Consensus 678 ~~~~~ 682 (692)
...+.
T Consensus 174 ~~~~~ 178 (350)
T d1q5ka_ 174 VRGEP 178 (350)
T ss_dssp CTTSC
T ss_pred CCCCC
T ss_conf 47765
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-28 Score=207.04 Aligned_cols=153 Identities=25% Similarity=0.391 Sum_probs=129.9
Q ss_pred HCCCCCEEEEECCCCCEEEEEEEE-CCCCEEEEEECCCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----EE
Q ss_conf 418953655642138274999995-5994999999045787-45888999999998279998000688999699----59
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----EK 596 (692)
Q Consensus 523 ~~~~f~~~~~iG~G~fG~Vyk~~~-~~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~----~~ 596 (692)
.+++|.+.++||+|+||+||+|.. .+++.||||++..... ...+.+.+|+.++..++|||++++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 38985997899406480999999999994999999803109589999999999999768989885888995056455414
Q ss_pred EEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf 99997367899768842999877789999999999999999998856999568437789967986999569972077231
Q 005519 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~ 676 (692)
++++||+.+|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 86 ~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEECCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf 999996259865664405----89999999999999999999999789---86777876437887999778754570565
Q ss_pred CCCCCC
Q ss_conf 089865
Q 005519 677 FGGDEL 682 (692)
Q Consensus 677 ~~~~~~ 682 (692)
......
T Consensus 159 ~~~~~~ 164 (345)
T d1pmea_ 159 ADPDHD 164 (345)
T ss_dssp CCGGGC
T ss_pred CCCCCC
T ss_conf 047776
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.3e-29 Score=210.81 Aligned_cols=152 Identities=30% Similarity=0.538 Sum_probs=133.2
Q ss_pred HCCCCCEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-CEEEEEEE
Q ss_conf 41895365564213827499999559949999990457874588899999999827999800068899969-95999997
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-GEKILIYE 601 (692)
Q Consensus 523 ~~~~f~~~~~iG~G~fG~Vyk~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 601 (692)
..++|++.++||+|+||.||+|.. .+..||||+++.. ...++|.+|+.++.+++||||++++|+|.+. +..++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf 789948857982079808999999-9909999998857--7799999999999867898985498788723892899996
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCC
Q ss_conf 36789976884299987778999999999999999999885699956843778996798699956997207723108986
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~ 681 (692)
|+++|+|.++|... ....+++..+++++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++......
T Consensus 82 y~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 82 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCC
T ss_conf 36999899998745-7888899999999999985232113376---5536665676014689977632456003447877
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=1.4e-27 Score=200.48 Aligned_cols=146 Identities=23% Similarity=0.410 Sum_probs=126.8
Q ss_pred CCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCC-CCCCCEEEEEEEEC--CEEEEEE
Q ss_conf 89536556421382749999955-99499999904578745888999999998279-99800068899969--9599999
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQ--GEKILIY 600 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 600 (692)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+.++..+. ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEEEECCCEECCC
Q ss_conf 736789976884299987778999999999999999999885699956843778996798699-9569972077231089
Q 005519 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGG 679 (692)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~-~~~ki~DFGla~~~~~ 679 (692)
||+++++|..+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+ ..+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 631798589974------68999999999999999998876433---443456441237748998366415654266468
Q ss_pred CCC
Q ss_conf 865
Q 005519 680 DEL 682 (692)
Q Consensus 680 ~~~ 682 (692)
+..
T Consensus 183 ~~~ 185 (328)
T d3bqca1 183 GQE 185 (328)
T ss_dssp TCC
T ss_pred CCC
T ss_conf 874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-27 Score=199.78 Aligned_cols=151 Identities=26% Similarity=0.424 Sum_probs=134.2
Q ss_pred CCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 89536556421382749999955-99499999904578--7458889999999982799980006889996995999997
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 601 (692)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++..++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCC
Q ss_conf 36789976884299987778999999999999999999885699956843778996798699956997207723108986
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (692)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~~~~~~ 681 (692)
++.+++|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.+..+||+|||.|+.+....
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 0233222112123---565403678999999999987743399---8600146761211337826652046011046887
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6e-28 Score=203.03 Aligned_cols=152 Identities=25% Similarity=0.389 Sum_probs=128.5
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCC------CCHHHHHHHHHHHHHCC--CCCCCEEEEEEEECC
Q ss_conf 189536556421382749999955-994999999045787------45888999999998279--998000688999699
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLLGCCIEQG 594 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~--H~niv~l~g~~~~~~ 594 (692)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ....++.+|+.++.+++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEECCCC-CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEEEEC
Q ss_conf 59999973678-997688429998777899999999999999999988569995684377899679869-9956997207
Q 005519 595 EKILIYEYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFG 672 (692)
Q Consensus 595 ~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~-~~~~ki~DFG 672 (692)
..++|+||+.+ +++..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 68999983368622899986---1589999999999999999999998779---75566761114774478848977546
Q ss_pred CCEECCCCC
Q ss_conf 723108986
Q 005519 673 MARMFGGDE 681 (692)
Q Consensus 673 la~~~~~~~ 681 (692)
+|+......
T Consensus 157 ~a~~~~~~~ 165 (273)
T d1xwsa_ 157 SGALLKDTV 165 (273)
T ss_dssp TCEECCSSC
T ss_pred CCEECCCCC
T ss_conf 535324445
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-27 Score=200.90 Aligned_cols=151 Identities=26% Similarity=0.405 Sum_probs=129.8
Q ss_pred HCCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-----
Q ss_conf 4189536556421382749999955-99499999904578--745888999999998279998000688999699-----
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----- 594 (692)
Q Consensus 523 ~~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~----- 594 (692)
..++|++.++||+|+||+||+|... +++.||||++.... ....+.+.+|+.++..++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -EEEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECC
Q ss_conf -5999997367899768842999877789999999999999999998856999568437789967986999569972077
Q 005519 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (692)
Q Consensus 595 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGl 673 (692)
+.++||||+ +.+|..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEECC-CCCHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf 1599998405-521899987----402269999999999999999987378---76456685111121001221134310
Q ss_pred CEECCCCC
Q ss_conf 23108986
Q 005519 674 ARMFGGDE 681 (692)
Q Consensus 674 a~~~~~~~ 681 (692)
|+......
T Consensus 168 a~~~~~~~ 175 (346)
T d1cm8a_ 168 ARQADSEM 175 (346)
T ss_dssp CEECCSSC
T ss_pred EECCCCCC
T ss_conf 22068763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.9e-27 Score=196.86 Aligned_cols=152 Identities=28% Similarity=0.494 Sum_probs=130.4
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCC--CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-------
Q ss_conf 189536556421382749999955-9949999990457--874588899999999827999800068899969-------
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------- 593 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------- 593 (692)
.++|++.++||+|+||+||+|+.. +++.||||++... .....+.+.+|+.++.+++|||++++++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred -CEEEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEEC
Q ss_conf -9599999736789976884299987778999999999999999999885699956843778996798699956997207
Q 005519 594 -GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (692)
Q Consensus 594 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFG 672 (692)
...++|+||++++.+..+. .....+.......++.|++.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEECCCCCCCCHHH---HCCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECC
T ss_conf 76389998535787410122---20344330899999999999998852299---8856767222036689968763135
Q ss_pred CCEECCCCC
Q ss_conf 723108986
Q 005519 673 MARMFGGDE 681 (692)
Q Consensus 673 la~~~~~~~ 681 (692)
+|+.+....
T Consensus 163 ~~~~~~~~~ 171 (318)
T d3blha1 163 LARAFSLAK 171 (318)
T ss_dssp TCEECCC--
T ss_pred EEEECCCCC
T ss_conf 002235544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=9.8e-28 Score=201.62 Aligned_cols=152 Identities=28% Similarity=0.388 Sum_probs=131.8
Q ss_pred CCCCEEEEECCCCCEEEEEEEEC----CCCEEEEEECCCC----CCCCHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCE
Q ss_conf 89536556421382749999955----9949999990457----87458889999999982799-980006889996995
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCIEQGE 595 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~----~~~~VAVK~l~~~----~~~~~~~f~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 595 (692)
++|++.++||+|+||+||++... +++.||||.++.. .....+.+.+|+.++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCE
Q ss_conf 99999736789976884299987778999999999999999999885699956843778996798699956997207723
Q 005519 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~ 675 (692)
.++++||+.+|+|..++.. ...+.......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 0012312341179999873---045437888888999999998851499---8965477320124699988874132022
Q ss_pred ECCCCCC
Q ss_conf 1089865
Q 005519 676 MFGGDEL 682 (692)
Q Consensus 676 ~~~~~~~ 682 (692)
.+.....
T Consensus 178 ~~~~~~~ 184 (322)
T d1vzoa_ 178 EFVADET 184 (322)
T ss_dssp ECCGGGG
T ss_pred HHCCCCC
T ss_conf 2034444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=4.8e-26 Score=190.20 Aligned_cols=149 Identities=21% Similarity=0.333 Sum_probs=127.8
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCEEEEEEE
Q ss_conf 189536556421382749999955-994999999045787458889999999982799-980006889996995999997
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 601 (692)
.++|++.++||+|+||+||+|+.. +++.||||.+.... ....++.|++.+..+.| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEEECCCEE
Q ss_conf 3678997688429998777899999999999999999988569995684377899679869-----99569972077231
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-----HMNPKISDFGMARM 676 (692)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~-----~~~~ki~DFGla~~ 676 (692)
|+ +++|..++.. ....++...+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHH--HCCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-8887999975--2031106899999999999999999779---6626677131523475434479568723660577
Q ss_pred CCCC
Q ss_conf 0898
Q 005519 677 FGGD 680 (692)
Q Consensus 677 ~~~~ 680 (692)
+...
T Consensus 156 ~~~~ 159 (293)
T d1csna_ 156 YRDP 159 (293)
T ss_dssp SBCT
T ss_pred CCCC
T ss_conf 1467
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.7e-26 Score=193.21 Aligned_cols=154 Identities=29% Similarity=0.438 Sum_probs=124.4
Q ss_pred HCCCCCEEEEECCCCCEEEEEEEEC-C-CCEEEEEECCCC--CCCCHHHHHHHHHHHHHC---CCCCCCEEEEEEEEC--
Q ss_conf 4189536556421382749999955-9-949999990457--874588899999999827---999800068899969--
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL---QHRNLVRLLGCCIEQ-- 593 (692)
Q Consensus 523 ~~~~f~~~~~iG~G~fG~Vyk~~~~-~-~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l---~H~niv~l~g~~~~~-- 593 (692)
..++|++.++||+|+||+||+|... + ++.||||++... .......+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred ---CEEEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf ---95999997367899768842999877789999999999999999998856999568437789967986999569972
Q 005519 594 ---GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (692)
Q Consensus 594 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~D 670 (692)
...++++||++++.+...... ....+++.....++.|++.||.|||+++ |+||||||+|||+++++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCCEEEEEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECC
T ss_conf 667469999974058714444430--3789998999999999999999997588---98357986278985899754210
Q ss_pred ECCCEECCCCC
Q ss_conf 07723108986
Q 005519 671 FGMARMFGGDE 681 (692)
Q Consensus 671 FGla~~~~~~~ 681 (692)
||+++......
T Consensus 160 fg~~~~~~~~~ 170 (305)
T d1blxa_ 160 FGLARIYSFQM 170 (305)
T ss_dssp CCSCCCCCGGG
T ss_pred HHHHHHHCCCC
T ss_conf 00101100234
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=8.7e-27 Score=195.19 Aligned_cols=151 Identities=29% Similarity=0.404 Sum_probs=129.4
Q ss_pred HCCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-----C
Q ss_conf 4189536556421382749999955-994999999045787--4588899999999827999800068899969-----9
Q 005519 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----G 594 (692)
Q Consensus 523 ~~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-----~ 594 (692)
..++|++.++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++..++|||++++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred EEEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCC
Q ss_conf 59999973678997688429998777899999999999999999988569995684377899679869995699720772
Q 005519 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (692)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla 674 (692)
..++++||+.+|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+|
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred CEEEEEEEECCCCHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf 64999996258862320022----45309999999999999999997388---765166776334554322001321000
Q ss_pred EECCCC
Q ss_conf 310898
Q 005519 675 RMFGGD 680 (692)
Q Consensus 675 ~~~~~~ 680 (692)
......
T Consensus 169 ~~~~~~ 174 (348)
T d2gfsa1 169 RHTDDE 174 (348)
T ss_dssp -CCTGG
T ss_pred CCCCCC
T ss_conf 125754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=1e-25 Score=188.03 Aligned_cols=150 Identities=23% Similarity=0.358 Sum_probs=121.6
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCC-CEEEEEEEECCEEEEEEE
Q ss_conf 189536556421382749999955-994999999045787458889999999982799980-006889996995999997
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYE 601 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 601 (692)
.++|++.++||+|+||.||+|... +++.||||.+.... ...++..|+.++..++|+|+ +.+.++..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 888999689850788099999998899899999972100--588899999999970389960179999951987789998
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEEECCCEECC
Q ss_conf 3678997688429998777899999999999999999988569995684377899679869---9956997207723108
Q 005519 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMARMFG 678 (692)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~---~~~~ki~DFGla~~~~ 678 (692)
|+.+ ++...+.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++. +..+||+|||+|+.+.
T Consensus 84 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred ECCC-CHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf 7387-13332443--0688768999999999999999999799---4426678766064335777615650467513425
Q ss_pred CCC
Q ss_conf 986
Q 005519 679 GDE 681 (692)
Q Consensus 679 ~~~ 681 (692)
...
T Consensus 158 ~~~ 160 (299)
T d1ckia_ 158 DAR 160 (299)
T ss_dssp CTT
T ss_pred CCC
T ss_conf 544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.7e-26 Score=189.69 Aligned_cols=150 Identities=28% Similarity=0.365 Sum_probs=127.8
Q ss_pred CCCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEE------CC
Q ss_conf 189536556421382749999955-99499999904578--7458889999999982799980006889996------99
Q 005519 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE------QG 594 (692)
Q Consensus 524 ~~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~------~~ 594 (692)
.++|.+.++||+|+||+||+|... +++.||||++.... ......+.+|+.++..++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCC
Q ss_conf 59999973678997688429998777899999999999999999988569995684377899679869995699720772
Q 005519 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (692)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla 674 (692)
+.++||||+.++.+.. +. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEEEECCCHHHHHH-HH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf 2699984144677876-50-----38999999999999999998865221---124567763211365443132010232
Q ss_pred EECCCCCC
Q ss_conf 31089865
Q 005519 675 RMFGGDEL 682 (692)
Q Consensus 675 ~~~~~~~~ 682 (692)
+.......
T Consensus 167 ~~~~~~~~ 174 (355)
T d2b1pa1 167 RTAGTSFM 174 (355)
T ss_dssp --------
T ss_pred HCCCCCCC
T ss_conf 11466655
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.87 E-value=9.4e-22 Score=161.16 Aligned_cols=153 Identities=22% Similarity=0.313 Sum_probs=118.2
Q ss_pred CCCCEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCC-----------CCCCCEEEEEEEE
Q ss_conf 89536556421382749999955-99499999904578745888999999998279-----------9980006889996
Q 005519 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCIE 592 (692)
Q Consensus 525 ~~f~~~~~iG~G~fG~Vyk~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----------H~niv~l~g~~~~ 592 (692)
.+|++.++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|+.++..++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 8579989975077818999999999979999998343-133689999999999840145555542276764789987631
Q ss_pred --CCEEEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCC-----
Q ss_conf --99599999736789976884299987778999999999999999999885-6999568437789967986999-----
Q 005519 593 --QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHM----- 664 (692)
Q Consensus 593 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~-~~~~~ivHrDikp~NILl~~~~----- 664 (692)
....++++++...+..............+.+..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012234678689999999999999888764058---6465677057056305765644
Q ss_pred -CEEEEEECCCEECCCCC
Q ss_conf -56997207723108986
Q 005519 665 -NPKISDFGMARMFGGDE 681 (692)
Q Consensus 665 -~~ki~DFGla~~~~~~~ 681 (692)
.+|++|||.|+......
T Consensus 169 ~~~kl~dfg~s~~~~~~~ 186 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY 186 (362)
T ss_dssp EEEEECCCTTCEETTBCC
T ss_pred CEEEEEECCCCCCCCCCC
T ss_conf 305675314421234454
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=5e-20 Score=149.51 Aligned_cols=137 Identities=20% Similarity=0.210 Sum_probs=106.2
Q ss_pred CCEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCC------------------CCHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 536556421382749999955994999999045787------------------45888999999998279998000688
Q 005519 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKLQHRNLVRLLG 588 (692)
Q Consensus 527 f~~~~~iG~G~fG~Vyk~~~~~~~~VAVK~l~~~~~------------------~~~~~f~~Ei~~l~~l~H~niv~l~g 588 (692)
+.+.++||+|+||.||+|...+++.||||.++.... ........|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEEECCEEEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 99969959999973678997688429998777899999999999999999988569995684377899679869995699
Q 005519 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (692)
Q Consensus 589 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~~~~~ivHrDikp~NILl~~~~~~ki 668 (692)
+. . .+++|||+++..+.. ++......++.|++.++.|||..+ |+||||||+|||++++ .++|
T Consensus 82 ~~--~--~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE--G--NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE--T--TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred EC--C--CEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEE
T ss_conf 62--8--889999504565420----------015789999999999999982688---8983689036114289-8999
Q ss_pred EEECCCEECCCCC
Q ss_conf 7207723108986
Q 005519 669 SDFGMARMFGGDE 681 (692)
Q Consensus 669 ~DFGla~~~~~~~ 681 (692)
+|||+|+....+.
T Consensus 144 iDFG~a~~~~~~~ 156 (191)
T d1zara2 144 IDFPQSVEVGEEG 156 (191)
T ss_dssp CCCTTCEETTSTT
T ss_pred EECCCCCCCCCCC
T ss_conf 8778843089987
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.81 E-value=2.4e-19 Score=144.92 Aligned_cols=112 Identities=25% Similarity=0.427 Sum_probs=94.9
Q ss_pred CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEECCCCCCEEEECCCCCCCCCCCCEEEEEECCEEEEEECC
Q ss_conf 21028998336999797089958997758999998299999548999269973599988899733999507809999089
Q 005519 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (692)
Q Consensus 41 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~l~iw~~~~~~t~vW~anr~~pv~~~~~~l~l~~~G~lvl~~~~ 120 (692)
+|+|.|||.|.+++.|+| |.|.|.|+.+|+ |.++.. .++||.||++.|. .++.|.|+.||+|||++.
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~~--~~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGKA--SGCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCTTSC--SSEEEEECTTSCEEEEET-
T ss_pred CCEECCCCEECCCCEEEE--CCEEEEECCCCC-----EEEECC---CCEEEECCCCCCC--CCCEEEEECCCCEEEEEC-
T ss_conf 989069999559999987--879999817998-----898739---8389984673478--885799961534999934-
Q ss_pred CCEEEEEECCCCCCCCEEEEECCCCEEEEECCCCCCCCCCEEEECCCCCC
Q ss_conf 97699940467867836899349987998289998877401111278863
Q 005519 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTD 170 (692)
Q Consensus 121 ~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WQSFd~PTD 170 (692)
+..+|++++........|+|+|+|||||++.+ +.++|||+.+|++
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCCCC
T ss_pred CCEEEEEEECCCCCCEEEEECCCCCEEEECCC-----CCEEECCCCCCCC
T ss_conf 87499983036887259999678999999899-----9679618885698
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.79 E-value=5.6e-19 Score=142.39 Aligned_cols=107 Identities=25% Similarity=0.367 Sum_probs=91.9
Q ss_pred CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEECCCCCCEEEECCCCCCCCCCCCEEEEEECCEEEEEECC
Q ss_conf 21028998336999797089958997758999998299999548999269973599988899733999507809999089
Q 005519 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (692)
Q Consensus 41 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~l~iw~~~~~~t~vW~anr~~pv~~~~~~l~l~~~G~lvl~~~~ 120 (692)
.|+|.+|+.|.+++.|. +|.|.|.|+.+|+ |.++.. .++||.||++.| +..+.|.|+.+|+|+|++++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV---DKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET---TEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCCCCCCCEECCCCEEE--CCCEEEEECCCCE-----EEEEEC---CCEEEEECCCCC--CCCCEEEEECCCEEEEECCC
T ss_conf 99956997726999897--2888999878980-----999709---902157078899--87547998126039997798
Q ss_pred CCEEEEEECCCCCCCCEEEEECCCCEEEEECCCCCCCCCCEEEECCC
Q ss_conf 97699940467867836899349987998289998877401111278
Q 005519 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (692)
Q Consensus 121 ~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WQSFd~ 167 (692)
+.++|+|++.......+|+|+|+|||||++. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred CCCEEECCCCCCCCCEEEEECCCCCEEEECC--------CCCCCCCC
T ss_conf 5512770455888767999968889999699--------84568888
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.79 E-value=1.6e-18 Score=139.34 Aligned_cols=108 Identities=23% Similarity=0.371 Sum_probs=91.5
Q ss_pred CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEECCCCCCEEEECCCCCCCCCCCCEEEEEECCEEEEEECC
Q ss_conf 21028998336999797089958997758999998299999548999269973599988899733999507809999089
Q 005519 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (692)
Q Consensus 41 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~l~iw~~~~~~t~vW~anr~~pv~~~~~~l~l~~~G~lvl~~~~ 120 (692)
.|+|.+|+.|.+++.|.+ |.|.|+|+.+|+ |.++.. .++||+||++.|+. ..+.|.|+.+|+|||++++
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~~---~~~vW~ant~~~~~-~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYDH---STSVWASNTGILGK-KGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCCCTTC-CCCEEEECTTSCEEEECSS
T ss_pred CCCCCCCCEEECCCEEEE--CCEEEEECCCCE-----EEEEEC---CEEEEEECCCCCCC-EEEEEEECCCCEEEEEECC
T ss_conf 989259998828998983--788999448986-----999869---98999837899875-1079999379609999089
Q ss_pred CCEEEEEECCCCCCCCEEEEECCCCEEEEECCCCCCCCCCEEEECCC
Q ss_conf 97699940467867836899349987998289998877401111278
Q 005519 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (692)
Q Consensus 121 ~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WQSFd~ 167 (692)
+.++|+|++....+..+|+|+|+|||||++ ..+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~--------~~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYG--------SDIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEEC--------CEEEECCCC
T ss_pred CCEEEEEEEECCCCCEEEEEECCCCEEEEC--------CCEECCCCC
T ss_conf 867999730889997799994797599979--------987217985
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.62 E-value=7.6e-16 Score=121.23 Aligned_cols=102 Identities=21% Similarity=0.278 Sum_probs=86.4
Q ss_pred EEEECCCC-CCEEEECCCCCCCCCCCCEEEEEECCEEEEEECCCCEEEEEECCCCCCCCEEEEECCCCEEEEECCCCCCC
Q ss_conf 99954899-92699735999888997339995078099990899769994046786783689934998799828999887
Q 005519 79 GIWYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNST 157 (692)
Q Consensus 79 ~iw~~~~~-~t~vW~anr~~pv~~~~~~l~l~~~G~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~ 157 (692)
.|||..++ .+.+|+++++.|+....-+|.++.||||||++. +.++|++++........+.|+++|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~----- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ----- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----
T ss_pred EEEECCCCCCCCCCEECCCCEEECCCEEEEECCCCCEEEECC-CCEEEEECCCCCCCCEEEEEECCEEEEEECCC-----
T ss_conf 699828988885628839972174887999968983899649-96899975224777479999077649999299-----
Q ss_pred CCCEEEECCCCCCCCCCCCCCCCEECCCCEEEEEECCCCCCCCCCCEEEEECCCCCCEEE
Q ss_conf 740111127886322345302202036960158962889999995239965178774999
Q 005519 158 ESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVC 217 (692)
Q Consensus 158 ~~~~WQSFd~PTDTlLpgq~l~~~~~~g~~~~L~Sw~s~~dps~G~ysl~~~~~g~~~~~ 217 (692)
+.++||||. +.++|.|.|.++++|++.++
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred CCEEEEECC-------------------------------CCCCCCEEEEECCCCCEEEE
T ss_conf 988998199-------------------------------99998489998889869996
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.57 E-value=2.2e-14 Score=111.31 Aligned_cols=104 Identities=19% Similarity=0.335 Sum_probs=83.1
Q ss_pred CCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEECCCCCCEEEECCCCCCCCCCCCEEEEEECCEEEEEECCC
Q ss_conf 10289983369997970899589977589999982999995489992699735999888997339995078099990899
Q 005519 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSN 121 (692)
Q Consensus 42 ~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~l~iw~~~~~~t~vW~anr~~pv~~~~~~l~l~~~G~lvl~~~~~ 121 (692)
++|.++++| ...+..|.|.|.|+.+|+ |.+ |.. .++||.+|+..+. ..+.|.|+.+|+|+|+|.++
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~~--~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d~~g 80 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YDN--NNPIWATNTGGLG--NGCRAVLQPDGVLVVITNEN 80 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EET--TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTC
T ss_pred CEEECCCEE----EEECCCCEEEEEECCCCC-----EEE-EEC--CEEEEEECCCCCC--CCEEEEEEECCCEEEECCCC
T ss_conf 888289758----870478538999889982-----999-979--9679994678877--41699998377799989998
Q ss_pred CEEEEEECCCCCCCCEEEEECCCCEEEEECCCCCCCCCCEEEECCC
Q ss_conf 7699940467867836899349987998289998877401111278
Q 005519 122 GTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (692)
Q Consensus 122 ~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WQSFd~ 167 (692)
.++|++++........++|+|+|||||++ .++|||-.+
T Consensus 81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T~ 118 (119)
T d1b2pa_ 81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWATQTV 118 (119)
T ss_dssp CEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEECCCC
T ss_pred CEEEECCCCCCCCCEEEEECCCCCEEEEC--------CCEECCCCC
T ss_conf 57997887699886599996998899979--------988416974
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.47 E-value=2.5e-14 Score=111.03 Aligned_cols=109 Identities=21% Similarity=0.249 Sum_probs=84.4
Q ss_pred EEECCCC-CCEEEECCCCCCCCCCCCEEEEEECCEEEEEECCCCEEEEEECCCCCCCCEEEEECCCCEEEEECCCCCCCC
Q ss_conf 9954899-926997359998889973399950780999908997699940467867836899349987998289998877
Q 005519 80 IWYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTE 158 (692)
Q Consensus 80 iw~~~~~-~t~vW~anr~~pv~~~~~~l~l~~~G~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~ 158 (692)
|||.-.+ .+..|..+.+.++.....+|.|+.||||||++. +.++|++++.+ ..+..+.|+++|||||++.+ +
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~-----~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAG-ATGCRAVLQSDGLLVILTAQ-----N 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCS-CSCCBCCBCSSSCBCCBCTT-----T
T ss_pred EEEECCCCCCCCCEECCCCCEECCCEEEEECCCCEEEEECC-CEEEEECCCCC-CCCEEEEEECCCCEEEECCC-----C
T ss_conf 77864789988212469981775988999979983999819-90689711689-97568999446789999058-----9
Q ss_pred CCEEEECCCCCCCCCCCCCCCCEECCCCEEEEEECCCCCCCCCCCEEEEECCCCCCEEEEECCCEEEEECCC
Q ss_conf 401111278863223453022020369601589628899999952399651787749999919856653288
Q 005519 159 SYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (692)
Q Consensus 159 ~~~WQSFd~PTDTlLpgq~l~~~~~~g~~~~L~Sw~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~y~~~g~ 230 (692)
.++|||+ ++.+.|.|.|.|+++|++.+ |. .++|.+|.
T Consensus 76 ~~vWsS~-------------------------------t~~~~g~y~l~Lq~DGNlvl--Y~--~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSG-------------------------------TKGSIGNYVLVLQPDRTVTI--YG--PGLWDSGT 112 (115)
T ss_dssp CCSCCCC-------------------------------CCCCSSCCEEEECSSSCEEE--EC--SEEEECSC
T ss_pred CEEEECC-------------------------------CCCCCCCEEEEECCCCCEEE--EC--CCEECCCC
T ss_conf 7899818-------------------------------88999978999989986999--68--97643889
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.33 E-value=1.4e-12 Score=99.26 Aligned_cols=100 Identities=22% Similarity=0.331 Sum_probs=79.0
Q ss_pred CCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEECCCCCCEEEECCCCCCCCCCCCEEEEEECCEEEEEECCCCEEE
Q ss_conf 99833699979708995899775899999829999954899926997359998889973399950780999908997699
Q 005519 46 PTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIW 125 (692)
Q Consensus 46 ~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~l~iw~~~~~~t~vW~anr~~pv~~~~~~l~l~~~G~lvl~~~~~~~~w 125 (692)
..|.|.+++.| .+|.|.|.|+.+|+ |.++.. ..+||.+|...+ ..+.+.|+.+|||||+|..+.++|
T Consensus 13 ~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~~---~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vW 79 (115)
T d1dlpa1 13 HPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRW 79 (115)
T ss_dssp SCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSC
T ss_pred CCCEECCCCCE--ECCCEEEEECCCCE-----EEEECC---CEEEEECCCCCC---CCEEEEEECCCCEEEECCCCCEEE
T ss_conf 82124699817--75988999979983-----999819---906897116899---756899944678999905897899
Q ss_pred EEECCCCCCCCEEEEECCCCEEEEECCCCCCCCCCEEEECC
Q ss_conf 94046786783689934998799828999887740111127
Q 005519 126 SSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFD 166 (692)
Q Consensus 126 ~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WQSFd 166 (692)
++.+....+..+++|+++|||||++ ..+|+|-.
T Consensus 80 sS~t~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssgt 112 (115)
T d1dlpa1 80 SSGTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGT 112 (115)
T ss_dssp CCCCCCCSSCCEEEECSSSCEEEEC--------SEEEECSC
T ss_pred ECCCCCCCCCEEEEECCCCCEEEEC--------CCEECCCC
T ss_conf 8188899997899998998699968--------97643889
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.16 E-value=1.2e-10 Score=86.16 Aligned_cols=98 Identities=20% Similarity=0.347 Sum_probs=73.8
Q ss_pred CCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEECCCCCCEEEECCCCCCCCCCCCEEEEEECCEEEEEECCCCEEEE
Q ss_conf 98336999797089958997758999998299999548999269973599988899733999507809999089976999
Q 005519 47 TTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWS 126 (692)
Q Consensus 47 g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~l~iw~~~~~~t~vW~anr~~pv~~~~~~l~l~~~G~lvl~~~~~~~~w~ 126 (692)
.+.|.+++.| ..|.|.|.|..+|+ |.++.. ..+||.++... .+..+.+.|+.+|||||+|.++.++|+
T Consensus 23 ~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~~---~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW~ 90 (120)
T d1dlpa2 23 PQTLHATQSL--QLSPYRLSMETDCN-----LVLFDR---DDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVWT 90 (120)
T ss_dssp CCEECSSCCC--BCSSCEEEEETTTE-----EEEEBT---TBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEEE
T ss_pred CCEECCCCEE--ECCCEEEEECCCCC-----EEEECC---CCEEEEECCCC--CCCCEEEEEECCEEEEEECCCCCEEEE
T ss_conf 6288399721--74887999968983-----899649---96899975224--777479999077649999299988998
Q ss_pred EECCCCCCCCEEEEECCCCEEEEECCCCCCCCCCEEEE
Q ss_conf 40467867836899349987998289998877401111
Q 005519 127 SNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (692)
Q Consensus 127 s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WQS 164 (692)
|.+........++|+++|||||++ ..+|.|
T Consensus 91 S~t~~~~~~~~l~Lq~DGnlvlY~--------~~~W~t 120 (120)
T d1dlpa2 91 SGNSRSAGRYVFVLQPDRNLAIYG--------GALWTT 120 (120)
T ss_dssp CCCCCSSSCCEEEECSSSCEEEEC--------CCCCBC
T ss_pred ECCCCCCCCEEEEECCCCCEEEEC--------CCCCCC
T ss_conf 199999984899988898699968--------974349
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.99 E-value=3.2e-09 Score=76.49 Aligned_cols=85 Identities=24% Similarity=0.300 Sum_probs=66.1
Q ss_pred EEEEEECCEEEEEECCCCEEEEEECCCCCCCCEEEEECCCCEEEEECCCCCCCCCCEEEECCCCCCCCCCCCCCCCEECC
Q ss_conf 39995078099990899769994046786783689934998799828999887740111127886322345302202036
Q 005519 105 VLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRT 184 (692)
Q Consensus 105 ~l~l~~~G~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~~~~ 184 (692)
.|.++.||||||++. +.++|++++.+......+.|+++|||||++.+ +.++|+|
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-----g~~vWsS-------------------- 86 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQS-------------------- 86 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEEC--------------------
T ss_pred EEEECCCCCEEEEEC-CEEEEEECCCCCCCCEEEEEEECCCEEEECCC-----CCEEEEC--------------------
T ss_conf 999889982999979-96799946788774169999837779998999-----8579978--------------------
Q ss_pred CCEEEEEECCCCCCCCCCCEEEEECCCCCCEEEEECCCEEEEECCC
Q ss_conf 9601589628899999952399651787749999919856653288
Q 005519 185 GLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (692)
Q Consensus 185 g~~~~L~Sw~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~y~~~g~ 230 (692)
.+.-+.|.|.+.|+++|++.++ . .+.|.++.
T Consensus 87 -----------~t~~~~~~~~l~Lq~DGNlvlY--g--~~~W~S~T 117 (119)
T d1b2pa_ 87 -----------PVAGKAGHYVLVLQPDRNVVIY--G--DALWATQT 117 (119)
T ss_dssp -----------SCCCCSSCEEEEECTTSCEEEE--E--SEEEECCC
T ss_pred -----------CCCCCCCCEEEEECCCCCEEEE--C--CCEECCCC
T ss_conf -----------8769988659999699889997--9--98841697
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.83 E-value=3.1e-08 Score=69.74 Aligned_cols=88 Identities=25% Similarity=0.351 Sum_probs=65.9
Q ss_pred CCEEEEEECCEEEEEECCCCEEEEEECCC-CCCCCEEEEECCCCEEEEECCCCCCCCCCEEEECCCCCCCCCCCCCCCCE
Q ss_conf 73399950780999908997699940467-86783689934998799828999887740111127886322345302202
Q 005519 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWD 181 (692)
Q Consensus 103 ~~~l~l~~~G~lvl~~~~~~~~w~s~~~~-~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~ 181 (692)
.-.|.|+.||||||+.. +.++|++++.. ......+.|+++|||||++.+ +.++|+|
T Consensus 20 ~~~l~~q~dgnLvl~~~-~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~s----------------- 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-----GRSLWAS----------------- 76 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-----SCEEEEC-----------------
T ss_pred CEEEEECCCCEEEEEEC-CEEEEEECCCCCCCEEEEEEECCCCEEEEEECC-----CCEEEEE-----------------
T ss_conf 88999448986999869-989998378998751079999379609999089-----8679997-----------------
Q ss_pred ECCCCEEEEEECCCCCCCCCCCEEEEECCCCCCEEEEECCCEEEEECCCC
Q ss_conf 03696015896288999999523996517877499999198566532888
Q 005519 182 LRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPW 231 (692)
Q Consensus 182 ~~~g~~~~L~Sw~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~y~~~g~w 231 (692)
.+..+.|.|.+.|+++|++.++ . .+.|.++.+
T Consensus 77 --------------~t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t~ 108 (109)
T d1kj1a_ 77 --------------HSVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGTY 108 (109)
T ss_dssp --------------CCCCCSSCCEEEECTTSCEEEE--C--CEEEECCCC
T ss_pred --------------EEECCCCCEEEEEECCCCEEEE--C--CCEECCCCC
T ss_conf --------------3088999779999479759997--9--987217985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.82 E-value=1.7e-08 Score=71.48 Aligned_cols=86 Identities=23% Similarity=0.363 Sum_probs=64.9
Q ss_pred CCEEEEEECCEEEEEECCCCEEEEEECCCCCCCCEEEEECCCCEEEEECCCCCCCCCCEEEECCCCCCCCCCCCCCCCEE
Q ss_conf 73399950780999908997699940467867836899349987998289998877401111278863223453022020
Q 005519 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (692)
Q Consensus 103 ~~~l~l~~~G~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~~ 182 (692)
.-.|.++.||||||++. +.+||++++.+......+.|+++|||||++.+ +.++|+|
T Consensus 20 ~~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-----g~~vWsS------------------ 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-----NKPIWAS------------------ 75 (108)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEEC------------------
T ss_pred CEEEEECCCCEEEEEEC-CCEEEEECCCCCCCCCEEEEECCCEEEEECCC-----CCCEEEC------------------
T ss_conf 88999878980999709-90215707889987547998126039997798-----5512770------------------
Q ss_pred CCCCEEEEEECCCCCCCCCCCEEEEECCCCCCEEEEECCCEEEEECC
Q ss_conf 36960158962889999995239965178774999991985665328
Q 005519 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTG 229 (692)
Q Consensus 183 ~~g~~~~L~Sw~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~y~~~g 229 (692)
.+....+.|.+.|+.+|++.++ . .+.|.++
T Consensus 76 -------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~ 105 (108)
T d1jpca_ 76 -------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATG 105 (108)
T ss_dssp -------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCC
T ss_pred -------------CCCCCCCCEEEEECCCCCEEEE--C--CCCCCCC
T ss_conf -------------4558887679999688899996--9--9845688
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.68 E-value=5.6e-07 Score=61.28 Aligned_cols=149 Identities=16% Similarity=0.104 Sum_probs=98.4
Q ss_pred HHHHHCCCCCEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCEEE
Q ss_conf 3765418953655642138274999995599499999904578745888999999998279-998000688999699599
Q 005519 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKI 597 (692)
Q Consensus 519 ~l~~~~~~f~~~~~iG~G~fG~Vyk~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 597 (692)
++...-..|+..+..+.++...||+... ++..+.+|+...........+..|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 9997513527997678998771899990-898699998488765325569999999998760699872899975089649
Q ss_pred EEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------
Q ss_conf 9997367899768842999877789999999999999999998856----------------------------------
Q 005519 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY---------------------------------- 643 (692)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~al~yLH~~---------------------------------- 643 (692)
+|||+.++..+........ .. ..++.++++.+..||..
T Consensus 87 lv~~~l~G~~~~~~~~~~~-----~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ-----SP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS-----CH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEECCCCCCCCCCCCCC-----CH---HHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 9998604334354334402-----69---999998999999985568421435764465655577899877655554303
Q ss_pred ----------------------CCCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf ----------------------999568437789967986999569972077231
Q 005519 644 ----------------------SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 644 ----------------------~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~ 676 (692)
....++|+|+.|.|||++++..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 3232005799999999844986781789860047642364996599960231441
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.65 E-value=1.6e-07 Score=65.01 Aligned_cols=87 Identities=24% Similarity=0.389 Sum_probs=59.8
Q ss_pred CEEEEEECCEEEEEECCCCEEEEEECCCCCCCCEEEEECCCCEEEEECCCCCCCCCCEEEECCCCCCCCCCCCCCCCEEC
Q ss_conf 33999507809999089976999404678678368993499879982899988774011112788632234530220203
Q 005519 104 GVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLR 183 (692)
Q Consensus 104 ~~l~l~~~G~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~~~ 183 (692)
-.|.|+.||||||++. +.++|++++.....+..+.|+.+|||||++.. ..+|.|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s------------------- 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS------------------- 74 (112)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC-------------------
T ss_pred EEEEECCCCCEEEECC-CCEEEECCCCCCCCCCEEEEECCCCEEEEECC------CEEEEE-------------------
T ss_conf 9999817998898739-83899846734788857999615349999348------749998-------------------
Q ss_pred CCCEEEEEECCCCCCCCCCCEEEEECCCCCCEEEEECC-CEEEEECCC
Q ss_conf 69601589628899999952399651787749999919-856653288
Q 005519 184 TGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNG-SAKYTCTGP 230 (692)
Q Consensus 184 ~g~~~~L~Sw~s~~dps~G~ysl~~~~~g~~~~~~~~~-~~~y~~~g~ 230 (692)
.+.-..+.|.+.|+.+|++.++ +. ..+.|.++.
T Consensus 75 ------------~t~~~~~~~~l~L~ddGNlvly--~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 ------------NTNRQNGNYYLILQRDRNVVIY--DNSNNAIWATHT 108 (112)
T ss_dssp ------------CCCCSCCCCEEEECTTSCEEEE--CTTSCEEEECCC
T ss_pred ------------EECCCCCCEEEEECCCCCEEEE--CCCCCEEECCCC
T ss_conf ------------3036887259999678999999--899967961888
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=0.00026 Score=43.29 Aligned_cols=143 Identities=16% Similarity=0.091 Sum_probs=84.9
Q ss_pred EEECCCCC-EEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHC--CCCCCCEEEEEEEECCEEEEEEECCCCCC
Q ss_conf 56421382-7499999559949999990457874588899999999827--99980006889996995999997367899
Q 005519 531 SKLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL--QHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (692)
Q Consensus 531 ~~iG~G~f-G~Vyk~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l--~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 607 (692)
+.+..|.. ..||+....++..+.+|....... ..+..|+..+..+ ....+.++++++.+.+..++|+|++++..
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCC
T ss_conf 876786547758999938987899995896677---68999999999998659998861322245661599987441355
Q ss_pred HHHH-----------------HCCCC-CCCC--CCHHHHHHHH--------------------HHHHHHHHHHHHC----
Q ss_conf 7688-----------------42999-8777--8999999999--------------------9999999998856----
Q 005519 608 LDVF-----------------LFDPT-KKHL--LGWQLRVRII--------------------DGIAQGLLYLHQY---- 643 (692)
Q Consensus 608 L~~~-----------------l~~~~-~~~~--l~~~~~~~i~--------------------~~ia~al~yLH~~---- 643 (692)
+... ||... .... -.......-. ......+..+...
T Consensus 93 ~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (255)
T d1nd4a_ 93 LLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 172 (255)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCC
T ss_conf 43221268999999999999873688544887554124688999999875411011340112137999999998718765
Q ss_pred CCCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf 999568437789967986999569972077231
Q 005519 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 644 ~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~ 676 (692)
.+..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.81 E-value=0.0002 Score=44.10 Aligned_cols=144 Identities=15% Similarity=0.176 Sum_probs=79.4
Q ss_pred EEEECCCCCEEEEEEEECC-CCEEEEEECCC----C---CCCCHHHHHHHHHHHHHC-CC--CCCCEEEEEEEECCEEEE
Q ss_conf 5564213827499999559-94999999045----7---874588899999999827-99--980006889996995999
Q 005519 530 QSKLGEGGFGPVYKGRLLN-GQEVAVKRLSN----Q---SGQGLKEFKNEMMLIAKL-QH--RNLVRLLGCCIEQGEKIL 598 (692)
Q Consensus 530 ~~~iG~G~fG~Vyk~~~~~-~~~VAVK~l~~----~---~~~~~~~f~~Ei~~l~~l-~H--~niv~l~g~~~~~~~~~l 598 (692)
.+.||.|....||+....+ ++.+.+|.-.. . -+....+...|.+.+..+ .+ ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEECCCCCCH-HHHHCCCCCCC--------------------CCCHHH--------------------------------
Q ss_conf 9973678997-68842999877--------------------789999--------------------------------
Q 005519 599 IYEYMVNKSL-DVFLFDPTKKH--------------------LLGWQL-------------------------------- 625 (692)
Q Consensus 599 V~Ey~~~gsL-~~~l~~~~~~~--------------------~l~~~~-------------------------------- 625 (692)
|||++++..+ ...+....... ..+...
T Consensus 109 vmE~L~~~~~~~~~l~~~~~~~~~a~~lg~~La~~h~~~~~~~~~~~~~~~~~~~~~n~~l~~~~e~~~~~~py~~~~~~ 188 (392)
T d2pula1 109 VMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDTN 188 (392)
T ss_dssp EECCCTTSEEHHHHHHHTCCCTTHHHHHHHHHHHHHHHTSTTTSCHHHHHHHHHHTCCHHHHHHHHHHTTTGGGTTCTTC
T ss_pred EEECCCCCCCCHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHH
T ss_conf 87135776530222015421289999999999999987350334421110123344657888777764010478898874
Q ss_pred ---------HHHHH--HHHHHHHHHHH---HCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf ---------99999--99999999988---56999568437789967986999569972077231
Q 005519 626 ---------RVRII--DGIAQGLLYLH---QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 626 ---------~~~i~--~~ia~al~yLH---~~~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~ 676 (692)
...+. ..+...+..|. ...+..++|+|+.|.|||++++ .++|+||..|..
T Consensus 189 ~~~~~~~~~~~~l~~d~~l~~~~~~l~~~~~~~~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 189 DFEEELRPFVEKLWNNDSVKIEAAKLKKSFLTSAETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp CCCGGGHHHHHHHHTCHHHHHHHHHHHHHHHHBCCEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred HCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCEECCCCCCCCEEECCC-CEEEECHHHCCC
T ss_conf 1065455778765520789999999874323688600335776784667599-308952265222
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.87 E-value=0.0067 Score=33.70 Aligned_cols=76 Identities=17% Similarity=0.194 Sum_probs=44.9
Q ss_pred CCCEEEEECCCCCEEEEEEEECCC--------CEEEEEECCCCCCCCHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCEE
Q ss_conf 953655642138274999995599--------499999904578745888999999998279-99800068899969959
Q 005519 526 NFSIQSKLGEGGFGPVYKGRLLNG--------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEK 596 (692)
Q Consensus 526 ~f~~~~~iG~G~fG~Vyk~~~~~~--------~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 596 (692)
.+++ +.|+.|-.-.+|+....++ ..|.++... . ........+|..++..+. +.-..++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred CEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----
T ss_conf 1699-991785334348999688775445789817999659-9-61165899999999999757999808998189----
Q ss_pred EEEEECCCCCCH
Q ss_conf 999973678997
Q 005519 597 ILIYEYMVNKSL 608 (692)
Q Consensus 597 ~lV~Ey~~~gsL 608 (692)
.+|+||+++..+
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEECCCCC
T ss_conf 569997345548
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.81 E-value=0.0052 Score=34.46 Aligned_cols=31 Identities=32% Similarity=0.365 Sum_probs=25.2
Q ss_pred CCCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf 999568437789967986999569972077231
Q 005519 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (692)
Q Consensus 644 ~~~~ivHrDikp~NILl~~~~~~ki~DFGla~~ 676 (692)
.+..++|+|+.+.|||++++ ..++||+-+..
T Consensus 190 ~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 87120247888042878389--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.36 E-value=0.062 Score=27.19 Aligned_cols=32 Identities=25% Similarity=0.253 Sum_probs=28.1
Q ss_pred CCCCEEECCCCCCCEEECCCCCEEEEEECCCE
Q ss_conf 99956843778996798699956997207723
Q 005519 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (692)
Q Consensus 644 ~~~~ivHrDikp~NILl~~~~~~ki~DFGla~ 675 (692)
-+.++||+|+.+.||+++.+...-|+||+.|-
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 54503337863656402045412674222123
|